PARADIGM pathway analysis of mRNA expression and copy number data
Breast Invasive Carcinoma (Primary solid tumor)
15 July 2014  |  analyses__2014_07_15
Maintainer Information
Citation Information
doi:10.7908/C1N29VNX
Maintained by Dan DiCara (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): PARADIGM pathway analysis of mRNA expression and copy number data. Broad Institute of MIT and Harvard. doi:10.7908/C1N29VNX
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 55 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Signaling mediated by p38-alpha and p38-beta 250
Signaling events mediated by Stem cell factor receptor (c-Kit) 220
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 158
Endothelins 152
EGFR-dependent Endothelin signaling events 146
Class IB PI3K non-lipid kinase events 126
IGF1 pathway 117
FOXM1 transcription factor network 115
Arf6 signaling events 102
Nongenotropic Androgen signaling 96
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 526 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 526 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Signaling mediated by p38-alpha and p38-beta 0.4753 250 11006 44 -0.61 0.034 1000 -1000 -0.002 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.4183 220 17214 78 -1 0.32 1000 -1000 -0.037 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.3004 158 10763 68 -0.88 0.45 1000 -1000 -0.055 -1000
Endothelins 0.2890 152 14593 96 -0.81 0.17 1000 -1000 -0.023 -1000
EGFR-dependent Endothelin signaling events 0.2776 146 3079 21 -0.31 0.048 1000 -1000 -0.035 -1000
Class IB PI3K non-lipid kinase events 0.2395 126 378 3 -0.11 -1000 1000 -1000 -0.024 -1000
IGF1 pathway 0.2224 117 6689 57 -0.26 0.11 1000 -1000 -0.029 -1000
FOXM1 transcription factor network 0.2186 115 5878 51 -0.12 0.71 1000 -1000 0.011 -1000
Arf6 signaling events 0.1939 102 6385 62 -0.31 0.082 1000 -1000 -0.003 -1000
Nongenotropic Androgen signaling 0.1825 96 5027 52 -0.57 0.3 1000 -1000 -0.019 -1000
Glucocorticoid receptor regulatory network 0.1635 86 9912 114 -0.95 0.29 1000 -1000 -0.051 -1000
S1P1 pathway 0.1483 78 2829 36 -0.62 0.046 1000 -1000 -0.018 -1000
HIF-1-alpha transcription factor network 0.1407 74 5642 76 -0.4 0.07 1000 -1000 -0.008 -1000
Calcium signaling in the CD4+ TCR pathway 0.1369 72 2245 31 -0.35 0.041 1000 -1000 -0.021 -1000
Signaling events mediated by PTP1B 0.1350 71 5401 76 -0.37 0.19 1000 -1000 -0.036 -1000
PDGFR-alpha signaling pathway 0.1350 71 3127 44 -0.7 0.063 1000 -1000 -0.018 -1000
Ephrin B reverse signaling 0.1312 69 3334 48 -0.18 0.06 1000 -1000 -0.033 -1000
BMP receptor signaling 0.1274 67 5492 81 -0.4 0.11 1000 -1000 -0.032 -1000
Plasma membrane estrogen receptor signaling 0.1141 60 5210 86 -0.25 0.18 1000 -1000 -0.043 -1000
E-cadherin signaling in keratinocytes 0.1084 57 2477 43 -0.27 0.036 1000 -1000 -0.013 -1000
Ras signaling in the CD4+ TCR pathway 0.1084 57 982 17 -0.2 0.034 1000 -1000 -0.01 -1000
IL23-mediated signaling events 0.1065 56 3379 60 -0.79 0.065 1000 -1000 -0.004 -1000
IL6-mediated signaling events 0.1046 55 4195 75 -0.37 0.074 1000 -1000 -0.037 -1000
IL4-mediated signaling events 0.1027 54 4933 91 -0.51 0.13 1000 -1000 -0.11 -1000
FAS signaling pathway (CD95) 0.1008 53 2535 47 -0.88 0.06 1000 -1000 -0.025 -1000
Integrins in angiogenesis 0.1008 53 4508 84 -0.39 0.14 1000 -1000 -0.025 -1000
EPHB forward signaling 0.0989 52 4498 85 -0.18 0.14 1000 -1000 -0.056 -1000
PLK1 signaling events 0.0932 49 4205 85 -0.036 0.17 1000 -1000 -0.025 -1000
Visual signal transduction: Rods 0.0894 47 2470 52 -0.43 0.074 1000 -1000 -0.014 -1000
Signaling events mediated by the Hedgehog family 0.0875 46 2396 52 -0.14 0.067 1000 -1000 -0.013 -1000
Fc-epsilon receptor I signaling in mast cells 0.0875 46 4484 97 -0.35 0.041 1000 -1000 -0.043 -1000
Aurora B signaling 0.0856 45 3049 67 -0.38 0.24 1000 -1000 -0.029 -1000
Glypican 1 network 0.0779 41 1996 48 -0.39 0.071 1000 -1000 -0.017 -1000
S1P5 pathway 0.0741 39 669 17 -0.17 0.066 1000 -1000 -0.005 -1000
Insulin Pathway 0.0741 39 2899 74 -0.28 0.091 1000 -1000 -0.032 -1000
p75(NTR)-mediated signaling 0.0722 38 4789 125 -0.13 0.095 1000 -1000 -0.042 -1000
PLK2 and PLK4 events 0.0684 36 108 3 0.016 0.056 1000 -1000 0.006 -1000
Presenilin action in Notch and Wnt signaling 0.0684 36 2231 61 -0.38 0.11 1000 -1000 -0.032 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0684 36 2734 74 -0.27 0.074 1000 -1000 -0.053 -1000
TCGA08_retinoblastoma 0.0684 36 290 8 -0.022 0.058 1000 -1000 -0.006 -1000
Nectin adhesion pathway 0.0646 34 2193 63 -0.077 0.054 1000 -1000 -0.035 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0627 33 2826 85 -0.54 0.043 1000 -1000 -0.029 -1000
IL27-mediated signaling events 0.0627 33 1706 51 -0.37 0.067 1000 -1000 -0.034 -1000
LPA receptor mediated events 0.0608 32 3365 102 -0.35 0.096 1000 -1000 -0.055 -1000
S1P4 pathway 0.0608 32 821 25 -0.17 0.046 1000 -1000 -0.014 -1000
ErbB2/ErbB3 signaling events 0.0589 31 2015 65 -0.35 0.047 1000 -1000 -0.039 -1000
Syndecan-1-mediated signaling events 0.0589 31 1078 34 -0.041 0.12 1000 -1000 -0.015 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0589 31 3776 120 -0.24 0.12 1000 -1000 -0.039 -1000
ErbB4 signaling events 0.0551 29 2042 69 -0.36 0.14 1000 -1000 -0.012 -1000
amb2 Integrin signaling 0.0551 29 2400 82 -0.52 0.14 1000 -1000 -0.02 -1000
TCGA08_rtk_signaling 0.0532 28 748 26 -0.27 0.043 1000 -1000 -0.021 -1000
Regulation of nuclear SMAD2/3 signaling 0.0513 27 3677 136 -0.36 0.075 1000 -1000 -0.039 -1000
FOXA2 and FOXA3 transcription factor networks 0.0513 27 1285 46 -0.74 0.051 1000 -1000 -0.008 -1000
TCR signaling in naïve CD8+ T cells 0.0513 27 2601 93 -0.039 0.083 1000 -1000 -0.042 -1000
Canonical Wnt signaling pathway 0.0513 27 1419 51 -0.38 0.16 1000 -1000 -0.034 -1000
Signaling events regulated by Ret tyrosine kinase 0.0494 26 2209 82 -0.1 0.12 1000 -1000 -0.053 -1000
IL12-mediated signaling events 0.0475 25 2201 87 -0.83 0.088 1000 -1000 -0.037 -1000
Syndecan-2-mediated signaling events 0.0475 25 1729 69 -0.32 0.14 1000 -1000 -0.028 -1000
Syndecan-3-mediated signaling events 0.0475 25 877 35 -0.36 0.076 1000 -1000 -0.021 -1000
Thromboxane A2 receptor signaling 0.0456 24 2623 105 -0.27 0.067 1000 -1000 -0.032 -1000
mTOR signaling pathway 0.0456 24 1292 53 -0.051 0.044 1000 -1000 -0.03 -1000
HIF-2-alpha transcription factor network 0.0456 24 1041 43 -0.23 0.26 1000 -1000 -0.11 -1000
S1P3 pathway 0.0456 24 1024 42 -0.17 0.063 1000 -1000 -0.024 -1000
Angiopoietin receptor Tie2-mediated signaling 0.0456 24 2116 88 -0.39 0.14 1000 -1000 -0.059 -1000
Reelin signaling pathway 0.0437 23 1337 56 -0.056 0.083 1000 -1000 -0.021 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.0437 23 1196 52 -0.38 0.11 1000 -1000 -0.012 -1000
Syndecan-4-mediated signaling events 0.0437 23 1542 67 -0.39 0.15 1000 -1000 -0.026 -1000
Regulation of Androgen receptor activity 0.0437 23 1611 70 -0.43 0.08 1000 -1000 -0.032 -1000
Osteopontin-mediated events 0.0418 22 848 38 -0.35 0.13 1000 -1000 -0.01 -1000
Ceramide signaling pathway 0.0418 22 1740 76 -0.25 0.083 1000 -1000 -0.019 -1000
IL1-mediated signaling events 0.0418 22 1370 62 -0.049 0.068 1000 -1000 -0.021 -1000
Coregulation of Androgen receptor activity 0.0399 21 1658 76 -0.23 0.054 1000 -1000 -0.019 -1000
Regulation of p38-alpha and p38-beta 0.0399 21 1147 54 -0.31 0.072 1000 -1000 -0.038 -1000
Regulation of Telomerase 0.0380 20 2124 102 -0.35 0.088 1000 -1000 -0.013 -1000
TCGA08_p53 0.0342 18 129 7 -0.01 0.029 1000 -1000 -0.002 -1000
Signaling mediated by p38-gamma and p38-delta 0.0342 18 276 15 -0.006 0.035 1000 -1000 -0.025 -1000
E-cadherin signaling in the nascent adherens junction 0.0342 18 1401 76 -0.04 0.059 1000 -1000 -0.044 -1000
Noncanonical Wnt signaling pathway 0.0304 16 430 26 -0.016 0.041 1000 -1000 -0.031 -1000
IL2 signaling events mediated by PI3K 0.0304 16 939 58 -0.12 0.049 1000 -1000 -0.027 -1000
Cellular roles of Anthrax toxin 0.0285 15 616 39 -0.063 0.038 1000 -1000 -0.014 -1000
Hedgehog signaling events mediated by Gli proteins 0.0285 15 1016 65 -0.17 0.078 1000 -1000 -0.033 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0285 15 711 45 -0.006 0.059 1000 -1000 -0.019 -1000
Signaling events mediated by PRL 0.0285 15 535 34 -0.31 0.052 1000 -1000 -0.025 -1000
E-cadherin signaling events 0.0285 15 77 5 0.007 0.035 1000 -1000 0.019 -1000
Caspase cascade in apoptosis 0.0247 13 1023 74 -0.15 0.049 1000 -1000 -0.023 -1000
ceramide signaling pathway 0.0247 13 638 49 -0.069 0.053 1000 -1000 -0.015 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0247 13 1650 125 -0.38 0.075 1000 -1000 -0.027 -1000
Wnt signaling 0.0247 13 92 7 -0.016 0.041 1000 -1000 -0.022 -1000
BCR signaling pathway 0.0247 13 1288 99 -0.14 0.093 1000 -1000 -0.042 -1000
VEGFR1 specific signals 0.0247 13 768 56 -0.38 0.076 1000 -1000 -0.03 -1000
IFN-gamma pathway 0.0209 11 805 68 -0.02 0.1 1000 -1000 -0.038 -1000
FoxO family signaling 0.0209 11 747 64 0 0.15 1000 -1000 -0.02 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0190 10 281 28 -0.17 0.054 1000 -1000 -0.013 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.0190 10 562 54 -0.04 0.084 1000 -1000 -0.024 -1000
EPO signaling pathway 0.0190 10 564 55 -0.089 0.069 1000 -1000 -0.014 -1000
JNK signaling in the CD4+ TCR pathway 0.0171 9 154 17 -0.04 0.091 1000 -1000 -0.023 -1000
Arf6 downstream pathway 0.0171 9 397 43 -0.092 0.093 1000 -1000 -0.031 -1000
Class I PI3K signaling events mediated by Akt 0.0171 9 639 68 -0.15 0.062 1000 -1000 -0.025 -1000
Signaling events mediated by HDAC Class III 0.0152 8 326 40 -0.062 0.063 1000 -1000 -0.032 -1000
TRAIL signaling pathway 0.0152 8 417 48 -0.002 0.047 1000 -1000 -0.012 -1000
Signaling events mediated by HDAC Class II 0.0133 7 565 75 -0.058 0.067 1000 -1000 -0.029 -1000
Circadian rhythm pathway 0.0133 7 171 22 -0.021 0.11 1000 -1000 -0.018 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0133 7 273 37 -0.02 0.085 1000 -1000 -0.015 -1000
PDGFR-beta signaling pathway 0.0133 7 702 97 -0.035 0.081 1000 -1000 -0.037 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0114 6 575 83 -0.069 0.066 1000 -1000 -0.007 -1000
Retinoic acid receptors-mediated signaling 0.0114 6 376 58 -0.054 0.081 1000 -1000 -0.023 -1000
Paxillin-dependent events mediated by a4b1 0.0114 6 235 36 -0.071 0.076 1000 -1000 -0.036 -1000
Arf6 trafficking events 0.0114 6 487 71 -0.25 0.056 1000 -1000 -0.027 -1000
p38 MAPK signaling pathway 0.0114 6 294 44 -0.016 0.067 1000 -1000 -0.013 -1000
Visual signal transduction: Cones 0.0095 5 192 38 0 0.071 1000 -1000 0 -1000
Insulin-mediated glucose transport 0.0095 5 182 32 -0.1 0.053 1000 -1000 -0.011 -1000
Class I PI3K signaling events 0.0095 5 414 73 -0.009 0.059 1000 -1000 -0.021 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0076 4 161 34 -0.048 0.084 1000 -1000 -0.023 -1000
Canonical NF-kappaB pathway 0.0076 4 180 39 0 0.072 1000 -1000 -0.016 -1000
Signaling events mediated by HDAC Class I 0.0076 4 492 104 -0.21 0.082 1000 -1000 -0.042 -1000
Atypical NF-kappaB pathway 0.0076 4 147 31 -0.02 0.049 1000 -1000 -0.001 -1000
IL2 signaling events mediated by STAT5 0.0076 4 91 22 -0.019 0.082 1000 -1000 -0.021 -1000
Aurora C signaling 0.0057 3 23 7 0 0.079 1000 -1000 -0.012 -1000
Effects of Botulinum toxin 0.0057 3 83 26 0 0.071 1000 -1000 0 -1000
LPA4-mediated signaling events 0.0038 2 28 12 -0.01 0.035 1000 -1000 -0.017 -1000
Aurora A signaling 0.0038 2 179 60 0 0.12 1000 -1000 -0.006 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0019 1 26 23 -0.007 0.066 1000 -1000 -0.01 -1000
BARD1 signaling events 0.0019 1 59 57 -0.075 0.13 1000 -1000 -0.042 -1000
Ephrin A reverse signaling 0.0019 1 7 7 0 0.044 1000 -1000 0 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0019 1 57 33 0 0.077 1000 -1000 -0.013 -1000
Rapid glucocorticoid signaling 0.0019 1 25 20 0 0.044 1000 -1000 0 -1000
Arf1 pathway 0.0019 1 59 54 -0.001 0.062 1000 -1000 -0.01 -1000
a4b1 and a4b7 Integrin signaling 0.0000 0 0 5 0.034 0.054 1000 -1000 0.019 -1000
Glypican 2 network 0.0000 0 0 4 0 0.032 1000 -1000 0 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0000 0 25 27 0 0.078 1000 -1000 -0.025 -1000
Alternative NF-kappaB pathway 0.0000 0 3 13 0 0.096 1000 -1000 0 -1000
Total NA 4436 268260 7203 -30 -990 131000 -131000 -3.1 -131000
Signaling mediated by p38-alpha and p38-beta

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.61 0.54 0.4 4 -1 306 310
MKNK1 0.034 0.006 -10000 0 -10000 0 0
MAPK14 -0.2 0.2 -10000 0 -0.35 306 306
ATF2/c-Jun -0.26 0.32 -10000 0 -0.66 153 153
MAPK11 -0.19 0.2 -10000 0 -0.36 286 286
MITF -0.24 0.23 -10000 0 -0.42 307 307
MAPKAPK5 -0.23 0.22 -10000 0 -0.41 308 308
KRT8 -0.22 0.22 -10000 0 -0.39 304 304
MAPKAPK3 0.034 0.012 -10000 0 -10000 0 0
MAPKAPK2 0.028 0.015 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.31 0.32 -10000 0 -0.54 309 309
CEBPB -0.22 0.23 0.3 1 -0.41 284 285
SLC9A1 -0.23 0.23 -10000 0 -0.42 304 304
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.24 0.24 -10000 0 -0.42 306 306
p38alpha-beta/MNK1 -0.25 0.28 -10000 0 -0.45 309 309
JUN -0.26 0.31 -10000 0 -0.65 153 153
PPARGC1A -0.28 0.29 0.29 1 -0.48 314 315
USF1 -0.21 0.22 0.33 4 -0.39 292 296
RAB5/GDP/GDI1 -0.17 0.18 -10000 0 -0.31 301 301
NOS2 -0.24 0.22 -10000 0 -0.41 308 308
DDIT3 -0.23 0.22 -10000 0 -0.41 306 306
RAB5A 0.034 0.005 -10000 0 -10000 0 0
HSPB1 -0.19 0.18 -10000 0 -0.34 272 272
p38alpha-beta/HBP1 -0.25 0.28 -10000 0 -0.45 307 307
CREB1 -0.25 0.24 -10000 0 -0.43 307 307
RAB5/GDP 0.025 0.004 -10000 0 -10000 0 0
EIF4E -0.23 0.24 0.24 1 -0.4 305 306
RPS6KA4 -0.23 0.23 -10000 0 -0.41 304 304
PLA2G4A -0.36 0.27 -10000 0 -0.52 356 356
GDI1 -0.23 0.22 -10000 0 -0.4 308 308
TP53 -0.31 0.29 -10000 0 -0.54 297 297
RPS6KA5 -0.25 0.23 -10000 0 -0.42 315 315
ESR1 -0.29 0.27 0.32 1 -0.43 354 355
HBP1 0.034 0.005 -10000 0 -10000 0 0
MEF2C -0.26 0.26 -10000 0 -0.44 313 313
MEF2A -0.23 0.23 0.3 1 -0.41 303 304
EIF4EBP1 -0.25 0.25 -10000 0 -0.44 301 301
KRT19 -0.21 0.23 0.33 1 -0.39 300 301
ELK4 -0.21 0.22 0.33 2 -0.39 288 290
ATF6 -0.21 0.22 0.33 4 -0.39 294 298
ATF1 -0.25 0.24 -10000 0 -0.43 309 309
p38alpha-beta/MAPKAPK2 -0.22 0.24 -10000 0 -0.42 289 289
p38alpha-beta/MAPKAPK3 -0.25 0.28 -10000 0 -0.45 308 308
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.3 0.16 -10000 0 -0.38 366 366
CRKL -0.32 0.17 -10000 0 -0.4 386 386
HRAS -0.23 0.15 -10000 0 -0.35 223 223
mol:PIP3 -0.28 0.17 -10000 0 -0.38 310 310
SPRED1 0.031 0.036 -10000 0 -0.54 2 2
SPRED2 0.034 0.005 -10000 0 -10000 0 0
GAB1 -0.33 0.18 -10000 0 -0.42 400 400
FOXO3 -0.27 0.16 -10000 0 -0.38 244 244
AKT1 -0.3 0.18 -10000 0 -0.4 278 278
BAD -0.28 0.16 -10000 0 -0.38 244 244
megakaryocyte differentiation -0.32 0.17 -10000 0 -0.41 400 400
GSK3B -0.28 0.16 -10000 0 -0.38 247 247
RAF1 -0.19 0.13 -10000 0 -0.32 52 52
SHC1 0.028 0.014 -10000 0 -10000 0 0
STAT3 -0.33 0.18 -10000 0 -0.42 397 397
STAT1 -0.81 0.43 -10000 0 -1 407 407
HRAS/SPRED1 -0.19 0.14 -10000 0 -0.33 55 55
cell proliferation -0.33 0.17 -10000 0 -0.41 401 401
PIK3CA 0.032 0.008 -10000 0 -10000 0 0
TEC 0.034 0.005 -10000 0 -10000 0 0
RPS6KB1 -0.32 0.18 -10000 0 -0.4 399 399
HRAS/SPRED2 -0.19 0.14 -10000 0 -0.32 53 53
LYN/TEC/p62DOK -0.29 0.18 -10000 0 -0.4 326 326
MAPK3 -0.13 0.097 -10000 0 -0.29 11 11
STAP1 -0.32 0.18 -10000 0 -0.41 398 398
GRAP2 0.035 0.019 -10000 0 -10000 0 0
JAK2 -0.68 0.37 -10000 0 -0.85 408 408
STAT1 (dimer) -0.79 0.42 -10000 0 -0.98 407 407
mol:Gleevec 0.013 0.007 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.29 0.19 -10000 0 -0.4 328 328
actin filament polymerization -0.33 0.17 -10000 0 -0.41 404 404
LYN 0.03 0.016 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.47 0.26 -10000 0 -0.58 408 408
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CBL/CRKL/GRB2 -0.28 0.17 -10000 0 -0.38 340 340
PI3K -0.32 0.2 -10000 0 -0.42 364 364
PTEN 0.03 0.045 -10000 0 -0.54 3 3
SCF/KIT/EPO/EPOR -0.95 0.51 -10000 0 -1.2 403 403
MAPK8 -0.33 0.18 -10000 0 -0.42 401 401
STAT3 (dimer) -0.33 0.17 -10000 0 -0.41 397 397
positive regulation of transcription -0.11 0.083 -10000 0 -0.25 8 8
mol:GDP -0.24 0.16 -10000 0 -0.36 230 230
PIK3C2B -0.31 0.18 -10000 0 -0.42 327 327
CBL/CRKL -0.3 0.16 -10000 0 -0.39 373 373
FER -0.33 0.18 -10000 0 -0.42 400 400
SH2B3 -0.34 0.17 -10000 0 -0.42 401 401
PDPK1 -0.25 0.17 -10000 0 -0.36 277 277
SNAI2 -0.34 0.2 -10000 0 -0.46 361 361
positive regulation of cell proliferation -0.59 0.3 -10000 0 -0.73 409 409
KITLG -0.011 0.07 -10000 0 -0.56 2 2
cell motility -0.59 0.3 -10000 0 -0.73 409 409
PTPN6 0.051 0.021 0.2 4 -10000 0 4
EPOR -0.23 0.2 -10000 0 -1.1 13 13
STAT5A (dimer) -0.48 0.26 -10000 0 -0.6 410 410
SOCS1 0.032 0.012 -10000 0 -10000 0 0
cell migration 0.32 0.17 0.41 396 -10000 0 396
SOS1 0.034 0.004 -10000 0 -10000 0 0
EPO 0.01 0.066 0.18 7 -10000 0 7
VAV1 0.038 0.025 -10000 0 -10000 0 0
GRB10 -0.34 0.18 -10000 0 -0.42 401 401
PTPN11 0.047 0.009 -10000 0 -10000 0 0
SCF/KIT -0.35 0.19 -10000 0 -0.44 404 404
GO:0007205 0.018 0.009 -10000 0 -10000 0 0
MAP2K1 -0.15 0.11 -10000 0 -0.28 18 18
CBL 0.031 0.011 -10000 0 -10000 0 0
KIT -1 0.53 -10000 0 -1.3 403 403
MAP2K2 -0.15 0.11 -10000 0 -0.28 23 23
SHC/Grb2/SOS1 -0.28 0.18 -10000 0 -0.4 286 286
STAT5A -0.5 0.26 -10000 0 -0.61 410 410
GRB2 0.034 0.019 -10000 0 -10000 0 0
response to radiation -0.34 0.2 0.28 2 -0.45 359 361
SHC/GRAP2 0.04 0.026 -10000 0 -10000 0 0
PTPRO -0.33 0.18 -10000 0 -0.42 401 401
SH2B2 -0.33 0.18 -10000 0 -0.42 404 404
DOK1 0.036 0.016 -10000 0 -10000 0 0
MATK -0.33 0.18 -10000 0 -0.42 397 397
CREBBP -0.081 0.072 -10000 0 -0.18 61 61
BCL2 -0.43 0.51 -10000 0 -1.4 109 109
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.047 0.031 0.21 6 -10000 0 6
NFATC2 -0.082 0.23 0.48 4 -0.55 55 59
NFATC3 -0.15 0.17 0.32 1 -0.32 227 228
CD40LG -0.67 0.53 0.75 5 -1 344 349
ITCH -0.064 0.14 -10000 0 -0.25 179 179
CBLB -0.067 0.14 -10000 0 -0.86 1 1
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.24 0.31 0.75 7 -0.69 72 79
JUNB 0.031 0.044 -10000 0 -0.54 3 3
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.077 0.17 -10000 0 -0.3 190 190
T cell anergy -0.13 0.21 0.33 1 -0.4 181 182
TLE4 -0.066 0.2 -10000 0 -0.59 38 38
Jun/NFAT1-c-4/p21SNFT -0.58 0.55 0.72 4 -0.94 329 333
AP-1/NFAT1-c-4 -0.8 0.68 0.93 5 -1.2 343 348
IKZF1 -0.045 0.17 0.47 10 -0.46 27 37
T-helper 2 cell differentiation -0.12 0.28 0.51 2 -0.73 55 57
AP-1/NFAT1 -0.3 0.3 0.54 6 -0.5 304 310
CALM1 -0.036 0.11 -10000 0 -0.31 1 1
EGR2 -0.8 0.76 0.7 4 -1.5 263 267
EGR3 -0.88 0.76 0.69 4 -1.4 344 348
NFAT1/FOXP3 -0.031 0.18 0.45 10 -0.4 48 58
EGR1 -0.43 0.23 -10000 0 -0.54 414 414
JUN -0.066 0.22 0.26 1 -0.54 89 90
EGR4 0.001 0.003 -10000 0 -10000 0 0
mol:Ca2+ -0.055 0.089 -10000 0 -0.17 190 190
GBP3 -0.079 0.24 0.44 2 -0.74 44 46
FOSL1 0.034 0.012 -10000 0 -10000 0 0
NFAT1-c-4/MAF/IRF4 -0.54 0.53 0.64 4 -0.9 322 326
DGKA -0.052 0.16 0.47 1 -0.46 28 29
CREM 0.033 0.008 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.75 0.55 0.55 2 -1.1 350 352
CTLA4 -0.022 0.16 0.43 15 -0.39 27 42
NFAT1-c-4 (dimer)/EGR1 -0.77 0.57 -10000 0 -1.1 352 352
NFAT1-c-4 (dimer)/EGR4 -0.56 0.52 0.68 1 -0.9 336 337
FOS -0.35 0.27 0.26 1 -0.54 344 345
IFNG -0.096 0.3 0.59 6 -0.81 43 49
T cell activation -0.38 0.34 0.69 3 -0.67 244 247
MAF -0.007 0.14 -10000 0 -0.54 33 33
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.45 0.41 0.72 338 -0.63 4 342
TNF -0.67 0.48 -10000 0 -0.96 352 352
FASLG -0.88 0.79 0.82 4 -1.4 332 336
TBX21 0.029 0.15 0.29 12 -0.54 30 42
BATF3 0 0.001 -10000 0 -10000 0 0
PRKCQ 0.043 0.036 0.24 6 -10000 0 6
PTPN1 -0.048 0.16 -10000 0 -0.46 27 27
NFAT1-c-4/ICER1 -0.55 0.53 0.57 3 -0.9 331 334
GATA3 0.036 0.16 -10000 0 -0.54 33 33
T-helper 1 cell differentiation -0.094 0.3 0.59 6 -0.79 43 49
IL2RA -0.25 0.31 0.74 6 -0.68 79 85
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.051 0.16 -10000 0 -0.44 32 32
E2F1 0.057 0.05 0.25 2 -10000 0 2
PPARG -0.38 0.26 -10000 0 -0.54 367 367
SLC3A2 -0.05 0.16 -10000 0 -0.42 42 42
IRF4 0.039 0.029 -10000 0 -10000 0 0
PTGS2 -0.77 0.57 0.73 4 -1.1 363 367
CSF2 -0.67 0.53 0.79 4 -1 342 346
JunB/Fra1/NFAT1-c-4 -0.53 0.52 0.6 2 -0.88 327 329
IL4 -0.12 0.3 0.53 1 -0.78 53 54
IL5 -0.68 0.52 0.7 5 -1 346 351
IL2 -0.39 0.35 0.69 3 -0.69 243 246
IL3 -0.088 0.16 -10000 0 -0.9 14 14
RNF128 -0.21 0.33 -10000 0 -0.63 191 191
NFATC1 -0.45 0.41 0.63 4 -0.72 338 342
CDK4 0.28 0.28 0.55 154 -0.64 2 156
PTPRK -0.086 0.24 -10000 0 -0.71 49 49
IL8 -0.66 0.53 0.74 5 -1 339 344
POU2F1 0.034 0.015 -10000 0 -10000 0 0
Endothelins

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.1 0.17 -10000 0 -0.35 138 138
PTK2B 0.027 0.014 -10000 0 -10000 0 0
mol:Ca2+ -0.17 0.29 -10000 0 -0.72 79 79
EDN1 -0.16 0.25 -10000 0 -0.54 154 154
EDN3 -0.39 0.25 -10000 0 -0.54 376 376
EDN2 0.1 0.08 -10000 0 -0.54 1 1
HRAS/GDP -0.25 0.24 -10000 0 -0.46 234 234
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.13 0.18 -10000 0 -0.37 131 131
ADCY4 -0.083 0.15 0.34 1 -0.3 142 143
ADCY5 -0.081 0.15 -10000 0 -0.3 139 139
ADCY6 -0.081 0.15 0.34 1 -0.3 142 143
ADCY7 -0.078 0.15 0.34 1 -0.3 137 138
ADCY1 -0.081 0.15 -10000 0 -0.3 139 139
ADCY2 -0.082 0.16 0.34 1 -0.3 142 143
ADCY3 -0.082 0.15 -10000 0 -0.3 143 143
ADCY8 -0.068 0.13 -10000 0 -0.3 103 103
ADCY9 -0.075 0.14 -10000 0 -0.3 124 124
arachidonic acid secretion -0.52 0.34 -10000 0 -0.69 379 379
ETB receptor/Endothelin-1/Gq/GTP -0.21 0.21 -10000 0 -0.37 273 273
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.032 0.013 -10000 0 -10000 0 0
ETA receptor/Endothelin-1/G12/GTP -0.092 0.16 -10000 0 -0.32 145 145
ETA receptor/Endothelin-1/Gs/GTP -0.088 0.15 -10000 0 -0.31 145 145
mol:GTP -0.007 0.008 -10000 0 -10000 0 0
COL3A1 -0.1 0.17 -10000 0 -0.35 140 140
EDNRB -0.21 0.28 -10000 0 -0.53 224 224
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.099 0.17 -10000 0 -0.35 133 133
CYSLTR1 -0.1 0.18 0.39 2 -0.36 120 122
SLC9A1 -0.068 0.12 -10000 0 -0.25 90 90
mol:GDP -0.27 0.25 -10000 0 -0.48 246 246
SLC9A3 -0.39 0.39 -10000 0 -0.72 250 250
RAF1 -0.36 0.27 -10000 0 -0.51 332 332
JUN -0.25 0.43 -10000 0 -1 111 111
JAK2 -0.1 0.17 -10000 0 -0.35 142 142
mol:IP3 -0.21 0.22 -10000 0 -0.42 201 201
ETA receptor/Endothelin-1 -0.12 0.2 -10000 0 -0.4 147 147
PLCB1 -0.048 0.2 -10000 0 -0.55 70 70
PLCB2 0.024 0.014 -10000 0 -10000 0 0
ETA receptor/Endothelin-3 -0.29 0.19 -10000 0 -0.4 375 375
FOS -0.68 0.43 -10000 0 -0.96 365 365
Gai/GDP -0.2 0.35 -10000 0 -0.94 82 82
CRK 0.031 0.01 -10000 0 -10000 0 0
mol:Ca ++ -0.26 0.26 -10000 0 -0.54 203 203
BCAR1 0.03 0.013 -10000 0 -10000 0 0
PRKCB1 -0.21 0.21 -10000 0 -0.42 208 208
GNAQ -0.008 0.009 -10000 0 -10000 0 0
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNAL 0.03 0.044 -10000 0 -0.54 3 3
Gs family/GDP -0.24 0.23 -10000 0 -0.45 232 232
ETA receptor/Endothelin-1/Gq/GTP -0.097 0.15 -10000 0 -0.31 129 129
MAPK14 -0.22 0.22 -10000 0 -0.41 249 249
TRPC6 -0.18 0.31 -10000 0 -0.77 79 79
GNAI2 0.034 0.01 -10000 0 -10000 0 0
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.23 0.23 -10000 0 -0.42 265 265
ETB receptor/Endothelin-2 -0.1 0.22 -10000 0 -0.34 222 222
ETB receptor/Endothelin-3 -0.42 0.27 -10000 0 -0.55 395 395
ETB receptor/Endothelin-1 -0.26 0.28 -10000 0 -0.48 297 297
MAPK3 -0.61 0.39 -10000 0 -0.84 369 369
MAPK1 -0.62 0.41 -10000 0 -0.86 369 369
Rac1/GDP -0.25 0.24 -10000 0 -0.46 233 233
cAMP biosynthetic process -0.032 0.15 0.38 4 -0.36 26 30
MAPK8 -0.18 0.3 -10000 0 -0.66 114 114
SRC 0.033 0.008 -10000 0 -10000 0 0
ETB receptor/Endothelin-1/Gi/GTP -0.28 0.29 -10000 0 -0.56 223 223
p130Cas/CRK/Src/PYK2 -0.27 0.29 -10000 0 -0.57 199 199
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.25 0.23 -10000 0 -0.45 236 236
COL1A2 -0.23 0.27 0.4 2 -0.48 220 222
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 0.072 0.078 0.27 1 -0.4 3 4
mol:DAG -0.21 0.22 -10000 0 -0.42 202 202
MAP2K2 -0.47 0.32 -10000 0 -0.64 371 371
MAP2K1 -0.47 0.32 0.36 1 -0.64 371 372
EDNRA 0.006 0.058 -10000 0 -0.55 2 2
positive regulation of muscle contraction -0.091 0.14 -10000 0 -0.31 138 138
Gq family/GDP -0.21 0.22 -10000 0 -0.44 184 184
HRAS/GTP -0.27 0.24 -10000 0 -0.45 259 259
PRKCH -0.21 0.21 -10000 0 -0.43 190 190
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA -0.2 0.21 -10000 0 -0.44 173 173
PRKCB -0.21 0.21 -10000 0 -0.41 212 212
PRKCE -0.21 0.21 -10000 0 -0.43 188 188
PRKCD -0.21 0.21 -10000 0 -0.44 188 188
PRKCG -0.21 0.21 0.3 1 -0.43 190 191
regulation of vascular smooth muscle contraction -0.81 0.51 -10000 0 -1.1 365 365
PRKCQ -0.2 0.21 -10000 0 -0.44 178 178
PLA2G4A -0.59 0.4 -10000 0 -0.78 379 379
GNA14 0.027 0.073 -10000 0 -0.55 4 4
GNA15 0.021 0.031 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA11 0.019 0.024 -10000 0 -10000 0 0
Rac1/GTP -0.092 0.16 -10000 0 -0.32 143 143
MMP1 0.17 0.15 0.41 84 -10000 0 84
EGFR-dependent Endothelin signaling events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.034 0.013 -9999 0 -10000 0 0
EGFR -0.27 0.29 -9999 0 -0.54 269 269
EGF/EGFR -0.3 0.26 -9999 0 -0.43 365 365
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.19 0.21 -9999 0 -0.36 267 267
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA 0.032 0.038 -9999 0 -0.54 2 2
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.15 0.27 -9999 0 -0.54 163 163
EGF/EGFR dimer/SHC -0.23 0.23 -9999 0 -0.41 288 288
mol:GDP -0.19 0.21 -9999 0 -0.36 267 267
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 -0.14 0.26 -9999 0 -0.54 153 153
GRB2/SOS1 0.048 0.019 -9999 0 -10000 0 0
HRAS/GTP -0.18 0.19 -9999 0 -0.34 264 264
SHC1 0.028 0.014 -9999 0 -10000 0 0
HRAS/GDP -0.18 0.2 -9999 0 -0.34 264 264
FRAP1 -0.2 0.17 -9999 0 -0.35 267 267
EGF/EGFR dimer -0.31 0.26 -9999 0 -0.46 356 356
SOS1 0.034 0.004 -9999 0 -10000 0 0
GRB2 0.034 0.019 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 -0.087 0.2 -9999 0 -0.4 154 154
Class IB PI3K non-lipid kinase events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process 0.11 0.25 0.54 126 -10000 0 126
PI3K Class IB/PDE3B -0.11 0.25 -10000 0 -0.54 126 126
PDE3B -0.11 0.25 -10000 0 -0.54 126 126
IGF1 pathway

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.035 0.008 -10000 0 -10000 0 0
PTK2 0.027 0.014 -10000 0 -10000 0 0
CRKL -0.16 0.2 -10000 0 -0.35 244 244
GRB2/SOS1/SHC 0.053 0.034 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
IRS1/Crk -0.16 0.21 -10000 0 -0.34 259 259
IGF-1R heterotetramer/IGF1/PTP1B -0.13 0.21 -10000 0 -0.35 223 223
AKT1 -0.16 0.19 -10000 0 -0.48 91 91
BAD -0.16 0.18 -10000 0 -0.45 88 88
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.16 0.2 -10000 0 -0.34 259 259
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.16 0.21 -10000 0 -0.34 258 258
RAF1 -0.12 0.18 -10000 0 -0.49 47 47
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos -0.12 0.22 -10000 0 -0.34 226 226
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.17 0.22 -10000 0 -0.36 259 259
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
RPS6KB1 -0.15 0.18 0.23 1 -0.45 93 94
GNB2L1 0.034 0.006 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade -0.098 0.15 0.33 1 -0.4 57 58
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
HRAS/GTP -0.11 0.18 -10000 0 -0.32 170 170
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc -0.07 0.18 -10000 0 -0.3 162 162
IGF-1R heterotetramer -0.048 0.14 -10000 0 -0.64 21 21
IGF-1R heterotetramer/IGF1/IRS/Nck -0.14 0.22 -10000 0 -0.34 257 257
Crk/p130 Cas/Paxillin -0.13 0.21 -10000 0 -0.33 237 237
IGF1R -0.048 0.14 -10000 0 -0.64 21 21
IGF1 -0.26 0.3 -10000 0 -0.57 253 253
IRS2/Crk -0.22 0.26 -10000 0 -0.42 267 267
PI3K -0.15 0.24 -10000 0 -0.37 243 243
apoptosis 0.11 0.15 0.4 58 -0.31 1 59
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
PRKCD -0.18 0.23 -10000 0 -0.39 241 241
RAF1/14-3-3 E -0.096 0.17 0.34 1 -0.44 38 39
BAD/14-3-3 -0.12 0.16 0.32 1 -0.43 58 59
PRKCZ -0.16 0.19 0.22 1 -0.34 225 226
Crk/p130 Cas/Paxillin/FAK1 -0.1 0.17 -10000 0 -0.4 76 76
PTPN1 0.037 0.03 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.19 0.23 -10000 0 -0.41 249 249
BCAR1 0.029 0.013 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 -0.094 0.19 -10000 0 -0.33 178 178
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.034 0.004 -10000 0 -10000 0 0
IRS1/NCK2 -0.15 0.21 -10000 0 -0.34 257 257
GRB10 0.03 0.051 -10000 0 -0.54 4 4
PTPN11 -0.16 0.2 -10000 0 -0.34 258 258
IRS1 -0.18 0.22 -10000 0 -0.36 259 259
IRS2 -0.23 0.26 -10000 0 -0.43 280 280
IGF-1R heterotetramer/IGF1 -0.2 0.26 -10000 0 -0.45 248 248
GRB2 0.034 0.019 -10000 0 -10000 0 0
PDPK1 -0.16 0.21 -10000 0 -0.36 225 225
YWHAE 0.031 0.011 -10000 0 -10000 0 0
PRKD1 -0.22 0.28 -10000 0 -0.47 247 247
SHC1 0.028 0.014 -10000 0 -10000 0 0
FOXM1 transcription factor network

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 0.57 0.46 1.1 124 -1.3 1 125
PLK1 0.23 0.2 0.64 43 -10000 0 43
BIRC5 0.37 0.25 0.69 123 -0.66 3 126
HSPA1B 0.57 0.46 1.1 144 -0.95 3 147
MAP2K1 0.17 0.13 0.34 139 -10000 0 139
BRCA2 0.6 0.49 1.2 141 -1.3 1 142
FOXM1 0.62 0.61 1.3 161 -1.2 3 164
XRCC1 0.57 0.46 1.1 124 -1.3 1 125
FOXM1B/p19 0.079 0.3 0.91 9 -1.1 3 12
Cyclin D1/CDK4 0.49 0.46 0.99 134 -0.91 8 142
CDC2 0.63 0.52 1.2 156 -1 3 159
TGFA 0.45 0.52 0.99 147 -0.93 20 167
SKP2 0.58 0.47 1.1 133 -1 2 135
CCNE1 0.088 0.065 0.23 47 -10000 0 47
CKS1B 0.62 0.5 1.2 161 -1 2 163
RB1 0.27 0.35 0.73 132 -0.85 6 138
FOXM1C/SP1 0.51 0.45 1 114 -1.1 6 120
AURKB 0.2 0.31 0.66 64 -0.84 21 85
CENPF 0.7 0.53 1.2 192 -1.3 1 193
CDK4 0.093 0.061 0.24 19 -10000 0 19
MYC 0.32 0.45 0.96 88 -0.87 10 98
CHEK2 0.17 0.13 0.34 129 -10000 0 129
ONECUT1 0.5 0.49 1 151 -0.9 6 157
CDKN2A -0.016 0.079 -10000 0 -0.24 13 13
LAMA4 0.57 0.48 1.1 129 -1.1 4 133
FOXM1B/HNF6 0.51 0.5 1.1 131 -1.1 6 137
FOS -0.12 0.65 1.1 50 -1 72 122
SP1 0.032 0.033 -10000 0 -0.21 5 5
CDC25B 0.58 0.47 1.1 135 -1 2 137
response to radiation 0.12 0.094 0.24 127 -10000 0 127
CENPB 0.57 0.46 1.1 137 -1 2 139
CENPA 0.65 0.51 1.2 154 -1.3 1 155
NEK2 0.71 0.52 1.2 178 -1.2 1 179
HIST1H2BA 0.57 0.46 1.1 127 -1.3 1 128
CCNA2 0.11 0.078 0.24 63 -10000 0 63
EP300 0.033 0.009 -10000 0 -10000 0 0
CCNB1/CDK1 0.61 0.52 1.2 132 -1.3 2 134
CCNB2 0.64 0.51 1.2 165 -1 2 167
CCNB1 0.65 0.54 1.3 150 -1.1 2 152
ETV5 0.54 0.52 1.1 123 -1.1 10 133
ESR1 0.39 0.61 1.1 118 -0.99 14 132
CCND1 0.51 0.51 1.1 161 -0.94 8 169
GSK3A 0.15 0.1 0.3 88 -10000 0 88
Cyclin A-E1/CDK1-2 0.21 0.14 0.38 132 -10000 0 132
CDK2 0.071 0.037 0.24 5 -10000 0 5
G2/M transition of mitotic cell cycle 0.14 0.12 0.28 170 -10000 0 170
FOXM1B/Cbp/p300 0.31 0.38 0.86 36 -1 3 39
GAS1 0.28 0.71 1.1 110 -1.1 55 165
MMP2 0.56 0.48 1.1 129 -1.2 6 135
RB1/FOXM1C 0.46 0.46 0.98 138 -1 6 144
CREBBP 0.032 0.01 -10000 0 -10000 0 0
Arf6 signaling events

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.018 0.018 -10000 0 -0.34 1 1
ARNO/beta Arrestin1-2 -0.11 0.14 -10000 0 -0.26 244 244
EGFR -0.27 0.29 -10000 0 -0.54 269 269
EPHA2 0.026 0.062 -10000 0 -0.54 6 6
USP6 0.033 0.018 -10000 0 -10000 0 0
IQSEC1 0.034 0.006 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF -0.31 0.26 -10000 0 -0.46 356 356
ARRB2 0.015 0.029 -10000 0 -0.33 3 3
mol:GTP 0.012 0.028 0.12 23 -10000 0 23
ARRB1 0.03 0.028 -10000 0 -0.54 1 1
FBXO8 0.033 0.007 -10000 0 -10000 0 0
TSHR 0.03 0.044 -10000 0 -0.54 3 3
EGF -0.15 0.27 -10000 0 -0.54 163 163
somatostatin receptor activity 0 0 -10000 0 -0.001 213 213
ARAP2 0 0 -10000 0 0 213 213
mol:GDP -0.14 0.14 -10000 0 -0.27 214 214
mol:PI-3-4-5-P3 0 0 -10000 0 -0.001 212 212
ITGA2B 0.034 0.012 -10000 0 -10000 0 0
ARF6 0.034 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.058 0.059 -10000 0 -0.31 6 6
ADAP1 0 0 -10000 0 0 129 129
KIF13B 0.027 0.029 -10000 0 -0.54 1 1
HGF/MET 0.006 0.13 -10000 0 -0.39 51 51
PXN 0.035 0.004 -10000 0 -10000 0 0
ARF6/GTP -0.14 0.12 -10000 0 -0.26 212 212
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.26 0.24 -10000 0 -0.41 347 347
ADRB2 -0.26 0.29 -10000 0 -0.54 263 263
receptor agonist activity 0 0 -10000 0 0 206 206
actin filament binding 0 0 -10000 0 0 232 232
SRC 0.033 0.008 -10000 0 -10000 0 0
ITGB3 0.035 0.019 -10000 0 -10000 0 0
GNAQ 0 0 -10000 0 -0.001 142 142
EFA6/PI-4-5-P2 0 0 -10000 0 -0.001 137 137
ARF6/GDP -0.031 0.084 -10000 0 -0.27 28 28
ARF6/GDP/GULP/ACAP1 -0.16 0.18 -10000 0 -0.35 198 198
alphaIIb/beta3 Integrin/paxillin/GIT1 0.082 0.031 -10000 0 -10000 0 0
ACAP1 0 0 -10000 0 -10000 0 0
ACAP2 0 0 -10000 0 0 232 232
LHCGR/beta Arrestin2 0.022 0.048 -10000 0 -0.46 3 3
EFNA1 0.028 0.016 -10000 0 -10000 0 0
HGF 0.035 0.01 -10000 0 -10000 0 0
CYTH3 0 0 -10000 0 -0.001 206 206
CYTH2 -0.002 0.002 -10000 0 -0.004 236 236
NCK1 0.034 0.005 -10000 0 -10000 0 0
fibronectin binding 0 0 -10000 0 0 133 133
endosomal lumen acidification 0 0 0.001 4 0 149 153
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 -0.071 0.22 -10000 0 -0.54 94 94
GNAQ/ARNO -0.003 0.003 -10000 0 -0.007 138 138
mol:Phosphatidic acid 0 0 -10000 0 0 232 232
PIP3-E 0 0 -10000 0 0 297 297
MET -0.022 0.17 -10000 0 -0.54 50 50
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GIT1 0.032 0.011 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -0.001 165 165
GNA11 0.034 0.006 -10000 0 -10000 0 0
LHCGR 0.032 0.046 -10000 0 -0.54 3 3
AGTR1 -0.18 0.3 -10000 0 -0.54 208 208
desensitization of G-protein coupled receptor protein signaling pathway 0.022 0.048 -10000 0 -0.46 3 3
IPCEF1/ARNO -0.21 0.18 -10000 0 -0.32 355 355
alphaIIb/beta3 Integrin 0.05 0.019 -10000 0 -10000 0 0
Nongenotropic Androgen signaling

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.006 0.005 -10000 0 -10000 0 0
GNB1/GNG2 0.012 0.13 -10000 0 -0.32 66 66
regulation of S phase of mitotic cell cycle -0.046 0.13 -10000 0 -0.3 93 93
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.032 0.013 -10000 0 -10000 0 0
SHBG/T-DHT 0.021 0.008 -10000 0 -10000 0 0
PELP1 0.029 0.01 -10000 0 -10000 0 0
AKT1 0.011 0.014 -10000 0 -10000 0 0
MAP2K1 -0.11 0.11 -10000 0 -0.36 62 62
T-DHT/AR -0.032 0.14 -10000 0 -0.4 67 67
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.005 0.003 -10000 0 -0.007 363 363
GNAI2 0.033 0.01 -10000 0 -10000 0 0
GNAI3 0.033 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
mol:GDP -0.079 0.16 -10000 0 -0.38 101 101
cell proliferation -0.29 0.21 -10000 0 -0.43 325 325
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
FOS -0.57 0.37 -10000 0 -0.8 365 365
mol:Ca2+ -0.037 0.037 -10000 0 -0.075 231 231
MAPK3 -0.2 0.16 -10000 0 -0.36 167 167
MAPK1 -0.16 0.16 -10000 0 -0.4 80 80
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 -0.003 0.002 -10000 0 -0.004 344 344
cAMP biosynthetic process 0.017 0.027 -10000 0 -10000 0 0
GNG2 0.033 0.026 -10000 0 -0.54 1 1
potassium channel inhibitor activity -0.003 0.002 -10000 0 -0.004 344 344
HRAS/GTP -0.059 0.12 -10000 0 -0.32 65 65
actin cytoskeleton reorganization 0.016 0.094 -10000 0 -0.28 43 43
SRC 0.031 0.008 -10000 0 -10000 0 0
voltage-gated calcium channel activity -0.003 0.002 -10000 0 -0.004 344 344
PI3K 0.007 0.11 -10000 0 -0.34 44 44
apoptosis 0.3 0.22 0.42 357 -10000 0 357
T-DHT/AR/PELP1 -0.014 0.13 -10000 0 -0.35 67 67
HRAS/GDP -0.069 0.17 -10000 0 -0.4 88 88
CREB1 -0.32 0.23 -10000 0 -0.46 357 357
RAC1-CDC42/GTP 0.026 0.099 -10000 0 -0.29 43 43
AR -0.042 0.2 -10000 0 -0.55 66 66
GNB1 0.034 0.012 -10000 0 -10000 0 0
RAF1 -0.085 0.11 -10000 0 -0.34 61 61
RAC1-CDC42/GDP -0.032 0.17 -10000 0 -0.44 66 66
T-DHT/AR/PELP1/Src -0.005 0.13 -10000 0 -0.33 66 66
MAP2K2 -0.11 0.11 -10000 0 -0.36 62 62
T-DHT/AR/PELP1/Src/PI3K -0.046 0.13 -10000 0 -0.3 93 93
GNAZ 0.025 0.062 -10000 0 -0.54 6 6
SHBG 0.031 0.011 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.11 0.19 -10000 0 -0.47 77 77
mol:T-DHT -0.001 0.002 -10000 0 -0.004 89 89
RAC1 0.034 0.005 -10000 0 -10000 0 0
GNRH1 -0.001 0.056 -10000 0 -0.4 10 10
Gi family/GTP -0.1 0.14 -10000 0 -0.26 184 184
CDC42 0.033 0.008 -10000 0 -10000 0 0
Glucocorticoid receptor regulatory network

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.11 0.11 0.52 5 -10000 0 5
SMARCC2 0.034 0.004 -10000 0 -10000 0 0
SMARCC1 0.035 0.02 -10000 0 -10000 0 0
TBX21 -0.12 0.22 0.41 1 -0.72 40 41
SUMO2 0.002 0.025 -10000 0 -10000 0 0
STAT1 (dimer) 0.073 0.07 0.29 25 -10000 0 25
FKBP4 0.037 0.027 -10000 0 -10000 0 0
FKBP5 0.025 0.082 -10000 0 -0.54 10 10
GR alpha/HSP90/FKBP51/HSP90 0.13 0.14 0.31 67 -0.36 4 71
PRL -0.06 0.11 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/TIF2 0.21 0.26 0.51 190 -10000 0 190
RELA -0.092 0.12 0.28 3 -0.25 37 40
FGG 0.23 0.23 0.45 222 -10000 0 222
GR beta/TIF2 0.11 0.14 0.29 124 -0.33 4 128
IFNG -0.39 0.34 -10000 0 -0.72 205 205
apoptosis -0.25 0.18 -10000 0 -0.55 39 39
CREB1 0.058 0.042 -10000 0 -10000 0 0
histone acetylation 0.035 0.14 0.39 40 -0.32 10 50
BGLAP -0.093 0.14 -10000 0 -0.45 14 14
GR/PKAc 0.15 0.14 0.33 65 -0.31 3 68
NF kappa B1 p50/RelA -0.16 0.2 0.48 3 -0.34 136 139
SMARCD1 0.034 0.004 -10000 0 -10000 0 0
MDM2 0.12 0.1 0.21 226 -10000 0 226
GATA3 0.044 0.17 -10000 0 -0.54 33 33
AKT1 0.028 0.025 -10000 0 -10000 0 0
CSF2 -0.008 0.11 -10000 0 -10000 0 0
GSK3B 0.002 0.027 -10000 0 -10000 0 0
NR1I3 -0.19 0.16 -10000 0 -0.56 8 8
CSN2 0.19 0.19 0.37 212 -10000 0 212
BRG1/BAF155/BAF170/BAF60A 0.084 0.028 -10000 0 -10000 0 0
NFATC1 0.038 0.038 -10000 0 -0.54 2 2
POU2F1 0.034 0.015 -10000 0 -10000 0 0
CDKN1A 0.021 0.12 -10000 0 -1.4 2 2
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.011 0.006 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.14 0.14 0.34 35 -0.4 2 37
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.65 0.33 -10000 0 -0.8 426 426
JUN -0.21 0.24 0.39 1 -0.49 158 159
IL4 -0.12 0.15 -10000 0 -0.48 14 14
CDK5R1 0.028 0.014 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.35 0.24 -10000 0 -0.49 330 330
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.15 0.14 0.34 44 -0.4 2 46
cortisol/GR alpha (monomer) 0.29 0.31 0.57 242 -10000 0 242
NCOA2 0.029 0.015 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.42 0.26 -10000 0 -0.57 361 361
AP-1/NFAT1-c-4 -0.58 0.41 -10000 0 -0.82 348 348
AFP -0.18 0.2 -10000 0 -0.59 25 25
SUV420H1 0.032 0.01 -10000 0 -10000 0 0
IRF1 0.21 0.18 0.43 115 -10000 0 115
TP53 0.046 0.034 -10000 0 -0.51 1 1
PPP5C 0.036 0.018 -10000 0 -10000 0 0
KRT17 -0.9 0.65 -10000 0 -1.4 326 326
KRT14 -0.83 0.63 -10000 0 -1.3 325 325
TBP 0.039 0.012 -10000 0 -10000 0 0
CREBBP 0.18 0.14 0.3 290 -10000 0 290
HDAC1 0.029 0.012 -10000 0 -10000 0 0
HDAC2 0.029 0.022 -10000 0 -10000 0 0
AP-1 -0.58 0.41 -10000 0 -0.82 348 348
MAPK14 0.014 0.021 -10000 0 -10000 0 0
MAPK10 -0.009 0.082 -10000 0 -0.55 10 10
MAPK11 0 0.026 -10000 0 -10000 0 0
KRT5 -0.95 0.63 -10000 0 -1.3 356 356
interleukin-1 receptor activity -0.003 0.006 -10000 0 -10000 0 0
NCOA1 0.037 0.027 -10000 0 -0.54 1 1
STAT1 0.073 0.07 0.29 25 -10000 0 25
CGA -0.084 0.16 -10000 0 -0.52 7 7
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.15 0.19 0.35 174 -0.39 1 175
MAPK3 0.001 0.024 -10000 0 -10000 0 0
MAPK1 0.012 0.021 -10000 0 -10000 0 0
ICAM1 -0.25 0.25 0.6 2 -0.53 147 149
NFKB1 -0.094 0.11 0.32 1 -0.27 20 21
MAPK8 -0.15 0.19 0.57 1 -0.37 142 143
MAPK9 0.013 0.023 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) -0.26 0.19 -10000 0 -0.57 40 40
BAX 0.027 0.076 -10000 0 -10000 0 0
POMC -0.14 0.19 -10000 0 -0.69 15 15
EP300 0.18 0.14 0.29 291 -10000 0 291
cortisol/GR alpha (dimer)/p53 0.23 0.26 0.52 193 -10000 0 193
proteasomal ubiquitin-dependent protein catabolic process 0.09 0.11 0.26 82 -10000 0 82
SGK1 0.23 0.17 0.36 303 -0.43 1 304
IL13 -0.29 0.25 -10000 0 -0.72 52 52
IL6 -0.75 0.48 0.62 1 -1 376 377
PRKACG 0.033 0.026 -10000 0 -0.54 1 1
IL5 -0.24 0.21 -10000 0 -0.62 39 39
IL2 -0.42 0.32 -10000 0 -0.67 276 276
CDK5 0.032 0.024 -10000 0 -10000 0 0
PRKACB 0.035 0.083 -10000 0 -0.54 8 8
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
IL8 -0.24 0.26 0.52 4 -0.53 142 146
CDK5R1/CDK5 0.038 0.023 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.094 0.18 0.43 3 -0.4 31 34
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.25 0.25 0.5 222 -10000 0 222
SMARCA4 0.035 0.013 -10000 0 -10000 0 0
chromatin remodeling 0.17 0.16 0.33 212 -10000 0 212
NF kappa B1 p50/RelA/Cbp -0.003 0.19 0.48 27 -0.34 6 33
JUN (dimer) -0.21 0.24 0.39 1 -0.49 158 159
YWHAH 0.033 0.014 -10000 0 -10000 0 0
VIPR1 -0.11 0.16 -10000 0 -0.56 24 24
NR3C1 0.19 0.2 0.38 200 -0.44 5 205
NR4A1 0.014 0.12 -10000 0 -0.55 24 24
TIF2/SUV420H1 0.039 0.023 -10000 0 -10000 0 0
MAPKKK cascade -0.25 0.18 -10000 0 -0.55 39 39
cortisol/GR alpha (dimer)/Src-1 0.27 0.27 0.51 237 -10000 0 237
PBX1 0.043 0.043 -10000 0 -10000 0 0
POU1F1 0.039 0.026 -10000 0 -0.54 1 1
SELE -0.26 0.35 0.52 4 -0.67 144 148
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.17 0.16 0.33 212 -10000 0 212
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.25 0.25 0.5 222 -10000 0 222
mol:cortisol 0.18 0.17 0.32 251 -10000 0 251
MMP1 -0.022 0.35 -10000 0 -0.94 53 53
S1P1 pathway

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.051 0.039 -10000 0 -10000 0 0
PDGFRB 0.03 0.007 -10000 0 -10000 0 0
SPHK1 -0.042 0.14 -10000 0 -0.9 11 11
mol:S1P -0.044 0.14 0.3 1 -0.82 11 12
S1P1/S1P/Gi -0.28 0.29 0.33 5 -0.49 303 308
GNAO1 0.003 0.028 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 -0.25 0.26 0.41 3 -0.45 286 289
PLCG1 -0.27 0.27 0.34 5 -0.47 290 295
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.03 0.007 -10000 0 -10000 0 0
GNAI2 0.004 0.03 -10000 0 -10000 0 0
GNAI3 0.006 0.029 -10000 0 -10000 0 0
GNAI1 -0.19 0.27 -10000 0 -0.55 183 183
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.004 0.04 0.14 4 -10000 0 4
S1P1/S1P -0.064 0.13 0.28 8 -0.66 11 19
negative regulation of cAMP metabolic process -0.28 0.28 0.33 5 -0.48 303 308
MAPK3 -0.37 0.35 0.36 7 -0.63 310 317
calcium-dependent phospholipase C activity -0.005 0.005 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
KDR 0.029 0.011 -10000 0 -10000 0 0
PLCB2 -0.054 0.12 0.34 4 -0.57 11 15
RAC1 0.034 0.005 -10000 0 -10000 0 0
RhoA/GTP -0.064 0.1 -10000 0 -0.54 11 11
receptor internalization -0.063 0.12 0.24 6 -0.6 11 17
PTGS2 -0.62 0.53 0.43 4 -1 315 319
Rac1/GTP -0.064 0.1 -10000 0 -0.54 11 11
RHOA 0.033 0.008 -10000 0 -10000 0 0
VEGFA 0.046 0.049 0.18 57 -10000 0 57
negative regulation of T cell proliferation -0.28 0.28 0.33 5 -0.48 303 308
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ -0.001 0.066 -10000 0 -0.55 6 6
MAPK1 -0.4 0.38 0.37 5 -0.67 315 320
S1P1/S1P/PDGFB-D/PDGFRB -0.079 0.14 0.34 8 -0.62 11 19
ABCC1 0.032 0.024 -10000 0 -10000 0 0
HIF-1-alpha transcription factor network

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 0.003 0.43 0.82 1 -0.7 87 88
HDAC7 0.007 0.015 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 0.004 0.37 0.82 5 -0.68 55 60
SMAD4 0.034 0.008 -10000 0 -10000 0 0
ID2 0 0.43 -10000 0 -0.71 83 83
AP1 -0.33 0.27 -10000 0 -0.48 358 358
ABCG2 -0.015 0.44 -10000 0 -0.71 92 92
HIF1A 0.023 0.13 0.32 5 -0.29 15 20
TFF3 -0.05 0.44 -10000 0 -0.73 94 94
GATA2 0.021 0.05 -10000 0 -10000 0 0
AKT1 0.021 0.13 -10000 0 -0.23 3 3
response to hypoxia -0.004 0.11 0.26 13 -0.16 66 79
MCL1 -0.029 0.4 -10000 0 -0.71 79 79
NDRG1 -0.018 0.4 0.89 1 -0.71 76 77
SERPINE1 0.011 0.44 0.84 9 -0.7 87 96
FECH -0.003 0.42 -10000 0 -0.7 84 84
FURIN 0.005 0.43 -10000 0 -0.7 86 86
NCOA2 0.035 0.024 -10000 0 -10000 0 0
EP300 0.034 0.17 0.46 14 -0.29 34 48
HMOX1 0.009 0.44 0.87 4 -0.7 87 91
BHLHE40 -0.053 0.4 0.72 4 -0.71 83 87
BHLHE41 -0.053 0.4 0.72 4 -0.71 83 87
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.043 0.16 -10000 0 -0.33 3 3
ENG 0.044 0.14 0.44 2 -0.39 1 3
JUN -0.074 0.22 -10000 0 -0.55 89 89
RORA -0.008 0.43 -10000 0 -0.72 88 88
ABCB1 -0.29 0.47 -10000 0 -0.94 163 163
TFRC 0.006 0.43 0.87 5 -0.72 80 85
CXCR4 0.009 0.43 0.81 4 -0.7 86 90
TF -0.007 0.44 -10000 0 -0.72 89 89
CITED2 -0.006 0.43 -10000 0 -0.71 87 87
HIF1A/ARNT -0.068 0.44 0.93 2 -0.82 73 75
LDHA -0.009 0.13 -10000 0 -0.73 13 13
ETS1 -0.003 0.43 0.78 1 -0.69 89 90
PGK1 0.006 0.43 0.83 4 -0.69 88 92
NOS2 -0.053 0.4 0.72 4 -0.71 83 87
ITGB2 0.006 0.43 0.82 8 -0.7 85 93
ALDOA 0.003 0.42 -10000 0 -0.69 86 86
Cbp/p300/CITED2 -0.013 0.43 0.82 2 -0.76 73 75
FOS -0.36 0.27 -10000 0 -0.55 344 344
HK2 0.002 0.43 -10000 0 -0.69 88 88
SP1 -0.018 0.094 -10000 0 -0.22 45 45
GCK 0.064 0.22 0.68 3 -0.48 4 7
HK1 0.004 0.43 -10000 0 -0.71 82 82
NPM1 0 0.43 -10000 0 -0.7 86 86
EGLN1 -0.024 0.4 -10000 0 -0.71 80 80
CREB1 0.04 0.01 -10000 0 -10000 0 0
PGM1 -0.001 0.43 -10000 0 -0.7 84 84
SMAD3 0.034 0.01 -10000 0 -10000 0 0
EDN1 -0.4 0.6 0.62 1 -1.2 164 165
IGFBP1 0.002 0.43 -10000 0 -0.71 83 83
VEGFA 0.068 0.37 0.8 20 -0.58 54 74
HIF1A/JAB1 0.04 0.1 0.31 5 -0.41 4 9
CP -0.063 0.51 0.85 6 -0.77 126 132
CXCL12 -0.088 0.48 -10000 0 -0.78 123 123
COPS5 0.034 0.02 -10000 0 -10000 0 0
SMAD3/SMAD4 0.048 0.022 -10000 0 -10000 0 0
BNIP3 -0.002 0.43 0.86 1 -0.69 91 92
EGLN3 0.02 0.44 0.85 9 -0.72 78 87
CA9 0.014 0.44 0.84 8 -0.71 83 91
TERT -0.012 0.42 -10000 0 -0.7 87 87
ENO1 0.001 0.43 -10000 0 -0.71 83 83
PFKL 0.001 0.43 -10000 0 -0.72 80 80
NCOA1 0.036 0.027 -10000 0 -0.54 1 1
ADM -0.11 0.5 -10000 0 -0.76 138 138
ARNT 0.021 0.099 0.29 3 -0.15 4 7
HNF4A 0.036 0.009 -10000 0 -10000 0 0
ADFP -0.053 0.4 0.72 4 -0.71 83 87
SLC2A1 0.069 0.36 0.82 16 -0.58 53 69
LEP -0.14 0.48 -10000 0 -0.77 141 141
HIF1A/ARNT/Cbp/p300 -0.019 0.37 0.81 3 -0.69 57 60
EPO 0.07 0.32 0.78 14 -0.6 25 39
CREBBP 0.041 0.16 0.46 14 -0.28 14 28
HIF1A/ARNT/Cbp/p300/HDAC7 -0.01 0.35 0.8 6 -0.67 52 58
PFKFB3 -0.006 0.42 -10000 0 -0.7 85 85
NT5E -0.005 0.44 -10000 0 -0.72 87 87
Calcium signaling in the CD4+ TCR pathway

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 0.008 0.058 0.25 10 -0.34 2 12
NFATC2 0.009 0.055 0.26 9 -0.34 1 10
NFATC3 0.012 0.052 0.26 9 -10000 0 9
CD40LG -0.22 0.29 0.69 10 -0.51 188 198
PTGS2 -0.32 0.36 0.67 9 -0.62 265 274
JUNB 0.031 0.044 -10000 0 -0.54 3 3
CaM/Ca2+/Calcineurin A alpha-beta B1 0.013 0.032 -10000 0 -10000 0 0
CaM/Ca2+ 0.013 0.032 -10000 0 -10000 0 0
CALM1 0.034 0.018 -10000 0 -10000 0 0
JUN -0.066 0.22 -10000 0 -0.54 89 89
mol:Ca2+ -0.003 0.012 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.024 0.012 0.13 1 -10000 0 1
FOSL1 0.034 0.012 -10000 0 -10000 0 0
CREM 0.033 0.007 -10000 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.032 0.17 0.46 15 -0.35 58 73
FOS -0.35 0.27 -10000 0 -0.54 344 344
IFNG -0.19 0.31 0.67 16 -0.52 176 192
AP-1/NFAT1-c-4 -0.25 0.34 0.71 11 -0.59 192 203
FASLG -0.19 0.29 0.65 17 -0.48 179 196
NFAT1-c-4/ICER1 0.015 0.098 0.41 9 -0.31 2 11
IL2RA -0.21 0.3 0.74 10 -0.51 180 190
FKBP12/FK506 0.025 0.008 -10000 0 -10000 0 0
CSF2 -0.22 0.3 0.68 12 -0.51 188 200
JunB/Fra1/NFAT1-c-4 0.041 0.11 0.44 10 -0.3 5 15
IL4 -0.22 0.29 0.66 10 -0.51 189 199
IL2 -0.009 0.14 -10000 0 -0.97 11 11
IL3 -0.009 0.13 -10000 0 -0.71 15 15
FKBP1A 0.034 0.012 -10000 0 -10000 0 0
BATF3 0 0 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
POU2F1 0.033 0.015 -10000 0 -10000 0 0
Signaling events mediated by PTP1B

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.006 -10000 0 -10000 0 0
Jak2/Leptin Receptor -0.23 0.21 -10000 0 -0.4 257 257
PTP1B/AKT1 -0.16 0.16 -10000 0 -0.37 94 94
FYN 0.03 0.037 -10000 0 -0.54 2 2
p210 bcr-abl/PTP1B -0.19 0.16 0.25 1 -0.33 226 227
EGFR -0.29 0.28 -10000 0 -0.56 269 269
EGF/EGFR -0.36 0.26 -10000 0 -0.51 348 348
CSF1 0.034 0.009 0.18 1 -10000 0 1
AKT1 0.035 0.017 -10000 0 -10000 0 0
INSR 0.034 0.006 -10000 0 -10000 0 0
PTP1B/N-cadherin -0.16 0.17 0.34 1 -0.33 185 186
Insulin Receptor/Insulin -0.11 0.14 -10000 0 -0.42 29 29
HCK 0.037 0.023 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
TYK2 -0.18 0.16 0.44 1 -0.32 209 210
EGF -0.18 0.26 -10000 0 -0.56 163 163
YES1 0.032 0.027 -10000 0 -0.54 1 1
CAV1 -0.37 0.23 -10000 0 -0.5 360 360
TXN 0.028 0.012 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 -0.2 0.18 -10000 0 -0.42 131 131
cell migration 0.19 0.16 0.33 226 -0.25 1 227
STAT3 0.032 0.007 -10000 0 -10000 0 0
PRLR 0.075 0.065 -10000 0 -10000 0 0
ITGA2B 0.032 0.012 -10000 0 -10000 0 0
CSF1R 0.034 0.006 -10000 0 -10000 0 0
Prolactin Receptor/Prolactin 0.083 0.05 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
PTP1B/p130 Cas -0.18 0.16 -10000 0 -0.32 207 207
Crk/p130 Cas -0.17 0.16 -10000 0 -0.38 93 93
DOK1 -0.15 0.15 0.27 1 -0.43 55 56
JAK2 -0.081 0.15 -10000 0 -0.52 33 33
Jak2/Leptin Receptor/Leptin -0.25 0.2 -10000 0 -0.43 228 228
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
PTPN1 -0.19 0.16 0.25 1 -0.33 230 231
LYN 0.03 0.016 -10000 0 -10000 0 0
CDH2 0.058 0.057 -10000 0 -10000 0 0
SRC -0.05 0.12 -10000 0 -0.66 14 14
ITGB3 0.033 0.019 -10000 0 -10000 0 0
CAT1/PTP1B -0.15 0.18 0.36 1 -0.43 95 96
CAPN1 0.031 0.015 -10000 0 -10000 0 0
CSK 0.034 0.011 -10000 0 -10000 0 0
PI3K -0.12 0.17 -10000 0 -0.45 52 52
mol:H2O2 -0.005 0.006 -10000 0 -10000 0 0
STAT3 (dimer) -0.22 0.19 -10000 0 -0.4 214 214
negative regulation of transcription -0.08 0.14 -10000 0 -0.52 33 33
FCGR2A 0.031 0.025 0.18 10 -10000 0 10
FER 0.027 0.008 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin 0.046 0.018 -10000 0 -10000 0 0
BLK 0.039 0.045 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.052 0.03 -10000 0 -10000 0 0
RHOA 0.03 0.007 -10000 0 -10000 0 0
LEPR -0.33 0.28 -10000 0 -0.54 321 321
BCAR1 0.029 0.013 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.034 0.019 -10000 0 -10000 0 0
mol:NADPH -0.006 0.004 -10000 0 -10000 0 0
TRPV6 -0.007 0.15 0.37 3 -0.4 42 45
PRL 0.037 0.009 -10000 0 -10000 0 0
SOCS3 0 0.25 -10000 0 -1.3 17 17
SPRY2 -0.32 0.28 -10000 0 -0.55 304 304
Insulin Receptor/Insulin/IRS1 0.015 0.13 -10000 0 -0.35 59 59
CSF1/CSF1R -0.17 0.16 -10000 0 -0.38 98 98
Ras protein signal transduction 0.089 0.18 0.67 37 -10000 0 37
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
INS 0.033 0.007 -10000 0 -10000 0 0
LEP -0.23 0.29 -10000 0 -0.54 237 237
STAT5B -0.14 0.16 0.25 1 -0.37 92 93
STAT5A -0.14 0.16 0.26 1 -0.37 92 93
GRB2 0.034 0.019 -10000 0 -10000 0 0
PDGFB-D/PDGFRB -0.18 0.16 -10000 0 -0.32 214 214
CSN2 0.078 0.062 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
LAT -0.036 0.081 -10000 0 -0.62 4 4
YBX1 0.044 0.029 -10000 0 -10000 0 0
LCK 0.049 0.045 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
NOX4 0.052 0.056 -10000 0 -10000 0 0
PDGFR-alpha signaling pathway

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.09 0.18 -10000 0 -0.58 61 61
PDGF/PDGFRA/CRKL -0.052 0.14 -10000 0 -0.4 64 64
positive regulation of JUN kinase activity 0.016 0.12 -10000 0 -0.32 45 45
CRKL 0.032 0.009 -10000 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.053 0.14 -10000 0 -0.41 65 65
AP1 -0.7 0.45 -10000 0 -0.97 366 366
mol:IP3 -0.085 0.14 -10000 0 -0.45 57 57
PLCG1 -0.085 0.14 -10000 0 -0.45 57 57
PDGF/PDGFRA/alphaV Integrin -0.053 0.14 -10000 0 -0.41 65 65
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
mol:Ca2+ -0.085 0.14 -10000 0 -0.45 57 57
CAV3 0.032 0.037 -10000 0 -0.54 2 2
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
SHC/Grb2/SOS1 0.017 0.12 -10000 0 -0.32 45 45
PDGF/PDGFRA/Shf -0.051 0.14 -10000 0 -0.4 64 64
FOS -0.69 0.44 -10000 0 -0.95 366 366
JUN -0.13 0.16 -10000 0 -0.46 86 86
oligodendrocyte development -0.053 0.14 -10000 0 -0.41 65 65
GRB2 0.034 0.019 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:DAG -0.085 0.14 -10000 0 -0.45 57 57
PDGF/PDGFRA -0.09 0.18 -10000 0 -0.58 61 61
actin cytoskeleton reorganization -0.05 0.14 -10000 0 -0.39 65 65
SRF 0.031 0.014 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
PI3K -0.028 0.18 -10000 0 -0.42 83 83
PDGF/PDGFRA/Crk/C3G 0.002 0.13 -10000 0 -0.36 61 61
JAK1 -0.064 0.13 -10000 0 -0.4 63 63
ELK1/SRF -0.065 0.12 0.33 1 -0.36 58 59
SHB 0.036 0.018 -10000 0 -10000 0 0
SHF 0.034 0.013 -10000 0 -10000 0 0
CSNK2A1 0.063 0.025 -10000 0 -10000 0 0
GO:0007205 -0.092 0.14 -10000 0 -0.46 62 62
SOS1 0.034 0.004 -10000 0 -10000 0 0
Ras protein signal transduction 0.016 0.12 -10000 0 -0.32 45 45
PDGF/PDGFRA/SHB -0.05 0.14 -10000 0 -0.39 65 65
PDGF/PDGFRA/Caveolin-1 -0.33 0.24 -10000 0 -0.46 376 376
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
ELK1 -0.11 0.13 0.23 2 -0.44 60 62
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PDGF/PDGFRA/Crk -0.053 0.14 -10000 0 -0.41 64 64
JAK-STAT cascade -0.064 0.13 -10000 0 -0.4 63 63
cell proliferation -0.051 0.14 -10000 0 -0.4 64 64
Ephrin B reverse signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.026 0.058 -10000 0 -0.54 5 5
EPHB2 0.043 0.038 -10000 0 -10000 0 0
EFNB1 0.016 0.027 -10000 0 -0.4 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.048 0.18 -10000 0 -0.28 180 180
Ephrin B2/EPHB1-2 -0.074 0.19 -10000 0 -0.31 190 190
neuron projection morphogenesis -0.06 0.16 -10000 0 -0.27 180 180
Ephrin B1/EPHB1-2/Tiam1 -0.059 0.18 -10000 0 -0.3 186 186
DNM1 0.035 0.008 -10000 0 -10000 0 0
cell-cell signaling -0.001 0.003 -10000 0 -10000 0 0
MAP2K4 -0.057 0.18 -10000 0 -0.57 56 56
YES1 -0.069 0.26 -10000 0 -0.8 56 56
Ephrin B1/EPHB1-2/NCK2 -0.06 0.18 -10000 0 -0.3 187 187
PI3K -0.045 0.22 -10000 0 -0.48 92 92
mol:GDP -0.06 0.18 -10000 0 -0.29 186 186
ITGA2B 0.034 0.012 -10000 0 -10000 0 0
endothelial cell proliferation 0.038 0.046 -10000 0 -0.31 7 7
FYN -0.071 0.26 -10000 0 -0.79 56 56
MAP3K7 -0.058 0.19 -10000 0 -0.6 56 56
FGR -0.065 0.26 -10000 0 -0.79 56 56
TIAM1 0.035 0.013 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RGS3 0.034 0.005 -10000 0 -10000 0 0
cell adhesion -0.046 0.2 -10000 0 -0.55 56 56
LYN -0.065 0.25 -10000 0 -0.78 56 56
Ephrin B1/EPHB1-2/Src Family Kinases -0.071 0.24 -10000 0 -0.74 57 57
Ephrin B1/EPHB1-2 -0.061 0.21 -10000 0 -0.64 56 56
SRC -0.064 0.26 -10000 0 -0.78 57 57
ITGB3 0.035 0.019 -10000 0 -10000 0 0
EPHB1 -0.18 0.28 -10000 0 -0.54 191 191
EPHB4 0.036 0.032 -10000 0 -0.54 1 1
RAC1 0.034 0.005 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.039 0.046 -10000 0 -0.31 7 7
alphaIIb/beta3 Integrin 0.05 0.019 -10000 0 -10000 0 0
BLK -0.077 0.26 -10000 0 -0.8 56 56
HCK -0.065 0.25 -10000 0 -0.78 56 56
regulation of stress fiber formation 0.06 0.18 0.29 187 -10000 0 187
MAPK8 -0.056 0.18 -10000 0 -0.55 57 57
Ephrin B1/EPHB1-2/RGS3 -0.06 0.18 -10000 0 -0.3 185 185
endothelial cell migration -0.05 0.17 0.26 1 -0.51 58 59
NCK2 0.035 0.008 -10000 0 -10000 0 0
PTPN13 -0.024 0.19 -10000 0 -0.65 45 45
regulation of focal adhesion formation 0.06 0.18 0.29 187 -10000 0 187
chemotaxis 0.06 0.18 0.29 186 -10000 0 186
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
Rac1/GTP -0.053 0.17 -10000 0 -0.28 180 180
angiogenesis -0.061 0.2 -10000 0 -0.64 56 56
LCK -0.061 0.26 -10000 0 -0.78 57 57
BMP receptor signaling

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS 0.11 0.08 -9999 0 -0.3 3 3
SMAD6-7/SMURF1 0.064 0.021 -9999 0 -10000 0 0
NOG 0.031 0.031 -9999 0 -0.54 1 1
SMAD9 -0.081 0.23 -9999 0 -0.67 60 60
SMAD4 0.033 0.008 -9999 0 -10000 0 0
SMAD5 -0.098 0.19 -9999 0 -0.44 75 75
BMP7/USAG1 -0.24 0.2 -9999 0 -0.39 314 314
SMAD5/SKI -0.087 0.19 -9999 0 -0.44 70 70
SMAD1 0.005 0.09 -9999 0 -0.45 9 9
BMP2 -0.22 0.29 -9999 0 -0.54 230 230
SMAD1/SMAD1/SMAD4 0.03 0.087 -9999 0 -0.49 4 4
BMPR1A 0.031 0.044 -9999 0 -0.54 3 3
BMPR1B 0.089 0.072 -9999 0 -10000 0 0
BMPR1A-1B/BAMBI 0.083 0.13 -9999 0 -0.3 38 38
AHSG 0.034 0.006 -9999 0 -10000 0 0
CER1 0.033 0.011 -9999 0 -10000 0 0
BMP2-4/CER1 -0.16 0.23 -9999 0 -0.38 261 261
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.097 0.18 -9999 0 -0.4 83 83
BMP2-4 (homodimer) -0.21 0.25 -9999 0 -0.44 266 266
RGMB 0.034 0.007 -9999 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B -0.019 0.19 -9999 0 -0.28 168 168
RGMA -0.052 0.2 -9999 0 -0.54 76 76
SMURF1 0.034 0.005 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.11 0.18 -9999 0 -0.39 107 107
BMP2-4/USAG1 -0.4 0.26 -9999 0 -0.51 410 410
SMAD6/SMURF1/SMAD5 -0.089 0.19 -9999 0 -0.44 70 70
SOSTDC1 -0.37 0.26 -9999 0 -0.54 359 359
BMP7/BMPR2/BMPR1A-1B 0.11 0.073 -9999 0 -0.31 3 3
SKI 0.033 0.007 -9999 0 -10000 0 0
BMP6 (homodimer) -0.16 0.27 -9999 0 -0.54 168 168
HFE2 0.027 0.039 -9999 0 -0.54 2 2
ZFYVE16 0.033 0.007 -9999 0 -10000 0 0
MAP3K7 0.032 0.009 -9999 0 -10000 0 0
BMP2-4/CHRD -0.16 0.23 -9999 0 -0.38 262 262
SMAD5/SMAD5/SMAD4 -0.089 0.19 -9999 0 -0.44 69 69
MAPK1 0.033 0.009 -9999 0 -10000 0 0
TAK1/TAB family -0.082 0.17 -9999 0 -0.36 96 96
BMP7 (homodimer) 0.043 0.043 -9999 0 -10000 0 0
NUP214 0.034 0.005 -9999 0 -10000 0 0
BMP6/FETUA -0.097 0.21 -9999 0 -0.4 165 165
SMAD1/SKI 0.015 0.096 -9999 0 -0.48 6 6
SMAD6 0.033 0.007 -9999 0 -10000 0 0
CTDSP2 0.034 0.006 -9999 0 -10000 0 0
BMP2-4/FETUA -0.17 0.23 -9999 0 -0.38 262 262
MAP3K7IP1 0 0 -9999 0 -10000 0 0
GREM1 0.049 0.047 -9999 0 -10000 0 0
BMPR2 (homodimer) 0.034 0.005 -9999 0 -10000 0 0
GADD34/PP1CA 0.061 0.038 -9999 0 -0.34 2 2
BMPR1A-1B (homodimer) 0.084 0.064 -9999 0 -0.4 3 3
CHRDL1 -0.3 0.28 -9999 0 -0.54 300 300
ENDOFIN/SMAD1 0.015 0.097 -9999 0 -0.5 6 6
SMAD6-7/SMURF1/SMAD1 0.048 0.1 -9999 0 -0.48 6 6
SMAD6/SMURF1 0.034 0.005 -9999 0 -10000 0 0
BAMBI 0.018 0.16 -9999 0 -0.54 36 36
SMURF2 0.031 0.013 -9999 0 -10000 0 0
BMP2-4/CHRDL1 -0.36 0.31 -9999 0 -0.53 356 356
BMP2-4/GREM1 -0.16 0.24 -9999 0 -0.37 266 266
SMAD7 0.033 0.008 -9999 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.073 0.23 -9999 0 -0.65 60 60
SMAD1/SMAD6 0.015 0.098 -9999 0 -0.5 6 6
TAK1/SMAD6 0.047 0.015 -9999 0 -10000 0 0
BMP7 0.043 0.043 -9999 0 -10000 0 0
BMP6 -0.16 0.27 -9999 0 -0.54 168 168
MAP3K7IP2 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.097 0.18 -9999 0 -0.4 106 106
PPM1A 0.034 0.006 -9999 0 -10000 0 0
SMAD1/SMURF2 0.012 0.093 -9999 0 -0.5 6 6
SMAD7/SMURF1 0.048 0.013 -9999 0 -10000 0 0
CTDSPL 0.031 0.036 -9999 0 -0.54 2 2
PPP1CA 0.034 0.021 -9999 0 -10000 0 0
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.034 0.005 -9999 0 -10000 0 0
PPP1R15A 0.032 0.036 -9999 0 -0.54 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.099 0.18 -9999 0 -0.39 100 100
CHRD 0.037 0.021 -9999 0 -10000 0 0
BMPR2 0.034 0.005 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.12 0.21 -9999 0 -0.45 109 109
BMP4 -0.039 0.2 -9999 0 -0.54 67 67
FST 0.032 0.04 -9999 0 -0.54 2 2
BMP2-4/NOG -0.16 0.22 -9999 0 -0.38 246 246
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.11 0.076 -9999 0 -0.3 3 3
Plasma membrane estrogen receptor signaling

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.008 0.16 -10000 0 -0.3 104 104
ER alpha/Gai/GDP/Gbeta gamma -0.15 0.24 -10000 0 -0.43 163 163
AKT1 -0.19 0.37 -10000 0 -0.78 138 138
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.19 0.38 -10000 0 -0.8 136 136
mol:Ca2+ -0.031 0.12 0.26 3 -0.31 46 49
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
E2/ER alpha (dimer)/Striatin -0.019 0.17 -10000 0 -0.33 109 109
SHC1 0.028 0.014 -10000 0 -10000 0 0
apoptosis 0.18 0.35 0.74 139 -10000 0 139
RhoA/GTP -0.024 0.11 -10000 0 -0.27 81 81
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.14 0.23 0.31 1 -0.44 140 141
regulation of stress fiber formation 0.014 0.12 -10000 0 -0.25 18 18
E2/ERA-ERB (dimer) -0.022 0.17 -10000 0 -0.34 108 108
KRAS 0.035 0.019 -10000 0 -10000 0 0
G13/GTP -0.018 0.15 -10000 0 -0.31 99 99
pseudopodium formation -0.014 0.12 0.25 18 -10000 0 18
E2/ER alpha (dimer)/PELP1 -0.024 0.17 -10000 0 -0.34 106 106
GRB2 0.034 0.019 -10000 0 -10000 0 0
GNG2 0.033 0.026 -10000 0 -0.54 1 1
GNAO1 0.03 0.012 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.14 0.25 -10000 0 -0.5 143 143
E2/ER beta (dimer) 0.025 0.005 -10000 0 -10000 0 0
mol:GDP -0.046 0.18 0.23 10 -0.38 105 115
mol:NADP -0.14 0.25 -10000 0 -0.5 143 143
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 -0.033 0.12 0.26 3 -0.32 45 48
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
PLCB1 -0.034 0.13 -10000 0 -0.32 51 51
PLCB2 0.003 0.088 -10000 0 -0.46 8 8
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
mol:L-citrulline -0.14 0.25 -10000 0 -0.5 143 143
RHOA 0.033 0.008 -10000 0 -10000 0 0
Gai/GDP -0.14 0.28 -10000 0 -0.72 80 80
JNK cascade 0.025 0.005 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
ESR2 0.033 0.007 -10000 0 -10000 0 0
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 -0.058 0.25 -10000 0 -0.54 106 106
Gq family/GDP/Gbeta gamma 0.009 0.16 -10000 0 -0.84 14 14
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.031 0.14 -10000 0 -0.54 13 13
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.12 0.21 0.31 1 -0.45 111 112
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
E2/ER alpha (dimer) -0.044 0.18 -10000 0 -0.39 110 110
STRN 0.034 0.028 -10000 0 -0.54 1 1
GNAL 0.03 0.044 -10000 0 -0.54 3 3
PELP1 0.031 0.011 -10000 0 -10000 0 0
MAPK11 0.017 0.006 -10000 0 -10000 0 0
GNAI2 0.034 0.01 -10000 0 -10000 0 0
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
HBEGF -0.11 0.23 0.37 7 -0.55 60 67
cAMP biosynthetic process -0.02 0.13 -10000 0 -0.28 102 102
SRC -0.14 0.23 0.31 4 -0.41 160 164
PI3K 0.006 0.13 -10000 0 -0.4 44 44
GNB1 0.034 0.012 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma -0.021 0.18 -10000 0 -0.36 93 93
SOS1 0.034 0.004 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.21 0.21 -10000 0 -0.42 218 218
Gs family/GTP -0.012 0.14 -10000 0 -0.28 102 102
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.062 0.025 -10000 0 -10000 0 0
vasodilation -0.14 0.24 -10000 0 -0.47 144 144
mol:DAG -0.033 0.12 0.26 3 -0.32 45 48
Gs family/GDP/Gbeta gamma -0.041 0.16 -10000 0 -0.34 97 97
MSN -0.016 0.12 0.26 18 -10000 0 18
Gq family/GTP 0.003 0.093 -10000 0 -0.43 10 10
mol:PI-3-4-5-P3 -0.18 0.36 -10000 0 -0.76 136 136
NRAS 0.036 0.017 -10000 0 -10000 0 0
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.14 0.24 0.47 144 -10000 0 144
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
RhoA/GDP -0.028 0.19 0.24 10 -0.37 105 115
NOS3 -0.15 0.26 -10000 0 -0.53 143 143
GNA11 0.034 0.006 -10000 0 -10000 0 0
MAPKKK cascade -0.13 0.27 -10000 0 -0.56 134 134
E2/ER alpha (dimer)/PELP1/Src -0.14 0.23 0.31 3 -0.46 141 144
ruffle organization -0.014 0.12 0.25 18 -10000 0 18
ROCK2 -0.014 0.13 0.28 18 -0.26 75 93
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
MMP9 -0.097 0.22 0.39 8 -0.52 62 70
MMP2 -0.14 0.22 0.3 5 -0.52 67 72
E-cadherin signaling in keratinocytes

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation -0.025 0.12 0.24 1 -0.33 47 48
adherens junction organization -0.025 0.13 0.23 1 -0.32 55 56
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.14 0.18 0.32 2 -0.38 103 105
FMN1 -0.025 0.12 -10000 0 -0.31 54 54
mol:IP3 -0.024 0.1 -10000 0 -0.29 45 45
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.023 0.12 -10000 0 -0.32 54 54
CTNNB1 0.03 0.051 -10000 0 -0.54 4 4
AKT1 -0.02 0.11 -10000 0 -0.29 48 48
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.028 0.18 -10000 0 -0.5 43 43
CTNND1 0.033 0.008 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.02 0.11 0.26 1 -0.32 42 43
VASP -0.02 0.12 0.24 1 -0.31 51 52
ZYX -0.026 0.12 -10000 0 -0.31 54 54
JUB -0.025 0.12 -10000 0 -0.31 54 54
EGFR(dimer) -0.16 0.2 -10000 0 -0.32 265 265
E-cadherin/beta catenin-gamma catenin 0.036 0.091 -10000 0 -0.32 25 25
mol:PI-3-4-5-P3 -0.007 0.13 -10000 0 -0.3 53 53
PIK3CA 0.032 0.011 -10000 0 -10000 0 0
PI3K -0.007 0.13 -10000 0 -0.3 53 53
FYN -0.025 0.11 0.24 1 -0.38 24 25
mol:Ca2+ -0.023 0.099 -10000 0 -0.28 45 45
JUP 0.034 0.009 -10000 0 -10000 0 0
PIK3R1 -0.018 0.17 -10000 0 -0.54 47 47
mol:DAG -0.024 0.1 -10000 0 -0.29 45 45
CDH1 0.007 0.12 -10000 0 -0.54 22 22
RhoA/GDP -0.14 0.18 0.32 2 -0.38 103 105
establishment of polarity of embryonic epithelium -0.02 0.12 0.24 1 -0.3 51 52
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
CASR -0.023 0.099 0.23 3 -0.32 17 20
RhoA/GTP -0.006 0.1 -10000 0 -0.26 44 44
AKT2 -0.022 0.11 -10000 0 -0.29 49 49
actin cable formation -0.02 0.12 0.25 3 -0.3 51 54
apoptosis 0.018 0.12 0.31 49 -0.26 5 54
CTNNA1 0.034 0.007 -10000 0 -10000 0 0
mol:GDP -0.16 0.18 -10000 0 -0.31 250 250
PIP5K1A -0.022 0.11 -10000 0 -0.32 42 42
PLCG1 -0.025 0.1 -10000 0 -0.29 45 45
Rac1/GTP -0.14 0.19 -10000 0 -0.3 253 253
homophilic cell adhesion -0.001 0.004 -10000 0 -10000 0 0
Ras signaling in the CD4+ TCR pathway

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.2 0.19 -9999 0 -0.41 85 85
MAP3K8 -0.047 0.19 -9999 0 -0.55 65 65
FOS -0.097 0.12 -9999 0 -0.39 20 20
PRKCA -0.006 0.028 -9999 0 -10000 0 0
PTPN7 -0.002 0.045 -9999 0 -10000 0 0
HRAS 0.032 0.013 -9999 0 -10000 0 0
PRKCB -0.013 0.009 -9999 0 -0.018 364 364
NRAS 0.034 0.017 -9999 0 -10000 0 0
RAS family/GTP 0.032 0.037 -9999 0 -10000 0 0
MAPK3 -0.029 0.075 -9999 0 -0.61 3 3
MAP2K1 -0.054 0.089 -9999 0 -0.28 41 41
ELK1 -0.015 0.037 -9999 0 -10000 0 0
BRAF -0.016 0.038 -9999 0 -0.25 6 6
mol:GTP -0.004 0.003 -9999 0 -0.006 365 365
MAPK1 -0.051 0.12 -9999 0 -0.46 28 28
RAF1 -0.017 0.035 -9999 0 -0.25 5 5
KRAS 0.033 0.019 -9999 0 -10000 0 0
IL23-mediated signaling events

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.28 0.53 1 6 -1.2 64 70
IL23A -0.24 0.47 1.1 6 -1 51 57
NF kappa B1 p50/RelA/I kappa B alpha -0.24 0.46 0.76 2 -0.99 62 64
positive regulation of T cell mediated cytotoxicity -0.27 0.52 1.1 8 -1.1 64 72
ITGA3 -0.23 0.46 0.96 6 -0.99 57 63
IL17F -0.18 0.35 0.7 9 -0.66 68 77
IL12B 0.007 0.083 0.31 7 -10000 0 7
STAT1 (dimer) -0.25 0.5 0.92 5 -0.87 117 122
CD4 -0.24 0.46 1 4 -1 55 59
IL23 -0.23 0.45 0.93 6 -1 50 56
IL23R -0.018 0.21 0.82 3 -1.1 10 13
IL1B -0.25 0.49 1.1 6 -1.1 55 61
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.21 0.46 0.95 7 -0.99 53 60
TYK2 0.004 0.06 0.27 3 -10000 0 3
STAT4 0.028 0.069 -10000 0 -0.54 7 7
STAT3 0.034 0.007 -10000 0 -10000 0 0
IL18RAP -0.006 0.16 0.2 2 -0.54 42 44
IL12RB1 0.004 0.06 0.27 3 -10000 0 3
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 0.01 0.074 0.28 5 -10000 0 5
IL23R/JAK2 -0.023 0.22 0.69 3 -1 10 13
positive regulation of chronic inflammatory response -0.27 0.52 1.1 8 -1.1 64 72
natural killer cell activation 0.001 0.015 0.08 2 -0.062 6 8
JAK2 0.004 0.076 0.31 5 -10000 0 5
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
NFKB1 0.034 0.009 -10000 0 -10000 0 0
RELA 0.034 0.01 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.22 0.44 0.92 6 -0.94 51 57
ALOX12B -0.24 0.46 1 4 -0.99 57 61
CXCL1 -0.64 0.73 1 8 -1.2 299 307
T cell proliferation -0.27 0.52 1.1 8 -1.1 64 72
NFKBIA 0.033 0.01 -10000 0 -10000 0 0
IL17A -0.12 0.3 0.66 12 -0.52 61 73
PI3K -0.28 0.47 0.82 1 -0.99 80 81
IFNG 0.022 0.075 0.18 63 -0.12 6 69
STAT3 (dimer) -0.26 0.46 0.81 1 -0.96 76 77
IL18R1 0.04 0.03 -10000 0 -0.54 1 1
IL23/IL23R/JAK2/TYK2/SOCS3 -0.13 0.34 0.79 10 -0.61 61 71
IL18/IL18R 0.065 0.14 0.29 27 -0.34 42 69
macrophage activation -0.013 0.028 0.078 19 -0.043 40 59
TNF -0.24 0.48 1.1 5 -1 57 62
STAT3/STAT4 -0.26 0.47 0.82 2 -1 66 68
STAT4 (dimer) -0.27 0.49 0.88 5 -0.88 120 125
IL18 0.048 0.047 0.2 27 -10000 0 27
IL19 -0.2 0.47 0.97 6 -0.99 50 56
STAT5A (dimer) -0.27 0.49 0.89 4 -0.88 112 116
STAT1 0.059 0.056 -10000 0 -10000 0 0
SOCS3 0.019 0.087 -10000 0 -0.54 12 12
CXCL9 -0.22 0.5 1.1 6 -1.1 57 63
MPO -0.22 0.46 1 4 -0.98 57 61
positive regulation of humoral immune response -0.27 0.52 1.1 8 -1.1 64 72
IL23/IL23R/JAK2/TYK2 -0.28 0.54 1.1 8 -1.2 63 71
IL6 -0.79 0.67 0.97 5 -1.2 368 373
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
IL2 0.049 0.039 0.25 1 -0.52 1 2
positive regulation of tyrosine phosphorylation of STAT protein 0.001 0.015 0.08 2 -0.062 6 8
CD3E -0.24 0.46 0.99 5 -0.99 57 62
keratinocyte proliferation -0.27 0.52 1.1 8 -1.1 64 72
NOS2 -0.24 0.46 0.93 6 -0.77 137 143
IL6-mediated signaling events

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.024 0.3 0.67 3 -0.73 30 33
CRP 0 0.31 0.68 8 -0.72 32 40
cell cycle arrest -0.052 0.34 0.66 6 -0.74 54 60
TIMP1 -0.012 0.28 0.68 8 -0.64 27 35
IL6ST 0.038 0.084 -10000 0 -0.54 9 9
Rac1/GDP -0.088 0.22 0.41 9 -0.42 87 96
AP1 -0.16 0.24 0.48 5 -0.53 93 98
GAB2 0.033 0.016 -10000 0 -10000 0 0
TNFSF11 -0.006 0.32 0.7 7 -0.71 32 39
HSP90B1 0.044 0.14 -10000 0 -0.95 6 6
GAB1 0.036 0.027 -10000 0 -0.54 1 1
MAPK14 -0.13 0.2 0.32 1 -0.54 62 63
AKT1 0.031 0.099 0.34 1 -0.44 10 11
FOXO1 0.004 0.14 0.33 1 -0.44 20 21
MAP2K6 -0.12 0.21 0.34 4 -0.46 86 90
mol:GTP 0.001 0.003 -10000 0 -10000 0 0
MAP2K4 -0.056 0.24 0.48 9 -0.47 72 81
MITF -0.11 0.21 0.35 6 -0.44 90 96
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.034 0.006 -10000 0 -10000 0 0
A2M -0.16 0.49 -10000 0 -1.3 74 74
CEBPB 0.039 0.03 -10000 0 -0.54 1 1
GRB2/SOS1/GAB family/SHP2 -0.002 0.14 0.36 2 -0.47 23 25
STAT3 -0.071 0.36 0.66 6 -0.82 54 60
STAT1 0.033 0.14 -10000 0 -0.84 9 9
CEBPD -0.08 0.44 0.67 4 -1 73 77
PIK3CA 0.034 0.009 -10000 0 -10000 0 0
PI3K 0.008 0.13 -10000 0 -0.4 44 44
JUN -0.066 0.22 -10000 0 -0.54 89 89
PIAS3/MITF -0.1 0.2 0.38 1 -0.44 73 74
MAPK11 -0.13 0.2 0.32 1 -0.54 61 62
STAT3 (dimer)/FOXO1 -0.085 0.33 0.6 8 -0.68 68 76
GRB2/SOS1/GAB family -0.083 0.18 0.37 2 -0.44 46 48
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.14 0.19 0.34 3 -0.42 98 101
GRB2 0.036 0.02 -10000 0 -10000 0 0
JAK2 0.033 0.011 0.18 1 -10000 0 1
LBP 0.009 0.28 0.7 7 -0.66 18 25
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
JAK1 0.038 0.013 -10000 0 -10000 0 0
MYC -0.014 0.38 0.72 9 -0.95 43 52
FGG -0.025 0.3 0.7 3 -0.74 29 32
macrophage differentiation -0.052 0.34 0.66 6 -0.74 54 60
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.15 0.19 -10000 0 -0.3 271 271
JUNB -0.03 0.3 0.64 3 -0.72 34 37
FOS -0.35 0.27 -10000 0 -0.54 344 344
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.12 0.22 0.37 9 -0.44 101 110
STAT1/PIAS1 -0.072 0.23 0.41 11 -0.43 81 92
GRB2/SOS1/GAB family/SHP2/PI3K 0.028 0.1 -10000 0 -0.45 11 11
STAT3 (dimer) -0.069 0.35 0.66 6 -0.8 54 60
PRKCD -0.035 0.26 0.52 11 -0.53 57 68
IL6R 0.03 0.031 -10000 0 -0.55 1 1
SOCS3 -0.15 0.24 -10000 0 -0.9 28 28
gp130 (dimer)/JAK1/JAK1/LMO4 0.074 0.12 0.31 3 -0.32 30 33
Rac1/GTP -0.077 0.23 0.43 10 -0.44 86 96
HCK 0.037 0.023 -10000 0 -10000 0 0
MAPKKK cascade 0.02 0.16 0.41 1 -0.56 26 27
bone resorption -0.002 0.31 0.67 10 -0.67 32 42
IRF1 -0.023 0.3 0.68 6 -0.7 35 41
mol:GDP -0.1 0.21 0.39 10 -0.42 98 108
SOS1 0.038 0.009 -10000 0 -10000 0 0
VAV1 -0.1 0.22 0.39 10 -0.42 98 108
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.15 0.2 -10000 0 -0.6 56 56
PTPN11 0.021 0.093 -10000 0 -0.8 5 5
IL6/IL6RA -0.23 0.2 -10000 0 -0.38 298 298
gp130 (dimer)/TYK2/TYK2/LMO4 0.068 0.11 0.29 1 -0.33 27 28
gp130 (dimer)/JAK2/JAK2/LMO4 0.063 0.11 0.29 1 -0.32 30 31
IL6 -0.37 0.26 0.23 1 -0.53 366 367
PIAS3 0.028 0.014 -10000 0 -10000 0 0
PTPRE 0.004 0.043 -10000 0 -0.52 1 1
PIAS1 0.034 0.007 -10000 0 -10000 0 0
RAC1 0.036 0.006 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.14 0.17 0.29 3 -0.37 103 106
LMO4 0.03 0.12 0.24 4 -0.54 21 25
STAT3 (dimer)/PIAS3 -0.066 0.32 0.63 4 -0.71 58 62
MCL1 0.068 0.13 0.52 2 -0.71 1 3
IL4-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.14 0.62 0.96 1 -1.2 90 91
STAT6 (cleaved dimer) -0.23 0.54 -10000 0 -1.1 107 107
IGHG1 0.028 0.3 0.63 16 -0.66 8 24
IGHG3 -0.15 0.58 0.78 3 -1.1 107 110
AKT1 -0.025 0.36 0.66 1 -0.71 37 38
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 0.029 0.29 0.59 4 -0.86 13 17
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.023 0.37 0.64 6 -0.76 38 44
THY1 -0.14 0.62 1 5 -1.1 97 102
MYB -0.006 0.16 -10000 0 -0.54 40 40
HMGA1 0.038 0.023 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.001 0.4 0.73 13 -0.66 52 65
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP 0.002 0.35 0.63 6 -0.78 20 26
SP1 0.057 0.045 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.007 0.057 -10000 0 -0.55 1 1
STAT6 (dimer)/ETS1 -0.16 0.59 0.84 1 -1.1 105 106
SOCS1 -0.059 0.41 0.77 1 -0.71 82 83
SOCS3 -0.015 0.39 -10000 0 -1.1 20 20
FCER2 -0.14 0.52 0.89 4 -0.89 75 79
PARP14 0.042 0.032 -10000 0 -10000 0 0
CCL17 -0.12 0.64 1 10 -1.1 94 104
GRB2 0.034 0.019 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP 0.031 0.29 0.58 11 -0.67 15 26
T cell proliferation -0.18 0.62 -10000 0 -1.1 106 106
IL4R/JAK1 -0.15 0.61 -10000 0 -1.1 96 96
EGR2 -0.51 0.86 0.98 4 -1.3 250 254
JAK2 0.031 0.089 0.26 4 -10000 0 4
JAK3 0.035 0.019 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
JAK1 0.036 0.047 -10000 0 -10000 0 0
COL1A2 0.039 0.32 0.66 9 -1.1 11 20
CCL26 -0.14 0.62 1.1 5 -1.1 97 102
IL4R -0.13 0.68 1.2 6 -1.2 95 101
PTPN6 0.016 0.044 0.2 3 -10000 0 3
IL13RA2 -0.15 0.63 0.97 4 -1.2 98 102
IL13RA1 0.032 0.091 -10000 0 -10000 0 0
IRF4 0.065 0.21 0.71 3 -0.68 7 10
ARG1 0.049 0.27 0.73 4 -1.2 4 8
CBL -0.013 0.37 0.66 6 -0.62 55 61
GTF3A 0.1 0.066 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL13RA1/JAK2 0.051 0.13 0.36 5 -10000 0 5
IRF4/BCL6 0.03 0.21 -10000 0 -0.66 9 9
CD40LG 0.049 0.033 0.32 2 -10000 0 2
MAPK14 -0.012 0.38 0.68 4 -0.67 50 54
mitosis -0.019 0.34 0.61 3 -0.68 35 38
STAT6 -0.15 0.76 1.2 14 -1.3 104 118
SPI1 0.044 0.034 -10000 0 -0.24 1 1
RPS6KB1 -0.002 0.33 0.65 5 -0.69 28 33
STAT6 (dimer) -0.15 0.76 1.2 13 -1.3 104 117
STAT6 (dimer)/PARP14 -0.17 0.64 -10000 0 -1.2 106 106
mast cell activation -0.006 0.027 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.016 0.36 0.63 7 -0.71 43 50
FRAP1 -0.025 0.36 0.66 1 -0.71 37 38
LTA -0.14 0.62 0.93 3 -1.1 97 100
FES 0.031 0.037 -10000 0 -0.54 2 2
T-helper 1 cell differentiation 0.13 0.74 1.3 105 -1.2 14 119
CCL11 -0.1 0.61 0.91 4 -1.1 96 100
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES 0.011 0.34 0.62 7 -0.87 17 24
IL2RG 0.045 0.043 0.22 7 -10000 0 7
IL10 -0.1 0.63 1.1 7 -1.1 84 91
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
IRS2 -0.1 0.24 -10000 0 -0.54 117 117
IL4 0.047 0.3 0.77 8 -1 14 22
IL5 -0.14 0.62 1 4 -1.1 101 105
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.058 0.55 0.98 14 -0.87 92 106
COL1A1 0.12 0.41 0.84 18 -1 19 37
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.16 0.62 -10000 0 -1.2 89 89
IL2R gamma/JAK3 0.063 0.04 -10000 0 -10000 0 0
TFF3 -0.26 0.73 0.96 1 -1.3 132 133
ALOX15 -0.14 0.62 0.93 3 -1.1 103 106
MYBL1 0.049 0.055 -10000 0 -10000 0 0
T-helper 2 cell differentiation -0.091 0.53 0.82 6 -0.91 98 104
SHC1 0.028 0.014 -10000 0 -10000 0 0
CEBPB 0.035 0.034 -10000 0 -0.39 2 2
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.042 0.37 0.62 5 -0.7 45 50
mol:PI-3-4-5-P3 -0.024 0.36 0.66 1 -0.71 37 38
PI3K -0.031 0.37 0.66 1 -0.76 38 39
DOK2 0.026 0.039 -10000 0 -0.54 2 2
ETS1 0.002 0.06 0.2 2 -0.29 3 5
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 0.04 0.28 0.56 11 -0.66 12 23
ITGB3 -0.14 0.62 1 2 -1.2 92 94
PIGR -0.39 0.84 1 11 -1.3 208 219
IGHE -0.044 0.1 0.18 11 -0.28 19 30
MAPKKK cascade 0.041 0.28 0.56 11 -0.64 12 23
BCL6 -0.025 0.17 -10000 0 -0.54 51 51
OPRM1 -0.14 0.62 0.92 4 -1.1 102 106
RETNLB -0.14 0.62 0.93 3 -1.1 95 98
SELP -0.29 0.82 1 10 -1.4 158 168
AICDA -0.14 0.59 0.94 1 -1.1 94 95
FAS signaling pathway (CD95)

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.017 0.09 0.21 72 -10000 0 72
RFC1 0.016 0.085 0.21 66 -10000 0 66
PRKDC 0.037 0.11 0.24 73 -10000 0 73
RIPK1 0.041 0.009 -10000 0 -10000 0 0
CASP7 -0.042 0.12 -10000 0 -0.76 10 10
FASLG/FAS/FADD/FAF1 -0.024 0.091 0.26 9 -0.32 16 25
MAP2K4 -0.18 0.19 -10000 0 -0.42 114 114
mol:ceramide -0.074 0.13 0.27 1 -0.37 34 35
GSN -0.06 0.17 0.22 54 -0.34 107 161
FASLG/FAS/FADD/FAF1/Caspase 8 -0.032 0.097 0.3 4 -0.32 16 20
FAS -0.047 0.14 -10000 0 -0.56 33 33
BID -0.023 0.022 -10000 0 -10000 0 0
MAP3K1 -0.093 0.14 0.28 1 -0.45 28 29
MAP3K7 0.026 0.01 -10000 0 -10000 0 0
RB1 0.018 0.082 0.21 69 -10000 0 69
CFLAR 0.04 0.026 -10000 0 -0.52 1 1
HGF/MET -0.008 0.16 -10000 0 -0.36 88 88
ARHGDIB 0.018 0.089 0.22 69 -10000 0 69
FADD -0.008 0.028 -10000 0 -10000 0 0
actin filament polymerization 0.058 0.17 0.34 108 -0.23 22 130
NFKB1 -0.1 0.13 -10000 0 -0.67 10 10
MAPK8 -0.32 0.25 -10000 0 -0.45 371 371
DFFA 0.015 0.084 0.21 66 -10000 0 66
DNA fragmentation during apoptosis 0.018 0.089 0.21 53 -10000 0 53
FAS/FADD/MET -0.029 0.15 -10000 0 -0.39 65 65
CFLAR/RIP1 0.06 0.027 -10000 0 -0.37 1 1
FAIM3 0.035 0.03 -10000 0 -10000 0 0
FAF1 -0.016 0.033 -10000 0 -10000 0 0
PARP1 0.023 0.097 0.24 73 -10000 0 73
DFFB 0.015 0.086 0.21 66 -10000 0 66
CHUK -0.11 0.12 -10000 0 -0.63 10 10
FASLG 0.001 0.062 -10000 0 -0.55 1 1
FAS/FADD -0.033 0.1 -10000 0 -0.42 28 28
HGF 0.035 0.01 -10000 0 -10000 0 0
LMNA 0.021 0.099 0.42 14 -10000 0 14
CASP6 0.017 0.086 0.21 64 -10000 0 64
CASP10 -0.012 0.03 -10000 0 -10000 0 0
CASP3 0.019 0.1 0.26 66 -0.22 17 83
PTPN13 -0.016 0.16 -10000 0 -0.54 45 45
CASP8 -0.028 0.022 -10000 0 -10000 0 0
IL6 -0.88 0.56 -10000 0 -1.2 380 380
MET -0.022 0.17 -10000 0 -0.54 50 50
ICAD/CAD 0.01 0.075 -10000 0 -10000 0 0
FASLG/FAS/FADD/FAF1/Caspase 10 -0.076 0.13 0.27 1 -0.37 34 35
activation of caspase activity by cytochrome c -0.023 0.022 -10000 0 -10000 0 0
PAK2 0.015 0.095 0.25 34 -10000 0 34
BCL2 -0.068 0.22 -10000 0 -0.54 91 91
Integrins in angiogenesis

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.06 0.036 -10000 0 -10000 0 0
alphaV beta3 Integrin -0.23 0.18 -10000 0 -0.34 370 370
PTK2 -0.046 0.12 0.38 3 -0.48 7 10
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
PI4KB 0.028 0.014 -10000 0 -10000 0 0
MFGE8 0.008 0.13 -10000 0 -0.54 25 25
SRC 0.033 0.008 -10000 0 -10000 0 0
CDKN1B -0.1 0.13 -10000 0 -0.57 27 27
VEGFA 0.051 0.048 0.18 59 -10000 0 59
ILK -0.087 0.095 -10000 0 -0.47 16 16
ROCK1 0.034 0.006 -10000 0 -10000 0 0
AKT1 -0.082 0.089 -10000 0 -0.45 15 15
PTK2B 0.027 0.05 0.31 5 -0.3 1 6
alphaV/beta3 Integrin/JAM-A -0.16 0.17 -10000 0 -0.3 276 276
CBL 0.031 0.011 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.065 0.03 -10000 0 -0.34 1 1
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.16 0.25 -10000 0 -0.38 258 258
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.038 0.061 -10000 0 -0.35 5 5
alphaV/beta3 Integrin/Syndecan-1 0.091 0.053 -10000 0 -0.34 1 1
PI4KA 0.032 0.009 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.3 0.25 -10000 0 -0.49 274 274
PI4 Kinase 0.038 0.023 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin 0.1 0.069 -10000 0 -0.34 4 4
RPS6KB1 -0.28 0.23 0.6 1 -0.51 204 205
TLN1 0.034 0.006 -10000 0 -10000 0 0
MAPK3 -0.36 0.29 -10000 0 -0.56 328 328
GPR124 0.009 0.1 -10000 0 -0.54 17 17
MAPK1 -0.38 0.29 -10000 0 -0.56 344 344
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
alphaV/beta3 Integrin/Tumstatin 0.066 0.029 -10000 0 -0.34 1 1
cell adhesion 0.034 0.093 -10000 0 -0.3 32 32
ANGPTL3 0.033 0.007 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Src 0.073 0.038 -10000 0 -10000 0 0
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
TGFBR2 -0.004 0.14 -10000 0 -0.54 34 34
ITGB3 0.035 0.019 -10000 0 -10000 0 0
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
RAC1 0.034 0.005 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.04 0.08 -10000 0 -0.34 18 18
apoptosis 0.034 0.027 -10000 0 -0.54 1 1
CD47 0.023 0.08 -10000 0 -0.54 10 10
alphaV/beta3 Integrin/CD47 0.058 0.064 -10000 0 -0.34 11 11
VCL 0.034 0.005 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Del1 0.057 0.096 0.26 2 -0.34 23 25
CSF1 0.034 0.009 0.18 1 -10000 0 1
PIK3C2A -0.084 0.09 -10000 0 -0.46 13 13
PI4 Kinase/Pyk2 -0.15 0.13 -10000 0 -0.27 179 179
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.09 0.046 -10000 0 -0.31 1 1
FAK1/Vinculin -0.032 0.11 0.39 3 -0.37 8 11
alphaV beta3/Integrin/ppsTEM5 0.041 0.081 -10000 0 -0.34 18 18
RHOA 0.033 0.008 -10000 0 -10000 0 0
VTN 0.033 0.011 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
F11R -0.23 0.2 -10000 0 -0.4 298 298
alphaV/beta3 Integrin/Lactadherin 0.048 0.091 -10000 0 -0.34 23 23
alphaV/beta3 Integrin/TGFBR2 0.04 0.1 -10000 0 -0.34 33 33
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.07 0.042 -10000 0 -0.31 1 1
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.062 0.028 -10000 0 -0.31 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.14 0.069 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Pyk2 0.057 0.048 0.3 1 -0.3 1 2
SDC1 0.074 0.066 -10000 0 -10000 0 0
VAV3 0.013 0.071 -10000 0 -0.3 19 19
PTPN11 0.034 0.004 -10000 0 -10000 0 0
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
FAK1/Paxillin -0.032 0.12 0.37 4 -0.37 8 12
cell migration -0.032 0.1 0.35 4 -0.35 7 11
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
PI3K -0.17 0.18 -10000 0 -0.31 273 273
SPP1 0.092 0.088 -10000 0 -0.54 3 3
KDR 0.034 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.034 0.027 -10000 0 -0.54 1 1
COL4A3 0.034 0.006 -10000 0 -10000 0 0
angiogenesis -0.37 0.28 -10000 0 -0.56 324 324
Rac1/GTP 0.031 0.068 -10000 0 -0.28 18 18
EDIL3 0.025 0.13 0.18 56 -0.54 22 78
cell proliferation 0.04 0.1 -10000 0 -0.34 33 33
EPHB forward signaling

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.048 0.034 0.23 2 -0.34 1 3
cell-cell adhesion 0.1 0.12 0.27 176 -10000 0 176
Ephrin B/EPHB2/RasGAP 0.081 0.068 -10000 0 -0.3 7 7
ITSN1 0.034 0.005 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
Ephrin B1/EPHB3 0.045 0.027 -10000 0 -0.34 2 2
Ephrin B1/EPHB1 -0.099 0.19 -10000 0 -0.34 193 193
HRAS/GDP -0.082 0.16 -10000 0 -0.37 48 48
Ephrin B/EPHB1/GRB7 -0.055 0.18 -10000 0 -0.31 158 158
Endophilin/SYNJ1 0.017 0.049 0.26 1 -0.28 7 8
KRAS 0.035 0.019 -10000 0 -10000 0 0
Ephrin B/EPHB1/Src -0.056 0.19 -10000 0 -0.31 175 175
endothelial cell migration 0.027 0.11 -10000 0 -0.3 47 47
GRB2 0.034 0.019 -10000 0 -10000 0 0
GRB7 0.029 0.013 -10000 0 -10000 0 0
PAK1 0.008 0.065 0.3 5 -0.28 5 10
HRAS 0.034 0.013 -10000 0 -10000 0 0
RRAS 0.017 0.049 0.26 1 -0.28 7 8
DNM1 0.035 0.008 -10000 0 -10000 0 0
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.093 0.16 0.36 2 -0.29 189 191
lamellipodium assembly -0.1 0.12 -10000 0 -0.27 176 176
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.062 0.15 -10000 0 -0.29 128 128
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
EPHB2 0.043 0.038 -10000 0 -10000 0 0
EPHB3 0.035 0.016 -10000 0 -10000 0 0
EPHB1 -0.18 0.28 -10000 0 -0.54 191 191
EPHB4 0.036 0.032 -10000 0 -0.54 1 1
mol:GDP -0.081 0.14 -10000 0 -0.39 46 46
Ephrin B/EPHB2 0.068 0.059 -10000 0 -0.3 7 7
Ephrin B/EPHB3 0.062 0.054 -10000 0 -0.3 7 7
JNK cascade -0.089 0.16 0.39 5 -0.3 182 187
Ephrin B/EPHB1 -0.069 0.18 -10000 0 -0.3 189 189
RAP1/GDP -0.059 0.14 -10000 0 -0.36 41 41
EFNB2 0.026 0.058 -10000 0 -0.54 5 5
EFNB3 0.031 0.011 -10000 0 -10000 0 0
EFNB1 0.033 0.036 -10000 0 -0.54 2 2
Ephrin B2/EPHB1-2 -0.076 0.19 -10000 0 -0.31 190 190
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CDC42/GTP -0.061 0.17 -10000 0 -0.34 44 44
Rap1/GTP -0.074 0.15 -10000 0 -0.47 7 7
axon guidance 0.048 0.034 0.23 2 -0.34 1 3
MAPK3 -0.047 0.14 0.26 1 -0.38 31 32
MAPK1 -0.054 0.14 -10000 0 -0.38 33 33
Rac1/GDP -0.074 0.14 -10000 0 -0.36 45 45
actin cytoskeleton reorganization -0.077 0.12 -10000 0 -0.31 31 31
CDC42/GDP -0.073 0.14 -10000 0 -0.37 44 44
PI3K 0.032 0.12 -10000 0 -0.3 47 47
EFNA5 0.033 0.029 -10000 0 -0.54 1 1
Ephrin B2/EPHB4 0.039 0.046 -10000 0 -0.31 7 7
Ephrin B/EPHB2/Intersectin/N-WASP 0.018 0.069 -10000 0 -0.29 8 8
CDC42 0.033 0.008 -10000 0 -10000 0 0
RAS family/GTP -0.076 0.14 -10000 0 -0.27 153 153
PTK2 0.14 0.27 0.67 101 -10000 0 101
MAP4K4 -0.09 0.16 0.39 5 -0.3 182 187
SRC 0.033 0.008 -10000 0 -10000 0 0
KALRN 0.034 0.006 -10000 0 -10000 0 0
Intersectin/N-WASP 0.049 0.022 -10000 0 -0.4 1 1
neuron projection morphogenesis -0.053 0.14 0.42 6 -0.34 14 20
MAP2K1 -0.059 0.14 -10000 0 -0.39 34 34
WASL 0.033 0.026 -10000 0 -0.54 1 1
Ephrin B1/EPHB1-2/NCK1 -0.061 0.2 -10000 0 -0.31 190 190
cell migration -0.064 0.17 0.31 4 -0.42 37 41
NRAS 0.036 0.017 -10000 0 -10000 0 0
SYNJ1 0.018 0.05 0.26 1 -0.28 7 8
PXN 0.034 0.004 -10000 0 -10000 0 0
TF -0.015 0.068 0.25 1 -0.28 22 23
HRAS/GTP -0.061 0.17 -10000 0 -0.28 177 177
Ephrin B1/EPHB1-2 -0.072 0.19 -10000 0 -0.31 190 190
cell adhesion mediated by integrin -0.008 0.048 0.27 7 -0.2 10 17
RAC1 0.034 0.005 -10000 0 -10000 0 0
mol:GTP -0.061 0.18 -10000 0 -0.29 180 180
RAC1-CDC42/GTP -0.087 0.14 -10000 0 -0.27 176 176
RASA1 0.034 0.012 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.062 0.14 -10000 0 -0.36 42 42
ruffle organization -0.095 0.14 0.41 3 -0.47 8 11
NCK1 0.034 0.005 -10000 0 -10000 0 0
receptor internalization -0.006 0.049 0.25 1 -0.27 7 8
Ephrin B/EPHB2/KALRN 0.082 0.067 -10000 0 -0.3 7 7
ROCK1 0.024 0.037 -10000 0 -0.31 2 2
RAS family/GDP -0.085 0.095 -10000 0 -0.31 28 28
Rac1/GTP -0.088 0.14 -10000 0 -0.28 176 176
Ephrin B/EPHB1/Src/Paxillin -0.087 0.16 -10000 0 -0.28 180 180
PLK1 signaling events

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.036 0.043 0.13 3 -0.12 25 28
BUB1B 0.094 0.063 0.16 155 -0.14 1 156
PLK1 0.046 0.036 0.11 64 -10000 0 64
PLK1S1 0.023 0.019 0.057 58 -10000 0 58
KIF2A 0.038 0.037 0.27 4 -10000 0 4
regulation of mitotic centrosome separation 0.046 0.035 0.11 63 -10000 0 63
GOLGA2 0.035 0.008 -10000 0 -10000 0 0
Hec1/SPC24 0.1 0.063 0.17 225 -10000 0 225
WEE1 0.049 0.079 0.22 2 -0.3 18 20
cytokinesis 0.13 0.082 0.22 153 -0.39 1 154
PP2A-alpha B56 0.14 0.11 -10000 0 -0.47 5 5
AURKA 0.052 0.04 0.13 18 -0.16 2 20
PICH/PLK1 0.13 0.095 0.24 172 -10000 0 172
CENPE 0.084 0.067 0.16 188 -10000 0 188
RhoA/GTP 0.025 0.006 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.039 0.037 0.27 4 -10000 0 4
PPP2CA 0.034 0.006 -10000 0 -10000 0 0
FZR1 0.034 0.009 0.18 1 -10000 0 1
TPX2 0.081 0.039 0.12 122 -10000 0 122
PAK1 0.043 0.045 -10000 0 -10000 0 0
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.034 0.007 -10000 0 -10000 0 0
CLSPN 0.044 0.054 0.14 37 -0.2 12 49
GORASP1 0.034 0.006 -10000 0 -10000 0 0
metaphase 0.001 0.004 0.015 40 -10000 0 40
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.023 0.019 0.057 58 -10000 0 58
G2 phase of mitotic cell cycle 0.001 0.003 0.016 7 -10000 0 7
STAG2 0.035 0.003 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP 0.021 0.093 -10000 0 -0.5 15 15
spindle elongation 0.046 0.035 0.11 63 -10000 0 63
ODF2 0.037 0.015 -10000 0 -10000 0 0
BUB1 0.12 0.12 -10000 0 -0.48 8 8
TPT1 0.014 0.059 0.13 1 -0.17 42 43
CDC25C 0.084 0.067 0.17 12 -0.22 11 23
CDC25B 0.049 0.041 -10000 0 -10000 0 0
SGOL1 0.036 0.043 0.12 25 -0.13 3 28
RHOA 0.033 0.008 -10000 0 -10000 0 0
CCNB1/CDK1 0.092 0.068 0.24 26 -0.21 1 27
CDC14B -0.001 0.065 -10000 0 -0.4 13 13
CDC20 0.084 0.071 -10000 0 -10000 0 0
PLK1/PBIP1 0.074 0.055 0.13 199 -10000 0 199
mitosis -0.001 0.003 0.033 2 -10000 0 2
FBXO5 0.038 0.044 0.16 24 -10000 0 24
CDC2 0.005 0.004 0.016 31 -10000 0 31
NDC80 0.11 0.076 -10000 0 -10000 0 0
metaphase plate congression 0.027 0.058 0.14 1 -0.21 25 26
ERCC6L 0.12 0.095 0.24 165 -10000 0 165
NLP/gamma Tubulin 0.025 0.024 0.086 12 -0.094 2 14
microtubule cytoskeleton organization 0.014 0.059 0.13 1 -0.17 42 43
G2/M transition DNA damage checkpoint 0 0.003 0.013 13 -10000 0 13
PPP1R12A 0.035 0.006 -10000 0 -10000 0 0
interphase 0 0.003 0.013 13 -10000 0 13
PLK1/PRC1-2 0.17 0.1 0.27 223 -10000 0 223
GRASP65/GM130/RAB1/GTP/PLK1 0.084 0.033 -10000 0 -10000 0 0
RAB1A 0.034 0.005 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.04 0.033 0.095 77 -10000 0 77
mitotic prometaphase 0.001 0.005 0.021 26 -10000 0 26
proteasomal ubiquitin-dependent protein catabolic process 0.052 0.045 -10000 0 -10000 0 0
microtubule-based process 0.12 0.066 0.18 263 -10000 0 263
Golgi organization 0.046 0.035 0.11 63 -10000 0 63
Cohesin/SA2 0.055 0.027 0.16 2 -10000 0 2
PPP1CB/MYPT1 0.051 0.01 -10000 0 -10000 0 0
KIF20A 0.13 0.072 -10000 0 -10000 0 0
APC/C/CDC20 0.095 0.067 0.18 161 -10000 0 161
PPP2R1A 0.034 0.005 -10000 0 -10000 0 0
chromosome segregation 0.073 0.054 0.13 199 -10000 0 199
PRC1 0.1 0.075 -10000 0 -10000 0 0
ECT2 0.073 0.074 0.2 90 -10000 0 90
C13orf34 0.039 0.031 0.093 64 -10000 0 64
NUDC 0.027 0.058 -10000 0 -0.21 25 25
regulation of attachment of spindle microtubules to kinetochore 0.094 0.063 0.16 155 -0.14 1 156
spindle assembly 0.036 0.029 0.097 35 -10000 0 35
spindle stabilization 0.023 0.019 0.057 58 -10000 0 58
APC/C/HCDH1 0.022 0.059 -10000 0 -0.34 13 13
MKLP2/PLK1 0.12 0.067 0.18 263 -10000 0 263
CCNB1 0.089 0.072 -10000 0 -10000 0 0
PPP1CB 0.035 0.004 -10000 0 -10000 0 0
BTRC 0.038 0.022 -10000 0 -10000 0 0
ROCK2 0.041 0.049 0.21 1 -0.28 6 7
TUBG1 0.027 0.039 0.12 3 -0.16 16 19
G2/M transition of mitotic cell cycle 0.061 0.064 0.21 25 -0.21 1 26
MLF1IP 0.071 0.066 0.14 247 -10000 0 247
INCENP 0.048 0.041 -10000 0 -10000 0 0
Visual signal transduction: Rods

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.034 0.007 -10000 0 -10000 0 0
GNAT1/GTP 0.025 0.005 -10000 0 -10000 0 0
Metarhodopsin II/Arrestin 0.058 0.041 -10000 0 -0.34 1 1
PDE6G/GNAT1/GTP 0.043 0.016 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.033 0.007 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
CNG Channel -0.09 0.17 -10000 0 -0.29 206 206
mol:Na + -0.088 0.17 -10000 0 -0.28 214 214
mol:ADP 0 0 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.05 0.1 -10000 0 -0.32 28 28
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel -0.082 0.18 -10000 0 -0.29 193 193
CNGB1 0.03 0.012 -10000 0 -10000 0 0
RDH5 -0.43 0.23 -10000 0 -0.54 412 412
SAG 0.056 0.061 -10000 0 -0.54 1 1
mol:Ca2+ -0.12 0.15 0.36 6 -0.5 7 13
Na + (4 Units) -0.089 0.16 -10000 0 -0.28 144 144
RGS9 0.002 0.13 -10000 0 -0.54 27 27
GNB1/GNGT1 0.072 0.046 0.26 1 -10000 0 1
GNAT1/GDP 0.058 0.092 -10000 0 -0.27 28 28
GUCY2D 0.031 0.011 -10000 0 -10000 0 0
GNGT1 0.068 0.062 -10000 0 -10000 0 0
GUCY2F 0.033 0.038 -10000 0 -0.54 2 2
GNB5 0.032 0.026 -10000 0 -0.54 1 1
mol:GMP (4 units) 0.026 0.052 -10000 0 -0.29 11 11
mol:11-cis-retinal -0.43 0.23 -10000 0 -0.54 412 412
mol:cGMP 0.056 0.073 -10000 0 -0.34 13 13
GNB1 0.034 0.012 -10000 0 -10000 0 0
Rhodopsin -0.31 0.18 -10000 0 -0.4 407 407
SLC24A1 0.034 0.007 -10000 0 -10000 0 0
CNGA1 -0.21 0.29 -10000 0 -0.54 219 219
Metarhodopsin II 0.022 0.003 -10000 0 -10000 0 0
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.067 0.072 -10000 0 -0.34 12 12
RGS9BP 0.055 0.066 -10000 0 -0.54 2 2
Metarhodopsin II/Transducin 0.037 0.038 0.17 1 -0.18 6 7
GCAP Family/Ca ++ 0.055 0.064 -10000 0 -0.34 12 12
PDE6A/B 0.038 0.071 -10000 0 -0.4 12 12
mol:Pi 0.049 0.1 -10000 0 -0.32 28 28
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin 0.08 0.044 0.24 1 -10000 0 1
PDE6B 0.021 0.089 -10000 0 -0.54 12 12
PDE6A 0.034 0.009 -10000 0 -10000 0 0
PDE6G 0.034 0.014 -10000 0 -10000 0 0
RHO 0.034 0.005 -10000 0 -10000 0 0
PDE6 0.067 0.11 -10000 0 -0.3 25 25
GUCA1A 0.024 0.076 -10000 0 -0.54 9 9
GC2/GCAP Family 0.074 0.076 -10000 0 -0.36 13 13
GUCA1C 0.031 0.046 -10000 0 -0.54 3 3
GUCA1B 0.033 0.027 -10000 0 -0.54 1 1
Signaling events mediated by the Hedgehog family

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.044 0.24 0.6 2 -0.55 78 80
IHH 0.021 0.075 0.24 2 -0.13 80 82
SHH Np/Cholesterol/GAS1 -0.068 0.15 -10000 0 -0.31 128 128
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.067 0.15 0.31 128 -10000 0 128
SMO/beta Arrestin2 -0.001 0.18 0.41 2 -0.47 31 33
SMO -0.016 0.18 0.45 2 -0.47 35 37
AKT1 -0.02 0.19 0.31 1 -0.59 37 38
ARRB2 0.031 0.011 -10000 0 -10000 0 0
BOC -0.091 0.24 -10000 0 -0.54 111 111
ADRBK1 0.032 0.01 -10000 0 -10000 0 0
heart looping -0.015 0.18 0.44 2 -0.47 35 37
STIL 0.041 0.15 0.34 30 -0.33 8 38
DHH N/PTCH2 0.05 0.01 -10000 0 -10000 0 0
DHH N/PTCH1 0.006 0.16 0.38 2 -0.32 85 87
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DHH 0.034 0.004 -10000 0 -10000 0 0
PTHLH -0.11 0.39 0.52 6 -0.9 95 101
determination of left/right symmetry -0.015 0.18 0.44 2 -0.47 35 37
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
skeletal system development -0.11 0.39 0.52 6 -0.88 95 101
IHH N/Hhip 0.038 0.053 -10000 0 -10000 0 0
DHH N/Hhip 0.05 0.012 -10000 0 -10000 0 0
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.015 0.18 0.44 2 -0.47 35 37
pancreas development 0.034 0.011 -10000 0 -10000 0 0
HHAT 0.024 0.059 -10000 0 -0.54 5 5
PI3K 0.006 0.13 -10000 0 -0.4 44 44
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.14 0.27 -10000 0 -0.54 158 158
somite specification -0.015 0.18 0.44 2 -0.47 35 37
SHH Np/Cholesterol/PTCH1 -0.009 0.12 -10000 0 -0.26 66 66
SHH Np/Cholesterol/PTCH2 0.024 0.037 -10000 0 -0.31 5 5
SHH Np/Cholesterol/Megalin -0.055 0.14 -10000 0 -0.32 110 110
SHH 0.011 0.043 -10000 0 -0.4 5 5
catabolic process -0.009 0.17 0.47 2 -0.35 90 92
SMO/Vitamin D3 0.01 0.17 0.41 15 -0.36 31 46
SHH Np/Cholesterol/Hhip 0.025 0.038 -10000 0 -0.31 5 5
LRP2 -0.12 0.25 -10000 0 -0.54 136 136
receptor-mediated endocytosis -0.061 0.2 0.35 8 -0.49 43 51
SHH Np/Cholesterol/BOC -0.038 0.13 -10000 0 -0.31 87 87
SHH Np/Cholesterol/CDO 0.02 0.049 -10000 0 -0.35 7 7
mesenchymal cell differentiation -0.025 0.038 0.31 5 -10000 0 5
mol:Vitamin D3 0.026 0.16 0.42 16 -0.27 66 82
IHH N/PTCH2 0.038 0.052 -10000 0 -10000 0 0
CDON 0.027 0.045 -10000 0 -0.54 3 3
IHH N/PTCH1 0 0.18 0.47 2 -0.35 92 94
Megalin/LRPAP1 -0.071 0.2 -10000 0 -0.39 139 139
PTCH2 0.034 0.006 -10000 0 -10000 0 0
SHH Np/Cholesterol 0.014 0.034 -10000 0 -0.31 5 5
PTCH1 -0.009 0.18 0.47 2 -0.35 90 92
HHIP 0.035 0.011 -10000 0 -10000 0 0
Fc-epsilon receptor I signaling in mast cells

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A -0.034 0.18 -10000 0 -0.54 60 60
LAT2 -0.029 0.13 -10000 0 -0.35 47 47
AP1 -0.19 0.23 -10000 0 -0.46 153 153
mol:PIP3 0.005 0.2 0.35 28 -0.46 34 62
IKBKB 0.022 0.14 0.28 54 -0.27 34 88
AKT1 -0.007 0.21 0.34 75 -0.47 28 103
IKBKG 0.004 0.13 0.27 24 -0.27 36 60
MS4A2 -0.056 0.21 -10000 0 -0.53 83 83
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
MAP3K1 0.01 0.15 0.34 14 -0.41 24 38
mol:Ca2+ 0.013 0.16 0.31 33 -0.35 31 64
LYN 0.032 0.018 -10000 0 -10000 0 0
CBLB -0.029 0.13 -10000 0 -0.36 45 45
SHC1 0.028 0.014 -10000 0 -10000 0 0
RasGAP/p62DOK -0.089 0.18 -10000 0 -0.31 203 203
positive regulation of cell migration 0 0 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.013 0.2 0.35 63 -0.34 86 149
PTPN13 -0.037 0.19 -10000 0 -0.54 35 35
PTPN11 0.033 0.021 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation 0.003 0.16 0.35 24 -0.34 31 55
SYK 0.041 0.027 -10000 0 -10000 0 0
GRB2 0.034 0.019 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.04 0.15 -10000 0 -0.42 49 49
LAT -0.026 0.12 0.22 1 -0.35 44 45
PAK2 0.008 0.16 0.34 15 -0.42 28 43
NFATC2 -0.011 0.057 -10000 0 -0.69 1 1
HRAS 0.004 0.16 0.3 14 -0.45 28 42
GAB2 0.03 0.012 -10000 0 -10000 0 0
PLA2G1B 0.01 0.11 -10000 0 -0.83 7 7
Fc epsilon R1 -0.036 0.19 -10000 0 -0.41 95 95
Antigen/IgE/Fc epsilon R1 -0.031 0.18 -10000 0 -0.37 95 95
mol:GDP -0.024 0.15 0.28 2 -0.45 29 31
JUN -0.066 0.22 -10000 0 -0.54 89 89
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
FOS -0.35 0.27 -10000 0 -0.54 344 344
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.026 0.13 -10000 0 -0.36 51 51
CHUK 0.003 0.13 0.27 24 -0.27 37 61
KLRG1 -0.024 0.12 -10000 0 -0.36 30 30
VAV1 -0.029 0.13 0.22 1 -0.35 47 48
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.028 0.12 -10000 0 -0.35 47 47
negative regulation of mast cell degranulation -0.028 0.11 -10000 0 -0.35 28 28
BTK -0.023 0.15 -10000 0 -0.49 25 25
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.046 0.17 -10000 0 -0.42 65 65
GAB2/PI3K/SHP2 -0.063 0.15 -10000 0 -0.38 65 65
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.032 0.13 -10000 0 -0.36 50 50
RAF1 0.008 0.12 -10000 0 -0.9 7 7
Fc epsilon R1/FcgammaRIIB/SHIP -0.018 0.18 -10000 0 -0.36 95 95
FCER1G 0.032 0.021 -10000 0 -10000 0 0
FCER1A -0.045 0.19 -10000 0 -0.55 64 64
Antigen/IgE/Fc epsilon R1/Fyn -0.02 0.17 -10000 0 -0.35 93 93
MAPK3 0.01 0.11 -10000 0 -0.86 7 7
MAPK1 0.005 0.11 -10000 0 -0.82 7 7
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.019 0.2 -10000 0 -0.62 34 34
DUSP1 -0.2 0.28 -10000 0 -0.54 207 207
NF-kappa-B/RelA 0.013 0.083 0.18 14 -0.18 20 34
actin cytoskeleton reorganization -0.013 0.18 -10000 0 -0.57 24 24
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.014 0.17 -10000 0 -0.46 37 37
FER -0.028 0.13 -10000 0 -0.35 48 48
RELA 0.033 0.007 -10000 0 -10000 0 0
ITK -0.002 0.069 -10000 0 -0.34 14 14
SOS1 0.034 0.004 -10000 0 -10000 0 0
PLCG1 -0.001 0.17 0.3 8 -0.46 28 36
cytokine secretion -0.002 0.05 -10000 0 -10000 0 0
SPHK1 -0.027 0.12 -10000 0 -0.35 43 43
PTK2 -0.015 0.18 -10000 0 -0.6 24 24
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.039 0.16 -10000 0 -0.44 51 51
EDG1 0 0 -10000 0 -10000 0 0
mol:DAG -0.03 0.22 0.35 20 -0.51 51 71
MAP2K2 0.004 0.11 -10000 0 -0.84 7 7
MAP2K1 0.005 0.11 -10000 0 -0.84 7 7
MAP2K7 0.034 0.005 -10000 0 -10000 0 0
KLRG1/SHP2 -0.013 0.11 0.24 1 -0.37 23 24
MAP2K4 -0.082 0.33 -10000 0 -0.86 75 75
Fc epsilon R1/FcgammaRIIB -0.019 0.19 -10000 0 -0.38 95 95
mol:Choline -0.012 0.2 0.34 63 -0.34 86 149
SHC/Grb2/SOS1 0.01 0.14 -10000 0 -0.41 23 23
FYN 0.03 0.037 -10000 0 -0.54 2 2
DOK1 0.036 0.016 -10000 0 -10000 0 0
PXN -0.014 0.17 -10000 0 -0.54 24 24
HCLS1 -0.028 0.13 0.21 2 -0.34 49 51
PRKCB -0.003 0.16 0.3 27 -0.35 44 71
FCGR2B 0.026 0.039 -10000 0 -0.54 2 2
IGHE 0.001 0.008 -10000 0 -10000 0 0
KLRG1/SHIP -0.028 0.11 -10000 0 -0.36 28 28
LCP2 0.037 0.024 -10000 0 -10000 0 0
PLA2G4A -0.15 0.2 -10000 0 -0.35 219 219
RASA1 0.034 0.012 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.012 0.2 0.34 63 -0.34 86 149
IKK complex 0.023 0.12 0.27 40 -0.22 19 59
WIPF1 0.038 0.023 -10000 0 -10000 0 0
Aurora B signaling

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex 0.05 0.079 0.25 33 -10000 0 33
STMN1 0.054 0.085 0.29 45 -10000 0 45
Aurora B/RasGAP/Survivin 0.11 0.078 0.27 1 -10000 0 1
Chromosomal passenger complex/Cul3 protein complex -0.071 0.13 0.21 25 -0.27 52 77
BIRC5 0.12 0.077 -10000 0 -10000 0 0
DES -0.013 0.13 -10000 0 -0.56 25 25
Aurora C/Aurora B/INCENP 0.076 0.053 0.24 1 -10000 0 1
Aurora B/TACC1 0.026 0.087 -10000 0 -0.32 24 24
Aurora B/PP2A 0.058 0.042 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CBX5 0.02 0.022 0.14 3 -10000 0 3
mitotic metaphase/anaphase transition -0.003 0.005 -10000 0 -10000 0 0
NDC80 0.1 0.1 0.29 85 -10000 0 85
Cul3 protein complex -0.23 0.18 -10000 0 -0.34 366 366
KIF2C 0.14 0.1 0.23 272 -10000 0 272
PEBP1 0.039 0.026 -10000 0 -0.54 1 1
KIF20A 0.13 0.072 0.2 1 -10000 0 1
mol:GDP 0 0 -10000 0 -10000 0 0
Aurora B/RasGAP 0.057 0.042 -10000 0 -10000 0 0
SEPT1 0.035 0.024 -10000 0 -10000 0 0
SMC2 0.041 0.031 -10000 0 -10000 0 0
SMC4 0.047 0.043 -10000 0 -10000 0 0
NSUN2/NPM1/Nucleolin 0.063 0.17 0.32 13 -0.42 35 48
PSMA3 0.034 0.006 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.001 0.005 -10000 0 -10000 0 0
H3F3B 0.031 0.037 -10000 0 -10000 0 0
AURKB 0.051 0.055 0.2 1 -10000 0 1
AURKC 0.036 0.019 -10000 0 -10000 0 0
CDCA8 0.11 0.076 -10000 0 -10000 0 0
cytokinesis 0.18 0.15 0.35 204 -10000 0 204
Aurora B/Septin1 0.18 0.15 0.38 134 -10000 0 134
AURKA 0.079 0.07 -10000 0 -10000 0 0
INCENP 0.054 0.042 -10000 0 -10000 0 0
KLHL13 -0.38 0.26 -10000 0 -0.54 371 371
BUB1 0.16 0.055 -10000 0 -10000 0 0
hSgo1/Aurora B/Survivin 0.13 0.1 0.32 64 -10000 0 64
EVI5 0.036 0.026 -10000 0 -0.53 1 1
RhoA/GTP 0.22 0.14 0.36 214 -10000 0 214
SGOL1 0.074 0.066 -10000 0 -10000 0 0
CENPA 0.14 0.12 0.28 187 -10000 0 187
NCAPG 0 0 -10000 0 -10000 0 0
Aurora B/HC8 Proteasome 0.058 0.043 -10000 0 -10000 0 0
NCAPD2 0.035 0.021 -10000 0 -10000 0 0
Aurora B/PP1-gamma 0.059 0.042 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
NCAPH 0.08 0.069 -10000 0 -10000 0 0
NPM1 0.026 0.11 -10000 0 -0.39 16 16
RASA1 0.034 0.012 -10000 0 -10000 0 0
KLHL9 0.032 0.009 -10000 0 -10000 0 0
mitotic prometaphase 0.005 0.004 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.058 0.042 -10000 0 -10000 0 0
PPP1CC 0.034 0.004 -10000 0 -10000 0 0
Centraspindlin 0.24 0.15 0.37 257 -10000 0 257
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
NSUN2 0.027 0.094 0.27 1 -0.38 9 10
MYLK -0.071 0.17 -10000 0 -0.34 139 139
KIF23 0.12 0.076 0.2 4 -10000 0 4
VIM -0.006 0.13 -10000 0 -0.39 47 47
RACGAP1 0.082 0.068 0.19 96 -10000 0 96
mitosis 0 0 -10000 0 -10000 0 0
NCL 0.025 0.11 -10000 0 -0.39 20 20
Chromosomal passenger complex 0.17 0.13 0.28 249 -10000 0 249
Chromosomal passenger complex/EVI5 0.15 0.11 0.36 28 -10000 0 28
TACC1 0.003 0.12 -10000 0 -0.54 23 23
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
CUL3 0.032 0.036 -10000 0 -0.54 2 2
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
Glypican 1 network

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer -0.22 0.18 -10000 0 -0.35 322 322
fibroblast growth factor receptor signaling pathway -0.22 0.18 -10000 0 -0.35 322 322
LAMA1 0.033 0.011 -10000 0 -10000 0 0
PRNP 0.017 0.094 -10000 0 -0.54 14 14
GPC1/SLIT2 -0.008 0.15 -10000 0 -0.4 63 63
SMAD2 -0.001 0.084 0.28 1 -0.31 32 33
GPC1/PrPc/Cu2+ 0.034 0.064 -10000 0 -0.34 14 14
GPC1/Laminin alpha1 0.048 0.017 -10000 0 -10000 0 0
TDGF1 0.033 0.007 -10000 0 -10000 0 0
CRIPTO/GPC1 0.049 0.015 -10000 0 -10000 0 0
APP/GPC1 0.045 0.048 -10000 0 -0.4 5 5
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.019 0.019 -10000 0 -0.34 1 1
FLT1 0.033 0.013 -10000 0 -10000 0 0
GPC1/TGFB/TGFBR1/TGFBR2 0.041 0.1 -10000 0 -0.34 34 34
SERPINC1 0.032 0.025 -10000 0 -10000 0 0
FYN 0.018 0.025 -10000 0 -0.34 2 2
FGR 0.02 0.01 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade 0.025 0.086 0.29 2 -0.37 10 12
SLIT2 -0.038 0.19 -10000 0 -0.54 63 63
GPC1/NRG -0.001 0.12 -10000 0 -0.4 40 40
NRG1 -0.017 0.15 -10000 0 -0.54 40 40
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.071 0.04 0.26 1 -10000 0 1
LYN 0.018 0.014 -10000 0 -10000 0 0
mol:Spermine 0.01 0.01 -10000 0 -10000 0 0
cell growth -0.22 0.18 -10000 0 -0.35 322 322
BMP signaling pathway -0.034 0.013 -10000 0 -10000 0 0
SRC 0.019 0.009 -10000 0 -10000 0 0
TGFBR1 0.036 0.017 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.03 0.2 -10000 0 -0.54 64 64
GPC1 0.035 0.013 -10000 0 -10000 0 0
TGFBR1 (dimer) 0.036 0.017 -10000 0 -10000 0 0
VEGFA 0.051 0.048 0.18 59 -10000 0 59
BLK 0.025 0.033 -10000 0 -10000 0 0
HCK 0.022 0.018 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
FGFR1 0.018 0.076 -10000 0 -0.54 9 9
VEGFR1 homodimer 0.033 0.013 -10000 0 -10000 0 0
TGFBR2 -0.004 0.14 -10000 0 -0.54 34 34
cell death 0.045 0.048 -10000 0 -0.4 5 5
ATIII/GPC1 0.044 0.027 -10000 0 -10000 0 0
PLA2G2A/GPC1 -0.004 0.16 -10000 0 -0.4 64 64
LCK 0.031 0.034 -10000 0 -10000 0 0
neuron differentiation -0.001 0.12 -10000 0 -0.4 40 40
PrPc/Cu2+ 0.013 0.069 -10000 0 -0.4 14 14
APP 0.029 0.06 -10000 0 -0.54 5 5
TGFBR2 (dimer) -0.004 0.14 -10000 0 -0.54 34 34
S1P5 pathway

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration 0.066 0.14 0.32 56 -10000 0 56
GNAI2 0.034 0.01 -10000 0 -10000 0 0
S1P/S1P5/G12 0.023 0.004 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 0.03 0.012 -10000 0 -10000 0 0
RhoA/GTP -0.066 0.14 -10000 0 -0.32 56 56
negative regulation of cAMP metabolic process -0.079 0.14 -10000 0 -0.25 184 184
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNAI3 0.034 0.006 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
S1PR5 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.079 0.14 -10000 0 -0.25 184 184
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
Insulin Pathway

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP -0.15 0.2 -10000 0 -0.32 283 283
TC10/GTP -0.13 0.16 -10000 0 -0.28 271 271
Insulin Receptor/Insulin/IRS1/Shp2 0.041 0.14 -10000 0 -0.32 59 59
HRAS 0.034 0.013 -10000 0 -10000 0 0
APS homodimer 0 0 -10000 0 -10000 0 0
GRB14 0.002 0.19 -10000 0 -0.54 51 51
FOXO3 -0.032 0.16 -10000 0 -0.6 35 35
AKT1 -0.046 0.16 0.33 7 -0.45 22 29
INSR 0.039 0.013 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.091 0.073 0.47 6 -10000 0 6
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 0.03 0.051 -10000 0 -0.54 4 4
SORBS1 -0.28 0.29 -10000 0 -0.54 277 277
CRK 0.031 0.011 -10000 0 -10000 0 0
PTPN1 0.019 0.054 0.28 17 -10000 0 17
CAV1 -0.23 0.18 -10000 0 -0.33 366 366
CBL/APS/CAP/Crk-II/C3G -0.13 0.18 -10000 0 -0.3 275 275
Insulin Receptor/Insulin/IRS1/NCK2 0.042 0.13 -10000 0 -0.32 57 57
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.002 0.15 -10000 0 -0.3 92 92
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.019 0.095 0.36 1 -0.4 6 7
RPS6KB1 -0.04 0.14 0.31 8 -0.4 21 29
PARD6A 0.031 0.019 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.019 0.056 -10000 0 -0.56 4 4
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.012 0.15 -10000 0 -0.42 20 20
HRAS/GTP -0.009 0.078 -10000 0 -0.26 39 39
Insulin Receptor 0.039 0.013 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.04 0.12 -10000 0 -0.3 41 41
PRKCI 0.011 0.088 -10000 0 -0.53 7 7
Insulin Receptor/Insulin/GRB14/PDK1 -0.044 0.16 -10000 0 -0.32 101 101
SHC1 0.028 0.014 -10000 0 -10000 0 0
negative regulation of MAPKKK cascade 0.059 0.053 -10000 0 -0.48 4 4
PI3K 0.008 0.15 -10000 0 -0.3 92 92
NCK2 0.035 0.008 -10000 0 -10000 0 0
RHOQ 0.033 0.026 -10000 0 -0.54 1 1
mol:H2O2 0.001 0.003 -10000 0 -10000 0 0
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
AKT2 -0.047 0.16 0.33 6 -0.44 22 28
PRKCZ -0.007 0.083 -10000 0 -0.49 9 9
SH2B2 0 0 -10000 0 -10000 0 0
SHC/SHIP -0.01 0.091 -10000 0 -0.28 46 46
F2RL2 0.047 0.066 -10000 0 -0.54 3 3
TRIP10 0.033 0.026 -10000 0 -0.54 1 1
Insulin Receptor/Insulin/Shc 0.056 0.036 -10000 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0.044 0.026 -10000 0 -0.34 2 2
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.078 0.055 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
CBL/APS/CAP/Crk-II -0.14 0.18 -10000 0 -0.31 277 277
TC10/GDP 0.025 0.019 -10000 0 -0.4 1 1
Insulin Receptor/Insulin/SHC/GRB10 0.07 0.057 -10000 0 -0.32 4 4
INPP5D -0.037 0.095 -10000 0 -0.29 59 59
SOS1 0.034 0.004 -10000 0 -10000 0 0
SGK1 -0.009 0.012 -10000 0 -10000 0 0
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
p62DOK/RasGAP 0.059 0.053 -10000 0 -0.48 4 4
INS 0.039 0.014 -10000 0 -10000 0 0
mol:PI-3-4-P2 -0.036 0.094 -10000 0 -0.29 59 59
GRB2 0.034 0.019 -10000 0 -10000 0 0
EIF4EBP1 -0.043 0.14 0.33 4 -0.4 20 24
PTPRA 0.038 0.013 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
TC10/GTP/CIP4 0.044 0.026 -10000 0 -0.34 2 2
PDPK1 0.032 0.01 -10000 0 -10000 0 0
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0 0.088 -10000 0 -0.25 42 42
Insulin Receptor/Insulin/IRS1 0.023 0.13 -10000 0 -0.32 59 59
Insulin Receptor/Insulin/IRS3 0.057 0.024 -10000 0 -10000 0 0
Par3/Par6 0.074 0.059 -10000 0 -0.29 5 5
p75(NTR)-mediated signaling

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.049 0.012 -10000 0 -10000 0 0
Necdin/E2F1 -0.044 0.18 -10000 0 -0.38 112 112
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E -0.002 0.15 -10000 0 -0.31 89 89
NGF (dimer)/p75(NTR)/BEX1 -0.006 0.14 -10000 0 -0.33 76 76
NT-4/5 (dimer)/p75(NTR) -0.041 0.15 -10000 0 -0.38 80 80
IKBKB 0.029 0.013 -10000 0 -10000 0 0
AKT1 -0.033 0.16 0.34 3 -0.32 96 99
IKBKG 0.034 0.004 -10000 0 -10000 0 0
BDNF 0.038 0.048 -10000 0 -0.54 2 2
MGDIs/NGR/p75(NTR)/LINGO1 0.014 0.15 -10000 0 -0.33 72 72
FURIN 0.037 0.024 0.18 12 -10000 0 12
proBDNF (dimer)/p75(NTR)/Sortilin 0.002 0.15 -10000 0 -0.34 75 75
LINGO1 0.056 0.054 -10000 0 -10000 0 0
Sortilin/TRAF6/NRIF 0.033 0.03 -10000 0 -0.28 1 1
proBDNF (dimer) 0.038 0.048 -10000 0 -0.54 2 2
NTRK1 0.031 0.022 -10000 0 -10000 0 0
RTN4R 0.041 0.036 -10000 0 -10000 0 0
neuron apoptosis -0.013 0.16 0.41 4 -0.47 16 20
IRAK1 0.036 0.015 -10000 0 -10000 0 0
SHC1 -0.026 0.11 -10000 0 -0.34 54 54
ARHGDIA 0.033 0.011 -10000 0 -10000 0 0
RhoA/GTP 0.025 0.006 -10000 0 -10000 0 0
Gamma Secretase 0.076 0.055 -10000 0 -0.3 1 1
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 -0.007 0.14 -10000 0 -0.32 83 83
MAGEH1 0.019 0.094 -10000 0 -0.54 14 14
proNGF (dimer)/p75(NTR)/Sortilin/Necdin -0.078 0.2 -10000 0 -0.37 151 151
Mammalian IAPs/DIABLO 0.046 0.078 -10000 0 -0.31 17 17
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 0.044 0.037 -10000 0 -10000 0 0
APP 0.029 0.06 -10000 0 -0.54 5 5
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.034 0.007 -10000 0 -10000 0 0
RhoA/GDP/RHOGDI -0.01 0.12 -10000 0 -0.29 74 74
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest -0.037 0.11 0.21 30 -0.27 74 104
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK -0.016 0.095 -10000 0 -0.25 58 58
NT-4/5 (dimer)/p75(NTR)/TRAF6 -0.018 0.14 -10000 0 -0.34 76 76
NCSTN 0.028 0.014 -10000 0 -10000 0 0
mol:GTP -0.018 0.15 -10000 0 -0.35 79 79
PSENEN 0.035 0.016 -10000 0 -10000 0 0
mol:ceramide -0.021 0.13 -10000 0 -0.31 74 74
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.012 0.078 -10000 0 -0.21 57 57
p75(NTR)/beta APP -0.025 0.16 -10000 0 -0.41 76 76
BEX1 0.055 0.051 -10000 0 -10000 0 0
mol:GDP -0.053 0.12 -10000 0 -0.34 76 76
NGF (dimer) 0.005 0.13 -10000 0 -0.31 65 65
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.028 0.15 -10000 0 -0.31 70 70
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RAC1/GTP -0.013 0.12 -10000 0 -0.29 75 75
MYD88 0.034 0.011 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA -0.018 0.15 -10000 0 -0.35 79 79
RHOB 0.033 0.037 -10000 0 -0.54 2 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.058 0.036 -10000 0 -10000 0 0
NT3 (dimer) -0.12 0.25 -10000 0 -0.54 134 134
TP53 -0.027 0.13 0.37 8 -0.29 71 79
PRDM4 -0.018 0.13 -10000 0 -0.31 74 74
BDNF (dimer) 0.057 0.17 -10000 0 -0.31 70 70
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
SORT1 0.034 0.006 -10000 0 -10000 0 0
activation of caspase activity -0.006 0.14 -10000 0 -0.31 89 89
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.001 0.13 -10000 0 -0.31 74 74
RHOC 0.034 0.005 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 -0.028 0.14 0.3 6 -0.33 66 72
DIABLO 0.035 0.003 -10000 0 -10000 0 0
SMPD2 -0.021 0.13 -10000 0 -0.31 74 74
APH1B 0.033 0.027 -10000 0 -0.54 1 1
APH1A 0.032 0.029 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin -0.017 0.14 -10000 0 -0.34 74 74
PSEN1 0.033 0.007 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.049 0.012 -10000 0 -10000 0 0
NT3 (dimer)/p75(NTR) -0.13 0.24 -10000 0 -0.44 173 173
MAPK8 -0.025 0.14 0.29 8 -0.33 64 72
MAPK9 -0.024 0.13 0.28 7 -0.32 63 70
APAF1 0.035 0.003 -10000 0 -10000 0 0
NTF3 -0.12 0.25 -10000 0 -0.54 134 134
NTF4 0 0 -10000 0 -10000 0 0
NDN -0.099 0.24 -10000 0 -0.54 117 117
RAC1/GDP 0.025 0.004 -10000 0 -10000 0 0
RhoA-B-C/GDP 0.009 0.14 -10000 0 -0.3 73 73
p75 CTF/Sortilin/TRAF6/NRIF 0.081 0.027 -10000 0 -10000 0 0
RhoA-B-C/GTP -0.018 0.15 -10000 0 -0.35 79 79
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.027 0.14 -10000 0 -0.3 71 71
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.017 0.14 -10000 0 -0.31 75 75
PRKACB 0.035 0.083 -10000 0 -0.54 8 8
proBDNF (dimer)/p75 ECD 0.052 0.037 -10000 0 -0.4 2 2
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BIRC2 0.031 0.011 -10000 0 -10000 0 0
neuron projection morphogenesis -0.1 0.16 -10000 0 -0.39 99 99
BAD -0.025 0.15 0.4 9 -0.34 64 73
RIPK2 0.029 0.022 -10000 0 -10000 0 0
NGFR -0.054 0.2 -10000 0 -0.54 76 76
CYCS -0.009 0.13 0.27 5 -0.29 67 72
ADAM17 0.034 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 -0.003 0.12 -10000 0 -0.31 62 62
BCL2L11 -0.024 0.15 0.4 9 -0.33 64 73
BDNF (dimer)/p75(NTR) -0.02 0.16 -10000 0 -0.39 77 77
PI3K -0.03 0.16 -10000 0 -0.34 100 100
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0 0.13 -10000 0 -0.31 74 74
NDNL2 0.033 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
PRKCI 0.035 0.018 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR) -0.041 0.15 -10000 0 -0.38 80 80
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.006 0.13 -10000 0 -0.3 74 74
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
PLG 0.031 0.027 -10000 0 -0.54 1 1
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 -0.027 0.13 -10000 0 -0.33 74 74
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
NGFRAP1 0.01 0.12 -10000 0 -0.54 22 22
CASP3 -0.023 0.14 0.39 9 -0.31 65 74
E2F1 0.051 0.049 -10000 0 -10000 0 0
CASP9 0.033 0.008 -10000 0 -10000 0 0
IKK complex 0.03 0.086 -10000 0 -0.3 1 1
NGF (dimer)/TRKA 0.023 0.016 -10000 0 -10000 0 0
MMP7 -0.041 0.19 -10000 0 -0.54 64 64
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.012 0.13 -10000 0 -0.3 73 73
MMP3 0.095 0.1 -10000 0 -0.54 5 5
APAF-1/Caspase 9 -0.033 0.1 -10000 0 -0.41 6 6
PLK2 and PLK4 events

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 0.016 0.1 -10000 0 -0.54 17 17
PLK4 0.056 0.053 0.18 75 -10000 0 75
regulation of centriole replication 0.023 0.086 -10000 0 -0.38 16 16
Presenilin action in Notch and Wnt signaling

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.037 0.085 -10000 0 -0.41 14 14
HDAC1 0.023 0.028 -10000 0 -10000 0 0
AES 0.033 0.008 -10000 0 -10000 0 0
FBXW11 0.034 0.007 -10000 0 -10000 0 0
DTX1 0.031 0.044 -10000 0 -0.54 3 3
LRP6/FZD1 0.047 0.024 -10000 0 -0.4 1 1
TLE1 0.016 0.098 -10000 0 -0.55 15 15
AP1 -0.22 0.19 -10000 0 -0.34 324 324
NCSTN 0.028 0.014 -10000 0 -10000 0 0
ADAM10 0.034 0.013 -10000 0 -10000 0 0
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.019 0.14 -10000 0 -0.65 12 12
NICD/RBPSUH 0.055 0.092 -10000 0 -0.41 14 14
WIF1 -0.38 0.26 -10000 0 -0.54 370 370
NOTCH1 0.02 0.072 -10000 0 -0.42 12 12
PSENEN 0.035 0.016 -10000 0 -10000 0 0
KREMEN2 0.11 0.077 -10000 0 -10000 0 0
DKK1 0.008 0.18 -10000 0 -0.54 44 44
beta catenin/beta TrCP1 0.009 0.093 -10000 0 -0.43 8 8
APH1B 0.033 0.027 -10000 0 -0.54 1 1
APH1A 0.032 0.029 -10000 0 -10000 0 0
AXIN1 0.016 0.07 -10000 0 -0.6 4 4
CtBP/CBP/TCF1/TLE1/AES 0.001 0.079 0.28 3 -0.33 11 14
PSEN1 0.033 0.007 -10000 0 -10000 0 0
FOS -0.35 0.27 -10000 0 -0.54 344 344
JUN -0.066 0.22 -10000 0 -0.54 89 89
MAP3K7 0.031 0.011 -10000 0 -10000 0 0
CTNNB1 -0.003 0.09 -10000 0 -0.46 8 8
MAPK3 0.032 0.01 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.1 0.071 0.26 2 -0.31 3 5
HNF1A 0.035 0.013 -10000 0 -10000 0 0
CTBP1 0.032 0.009 -10000 0 -10000 0 0
MYC -0.052 0.32 -10000 0 -1.3 31 31
NKD1 0.032 0.021 -10000 0 -10000 0 0
FZD1 0.033 0.026 -10000 0 -0.54 1 1
NOTCH1 precursor/Deltex homolog 1 0.056 0.095 -10000 0 -0.41 14 14
apoptosis -0.22 0.19 -10000 0 -0.34 324 324
Delta 1/NOTCHprecursor 0.054 0.092 -10000 0 -0.41 14 14
DLL1 0.032 0.009 -10000 0 -10000 0 0
PPARD 0.024 0.1 -10000 0 -0.79 7 7
Gamma Secretase 0.076 0.055 -10000 0 -0.3 1 1
APC 0.005 0.1 -10000 0 -0.53 13 13
DVL1 -0.04 0.096 -10000 0 -0.36 30 30
CSNK2A1 0.034 0.008 -10000 0 -10000 0 0
MAP3K7IP1 -0.002 0.006 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 0.083 0.13 0.26 50 -0.29 42 92
LRP6 0.033 0.008 -10000 0 -10000 0 0
CSNK1A1 0.034 0.006 -10000 0 -10000 0 0
NLK 0.015 0.026 -10000 0 -10000 0 0
CCND1 0.037 0.23 -10000 0 -1.3 12 12
WNT1 0.034 0.005 -10000 0 -10000 0 0
Axin1/APC/beta catenin 0.018 0.12 0.34 2 -0.48 13 15
DKK2 0.032 0.054 -10000 0 -0.54 4 4
NOTCH1 precursor/DVL1 -0.015 0.12 -10000 0 -0.65 12 12
GSK3B 0.034 0.009 -10000 0 -10000 0 0
FRAT1 0.034 0.008 -10000 0 -10000 0 0
NOTCH/Deltex homolog 1 0.037 0.088 -10000 0 -0.41 14 14
PPP2R5D -0.002 0.063 -10000 0 -0.37 10 10
MAPK1 0.033 0.009 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 -0.2 0.17 -10000 0 -0.31 355 355
RBPJ 0.033 0.008 -10000 0 -10000 0 0
CREBBP 0.035 0.017 -10000 0 -10000 0 0
Stabilization and expansion of the E-cadherin adherens junction

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.01 0.091 -10000 0 -0.26 46 46
epithelial cell differentiation 0.04 0.086 -10000 0 -0.29 26 26
CYFIP2 0.051 0.048 -10000 0 -10000 0 0
ENAH -0.009 0.07 0.28 5 -0.29 2 7
EGFR -0.27 0.29 -10000 0 -0.54 269 269
EPHA2 0.026 0.062 -10000 0 -0.54 6 6
MYO6 0.001 0.074 -10000 0 -0.28 25 25
CTNNB1 0.029 0.051 -10000 0 -0.54 4 4
ABI1/Sra1/Nap1 0.074 0.036 -10000 0 -10000 0 0
AQP5 -0.14 0.24 -10000 0 -0.49 151 151
CTNND1 0.033 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.001 0.072 -10000 0 -0.28 25 25
regulation of calcium-dependent cell-cell adhesion -0.023 0.1 -10000 0 -0.29 63 63
EGF -0.15 0.27 -10000 0 -0.54 163 163
NCKAP1 0.034 0.005 -10000 0 -10000 0 0
AQP3 -0.052 0.18 -10000 0 -0.49 64 64
cortical microtubule organization 0.04 0.086 -10000 0 -0.29 26 26
GO:0000145 -0.021 0.064 -10000 0 -0.27 25 25
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.046 0.089 -10000 0 -0.29 26 26
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
ARF6/GDP -0.03 0.059 -10000 0 -0.27 26 26
ARF6 0.034 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.058 0.059 -10000 0 -0.31 6 6
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.001 0.069 -10000 0 -0.42 1 1
PVRL2 0.039 0.028 -10000 0 -10000 0 0
ZYX -0.002 0.073 -10000 0 -0.28 26 26
ARF6/GTP 0.064 0.062 -10000 0 -0.3 6 6
CDH1 0.007 0.12 -10000 0 -0.54 22 22
EGFR/EGFR/EGF/EGF -0.23 0.2 -10000 0 -0.35 354 354
RhoA/GDP 0.041 0.084 -10000 0 -0.28 26 26
actin cytoskeleton organization -0.021 0.068 -10000 0 -0.28 25 25
IGF-1R heterotetramer 0.011 0.12 -10000 0 -0.54 21 21
GIT1 0.033 0.011 -10000 0 -10000 0 0
IGF1R 0.011 0.12 -10000 0 -0.54 21 21
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
DIAPH1 0.058 0.13 -10000 0 -0.55 9 9
Wnt receptor signaling pathway -0.04 0.086 0.29 26 -10000 0 26
RHOA 0.033 0.008 -10000 0 -10000 0 0
RhoA/GTP -0.03 0.059 -10000 0 -0.27 26 26
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
VCL -0.022 0.069 -10000 0 -0.28 25 25
EFNA1 0.028 0.016 -10000 0 -10000 0 0
LPP -0.023 0.066 -10000 0 -0.27 25 25
Ephrin A1/EPHA2 0.023 0.084 -10000 0 -0.29 26 26
SEC6/SEC8 -0.007 0.068 -10000 0 -0.27 26 26
MGAT3 -0.024 0.11 -10000 0 -0.29 63 63
HGF/MET 0.004 0.13 -10000 0 -0.29 73 73
HGF 0.035 0.01 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.011 0.092 -10000 0 -0.26 46 46
actin cable formation 0.053 0.11 0.33 19 -0.29 1 20
KIAA1543 -0.022 0.065 -10000 0 -0.27 25 25
KIFC3 0.001 0.07 -10000 0 -0.28 25 25
NCK1 0.034 0.005 -10000 0 -10000 0 0
EXOC3 0.033 0.008 -10000 0 -10000 0 0
ACTN1 -0.001 0.072 -10000 0 -0.28 25 25
NCK1/GIT1 0.047 0.016 -10000 0 -10000 0 0
mol:GDP 0.04 0.086 -10000 0 -0.29 26 26
EXOC4 0.034 0.006 -10000 0 -10000 0 0
STX4 -0.002 0.071 -10000 0 -0.28 25 25
PIP5K1C -0.001 0.073 -10000 0 -0.28 25 25
LIMA1 0.013 0.11 -10000 0 -0.54 19 19
ABI1 0.034 0.007 -10000 0 -10000 0 0
ROCK1 0.012 0.1 0.3 12 -0.34 2 14
adherens junction assembly -0.031 0.13 0.3 1 -0.62 14 15
IGF-1R heterotetramer/IGF1 -0.13 0.18 -10000 0 -0.3 248 248
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
MET -0.022 0.17 -10000 0 -0.54 50 50
PLEKHA7 -0.001 0.072 -10000 0 -0.28 25 25
mol:GTP 0.056 0.058 -10000 0 -0.31 6 6
establishment of epithelial cell apical/basal polarity -0.012 0.088 0.36 5 -0.35 1 6
cortical actin cytoskeleton stabilization -0.01 0.091 -10000 0 -0.26 46 46
regulation of cell-cell adhesion -0.021 0.068 -10000 0 -0.28 25 25
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.011 0.092 -10000 0 -0.26 46 46
TCGA08_retinoblastoma

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.036 0.033 -10000 0 -10000 0 0
CDKN2C -0.022 0.15 -10000 0 -0.52 41 41
CDKN2A 0.058 0.056 -10000 0 -10000 0 0
CCND2 -0.008 0.061 0.17 28 -0.2 15 43
RB1 0.005 0.071 0.22 12 -0.2 31 43
CDK4 -0.004 0.073 0.21 36 -0.21 13 49
CDK6 -0.006 0.073 0.21 33 -0.22 16 49
G1/S progression 0.002 0.086 0.21 51 -0.23 14 65
Nectin adhesion pathway

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.006 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.05 0.027 -10000 0 -0.4 1 1
PTK2 -0.054 0.18 -10000 0 -0.44 69 69
positive regulation of JNK cascade -0.024 0.15 -10000 0 -0.33 70 70
CDC42/GDP -0.02 0.21 0.46 1 -0.44 76 77
Rac1/GDP -0.02 0.2 -10000 0 -0.43 77 77
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CTNNB1 0.029 0.051 -10000 0 -0.54 4 4
CDC42/GTP -0.025 0.19 -10000 0 -0.4 69 69
nectin-3/I-afadin -0.024 0.17 -10000 0 -0.4 79 79
RAPGEF1 -0.045 0.2 0.47 1 -0.47 70 71
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.057 0.22 -10000 0 -0.52 78 78
PDGFB-D/PDGFRB 0.034 0.006 -10000 0 -10000 0 0
TLN1 -0.039 0.12 0.2 4 -0.5 20 24
Rap1/GTP -0.031 0.15 -10000 0 -0.34 64 64
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.054 0.042 -10000 0 -0.31 3 3
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.024 0.17 -10000 0 -0.4 79 79
PVR 0.036 0.015 -10000 0 -10000 0 0
Necl-5(dimer) 0.036 0.015 -10000 0 -10000 0 0
mol:GDP -0.047 0.24 0.47 1 -0.53 80 81
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PI3K -0.004 0.18 -10000 0 -0.34 105 105
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
positive regulation of lamellipodium assembly -0.021 0.16 -10000 0 -0.34 74 74
PVRL1 0.031 0.015 -10000 0 -10000 0 0
PVRL3 -0.052 0.21 -10000 0 -0.54 77 77
PVRL2 0.039 0.028 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CDH1 0.007 0.12 -10000 0 -0.54 22 22
CLDN1 -0.002 0.16 -10000 0 -0.54 41 41
JAM-A/CLDN1 -0.007 0.17 -10000 0 -0.35 83 83
SRC -0.077 0.24 -10000 0 -0.57 81 81
ITGB3 0.035 0.019 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
FARP2 -0.047 0.24 0.48 1 -0.6 43 44
RAC1 0.034 0.005 -10000 0 -10000 0 0
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) -0.001 0.15 -10000 0 -0.35 79 79
nectin-1/I-afadin 0.038 0.046 -10000 0 -0.4 3 3
nectin-2/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
RAC1/GTP/IQGAP1/filamentous actin 0.044 0.011 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin -0.005 0.15 -10000 0 -0.35 79 79
CDC42/GTP/IQGAP1/filamentous actin 0.043 0.014 -10000 0 -10000 0 0
F11R 0.028 0.017 -10000 0 -10000 0 0
positive regulation of filopodium formation -0.024 0.15 -10000 0 -0.33 70 70
alphaV/beta3 Integrin/Talin -0.006 0.13 0.3 1 -0.51 17 18
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
nectin-2(dimer)/I-afadin/I-afadin 0.045 0.049 -10000 0 -0.4 3 3
PIP5K1C -0.037 0.13 -10000 0 -0.5 23 23
VAV2 -0.044 0.24 0.46 1 -0.55 70 71
RAP1/GDP -0.016 0.19 -10000 0 -0.4 71 71
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.001 0.15 -10000 0 -0.34 79 79
nectin-3(dimer)/I-afadin/I-afadin -0.024 0.17 -10000 0 -0.4 79 79
Rac1/GTP -0.023 0.19 -10000 0 -0.42 73 73
PTPRM -0.035 0.14 -10000 0 -0.3 83 83
E-cadherin/beta catenin/alpha catenin 0.052 0.1 -10000 0 -0.29 26 26
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 0.006 0.13 -10000 0 -0.39 50 50
CRKL 0 0.12 0.32 2 -0.39 17 19
mol:PIP3 0.005 0.062 0.49 3 -0.8 1 4
AKT1 0.018 0.08 0.38 6 -0.7 1 7
PTK2B 0.028 0.014 -10000 0 -10000 0 0
RAPGEF1 -0.001 0.11 0.31 2 -0.42 11 13
RANBP10 0.03 0.012 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
HGF/MET/SHIP2 0.023 0.12 -10000 0 -0.34 50 50
MAP3K5 -0.011 0.13 0.37 1 -0.41 24 25
HGF/MET/CIN85/CBL/ENDOPHILINS 0.037 0.12 -10000 0 -0.31 51 51
AP1 -0.29 0.24 -10000 0 -0.43 346 346
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
apoptosis -0.54 0.38 -10000 0 -0.77 367 367
STAT3 (dimer) -0.006 0.11 -10000 0 -0.42 16 16
GAB1/CRKL/SHP2/PI3K 0.012 0.15 -10000 0 -0.44 16 16
INPP5D 0 0 -10000 0 -10000 0 0
CBL/CRK 0.014 0.11 0.36 1 -0.37 17 18
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.033 0.008 -10000 0 -10000 0 0
PTEN 0.029 0.045 -10000 0 -0.54 3 3
ELK1 -0.019 0.085 0.3 6 -10000 0 6
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 0.006 0.065 -10000 0 -0.24 7 7
PAK1 0.043 0.098 0.39 12 -0.67 1 13
HGF/MET/RANBP10 0.022 0.12 -10000 0 -0.34 50 50
HRAS -0.032 0.2 -10000 0 -0.58 58 58
DOCK1 -0.003 0.11 0.43 2 -0.42 11 13
GAB1 -0.003 0.12 -10000 0 -0.38 22 22
CRK -0.002 0.11 0.37 1 -0.39 17 18
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.022 0.18 -10000 0 -0.53 55 55
JUN -0.066 0.22 -10000 0 -0.54 89 89
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.012 0.087 -10000 0 -0.27 51 51
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
cell morphogenesis -0.016 0.15 0.4 7 -0.44 18 25
GRB2/SHC 0.02 0.083 -10000 0 -0.25 32 32
FOS -0.35 0.27 -10000 0 -0.54 344 344
GLMN 0.005 0.004 -10000 0 -10000 0 0
cell motility -0.019 0.085 0.29 7 -10000 0 7
HGF/MET/MUC20 0.008 0.12 -10000 0 -0.34 51 51
cell migration 0.019 0.081 -10000 0 -0.25 32 32
GRB2 0.034 0.019 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
MET/RANBP10 0.001 0.13 -10000 0 -0.39 51 51
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.011 0.098 -10000 0 -0.39 14 14
MET/MUC20 -0.016 0.12 -10000 0 -0.39 52 52
RAP1B 0.004 0.11 0.36 3 -0.4 10 13
RAP1A -0.002 0.11 0.51 1 -0.42 9 10
HGF/MET/RANBP9 0.027 0.12 -10000 0 -0.34 48 48
RAF1 -0.024 0.19 -10000 0 -0.55 58 58
STAT3 -0.007 0.11 -10000 0 -0.43 16 16
cell proliferation 0.024 0.15 0.34 9 -0.39 33 42
RPS6KB1 0.002 0.061 -10000 0 -0.35 8 8
MAPK3 -0.037 0.081 0.62 3 -10000 0 3
MAPK1 -0.004 0.17 0.66 28 -10000 0 28
RANBP9 0.034 0.009 -10000 0 -10000 0 0
MAPK8 -0.002 0.13 0.45 1 -0.4 17 18
SRC -0.006 0.097 -10000 0 -0.37 14 14
PI3K -0.009 0.13 -10000 0 -0.28 86 86
MET/Glomulin -0.012 0.11 -10000 0 -0.35 50 50
SOS1 0.034 0.004 -10000 0 -10000 0 0
MAP2K1 -0.02 0.18 0.48 1 -0.52 56 57
MET -0.022 0.17 -10000 0 -0.54 50 50
MAP4K1 0.003 0.12 0.39 1 -0.44 15 16
PTK2 0.027 0.014 -10000 0 -10000 0 0
MAP2K2 -0.021 0.18 0.48 1 -0.52 56 57
BAD 0.015 0.075 0.35 5 -0.67 1 6
MAP2K4 -0.011 0.12 0.36 1 -0.39 20 21
SHP2/GRB2/SOS1/GAB1 0.02 0.14 -10000 0 -0.36 52 52
INPPL1 0.032 0.01 -10000 0 -10000 0 0
PXN 0.034 0.004 -10000 0 -10000 0 0
SH3KBP1 0.034 0.027 -10000 0 -0.54 1 1
HGS -0.015 0.078 -10000 0 -0.26 45 45
PLCgamma1/PKC 0.024 0.006 -10000 0 -10000 0 0
HGF 0.035 0.01 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
PTPRJ 0.036 0.017 -10000 0 -10000 0 0
NCK/PLCgamma1 0.026 0.094 -10000 0 -0.24 48 48
PDPK1 0.02 0.084 0.41 5 -0.74 1 6
HGF/MET/SHIP 0.008 0.12 -10000 0 -0.34 51 51
IL27-mediated signaling events

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.042 0.009 -10000 0 -10000 0 0
CD4-positive alpha-beta T cell lineage commitment 0 0.001 -10000 0 -10000 0 0
cytokine production during immune response -0.011 0.22 0.67 26 -0.46 13 39
IL27/IL27R/JAK1 0.03 0.28 0.65 16 -1 19 35
TBX21 0.024 0.26 0.55 38 -0.59 39 77
IL12B 0.042 0.027 0.2 11 -10000 0 11
IL12A 0.005 0.061 0.14 6 -0.4 11 17
IL6ST 0.034 0.08 0.24 1 -0.54 8 9
IL27RA/JAK1 0.002 0.24 0.47 5 -1.2 18 23
IL27 -0.019 0.18 0.34 1 -0.54 52 53
TYK2 0.043 0.026 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.19 0.14 -10000 0 -0.53 7 7
T-helper 2 cell differentiation -0.011 0.22 0.67 26 -0.46 13 39
T cell proliferation during immune response -0.011 0.22 0.67 26 -0.46 13 39
MAPKKK cascade 0.011 0.22 0.46 13 -0.67 26 39
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT2 0.034 0.004 -10000 0 -10000 0 0
STAT1 0.061 0.058 0.19 27 -10000 0 27
IL12RB1 0.037 0.008 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 0.049 0.25 0.55 48 -0.64 22 70
IL27/IL27R/JAK2/TYK2 0.01 0.22 0.47 12 -0.68 26 38
positive regulation of T cell mediated cytotoxicity 0.011 0.22 0.46 13 -0.67 26 39
STAT1 (dimer) 0.035 0.32 0.79 23 -1 21 44
JAK2 0.039 0.023 0.24 1 -10000 0 1
JAK1 0.036 0.013 -10000 0 -10000 0 0
STAT2 (dimer) 0.026 0.21 0.47 8 -0.67 24 32
T cell proliferation -0.18 0.25 0.5 5 -0.57 82 87
IL12/IL12R/TYK2/JAK2 0.067 0.19 0.53 2 -0.77 15 17
IL17A -0.19 0.14 -10000 0 -0.53 7 7
mast cell activation -0.011 0.22 0.67 26 -0.46 13 39
IFNG 0.034 0.066 0.14 102 -0.11 9 111
T cell differentiation 0 0.009 0.02 28 -0.024 20 48
STAT3 (dimer) 0.024 0.21 0.47 7 -0.68 23 30
STAT5A (dimer) 0.023 0.21 0.47 7 -0.66 25 32
STAT4 (dimer) 0.022 0.22 0.48 7 -0.67 25 32
STAT4 0.028 0.069 -10000 0 -0.54 7 7
T cell activation -0.005 0.028 0.12 17 -0.12 9 26
IL27R/JAK2/TYK2 0.052 0.25 0.52 4 -1.1 18 22
GATA3 -0.013 0.38 0.61 21 -1.3 33 54
IL18 0.019 0.036 0.14 41 -10000 0 41
positive regulation of mast cell cytokine production 0.025 0.2 0.47 7 -0.66 23 30
IL27/EBI3 0.015 0.14 0.34 3 -0.39 51 54
IL27RA -0.016 0.25 0.52 5 -1.3 18 23
IL6 -0.37 0.26 -10000 0 -0.54 366 366
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
monocyte differentiation 0.002 0.003 -10000 0 -10000 0 0
IL2 -0.009 0.11 0.47 18 -0.82 2 20
IL1B 0.009 0.044 -10000 0 -0.4 5 5
EBI3 0.041 0.026 0.23 2 -10000 0 2
TNF 0.014 0.02 0.14 13 -10000 0 13
LPA receptor mediated events

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.047 0.035 -10000 0 -0.24 5 5
NF kappa B1 p50/RelA/I kappa B alpha 0.058 0.06 0.28 3 -0.26 1 4
AP1 -0.21 0.19 -10000 0 -0.33 344 344
mol:PIP3 -0.15 0.16 -10000 0 -0.28 277 277
AKT1 0.005 0.091 -10000 0 -0.33 7 7
PTK2B -0.016 0.08 -10000 0 -0.18 84 84
RHOA 0.01 0.066 -10000 0 -0.26 20 20
PIK3CB 0.034 0.006 -10000 0 -10000 0 0
mol:Ca2+ 0.026 0.057 0.19 43 -0.27 1 44
MAGI3 0.041 0.042 -10000 0 -0.54 1 1
RELA 0.033 0.007 -10000 0 -10000 0 0
apoptosis 0.017 0.022 -10000 0 -0.19 5 5
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization -0.014 0.079 0.23 5 -0.28 6 11
NF kappa B1 p50/RelA 0.02 0.041 0.17 1 -0.31 1 2
endothelial cell migration 0.017 0.053 0.27 2 -0.47 5 7
ADCY4 -0.047 0.095 -10000 0 -0.3 16 16
ADCY5 -0.045 0.093 -10000 0 -0.29 12 12
ADCY6 -0.046 0.093 -10000 0 -0.29 12 12
ADCY7 -0.037 0.09 -10000 0 -0.3 13 13
ADCY1 -0.045 0.093 -10000 0 -0.29 13 13
ADCY2 -0.047 0.097 -10000 0 -0.31 17 17
ADCY3 -0.045 0.093 -10000 0 -0.29 12 12
ADCY8 -0.04 0.086 -10000 0 -0.31 10 10
ADCY9 -0.042 0.09 -10000 0 -0.3 12 12
GSK3B -0.015 0.079 0.24 5 -0.22 17 22
arachidonic acid secretion -0.053 0.1 -10000 0 -0.25 55 55
GNG2 0.033 0.026 -10000 0 -0.54 1 1
TRIP6 0.024 0.02 -10000 0 -0.39 1 1
GNAO1 0.019 0.021 -10000 0 -0.26 2 2
HRAS 0.034 0.013 -10000 0 -10000 0 0
NFKBIA 0.026 0.06 0.26 3 -0.25 3 6
GAB1 0.033 0.027 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly 0.046 0.13 -10000 0 -0.84 10 10
JUN -0.066 0.22 -10000 0 -0.54 89 89
LPA/LPA2/NHERF2 0.024 0.017 -10000 0 -0.13 1 1
TIAM1 0.026 0.14 -10000 0 -0.98 10 10
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.026 0.055 0.19 43 -10000 0 43
PLCB3 0.036 0.049 0.19 40 -10000 0 40
FOS -0.35 0.27 -10000 0 -0.54 344 344
positive regulation of mitosis -0.053 0.1 -10000 0 -0.25 55 55
LPA/LPA1-2-3 0.007 0.019 -10000 0 -0.18 5 5
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
stress fiber formation 0.015 0.061 -10000 0 -0.28 8 8
GNAZ 0.016 0.044 -10000 0 -0.28 10 10
EGFR/PI3K-beta/Gab1 -0.15 0.17 -10000 0 -0.3 277 277
positive regulation of dendritic cell cytokine production 0.007 0.019 -10000 0 -0.18 5 5
LPA/LPA2/MAGI-3 0.029 0.031 -10000 0 -0.2 3 3
ARHGEF1 0.038 0.056 -10000 0 -0.22 2 2
GNAI2 0.02 0.025 -10000 0 -0.21 5 5
GNAI3 0.021 0.023 -10000 0 -0.22 4 4
GNAI1 -0.1 0.17 -10000 0 -0.33 184 184
LPA/LPA3 0.002 0.01 -10000 0 -0.093 5 5
LPA/LPA2 0.002 0.01 -10000 0 -0.092 5 5
LPA/LPA1 0.007 0.025 -10000 0 -0.24 5 5
HB-EGF/EGFR -0.12 0.2 -10000 0 -0.31 250 250
HBEGF 0.067 0.077 -10000 0 -0.4 4 4
mol:DAG 0.026 0.055 0.19 43 -10000 0 43
cAMP biosynthetic process -0.055 0.1 0.24 1 -0.3 21 22
NFKB1 0.034 0.005 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
GNB1 0.034 0.012 -10000 0 -10000 0 0
LYN 0.04 0.069 0.27 18 -0.28 1 19
GNAQ 0.003 0.009 0.057 2 -0.074 5 7
LPAR2 0 0.001 -10000 0 -10000 0 0
LPAR3 0 0 -10000 0 -10000 0 0
LPAR1 0.003 0.016 0.075 2 -0.14 5 7
IL8 -0.19 0.22 0.35 13 -0.39 254 267
PTK2 0.02 0.021 -10000 0 -0.16 4 4
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
CASP3 0.017 0.022 -10000 0 -0.19 5 5
EGFR -0.27 0.29 -10000 0 -0.54 269 269
PLCG1 0.017 0.018 -10000 0 -0.11 2 2
PLD2 0.023 0.025 -10000 0 -0.2 5 5
G12/G13 0.045 0.03 -10000 0 -0.19 5 5
PI3K-beta -0.009 0.089 -10000 0 -0.27 36 36
cell migration 0.026 0.049 -10000 0 -0.25 10 10
SLC9A3R2 0.033 0.015 -10000 0 -10000 0 0
PXN 0.014 0.062 -10000 0 -0.29 8 8
HRAS/GTP -0.053 0.1 -10000 0 -0.25 55 55
RAC1 0.034 0.005 -10000 0 -10000 0 0
MMP9 0.096 0.076 -10000 0 -10000 0 0
PRKCE 0.034 0.004 -10000 0 -10000 0 0
PRKCD 0.024 0.058 0.22 6 -0.26 1 7
Gi(beta/gamma) -0.05 0.11 -10000 0 -0.27 47 47
mol:LPA 0.003 0.016 0.075 2 -0.14 5 7
TRIP6/p130 Cas/FAK1/Paxillin 0.03 0.052 -10000 0 -0.24 4 4
MAPKKK cascade -0.053 0.1 -10000 0 -0.25 55 55
contractile ring contraction involved in cytokinesis 0.009 0.068 -10000 0 -0.26 22 22
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 0.021 0.039 -10000 0 -0.31 4 4
GNA15 0.017 0.014 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
MAPT -0.014 0.08 0.23 5 -0.29 6 11
GNA11 0.015 0.009 -10000 0 -10000 0 0
Rac1/GTP 0.047 0.13 -10000 0 -0.89 10 10
MMP2 0.017 0.053 0.27 2 -0.47 5 7
S1P4 pathway

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
GNAO1 0.03 0.012 -10000 0 -10000 0 0
CDC42/GTP -0.066 0.14 -10000 0 -0.32 55 55
PLCG1 -0.073 0.13 -10000 0 -0.33 52 52
mol:GTP 0 0 -10000 0 -10000 0 0
GNAI2 0.034 0.01 -10000 0 -10000 0 0
GNAI3 0.034 0.006 -10000 0 -10000 0 0
G12/G13 0.046 0.017 -10000 0 -10000 0 0
cell migration -0.066 0.14 -10000 0 -0.32 55 55
S1PR5 0 0 -10000 0 -10000 0 0
S1PR4 0 0 -10000 0 -10000 0 0
MAPK3 -0.068 0.13 -10000 0 -0.34 45 45
MAPK1 -0.076 0.13 -10000 0 -0.33 54 54
S1P/S1P5/Gi -0.079 0.14 -10000 0 -0.25 184 184
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
CDC42/GDP 0.024 0.006 -10000 0 -10000 0 0
S1P/S1P5/G12 0.023 0.004 -10000 0 -10000 0 0
RHOA 0.034 0.051 0.2 3 -10000 0 3
S1P/S1P4/Gi -0.079 0.14 -10000 0 -0.25 184 184
mol:GDP 0 0 -10000 0 -10000 0 0
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
S1P/S1P4/G12/G13 0.039 0.015 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
ErbB2/ErbB3 signaling events

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 -0.005 0.015 -10000 0 -10000 0 0
RAS family/GTP -0.005 0.1 -10000 0 -0.28 15 15
NFATC4 -0.026 0.083 0.27 5 -10000 0 5
ERBB2IP 0.034 0.008 -10000 0 -10000 0 0
HSP90 (dimer) 0.034 0.007 -10000 0 -10000 0 0
mammary gland morphogenesis -0.035 0.085 -10000 0 -0.3 26 26
JUN -0.055 0.071 -10000 0 -10000 0 0
HRAS 0.033 0.013 -10000 0 -10000 0 0
DOCK7 -0.036 0.088 0.26 2 -0.29 26 28
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.019 0.096 -10000 0 -0.31 24 24
AKT1 0.007 0.016 -10000 0 -10000 0 0
BAD -0.005 0.014 -10000 0 -10000 0 0
MAPK10 -0.019 0.073 0.24 5 -0.25 7 12
mol:GTP -0.002 0.002 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta -0.037 0.091 -10000 0 -0.32 26 26
RAF1 -0.037 0.096 -10000 0 -0.3 18 18
ErbB2/ErbB3/neuregulin 2 -0.18 0.17 -10000 0 -0.33 273 273
STAT3 0.01 0.16 -10000 0 -0.84 18 18
cell migration -0.012 0.073 0.26 7 -0.26 3 10
mol:PI-3-4-5-P3 -0.001 0.002 -10000 0 -10000 0 0
cell proliferation -0.26 0.28 -10000 0 -0.65 126 126
FOS -0.33 0.26 -10000 0 -0.49 366 366
NRAS 0.035 0.017 -10000 0 -10000 0 0
mol:Ca2+ -0.035 0.085 -10000 0 -0.3 26 26
MAPK3 -0.16 0.21 -10000 0 -0.51 88 88
MAPK1 -0.18 0.24 -10000 0 -0.55 107 107
JAK2 -0.033 0.087 0.26 2 -0.29 26 28
NF2 0.003 0.069 -10000 0 -0.68 5 5
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0 0.079 -10000 0 -0.28 23 23
NRG1 -0.018 0.15 -10000 0 -0.54 40 40
GRB2/SOS1 0.047 0.019 -10000 0 -10000 0 0
MAPK8 -0.039 0.1 -10000 0 -0.29 29 29
MAPK9 -0.017 0.067 0.24 4 -10000 0 4
ERBB2 -0.022 0.013 -10000 0 -10000 0 0
ERBB3 0.037 0.026 -10000 0 -10000 0 0
SHC1 0.027 0.014 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
apoptosis 0.019 0.027 -10000 0 -0.18 2 2
STAT3 (dimer) 0.011 0.16 -10000 0 -0.82 18 18
RNF41 -0.009 0.014 -10000 0 -10000 0 0
FRAP1 -0.002 0.013 -10000 0 -10000 0 0
RAC1-CDC42/GTP -0.036 0.059 -10000 0 -0.22 26 26
ErbB2/ErbB2/HSP90 (dimer) -0.007 0.024 -10000 0 -10000 0 0
CHRNA1 -0.12 0.16 -10000 0 -0.38 89 89
myelination -0.018 0.092 0.4 4 -10000 0 4
PPP3CB -0.034 0.083 0.25 2 -0.28 16 18
KRAS 0.034 0.019 -10000 0 -10000 0 0
RAC1-CDC42/GDP 0.035 0.1 -10000 0 -0.25 22 22
NRG2 -0.35 0.27 -10000 0 -0.54 338 338
mol:GDP 0 0.079 -10000 0 -0.28 23 23
SOS1 0.034 0.004 -10000 0 -10000 0 0
MAP2K2 -0.053 0.1 -10000 0 -0.32 20 20
SRC 0.033 0.008 -10000 0 -10000 0 0
mol:cAMP -0.001 0.001 -10000 0 -10000 0 0
PTPN11 -0.034 0.089 0.27 2 -0.29 26 28
MAP2K1 -0.17 0.22 -10000 0 -0.59 57 57
heart morphogenesis -0.035 0.085 -10000 0 -0.3 26 26
RAS family/GDP 0.029 0.11 -10000 0 -0.27 14 14
GRB2 0.033 0.018 -10000 0 -10000 0 0
PRKACA 0.004 0.082 -10000 0 -0.68 7 7
CHRNE -0.006 0.018 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
activation of caspase activity -0.007 0.016 -10000 0 -10000 0 0
nervous system development -0.035 0.085 -10000 0 -0.3 26 26
CDC42 0.033 0.008 -10000 0 -10000 0 0
Syndecan-1-mediated signaling events

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.034 0.008 -10000 0 -10000 0 0
CCL5 0.029 0.06 -10000 0 -0.54 5 5
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
FGFR/FGF2/Syndecan-1 0.087 0.14 0.26 96 -0.34 8 104
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 0.07 0.14 0.28 17 -0.34 9 26
Syndecan-1/Syntenin 0.072 0.14 0.3 23 -0.34 9 32
MAPK3 0.071 0.13 0.28 28 -0.33 7 35
HGF/MET 0.006 0.13 -10000 0 -0.39 51 51
TGFB1/TGF beta receptor Type II 0.034 0.008 -10000 0 -10000 0 0
BSG 0.034 0.015 -10000 0 -10000 0 0
keratinocyte migration 0.069 0.14 0.28 17 -0.34 9 26
Syndecan-1/RANTES 0.075 0.15 0.3 30 -0.37 11 41
Syndecan-1/CD147 0.092 0.15 0.32 24 -0.32 10 34
Syndecan-1/Syntenin/PIP2 0.067 0.13 0.28 23 -0.32 9 32
LAMA5 0.032 0.012 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.065 0.13 0.27 23 -0.32 9 32
MMP7 -0.041 0.19 -10000 0 -0.54 64 64
HGF 0.035 0.01 -10000 0 -10000 0 0
Syndecan-1/CASK 0.059 0.13 0.25 26 -0.32 11 37
Syndecan-1/HGF/MET 0.063 0.18 0.33 9 -0.38 32 41
regulation of cell adhesion 0.061 0.12 0.3 9 -0.33 6 15
HPSE 0.046 0.041 -10000 0 -10000 0 0
positive regulation of cell migration 0.087 0.14 0.26 96 -0.34 8 104
SDC1 0.087 0.13 0.26 94 -0.27 10 104
Syndecan-1/Collagen 0.087 0.14 0.26 96 -0.34 8 104
PPIB 0.034 0.009 0.18 1 -10000 0 1
MET -0.022 0.17 -10000 0 -0.54 50 50
PRKACA 0.034 0.005 -10000 0 -10000 0 0
MMP9 0.096 0.075 -10000 0 -10000 0 0
MAPK1 0.071 0.13 0.28 28 -0.32 7 35
homophilic cell adhesion 0.085 0.14 0.26 96 -0.34 8 104
MMP1 0.12 0.078 -10000 0 -10000 0 0
Neurotrophic factor-mediated Trk receptor signaling

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.032 0.009 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.027 0.096 0.19 1 -0.27 18 19
NT3 (dimer)/TRKC -0.082 0.21 -10000 0 -0.4 146 146
NT3 (dimer)/TRKB -0.24 0.29 -10000 0 -0.48 279 279
SHC/Grb2/SOS1/GAB1/PI3K 0.003 0.074 -10000 0 -0.24 27 27
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
BDNF 0.038 0.048 -10000 0 -0.54 2 2
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DYNLT1 0.032 0.009 -10000 0 -10000 0 0
NTRK1 0.031 0.022 -10000 0 -10000 0 0
NTRK2 -0.23 0.29 -10000 0 -0.54 236 236
NTRK3 0.015 0.1 -10000 0 -0.54 16 16
NT-4/5 (dimer)/TRKB -0.17 0.23 -10000 0 -0.41 224 224
neuron apoptosis 0.12 0.21 0.45 113 -10000 0 113
SHC 2-3/Grb2 -0.13 0.23 -10000 0 -0.49 113 113
SHC1 0.028 0.014 -10000 0 -10000 0 0
SHC2 -0.14 0.24 -10000 0 -0.56 105 105
SHC3 -0.12 0.21 -10000 0 -0.49 94 94
STAT3 (dimer) 0.055 0.077 -10000 0 -0.36 10 10
NT3 (dimer)/TRKA -0.085 0.2 -10000 0 -0.38 138 138
RIN/GDP 0.005 0.11 0.27 5 -0.29 16 21
GIPC1 0.035 0.011 -10000 0 -10000 0 0
KRAS 0.035 0.019 -10000 0 -10000 0 0
DNAJA3 -0.056 0.13 -10000 0 -0.35 71 71
RIN/GTP 0.024 0.019 -10000 0 -0.4 1 1
CCND1 0.015 0.12 -10000 0 -0.77 10 10
MAGED1 0.044 0.037 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.053 0.034 -10000 0 -10000 0 0
GRB2 0.034 0.019 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.041 0.027 -10000 0 -10000 0 0
TRKA/NEDD4-2 0.033 0.068 -10000 0 -0.4 10 10
ELMO1 0.034 0.005 -10000 0 -10000 0 0
RhoG/GTP/ELMO1/DOCK1 0.042 0.032 -10000 0 -0.34 3 3
NGF 0 0 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
DOCK1 0.03 0.044 -10000 0 -0.54 3 3
GAB2 0.03 0.012 -10000 0 -10000 0 0
RIT2 0.032 0.026 -10000 0 -0.54 1 1
RIT1 0.029 0.013 -10000 0 -10000 0 0
FRS2 0.033 0.029 0.18 3 -0.54 1 4
DNM1 0.035 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP -0.034 0.15 -10000 0 -0.36 65 65
mol:GDP -0.01 0.15 0.34 6 -0.42 21 27
NGF (dimer) 0 0 -10000 0 -10000 0 0
RhoG/GDP 0.025 0.004 -10000 0 -10000 0 0
RIT1/GDP -0.006 0.098 0.25 2 -0.29 15 17
TIAM1 0.035 0.013 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
BDNF (dimer)/TRKB -0.12 0.2 -10000 0 -0.34 233 233
KIDINS220/CRKL/C3G 0.047 0.015 -10000 0 -10000 0 0
SHC/RasGAP 0.04 0.023 -10000 0 -10000 0 0
FRS2 family/SHP2 0.064 0.028 -10000 0 -0.34 1 1
SHC/GRB2/SOS1/GAB1 0.065 0.043 -10000 0 -10000 0 0
RIT1/GTP 0.021 0.01 -10000 0 -10000 0 0
NT3 (dimer) -0.12 0.25 -10000 0 -0.54 134 134
RAP1/GDP 0.002 0.091 0.19 1 -0.25 15 16
KIDINS220/CRKL 0.032 0.009 -10000 0 -10000 0 0
BDNF (dimer) 0.038 0.048 -10000 0 -0.54 2 2
ubiquitin-dependent protein catabolic process 0.03 0.059 -10000 0 -0.34 10 10
Schwann cell development -0.037 0.032 -10000 0 -10000 0 0
EHD4 0.033 0.007 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.076 0.039 -10000 0 -0.31 1 1
FRS2 family/SHP2/CRK family/C3G/GAB2 0.025 0.069 -10000 0 -0.3 8 8
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CDC42/GTP -0.16 0.22 -10000 0 -0.35 270 270
ABL1 0.034 0.005 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
Rap1/GTP -0.042 0.13 -10000 0 -0.46 22 22
STAT3 0.055 0.077 -10000 0 -0.36 10 10
axon guidance -0.17 0.2 -10000 0 -0.34 270 270
MAPK3 0.047 0.065 0.28 3 -10000 0 3
MAPK1 0.05 0.067 0.28 4 -10000 0 4
CDC42/GDP 0.006 0.11 0.29 6 -0.28 17 23
NTF3 -0.12 0.25 -10000 0 -0.54 134 134
NTF4 0 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/FAIM 0.039 0.022 -10000 0 -10000 0 0
PI3K 0.006 0.13 -10000 0 -0.4 44 44
FRS3 0.034 0.006 -10000 0 -10000 0 0
FAIM 0.034 0.006 -10000 0 -10000 0 0
GAB1 0.033 0.027 -10000 0 -0.54 1 1
RASGRF1 -0.053 0.14 -10000 0 -0.37 64 64
SOS1 0.034 0.004 -10000 0 -10000 0 0
MCF2L -0.082 0.17 -10000 0 -0.35 140 140
RGS19 0.034 0.022 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
RAS family/GTP 0.049 0.1 0.36 1 -0.43 5 6
Rac1/GDP 0.006 0.11 0.27 6 -0.28 18 24
NGF (dimer)/TRKA/GRIT 0.021 0.014 -10000 0 -10000 0 0
neuron projection morphogenesis -0.025 0.22 0.42 1 -0.73 28 29
NGF (dimer)/TRKA/NEDD4-2 0.03 0.059 -10000 0 -0.34 10 10
MAP2K1 0.062 0.085 0.36 12 -10000 0 12
NGFR -0.054 0.2 -10000 0 -0.54 76 76
NGF (dimer)/TRKA/GIPC/GAIP 0.024 0.026 -10000 0 -10000 0 0
RAS family/GTP/PI3K 0 0.086 -10000 0 -0.26 40 40
FRS2 family/SHP2/GRB2/SOS1 0.087 0.044 -10000 0 -0.3 1 1
NRAS 0.036 0.017 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
PRKCI 0.035 0.018 -10000 0 -10000 0 0
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAPKKK cascade -0.017 0.071 -10000 0 -0.64 3 3
RASA1 0.034 0.012 -10000 0 -10000 0 0
TRKA/c-Abl 0.043 0.024 -10000 0 -10000 0 0
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
BDNF (dimer)/TRKB/GIPC -0.098 0.2 -10000 0 -0.31 231 231
NGF (dimer)/TRKA/p62/Atypical PKCs 0.05 0.03 -10000 0 -10000 0 0
MATK 0.039 0.028 -10000 0 -10000 0 0
NEDD4L 0.019 0.091 -10000 0 -0.54 13 13
RAS family/GDP -0.034 0.058 -10000 0 -0.22 17 17
NGF (dimer)/TRKA -0.06 0.14 -10000 0 -0.36 80 80
Rac1/GTP -0.05 0.098 -10000 0 -0.28 41 41
FRS2 family/SHP2/CRK family 0.081 0.048 -10000 0 -0.3 1 1
ErbB4 signaling events

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.035 0.11 -10000 0 -0.36 5 5
epithelial cell differentiation 0.088 0.092 -10000 0 -10000 0 0
ITCH 0.047 0.026 -10000 0 -10000 0 0
WWP1 0.05 0.15 0.53 29 -10000 0 29
FYN 0.03 0.037 -10000 0 -0.54 2 2
EGFR -0.27 0.29 -10000 0 -0.54 269 269
PRL 0.034 0.006 -10000 0 -10000 0 0
neuron projection morphogenesis 0.029 0.12 0.38 11 -0.37 4 15
PTPRZ1 -0.36 0.27 -10000 0 -0.54 353 353
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.017 0.1 -10000 0 -0.38 6 6
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.012 0.11 0.28 1 -0.32 32 33
ADAM17 0.048 0.025 -10000 0 -10000 0 0
ErbB4/ErbB4 0.035 0.13 0.44 30 -0.4 3 33
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.036 0.11 0.36 1 -0.34 4 5
NCOR1 0.031 0.011 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.005 0.11 -10000 0 -0.39 7 7
GRIN2B -0.013 0.11 0.41 1 -0.37 7 8
ErbB4/ErbB2/betacellulin 0.03 0.099 -10000 0 -0.36 4 4
STAT1 0.059 0.056 -10000 0 -10000 0 0
HBEGF 0.029 0.051 -10000 0 -0.54 4 4
PRLR 0.072 0.065 -10000 0 -10000 0 0
E4ICDs/ETO2 -0.005 0.15 0.32 2 -0.39 42 44
axon guidance 0.12 0.14 0.45 32 -10000 0 32
NEDD4 0.04 0.06 -10000 0 -0.52 5 5
Prolactin receptor/Prolactin receptor/Prolactin 0.075 0.048 -10000 0 -10000 0 0
CBFA2T3 -0.022 0.17 -10000 0 -0.54 47 47
ErbB4/ErbB2/HBEGF 0.038 0.089 -10000 0 -0.33 3 3
MAPK3 0.03 0.12 0.39 7 -0.38 4 11
STAT1 (dimer) 0.055 0.11 0.37 8 -0.36 3 11
MAPK1 0.035 0.12 0.41 10 -0.38 4 14
JAK2 0.033 0.011 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta 0.003 0.11 -10000 0 -0.38 7 7
NRG1 -0.013 0.11 -10000 0 -0.4 38 38
NRG3 0.035 0.044 -10000 0 -0.54 2 2
NRG2 -0.35 0.27 -10000 0 -0.54 338 338
NRG4 0.035 0.013 -10000 0 -10000 0 0
heart development 0.12 0.14 0.45 32 -10000 0 32
neural crest cell migration 0.003 0.11 -10000 0 -0.38 7 7
ERBB2 0.021 0.029 0.3 1 -0.37 1 2
WWOX/E4ICDs 0.026 0.1 0.35 5 -0.36 3 8
SHC1 0.028 0.014 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 -0.12 0.16 -10000 0 -0.36 23 23
apoptosis -0.036 0.1 0.32 6 -0.34 9 15
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.18 0.17 -10000 0 -0.32 251 251
ErbB4/ErbB2/epiregulin 0.049 0.097 0.36 4 -0.34 1 5
ErbB4/ErbB4/betacellulin/betacellulin 0.021 0.13 -10000 0 -0.4 9 9
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.088 0.12 0.38 9 -0.33 1 10
MDM2 0.028 0.11 0.35 27 -0.36 3 30
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.001 0.1 -10000 0 -0.3 32 32
STAT5A 0.11 0.13 0.41 32 -10000 0 32
ErbB4/EGFR/neuregulin 1 beta -0.15 0.18 -10000 0 -0.45 58 58
DLG4 0.031 0.011 -10000 0 -10000 0 0
GRB2/SHC 0.039 0.026 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.024 0.091 -10000 0 -0.33 3 3
STAT5A (dimer) 0.14 0.12 0.4 23 -10000 0 23
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.13 0.12 0.41 26 -0.36 1 27
LRIG1 0.014 0.1 -10000 0 -0.54 17 17
EREG 0.045 0.05 -10000 0 -0.54 1 1
BTC 0.011 0.12 -10000 0 -0.54 21 21
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.11 0.14 0.46 31 -10000 0 31
ERBB4 0.031 0.13 0.43 26 -0.4 3 29
STAT5B 0.033 0.01 -10000 0 -10000 0 0
YAP1 -0.001 0.12 0.28 1 -0.43 26 27
GRB2 0.034 0.019 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.04 0.085 -10000 0 -10000 0 0
glial cell differentiation -0.023 0.091 0.33 3 -10000 0 3
WWOX 0.034 0.031 -10000 0 -10000 0 0
cell proliferation 0.055 0.14 0.42 15 -0.41 6 21
amb2 Integrin signaling

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.021 0.078 -10000 0 -0.28 5 5
alphaM/beta2 Integrin/GPIbA -0.015 0.08 0.27 3 -10000 0 3
alphaM/beta2 Integrin/proMMP-9 0.044 0.1 0.3 2 -10000 0 2
PLAUR 0.069 0.063 -10000 0 -10000 0 0
HMGB1 -0.03 0.045 -10000 0 -0.23 2 2
alphaM/beta2 Integrin/Talin -0.019 0.073 -10000 0 -10000 0 0
AGER -0.034 0.051 -10000 0 -0.38 2 2
RAP1A 0.034 0.005 -10000 0 -10000 0 0
SELPLG 0.034 0.028 -10000 0 -0.54 1 1
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.1 0.14 -10000 0 -0.36 8 8
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 0.096 0.075 -10000 0 -10000 0 0
CYR61 -0.13 0.26 -10000 0 -0.54 143 143
TLN1 0.034 0.006 -10000 0 -10000 0 0
Rap1/GTP 0.062 0.085 -10000 0 -0.32 8 8
RHOA 0.033 0.008 -10000 0 -10000 0 0
P-selectin oligomer -0.1 0.24 -10000 0 -0.54 117 117
MYH2 0.064 0.092 0.29 5 -0.5 4 9
MST1R 0.043 0.038 -10000 0 -10000 0 0
leukocyte activation during inflammatory response -0.013 0.068 -10000 0 -10000 0 0
APOB 0.034 0.004 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.029 0.039 -10000 0 -0.54 2 2
JAM3 -0.008 0.14 -10000 0 -0.54 34 34
GP1BA 0.036 0.03 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CTGF -0.032 0.1 -10000 0 -0.36 21 21
alphaM/beta2 Integrin 0.049 0.083 0.24 3 -0.36 8 11
JAM3 homodimer -0.008 0.14 -10000 0 -0.54 34 34
ICAM2 0.021 0.076 -10000 0 -0.54 9 9
ICAM1 0.04 0.029 -10000 0 -10000 0 0
phagocytosis triggered by activation of immune response cell surface activating receptor 0.047 0.087 0.24 3 -0.35 10 13
cell adhesion -0.016 0.079 0.27 3 -10000 0 3
NFKB1 -0.22 0.19 0.4 1 -0.36 304 305
THY1 0.034 0.026 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
Lipoprotein(a) 0.043 0.013 -10000 0 -10000 0 0
alphaM/beta2 Integrin/LRP/tPA -0.063 0.13 -10000 0 -0.33 75 75
IL6 -0.52 0.36 0.38 1 -0.74 375 376
ITGB2 -0.022 0.064 -10000 0 -10000 0 0
elevation of cytosolic calcium ion concentration 0.033 0.11 0.31 9 -10000 0 9
alphaM/beta2 Integrin/JAM2/JAM3 -0.11 0.2 -10000 0 -0.42 123 123
JAM2 -0.12 0.25 -10000 0 -0.54 132 132
alphaM/beta2 Integrin/ICAM1 0.01 0.093 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA/Plg 0.011 0.092 -10000 0 -0.36 1 1
RhoA/GTP 0.045 0.1 -10000 0 -0.41 12 12
positive regulation of phagocytosis 0.039 0.082 0.27 6 -0.3 3 9
Ron/MSP 0.056 0.029 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPAR/uPA 0.035 0.12 0.32 9 -10000 0 9
alphaM/beta2 Integrin/uPAR 0.011 0.097 0.26 12 -10000 0 12
PLAU 0.058 0.054 -10000 0 -10000 0 0
PLAT -0.066 0.21 -10000 0 -0.54 85 85
actin filament polymerization 0.065 0.097 0.31 10 -0.44 5 15
MST1 0.033 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/lipoprotein(a) -0.01 0.072 -10000 0 -10000 0 0
TNF -0.21 0.18 0.42 3 -0.34 267 270
RAP1B 0.033 0.007 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA 0.004 0.087 0.26 1 -10000 0 1
fibrinolysis 0.01 0.09 -10000 0 -0.36 1 1
HCK 0.037 0.023 -10000 0 -10000 0 0
dendritic cell antigen processing and presentation 0.047 0.087 0.24 3 -0.35 10 13
VTN 0.033 0.011 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CYR61 -0.11 0.17 -10000 0 -0.37 138 138
LPA 0.032 0.009 -10000 0 -10000 0 0
LRP1 0.034 0.005 -10000 0 -10000 0 0
cell migration 0.03 0.092 0.28 2 -0.36 2 4
FN1 0.14 0.069 -10000 0 -10000 0 0
alphaM/beta2 Integrin/Thy1 -0.016 0.076 0.26 1 -10000 0 1
MPO 0.032 0.016 -10000 0 -10000 0 0
KNG1 0.034 0.006 -10000 0 -10000 0 0
RAP1/GDP 0.044 0.012 -10000 0 -10000 0 0
ROCK1 0.064 0.11 0.27 10 -0.41 10 20
ELA2 0 0 -10000 0 -10000 0 0
PLG 0.031 0.027 -10000 0 -0.54 1 1
CTGF 0.012 0.11 -10000 0 -0.54 19 19
alphaM/beta2 Integrin/Hck -0.017 0.077 0.28 5 -10000 0 5
ITGAM -0.028 0.044 -10000 0 -10000 0 0
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.073 0.16 -10000 0 -0.35 100 100
HP 0.03 0.012 -10000 0 -10000 0 0
leukocyte adhesion -0.17 0.2 -10000 0 -0.46 120 120
SELP -0.1 0.24 -10000 0 -0.54 117 117
TCGA08_rtk_signaling

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.034 0.19 -10000 0 -0.54 61 61
HRAS 0.034 0.013 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
AKT -0.017 0.12 0.36 5 -0.29 24 29
FOXO3 0.032 0.01 -10000 0 -10000 0 0
AKT1 0.035 0.017 -10000 0 -10000 0 0
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
AKT3 0.029 0.019 -10000 0 -10000 0 0
FOXO4 0.035 0.002 -10000 0 -10000 0 0
MET -0.022 0.17 -10000 0 -0.54 50 50
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PIK3CB 0.034 0.006 -10000 0 -10000 0 0
NRAS 0.036 0.017 -10000 0 -10000 0 0
PIK3CG 0.037 0.022 -10000 0 -10000 0 0
PIK3R3 0.043 0.035 -10000 0 -10000 0 0
PIK3R2 0.036 0.017 -10000 0 -10000 0 0
NF1 0.032 0.009 -10000 0 -10000 0 0
RAS -0.076 0.14 0.24 1 -0.33 85 86
ERBB2 0.028 0.029 -10000 0 -0.54 1 1
proliferation/survival/translation -0.016 0.1 0.31 26 -0.3 1 27
PI3K -0.067 0.16 0.3 10 -0.31 104 114
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
KRAS 0.035 0.019 -10000 0 -10000 0 0
FOXO 0.036 0.081 0.33 6 -0.18 7 13
AKT2 0.034 0.005 -10000 0 -10000 0 0
PTEN 0.029 0.045 -10000 0 -0.54 3 3
Regulation of nuclear SMAD2/3 signaling

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.036 0.016 -10000 0 -10000 0 0
HSPA8 0.03 0.012 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha -0.071 0.19 0.33 1 -0.4 106 107
AKT1 0.038 0.021 -10000 0 -10000 0 0
GSC -0.096 0.4 -10000 0 -1.3 45 45
NKX2-5 0.046 0.051 -10000 0 -10000 0 0
muscle cell differentiation 0 0.12 0.48 16 -10000 0 16
SMAD2-3/SMAD4/SP1 0.053 0.12 -10000 0 -0.33 9 9
SMAD4 -0.027 0.081 -10000 0 -0.26 20 20
CBFB 0.03 0.014 -10000 0 -10000 0 0
SAP18 0.032 0.009 -10000 0 -10000 0 0
Cbp/p300/MSG1 -0.16 0.2 -10000 0 -0.34 275 275
SMAD3/SMAD4/VDR 0.053 0.093 -10000 0 -0.38 4 4
MYC -0.006 0.12 -10000 0 -0.55 25 25
CDKN2B -0.05 0.2 -10000 0 -0.76 19 19
AP1 -0.26 0.29 -10000 0 -0.44 277 277
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.014 0.11 -10000 0 -0.38 21 21
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.01 0.11 -10000 0 -0.39 17 17
SP3 0.035 0.008 -10000 0 -10000 0 0
CREB1 0.034 0.006 -10000 0 -10000 0 0
FOXH1 0.018 0.041 -10000 0 -0.17 3 3
SMAD3/SMAD4/GR -0.044 0.14 -10000 0 -0.39 50 50
GATA3 0.039 0.16 -10000 0 -0.53 33 33
SKI/SIN3/HDAC complex/NCoR1 0.016 0.085 -10000 0 -0.37 16 16
MEF2C/TIF2 0.008 0.15 0.34 1 -0.54 25 26
endothelial cell migration -0.06 0.11 0.56 7 -10000 0 7
MAX 0.025 0.024 -10000 0 -10000 0 0
RBBP7 0.038 0.023 -10000 0 -10000 0 0
RBBP4 0.034 0.006 -10000 0 -10000 0 0
RUNX2 0.036 0.02 -10000 0 -10000 0 0
RUNX3 -0.006 0.15 -10000 0 -0.54 36 36
RUNX1 0.018 0.098 -10000 0 -0.54 15 15
CTBP1 0.033 0.008 -10000 0 -10000 0 0
NR3C1 -0.019 0.16 -10000 0 -0.54 40 40
VDR 0.032 0.037 -10000 0 -0.54 2 2
CDKN1A 0.005 0.11 -10000 0 -1.1 3 3
KAT2B 0.001 0.004 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.027 0.11 -10000 0 -0.32 31 31
DCP1A 0.033 0.008 -10000 0 -10000 0 0
SKI 0.033 0.007 -10000 0 -10000 0 0
SERPINE1 0.06 0.11 -10000 0 -0.56 7 7
SMAD3/SMAD4/ATF2 0.007 0.091 -10000 0 -0.27 10 10
SMAD3/SMAD4/ATF3 -0.088 0.2 -10000 0 -0.41 131 131
SAP30 0.034 0.009 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.056 0.043 -10000 0 -10000 0 0
JUN -0.26 0.28 -10000 0 -0.62 137 137
SMAD3/SMAD4/IRF7 0.022 0.093 -10000 0 -0.28 8 8
TFE3 0.03 0.045 -10000 0 -0.19 1 1
COL1A2 0.074 0.13 0.4 10 -0.71 5 15
mesenchymal cell differentiation -0.007 0.091 0.26 13 -10000 0 13
DLX1 0.044 0.037 -10000 0 -10000 0 0
TCF3 0.035 0.018 -10000 0 -10000 0 0
FOS -0.36 0.28 -10000 0 -0.56 344 344
SMAD3/SMAD4/Max -0.017 0.088 -10000 0 -0.28 8 8
Cbp/p300/SNIP1 0.062 0.028 -10000 0 -10000 0 0
ZBTB17 0.028 0.022 -10000 0 -10000 0 0
LAMC1 -0.037 0.15 -10000 0 -0.6 28 28
TGIF2/HDAC complex/SMAD3/SMAD4 0.007 0.09 -10000 0 -0.28 9 9
IRF7 0.04 0.024 0.23 1 -10000 0 1
ESR1 -0.068 0.25 0.23 3 -0.55 106 109
HNF4A 0.033 0.008 -10000 0 -10000 0 0
MEF2C 0.016 0.17 0.42 10 -0.55 28 38
SMAD2-3/SMAD4 0.009 0.11 -10000 0 -0.31 19 19
Cbp/p300/Src-1 0.063 0.035 -10000 0 -0.32 1 1
IGHV3OR16-13 -0.006 0.067 -10000 0 -0.45 9 9
TGIF2/HDAC complex 0.033 0.01 -10000 0 -10000 0 0
CREBBP 0.034 0.013 -10000 0 -10000 0 0
SKIL 0.046 0.042 -10000 0 -10000 0 0
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC2 0.034 0.017 0.18 3 -10000 0 3
SNIP1 0.033 0.007 -10000 0 -10000 0 0
GCN5L2 0.003 0.009 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.019 0.13 -10000 0 -0.37 30 30
MSG1/HSC70 -0.21 0.22 -10000 0 -0.4 297 297
SMAD2 0.02 0.053 -10000 0 -0.23 1 1
SMAD3 -0.015 0.063 -10000 0 -0.21 6 6
SMAD3/E2F4-5/DP1/p107/SMAD4 0.005 0.07 -10000 0 -0.3 7 7
SMAD2/SMAD2/SMAD4 0.017 0.057 0.22 7 -0.21 4 11
NCOR1 0.031 0.011 -10000 0 -10000 0 0
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
MYOD/E2A 0.049 0.035 -10000 0 -0.4 2 2
SMAD2-3/SMAD4/SP1/MIZ-1 0.075 0.12 -10000 0 -0.33 6 6
IFNB1 -0.012 0.072 0.33 2 -0.3 1 3
SMAD3/SMAD4/MEF2C 0.023 0.18 0.41 1 -0.56 29 30
CITED1 -0.3 0.29 -10000 0 -0.54 296 296
SMAD2-3/SMAD4/ARC105 0.024 0.11 -10000 0 -0.29 14 14
RBL1 0.04 0.032 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.002 0.11 -10000 0 -0.48 9 9
RUNX1-3/PEBPB2 0.021 0.13 -10000 0 -0.35 49 49
SMAD7 -0.18 0.22 -10000 0 -0.51 94 94
MYC/MIZ-1 0.008 0.098 -10000 0 -0.41 25 25
SMAD3/SMAD4 0.04 0.098 0.33 12 -0.39 2 14
IL10 -0.005 0.12 0.4 1 -0.37 26 27
PIASy/HDAC complex 0.027 0.028 -10000 0 -10000 0 0
PIAS3 0.029 0.015 -10000 0 -10000 0 0
CDK2 0.04 0.024 -10000 0 -10000 0 0
IL5 -0.002 0.12 0.36 2 -0.36 32 34
CDK4 0.037 0.011 -10000 0 -10000 0 0
PIAS4 0.027 0.028 -10000 0 -10000 0 0
ATF3 -0.12 0.25 -10000 0 -0.54 128 128
SMAD3/SMAD4/SP1 0.039 0.1 -10000 0 -0.3 9 9
FOXG1 0.042 0.037 -10000 0 -10000 0 0
FOXO3 0.021 0.021 -10000 0 -10000 0 0
FOXO1 -0.018 0.12 -10000 0 -0.39 48 48
FOXO4 0.022 0.02 -10000 0 -10000 0 0
heart looping 0.017 0.17 0.42 10 -0.54 28 38
CEBPB 0.032 0.028 -10000 0 -0.54 1 1
SMAD3/SMAD4/DLX1 0.015 0.093 -10000 0 -0.26 12 12
MYOD1 0.034 0.041 -10000 0 -0.54 2 2
SMAD3/SMAD4/HNF4 0.008 0.09 -10000 0 -0.28 9 9
SMAD3/SMAD4/GATA3 0.027 0.15 -10000 0 -0.4 33 33
SnoN/SIN3/HDAC complex/NCoR1 0.046 0.042 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.007 0.15 -10000 0 -0.36 47 47
SMAD3/SMAD4/SP1-3 0.061 0.1 -10000 0 -0.36 3 3
MED15 0.032 0.009 -10000 0 -10000 0 0
SP1 0.047 0.024 -10000 0 -10000 0 0
SIN3B 0.035 0.014 -10000 0 -10000 0 0
SIN3A 0.034 0.006 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.046 0.12 -10000 0 -0.35 26 26
ITGB5 -0.002 0.083 0.34 1 -0.53 2 3
TGIF/SIN3/HDAC complex/CtBP 0.024 0.07 -10000 0 -0.34 11 11
SMAD3/SMAD4/AR -0.041 0.16 -10000 0 -0.38 75 75
AR -0.039 0.19 -10000 0 -0.54 66 66
negative regulation of cell growth -0.022 0.13 -10000 0 -0.38 22 22
SMAD3/SMAD4/MYOD 0.007 0.094 -10000 0 -0.28 15 15
E2F5 0.036 0.037 -10000 0 -10000 0 0
E2F4 0.03 0.012 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.051 0.11 -10000 0 -0.34 12 12
SMAD2-3/SMAD4/FOXO1-3a-4 -0.008 0.11 -10000 0 -0.39 17 17
TFDP1 0.034 0.022 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 -0.25 0.3 -10000 0 -0.62 142 142
SMAD3/SMAD4/RUNX2 0.008 0.092 -10000 0 -0.26 13 13
TGIF2 0.033 0.01 -10000 0 -10000 0 0
TGIF1 0.032 0.027 -10000 0 -0.54 1 1
ATF2 0.034 0.005 -10000 0 -10000 0 0
FOXA2 and FOXA3 transcription factor networks

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL 0.017 0.18 -10000 0 -0.75 3 3
PCK1 -0.74 0.54 -10000 0 -1 387 387
HNF4A 0.032 0.2 0.71 2 -0.75 3 5
KCNJ11 0.039 0.24 0.8 2 -0.76 3 5
AKT1 0.012 0.15 -10000 0 -0.49 4 4
response to starvation 0.005 0.002 -10000 0 -10000 0 0
DLK1 0.027 0.22 0.88 1 -0.81 3 4
NKX2-1 0.033 0.12 0.65 1 -10000 0 1
ACADM 0.015 0.21 -10000 0 -0.86 8 8
TAT -0.058 0.2 -10000 0 -0.73 15 15
CEBPB 0.034 0.028 -10000 0 -0.54 1 1
CEBPA 0.036 0.045 -10000 0 -0.54 3 3
TTR -0.034 0.26 0.59 1 -0.67 35 36
PKLR 0.036 0.19 -10000 0 -0.79 2 2
APOA1 0.02 0.22 -10000 0 -0.88 3 3
CPT1C 0.027 0.2 0.71 1 -0.76 3 4
ALAS1 0.031 0.14 -10000 0 -10000 0 0
TFRC -0.018 0.2 0.68 3 -0.55 1 4
FOXF1 0.026 0.021 -10000 0 -10000 0 0
NF1 0.038 0.01 -10000 0 -10000 0 0
HNF1A (dimer) 0.051 0.022 -10000 0 -0.22 1 1
CPT1A 0.027 0.21 0.68 5 -0.7 3 8
HMGCS1 0.022 0.2 0.75 2 -0.76 3 5
NR3C1 0 0.16 -10000 0 -0.51 43 43
CPT1B 0.017 0.19 -10000 0 -0.75 3 3
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.041 0.015 -10000 0 -10000 0 0
GCK 0.023 0.19 -10000 0 -0.76 3 3
CREB1 -0.18 0.14 -10000 0 -0.26 371 371
IGFBP1 0.015 0.14 -10000 0 -0.82 2 2
PDX1 0.043 0.16 -10000 0 -1.1 2 2
UCP2 0.026 0.2 0.66 2 -0.7 3 5
ALDOB 0.021 0.22 -10000 0 -0.81 3 3
AFP -0.051 0.14 0.39 1 -0.37 39 40
BDH1 0.024 0.2 0.68 2 -0.76 3 5
HADH 0.018 0.23 -10000 0 -0.93 5 5
F2 0.037 0.22 -10000 0 -0.82 3 3
HNF1A 0.051 0.022 -10000 0 -0.22 1 1
G6PC -0.098 0.12 -10000 0 -10000 0 0
SLC2A2 0.047 0.16 -10000 0 -1.1 1 1
INS 0.023 0.014 0.25 1 -10000 0 1
FOXA1 -0.002 0.23 0.39 3 -0.53 73 76
FOXA3 -0.11 0.15 0.31 1 -0.26 126 127
FOXA2 0.031 0.27 0.76 1 -0.92 3 4
ABCC8 -0.065 0.43 0.91 1 -0.93 86 87
ALB -0.054 0.15 0.39 1 -0.84 3 4
TCR signaling in naïve CD8+ T cells

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.088 0.16 0.34 65 -0.4 11 76
FYN 0.062 0.16 0.39 31 -0.4 18 49
LAT/GRAP2/SLP76 0.071 0.16 0.41 30 -0.41 11 41
IKBKB 0.029 0.013 -10000 0 -10000 0 0
AKT1 0.059 0.16 0.37 48 -0.31 29 77
B2M 0.037 0.011 -10000 0 -10000 0 0
IKBKG 0.034 0.071 0.19 52 -0.12 2 54
MAP3K8 -0.039 0.19 -10000 0 -0.54 65 65
mol:Ca2+ -0.011 0.017 0.032 9 -0.09 12 21
integrin-mediated signaling pathway 0.038 0.023 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1/PI3K Class IA 0.053 0.18 0.5 22 -0.41 28 50
TRPV6 0.013 0.22 1.3 10 -0.54 17 27
CD28 0.028 0.084 -10000 0 -0.54 10 10
SHC1 0.071 0.18 0.35 73 -0.42 20 93
receptor internalization 0.024 0.19 0.36 26 -0.39 65 91
PRF1 0.037 0.17 0.54 10 -0.79 6 16
KRAS 0.035 0.019 -10000 0 -10000 0 0
GRB2 0.034 0.019 -10000 0 -10000 0 0
COT/AKT1 0.037 0.16 0.34 43 -0.31 34 77
LAT 0.055 0.17 0.39 33 -0.41 21 54
EntrezGene:6955 0.001 0.004 -10000 0 -10000 0 0
CD3D 0.04 0.037 0.22 4 -10000 0 4
CD3E 0.034 0.016 0.22 1 -10000 0 1
CD3G 0.039 0.073 0.21 10 -0.54 5 15
RASGRP2 0.009 0.05 0.17 10 -0.16 29 39
RASGRP1 0.065 0.16 0.44 30 -0.34 14 44
HLA-A 0.041 0.025 0.22 2 -10000 0 2
RASSF5 0.03 0.024 -10000 0 -10000 0 0
RAP1A/GTP/RAPL 0.038 0.023 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.066 0.098 0.26 58 -0.13 1 59
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.01 0.048 -10000 0 -0.17 20 20
PRKCA 0.042 0.1 0.33 25 -0.22 5 30
GRAP2 0.035 0.019 -10000 0 -10000 0 0
mol:IP3 0.003 0.091 0.29 10 -0.32 10 20
EntrezGene:6957 0.003 0.006 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 0.025 0.13 0.32 21 -0.3 48 69
ORAI1 -0.019 0.17 -10000 0 -1.1 10 10
CSK 0.046 0.16 0.4 20 -0.41 20 40
B7 family/CD28 0.083 0.17 0.48 23 -0.44 13 36
CHUK 0.034 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 0.042 0.17 0.39 24 -0.37 45 69
PTPN6 0.044 0.16 0.37 26 -0.39 21 47
VAV1 0.044 0.16 0.44 19 -0.42 20 39
Monovalent TCR/CD3 0.023 0.1 0.28 21 -0.36 21 42
CBL 0.031 0.011 -10000 0 -10000 0 0
LCK 0.063 0.16 0.38 33 -0.41 14 47
PAG1 0.063 0.17 0.39 31 -0.41 19 50
RAP1A 0.034 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK 0.04 0.17 0.37 28 -0.38 35 63
CD80 0.046 0.039 -10000 0 -10000 0 0
CD86 0.036 0.013 -10000 0 -10000 0 0
PDK1/CARD11/BCL10/MALT1 0.009 0.067 -10000 0 -0.21 16 16
HRAS 0.034 0.013 -10000 0 -10000 0 0
GO:0035030 0.042 0.14 0.39 26 -0.38 13 39
CD8A 0.003 0.006 0.047 2 -10000 0 2
CD8B 0.041 0.026 0.22 5 -10000 0 5
PTPRC 0.036 0.036 -10000 0 -10000 0 0
PDK1/PKC theta 0.07 0.19 0.42 55 -0.36 23 78
CSK/PAG1 0.066 0.16 0.38 32 -0.44 13 45
SOS1 0.034 0.004 -10000 0 -10000 0 0
peptide-MHC class I 0.057 0.025 -10000 0 -10000 0 0
GRAP2/SLP76 0.066 0.17 0.46 19 -0.42 16 35
STIM1 0.004 0.1 1.2 3 -10000 0 3
RAS family/GTP 0.076 0.11 0.28 54 -0.18 11 65
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin 0.022 0.19 0.36 27 -0.41 65 92
mol:DAG -0.016 0.068 0.13 2 -0.28 12 14
RAP1A/GDP 0.035 0.048 0.14 47 -10000 0 47
PLCG1 0.033 0.008 -10000 0 -10000 0 0
CD247 0.023 0.11 -10000 0 -0.54 15 15
cytotoxic T cell degranulation 0.038 0.16 0.54 10 -0.75 6 16
RAP1A/GTP 0.002 0.016 -10000 0 -0.06 27 27
mol:PI-3-4-5-P3 0.055 0.17 0.45 26 -0.35 28 54
LAT/GRAP2/SLP76/VAV1/PLCgamma1 0.023 0.12 0.33 9 -0.4 10 19
NRAS 0.036 0.017 -10000 0 -10000 0 0
ZAP70 0.039 0.025 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.019 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 0.047 0.13 0.34 10 -0.4 11 21
MALT1 0.034 0.01 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
CD8 heterodimer 0.033 0.022 0.19 5 -10000 0 5
CARD11 0.039 0.027 -10000 0 -10000 0 0
PRKCB -0.013 0.051 0.16 4 -0.2 12 16
PRKCE 0.046 0.11 0.32 29 -0.22 8 37
PRKCQ 0.059 0.18 0.48 28 -0.39 25 53
LCP2 0.037 0.023 -10000 0 -10000 0 0
BCL10 0.034 0.007 -10000 0 -10000 0 0
regulation of survival gene product expression 0.059 0.15 0.34 53 -0.27 29 82
IKK complex 0.056 0.092 0.23 69 -10000 0 69
RAS family/GDP 0 0.009 -10000 0 -10000 0 0
MAP3K14 0.029 0.14 0.28 49 -0.26 27 76
PDPK1 0.063 0.16 0.38 54 -0.3 26 80
TCR/CD3/MHC I/CD8/Fyn 0.015 0.17 0.38 16 -0.47 27 43
Canonical Wnt signaling pathway

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.027 0.043 0.24 8 -10000 0 8
AES 0.026 0.036 0.22 4 -10000 0 4
FBXW11 0.034 0.007 -10000 0 -10000 0 0
mol:GTP 0 0.002 -10000 0 -10000 0 0
LRP6/FZD1 0.048 0.024 -10000 0 -0.4 1 1
SMAD4 0.033 0.008 -10000 0 -10000 0 0
DKK2 0.031 0.054 -10000 0 -0.54 4 4
TLE1 0.01 0.1 0.24 4 -0.55 15 19
MACF1 0.035 0.006 -10000 0 -10000 0 0
CTNNB1 0.15 0.11 0.34 32 -0.41 3 35
WIF1 -0.38 0.26 -10000 0 -0.54 370 370
beta catenin/RanBP3 0.042 0.15 0.5 40 -0.4 3 43
KREMEN2 0.11 0.077 -10000 0 -10000 0 0
DKK1 0.008 0.18 -10000 0 -0.54 44 44
beta catenin/beta TrCP1 0.16 0.1 0.35 28 -0.38 3 31
FZD1 0.034 0.026 -10000 0 -0.54 1 1
AXIN2 0.026 0.28 0.65 45 -1.1 15 60
AXIN1 0.033 0.01 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.07 0.086 -10000 0 -0.54 7 7
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.092 0.15 0.36 8 -0.57 14 22
Axin1/APC/GSK3 0.065 0.058 0.32 1 -10000 0 1
Axin1/APC/GSK3/beta catenin/Macf1 0.062 0.076 0.37 1 -0.55 1 2
HNF1A 0.028 0.042 0.26 6 -10000 0 6
CTBP1 0.025 0.039 0.25 4 -10000 0 4
MYC 0.097 0.44 0.64 111 -1.3 29 140
RANBP3 0.034 0.006 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.1 0.071 0.26 2 -0.31 3 5
NKD1 0.032 0.021 -10000 0 -10000 0 0
TCF4 0.019 0.076 0.23 6 -0.53 7 13
TCF3 0.028 0.043 0.27 5 -10000 0 5
WNT1/LRP6/FZD1/Axin1 0.077 0.039 -10000 0 -0.32 1 1
Ran/GTP 0.025 0.005 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0 0.21 0.55 32 -0.55 13 45
LEF1 0.055 0.069 0.27 8 -10000 0 8
DVL1 0.079 0.058 0.25 3 -10000 0 3
CSNK2A1 0.034 0.008 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.097 0.17 0.33 5 -0.57 16 21
DKK1/LRP6/Kremen 2 0.083 0.13 0.26 50 -0.28 42 92
LRP6 0.034 0.009 -10000 0 -10000 0 0
CSNK1A1 0.027 0.042 0.26 5 -10000 0 5
NLK 0.036 0.033 -10000 0 -10000 0 0
CCND1 0.12 0.38 0.76 93 -1.3 13 106
WNT1 0.035 0.005 -10000 0 -10000 0 0
GSK3A 0.035 0.005 -10000 0 -10000 0 0
GSK3B 0.034 0.009 -10000 0 -10000 0 0
FRAT1 0.035 0.008 -10000 0 -10000 0 0
PPP2R5D 0.055 0.058 -10000 0 -0.39 3 3
APC 0.038 0.062 0.38 4 -0.3 1 5
WNT1/LRP6/FZD1 0.16 0.1 0.23 301 -0.3 1 302
CREBBP 0.024 0.037 0.26 3 -10000 0 3
Signaling events regulated by Ret tyrosine kinase

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.029 0.08 -10000 0 -0.45 9 9
Crk/p130 Cas/Paxillin -0.082 0.14 -10000 0 -0.38 69 69
JUN -0.001 0.15 0.29 2 -0.43 20 22
HRAS 0.034 0.013 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/GRB10 0.11 0.17 -10000 0 -0.29 59 59
RAP1A 0.034 0.005 -10000 0 -10000 0 0
FRS2 0.033 0.029 0.18 3 -0.54 1 4
RAP1A/GDP 0.025 0.004 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 0.12 0.17 0.36 3 -0.29 56 59
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.034 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma 0.057 0.14 -10000 0 -0.31 60 60
RHOA 0.033 0.008 -10000 0 -10000 0 0
RAP1A/GTP 0.078 0.15 -10000 0 -0.28 45 45
GRB7 0.029 0.013 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF 0.12 0.17 -10000 0 -0.29 56 56
MAPKKK cascade 0.06 0.14 0.25 8 -0.29 41 49
BCAR1 0.029 0.013 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 0.018 0.2 -10000 0 -0.38 92 92
lamellipodium assembly -0.042 0.16 -10000 0 -0.35 72 72
RET51/GFRalpha1/GDNF/SHC 0.095 0.16 -10000 0 -0.3 44 44
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC 0.047 0.13 -10000 0 -0.31 45 45
RET9/GFRalpha1/GDNF/Shank3 0.051 0.14 -10000 0 -0.31 60 60
MAPK3 0.043 0.13 0.28 9 -10000 0 9
DOK1 0.036 0.016 -10000 0 -10000 0 0
DOK6 0.033 0.049 -10000 0 -0.54 3 3
PXN 0.034 0.004 -10000 0 -10000 0 0
neurite development 0.044 0.12 0.33 1 -0.37 1 2
DOK5 0.012 0.11 -10000 0 -0.54 18 18
GFRA1 0.032 0.23 -10000 0 -0.54 63 63
MAPK8 0.054 0.12 0.27 4 -0.37 8 12
HRAS/GTP 0.095 0.16 0.31 4 -0.32 42 46
tube development 0.057 0.14 0.31 12 -0.3 57 69
MAPK1 0.045 0.13 0.28 9 -10000 0 9
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.021 0.11 -10000 0 -0.26 57 57
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
PDLIM7 0.034 0.009 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 0.11 0.17 0.36 2 -0.3 42 44
SHC1 0.028 0.014 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 0.093 0.17 -10000 0 -0.3 57 57
RET51/GFRalpha1/GDNF/Dok5 0.089 0.18 -10000 0 -0.3 63 63
PRKCA 0.031 0.013 -10000 0 -10000 0 0
HRAS/GDP 0.025 0.009 -10000 0 -10000 0 0
CREB1 0.046 0.12 -10000 0 -0.46 3 3
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.02 0.097 -10000 0 -0.25 40 40
RET51/GFRalpha1/GDNF/Grb7 0.1 0.16 -10000 0 -0.3 43 43
mol:GDP 0 0 -10000 0 -10000 0 0
RET 0.1 0.074 -10000 0 -10000 0 0
DOK4 0.03 0.012 -10000 0 -10000 0 0
JNK cascade 0 0.15 0.29 2 -0.42 20 22
RET9/GFRalpha1/GDNF/FRS2 0.052 0.14 0.24 1 -0.31 60 61
SHANK3 0.032 0.009 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.02 0.099 -10000 0 -0.25 41 41
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.057 0.13 0.26 10 -0.38 5 15
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK 0.062 0.13 0.25 4 -0.39 8 12
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.049 0.12 0.25 6 -0.38 3 9
PI3K -0.038 0.25 0.35 2 -0.55 72 74
SOS1 0.034 0.004 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 0.06 0.14 -10000 0 -0.3 57 57
GRB10 0.03 0.051 -10000 0 -0.54 4 4
activation of MAPKK activity 0.056 0.12 0.26 5 -0.34 3 8
RET51/GFRalpha1/GDNF/FRS2 0.11 0.17 0.36 1 -0.3 58 59
GAB1 0.033 0.027 -10000 0 -0.54 1 1
IRS1 -0.034 0.18 -10000 0 -0.54 60 60
IRS2 -0.1 0.24 -10000 0 -0.54 117 117
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.049 0.12 0.25 6 -0.35 3 9
RET51/GFRalpha1/GDNF/PKC alpha 0.1 0.17 -10000 0 -0.3 55 55
GRB2 0.034 0.019 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GDNF 0.034 0.009 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 0.074 0.23 -10000 0 -0.38 85 85
Rac1/GTP -0.031 0.2 -10000 0 -0.43 70 70
RET9/GFRalpha1/GDNF 0.04 0.15 -10000 0 -0.34 60 60
GFRalpha1/GDNF 0.042 0.17 -10000 0 -0.4 60 60
IL12-mediated signaling events

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 0.012 0.096 0.34 9 -0.28 13 22
TBX21 -0.13 0.37 0.72 6 -1.1 43 49
B2M 0.039 0.014 -10000 0 -10000 0 0
TYK2 0.017 0.036 -10000 0 -10000 0 0
IL12RB1 0.018 0.036 -10000 0 -10000 0 0
GADD45B -0.07 0.28 0.62 7 -0.75 46 53
IL12RB2 0.03 0.076 0.26 7 -0.55 1 8
GADD45G -0.061 0.26 0.63 7 -0.69 43 50
natural killer cell activation -0.008 0.022 -10000 0 -10000 0 0
RELB 0.037 0.02 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
IL18 0.045 0.047 0.22 13 -10000 0 13
IL2RA 0.041 0.035 -10000 0 -10000 0 0
IFNG 0.064 0.067 -10000 0 -0.54 1 1
STAT3 (dimer) -0.062 0.24 0.57 10 -0.58 50 60
HLA-DRB5 -0.007 0.032 -10000 0 -10000 0 0
FASLG -0.062 0.26 0.73 7 -0.8 18 25
NF kappa B2 p52/RelB -0.081 0.25 0.54 6 -0.59 62 68
CD4 -0.007 0.032 -10000 0 -10000 0 0
SOCS1 0.032 0.012 -10000 0 -10000 0 0
EntrezGene:6955 -0.014 0.015 -10000 0 -10000 0 0
CD3D 0.004 0.051 -10000 0 -10000 0 0
CD3E -0.001 0.034 -10000 0 -10000 0 0
CD3G 0.004 0.082 0.21 12 -0.55 5 17
IL12Rbeta2/JAK2 0.028 0.076 0.3 7 -0.41 1 8
CCL3 -0.086 0.25 0.71 2 -0.78 20 22
CCL4 -0.086 0.25 0.71 2 -0.78 20 22
HLA-A 0.043 0.027 0.21 2 -10000 0 2
IL18/IL18R 0.059 0.14 0.38 16 -0.36 42 58
NOS2 -0.086 0.26 0.6 9 -0.58 69 78
IL12/IL12R/TYK2/JAK2/SPHK2 0.009 0.099 0.34 9 -0.32 9 18
IL1R1 -0.17 0.43 0.71 2 -1.2 63 65
IL4 0.039 0.03 -10000 0 -10000 0 0
JAK2 0.017 0.037 0.26 1 -10000 0 1
EntrezGene:6957 -0.011 0.014 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.002 0.15 0.35 21 -0.46 13 34
RAB7A -0.045 0.24 0.66 3 -0.72 24 27
lysosomal transport -0.041 0.24 0.64 4 -0.67 25 29
FOS -0.83 0.6 0.57 1 -1.2 367 368
STAT4 (dimer) -0.034 0.27 0.62 10 -0.65 47 57
STAT5A (dimer) -0.061 0.26 0.58 8 -0.6 57 65
GZMA -0.092 0.25 0.58 7 -0.58 65 72
GZMB -0.091 0.26 0.72 6 -0.83 21 27
HLX 0.026 0.038 -10000 0 -0.54 2 2
LCK -0.085 0.27 0.7 9 -0.63 62 71
TCR/CD3/MHC II/CD4 -0.12 0.16 0.28 5 -0.44 63 68
IL2/IL2R 0.088 0.057 0.38 4 -0.31 1 5
MAPK14 -0.059 0.28 0.64 8 -0.72 47 55
CCR5 -0.067 0.28 0.72 10 -0.71 48 58
IL1B 0.015 0.071 0.26 1 -0.55 5 6
STAT6 -0.039 0.18 0.38 8 -0.66 27 35
STAT4 0.028 0.069 -10000 0 -0.54 7 7
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT1 0.059 0.056 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
NFKB2 0.035 0.012 -10000 0 -10000 0 0
IL12B 0.01 0.048 0.24 3 -10000 0 3
CD8A 0.005 0.009 -10000 0 -10000 0 0
CD8B 0.043 0.027 0.21 2 -10000 0 2
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity -0.012 0.095 0.28 13 -0.34 9 22
IL2RB 0.035 0.022 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.028 0.26 0.61 10 -0.6 47 57
IL2RG 0.044 0.036 -10000 0 -10000 0 0
IL12 0.008 0.089 0.29 4 -0.41 11 15
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
CD247 -0.003 0.11 -10000 0 -0.55 15 15
IL2 0.033 0.027 -10000 0 -0.54 1 1
SPHK2 0.034 0.005 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A 0.007 0.093 0.23 2 -0.56 11 13
IL12/IL12R/TYK2/JAK2 -0.1 0.28 0.68 8 -0.66 63 71
MAP2K3 -0.071 0.29 0.63 8 -0.75 50 58
RIPK2 0.029 0.022 -10000 0 -10000 0 0
MAP2K6 -0.062 0.28 0.63 8 -0.7 47 55
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.012 0.034 -10000 0 -10000 0 0
IL18RAP -0.008 0.16 0.22 3 -0.55 42 45
IL12Rbeta1/TYK2 0.03 0.047 0.25 1 -10000 0 1
EOMES 0.042 0.1 -10000 0 -0.58 4 4
STAT1 (dimer) -0.012 0.26 0.68 15 -0.59 39 54
T cell proliferation -0.031 0.22 0.53 10 -0.53 44 54
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.038 0.031 0.22 1 -0.55 1 2
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.022 0.23 0.53 2 -0.59 45 47
ATF2 -0.056 0.26 0.6 8 -0.67 47 55
Syndecan-2-mediated signaling events

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin 0.072 0.095 0.24 3 -0.32 16 19
EPHB2 0.043 0.038 -10000 0 -10000 0 0
Syndecan-2/TACI 0.016 0.066 -10000 0 -0.33 16 16
LAMA1 0.033 0.011 -10000 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 -0.058 0.17 -10000 0 -0.32 137 137
HRAS 0.034 0.013 -10000 0 -10000 0 0
Syndecan-2/CASK -0.001 0.06 -10000 0 -0.33 16 16
ITGA5 0.035 0.008 -10000 0 -10000 0 0
BAX -0.001 0.064 0.49 2 -10000 0 2
EPB41 0.033 0.007 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.016 0.059 -10000 0 -0.3 16 16
LAMA3 -0.15 0.27 -10000 0 -0.54 161 161
EZR 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 -0.32 0.28 -10000 0 -0.54 318 318
Syndecan-2/MMP2 0.014 0.073 -10000 0 -0.36 16 16
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.033 0.08 -10000 0 -0.37 18 18
dendrite morphogenesis 0.022 0.071 -10000 0 -0.33 16 16
Syndecan-2/GM-CSF 0.021 0.068 -10000 0 -0.33 16 16
determination of left/right symmetry 0 0.071 -10000 0 -0.39 16 16
Syndecan-2/PKC delta 0.018 0.066 -10000 0 -0.33 16 16
GNB2L1 0.034 0.006 -10000 0 -10000 0 0
MAPK3 0.041 0.093 0.26 4 -0.3 16 20
MAPK1 0.047 0.097 0.24 7 -0.3 16 23
Syndecan-2/RACK1 0.031 0.062 -10000 0 -0.28 16 16
NF1 0.032 0.009 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 0 0.071 -10000 0 -0.39 16 16
ITGA2 0.015 0.1 -10000 0 -0.54 17 17
MAPK8 0.001 0.067 0.41 2 -0.33 17 19
Syndecan-2/alpha2/beta1 Integrin 0.035 0.091 -10000 0 -0.33 23 23
Syndecan-2/Kininogen 0.017 0.065 -10000 0 -0.33 16 16
ITGB1 0.034 0.006 -10000 0 -10000 0 0
SRC 0.043 0.089 0.3 6 -0.28 15 21
Syndecan-2/CASK/Protein 4.1 0.015 0.059 -10000 0 -0.3 16 16
extracellular matrix organization 0.018 0.065 -10000 0 -0.33 16 16
actin cytoskeleton reorganization 0.072 0.094 0.24 3 -0.32 16 19
Syndecan-2/Caveolin-2/Ras -0.15 0.18 -10000 0 -0.32 237 237
Syndecan-2/Laminin alpha3 -0.082 0.17 -10000 0 -0.35 134 134
Syndecan-2/RasGAP 0.042 0.066 -10000 0 -0.28 15 15
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
PRKCD 0.035 0.018 -10000 0 -10000 0 0
Syndecan-2 dimer 0.022 0.071 -10000 0 -0.33 16 16
GO:0007205 0.003 0.005 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.028 0.058 -10000 0 -0.27 15 15
RHOA 0.033 0.008 -10000 0 -10000 0 0
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
TNFRSF13B 0.032 0.014 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
alpha2/beta1 Integrin 0.033 0.08 -10000 0 -0.37 18 18
Syndecan-2/Synbindin 0.015 0.065 -10000 0 -0.33 16 16
TGFB1 0.034 0.008 -10000 0 -10000 0 0
CASP3 0.042 0.095 0.25 7 -0.3 16 23
FN1 0.14 0.069 -10000 0 -10000 0 0
Syndecan-2/IL8 0.025 0.074 0.24 1 -0.33 16 17
SDC2 0 0.071 -10000 0 -0.39 16 16
KNG1 0.034 0.006 -10000 0 -10000 0 0
Syndecan-2/Neurofibromin 0.016 0.065 -10000 0 -0.33 16 16
TRAPPC4 0.031 0.011 -10000 0 -10000 0 0
CSF2 0.039 0.029 -10000 0 -10000 0 0
Syndecan-2/TGFB1 0.018 0.066 -10000 0 -0.33 16 16
Syndecan-2/Syntenin/PI-4-5-P2 0.016 0.06 -10000 0 -0.3 16 16
Syndecan-2/Ezrin 0.016 0.059 -10000 0 -0.3 16 16
PRKACA 0.044 0.096 0.2 100 -0.3 16 116
angiogenesis 0.025 0.074 0.24 1 -0.33 16 17
MMP2 0.029 0.039 -10000 0 -0.54 2 2
IL8 0.048 0.054 -10000 0 -0.54 1 1
calcineurin-NFAT signaling pathway 0.016 0.065 -10000 0 -0.33 16 16
Syndecan-3-mediated signaling events

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.028 0.014 -10000 0 -10000 0 0
Syndecan-3/Src/Cortactin -0.13 0.17 -10000 0 -0.56 19 19
Syndecan-3/Neurocan 0.043 0.1 -10000 0 -0.47 16 16
POMC 0.035 0.031 -10000 0 -0.54 1 1
EGFR -0.27 0.29 -10000 0 -0.54 269 269
Syndecan-3/EGFR -0.12 0.18 -10000 0 -0.61 19 19
AGRP 0.031 0.015 -10000 0 -10000 0 0
NCSTN 0.028 0.014 -10000 0 -10000 0 0
PSENEN 0.035 0.016 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
APH1B 0.033 0.027 -10000 0 -0.54 1 1
APH1A 0.032 0.029 -10000 0 -10000 0 0
NCAN 0.039 0.028 0.18 19 -10000 0 19
long-term memory 0.041 0.096 -10000 0 -0.45 13 13
Syndecan-3/IL8 0.049 0.11 -10000 0 -0.47 16 16
PSEN1 0.033 0.007 -10000 0 -10000 0 0
Src/Cortactin 0.04 0.022 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
limb bud formation -0.001 0.089 -10000 0 -0.48 16 16
MC4R 0.034 0.014 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
PTN -0.36 0.27 -10000 0 -0.54 354 354
FGFR/FGF/Syndecan-3 -0.001 0.09 -10000 0 -0.49 16 16
neuron projection morphogenesis -0.12 0.16 -10000 0 -0.55 19 19
Syndecan-3/AgRP 0.034 0.1 -10000 0 -0.47 16 16
Syndecan-3/AgRP/MC4R 0.05 0.1 -10000 0 -0.46 15 15
Fyn/Cortactin 0.038 0.031 -10000 0 -0.28 2 2
SDC3 -0.001 0.091 -10000 0 -0.49 16 16
GO:0007205 0 0 -10000 0 -10000 0 0
positive regulation of leukocyte migration 0.049 0.11 -10000 0 -0.46 16 16
IL8 0.048 0.054 -10000 0 -0.54 1 1
Syndecan-3/Fyn/Cortactin 0.042 0.098 -10000 0 -0.46 13 13
Syndecan-3/CASK -0.003 0.087 -10000 0 -0.47 16 16
alpha-MSH/MC4R 0.05 0.027 -10000 0 -0.4 1 1
Gamma Secretase 0.076 0.055 -10000 0 -0.3 1 1
Thromboxane A2 receptor signaling

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.047 0.043 0.18 43 -10000 0 43
GNB1/GNG2 -0.019 0.054 -10000 0 -0.18 48 48
AKT1 0.06 0.13 0.41 18 -0.36 5 23
EGF -0.15 0.27 -10000 0 -0.54 163 163
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.029 0.053 0.26 2 -10000 0 2
mol:Ca2+ 0.06 0.16 0.49 16 -0.3 43 59
LYN 0.027 0.052 0.26 3 -10000 0 3
RhoA/GTP 0.025 0.067 0.22 9 -0.14 8 17
mol:PGI2 0 0.001 -10000 0 -10000 0 0
SYK 0.058 0.17 0.49 18 -0.34 44 62
GNG2 0.033 0.026 -10000 0 -0.54 1 1
ARRB2 0.031 0.011 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 0.013 0.12 -10000 0 -0.6 15 15
G beta5/gamma2 -0.014 0.075 -10000 0 -0.24 45 45
PRKCH 0.053 0.18 0.56 12 -0.36 45 57
DNM1 0.035 0.008 -10000 0 -10000 0 0
TXA2/TP beta/beta Arrestin3 0.015 0.03 -10000 0 -0.53 1 1
mol:GTP 0.001 0.003 -10000 0 -10000 0 0
PTGDR 0.031 0.06 -10000 0 -0.54 5 5
G12 family/GTP 0.005 0.11 -10000 0 -0.3 42 42
ADRBK1 0.032 0.01 -10000 0 -10000 0 0
ADRBK2 0.03 0.037 -10000 0 -0.54 2 2
RhoA/GTP/ROCK1 0.045 0.012 -10000 0 -10000 0 0
mol:GDP -0.042 0.13 0.37 14 -0.47 9 23
mol:NADP 0.034 0.006 -10000 0 -10000 0 0
RAB11A 0.034 0.007 -10000 0 -10000 0 0
PRKG1 0.034 0.006 -10000 0 -10000 0 0
mol:IP3 0.059 0.18 0.65 9 -0.37 45 54
cell morphogenesis 0.044 0.012 -10000 0 -10000 0 0
PLCB2 0.052 0.22 0.72 8 -0.5 45 53
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK 0.031 0.055 0.25 3 -10000 0 3
mol:PDG2 0 0.001 -10000 0 -10000 0 0
HCK 0.03 0.056 0.26 2 -10000 0 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
PTGIR 0.035 0.005 -10000 0 -10000 0 0
PRKCB1 0.055 0.18 0.61 10 -0.37 45 55
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.034 0.006 -10000 0 -10000 0 0
TXA2/TXA2-R family 0.054 0.23 0.73 8 -0.51 46 54
LCK 0.039 0.061 0.26 6 -10000 0 6
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.044 0.042 -10000 0 -0.23 5 5
TXA2-R family/G12 family/GDP/G beta/gamma 0.023 0.1 -10000 0 -0.4 25 25
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.04 0.042 -10000 0 -0.23 5 5
MAPK14 0.052 0.13 0.41 19 -0.23 39 58
TGM2/GTP 0.056 0.2 0.68 9 -0.41 39 48
MAPK11 0.051 0.13 0.42 19 -0.23 35 54
ARHGEF1 0.047 0.11 0.37 15 -0.19 12 27
GNAI2 0.034 0.01 -10000 0 -10000 0 0
JNK cascade 0.06 0.19 0.53 16 -0.38 46 62
RAB11/GDP 0.032 0.01 -10000 0 -10000 0 0
ICAM1 0.058 0.15 0.46 20 -0.28 43 63
cAMP biosynthetic process 0.055 0.17 0.58 10 -0.34 41 51
Gq family/GTP/EBP50 0.034 0.048 0.16 2 -0.22 6 8
actin cytoskeleton reorganization 0.044 0.012 -10000 0 -10000 0 0
SRC 0.028 0.053 0.26 2 -10000 0 2
GNB5 0.033 0.026 -10000 0 -0.54 1 1
GNB1 0.034 0.012 -10000 0 -10000 0 0
EGF/EGFR -0.063 0.11 0.26 3 -0.29 46 49
VCAM1 0.054 0.16 0.47 17 -0.31 46 63
TP beta/Gq family/GDP/G beta5/gamma2 0.013 0.12 -10000 0 -0.6 15 15
platelet activation 0.063 0.16 0.48 19 -0.3 39 58
PGI2/IP 0.026 0.004 -10000 0 -10000 0 0
PRKACA 0.023 0.031 -10000 0 -0.26 5 5
Gq family/GDP/G beta5/gamma2 0.016 0.11 -10000 0 -0.49 17 17
TXA2/TP beta/beta Arrestin2 -0.004 0.061 -10000 0 -0.39 7 7
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.013 0.031 -10000 0 -0.25 5 5
mol:DAG 0.058 0.2 0.66 9 -0.42 45 54
EGFR -0.27 0.29 -10000 0 -0.54 269 269
TXA2/TP alpha 0.058 0.21 0.71 8 -0.46 41 49
Gq family/GTP 0.01 0.052 0.22 1 -0.22 18 19
YES1 0.029 0.057 0.26 2 -0.42 1 3
GNAI2/GTP 0.031 0.04 -10000 0 -0.24 4 4
PGD2/DP 0.023 0.044 -10000 0 -0.4 5 5
SLC9A3R1 0.06 0.06 0.18 97 -10000 0 97
FYN 0.027 0.055 0.27 1 -0.29 2 3
mol:NO 0.034 0.006 -10000 0 -10000 0 0
GNA15 0.036 0.019 -10000 0 -10000 0 0
PGK/cGMP 0.045 0.011 -10000 0 -10000 0 0
RhoA/GDP 0.031 0.011 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma 0.067 0.057 0.29 1 -0.34 1 2
NOS3 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.064 0.18 0.55 13 -0.35 40 53
PRKCB 0.054 0.17 0.55 12 -0.35 46 58
PRKCE 0.055 0.17 0.58 11 -0.35 45 56
PRKCD 0.054 0.18 0.61 10 -0.38 46 56
PRKCG 0.056 0.18 0.55 13 -0.38 45 58
muscle contraction 0.055 0.22 0.69 9 -0.47 46 55
PRKCZ 0.057 0.17 0.5 16 -0.34 46 62
ARR3 0.035 0.002 -10000 0 -10000 0 0
TXA2/TP beta 0.045 0.049 -10000 0 -0.24 6 6
PRKCQ 0.06 0.18 0.5 20 -0.35 45 65
MAPKKK cascade 0.054 0.2 0.66 9 -0.44 44 53
SELE 0.049 0.18 0.47 18 -0.38 49 67
TP beta/GNAI2/GDP/G beta/gamma 0.062 0.049 0.29 1 -0.34 1 2
ROCK1 0.034 0.006 -10000 0 -10000 0 0
GNA14 0.044 0.068 -10000 0 -0.54 4 4
chemotaxis 0.05 0.25 0.76 8 -0.59 49 57
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
Rac1/GTP 0.026 0.004 -10000 0 -10000 0 0
mTOR signaling pathway

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0 0 -10000 0 -10000 0 0
MKNK1 0.034 0.006 -10000 0 -10000 0 0
mol:PIP3 -0.049 0.13 0.26 1 -0.3 93 94
FRAP1 -0.013 0.11 0.33 1 -0.5 18 19
AKT1 -0.039 0.12 -10000 0 -0.3 62 62
INSR 0.034 0.006 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.044 0.011 -10000 0 -10000 0 0
mol:GTP -0.001 0.12 0.26 2 -0.28 31 33
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.007 0.056 -10000 0 -0.22 9 9
TSC2 0.032 0.01 -10000 0 -10000 0 0
RHEB/GDP -0.013 0.092 -10000 0 -0.26 31 31
TSC1 0.034 0.006 -10000 0 -10000 0 0
Insulin Receptor/IRS1 -0.018 0.13 -10000 0 -0.33 72 72
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.006 0.072 -10000 0 -0.26 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.034 0.006 -10000 0 -10000 0 0
RPS6KB1 -0.008 0.11 0.34 2 -0.37 15 17
MAP3K5 -0.018 0.097 0.2 6 -0.29 51 57
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
apoptosis -0.018 0.097 0.2 6 -0.29 51 57
mol:LY294002 0 0.001 0.001 1 -0.002 61 62
EIF4B -0.006 0.097 0.32 2 -0.32 15 17
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.018 0.099 -10000 0 -0.32 10 10
eIF4E/eIF4G1/eIF4A1 -0.002 0.069 -10000 0 -0.3 18 18
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K -0.025 0.15 -10000 0 -0.31 104 104
mTOR/RHEB/GTP/Raptor/GBL 0.009 0.076 0.26 9 -0.21 10 19
FKBP1A 0.034 0.012 -10000 0 -10000 0 0
RHEB/GTP 0.007 0.1 0.26 1 -0.34 9 10
mol:Amino Acids 0 0.001 0.001 1 -0.002 61 62
FKBP12/Rapamycin 0.025 0.009 -10000 0 -10000 0 0
PDPK1 -0.051 0.12 0.2 1 -0.29 83 84
EIF4E 0.034 0.005 -10000 0 -10000 0 0
ASK1/PP5C -0.038 0.21 -10000 0 -0.58 59 59
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.009 0.05 -10000 0 -0.25 2 2
TSC1/TSC2 0 0.12 0.28 2 -0.3 31 33
tumor necrosis factor receptor activity 0 0.001 0.002 61 -0.001 1 62
RPS6 0.032 0.026 -10000 0 -0.54 1 1
PPP5C 0.036 0.018 -10000 0 -10000 0 0
EIF4G1 0.034 0.006 -10000 0 -10000 0 0
IRS1 -0.04 0.13 -10000 0 -0.35 73 73
INS 0.034 0.007 -10000 0 -10000 0 0
PTEN 0.029 0.044 -10000 0 -0.54 3 3
PDK2 -0.046 0.12 0.21 3 -0.29 71 74
EIF4EBP1 -0.03 0.25 -10000 0 -1 28 28
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PPP2R5D -0.011 0.1 0.34 3 -0.44 18 21
peptide biosynthetic process 0.02 0.018 -10000 0 -10000 0 0
RHEB 0.034 0.009 -10000 0 -10000 0 0
EIF4A1 0.031 0.011 -10000 0 -10000 0 0
mol:Rapamycin 0 0.001 0.005 10 -0.003 6 16
EEF2 0.02 0.018 -10000 0 -10000 0 0
eIF4E/4E-BP1 -0.014 0.23 -10000 0 -0.97 28 28
HIF-2-alpha transcription factor network

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 0.037 0.1 0.48 2 -0.67 4 6
oxygen homeostasis 0.025 0.03 0.19 4 -10000 0 4
TCEB2 0.032 0.01 -10000 0 -10000 0 0
TCEB1 0.028 0.014 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A 0.13 0.14 0.46 20 -0.32 5 25
EPO 0.22 0.25 0.68 59 -0.46 3 62
FIH (dimer) 0.056 0.031 0.23 2 -10000 0 2
APEX1 0.058 0.038 0.24 1 -10000 0 1
SERPINE1 0.26 0.24 0.71 44 -0.49 4 48
FLT1 -0.014 0.17 -10000 0 -0.62 28 28
ADORA2A 0.26 0.25 0.66 73 -0.48 4 77
germ cell development 0.25 0.23 0.69 37 -0.49 3 40
SLC11A2 0.26 0.24 0.7 40 -0.49 4 44
BHLHE40 0.18 0.23 0.67 36 -0.45 7 43
HIF1AN 0.056 0.031 0.23 2 -10000 0 2
HIF2A/ARNT/SIRT1 0.17 0.19 0.55 44 -0.36 5 49
ETS1 0.041 0.034 -10000 0 -0.54 1 1
CITED2 0.006 0.15 -10000 0 -0.79 14 14
KDR -0.006 0.15 -10000 0 -0.63 20 20
PGK1 0.26 0.24 0.7 42 -0.49 4 46
SIRT1 0.036 0.008 -10000 0 -10000 0 0
response to hypoxia 0.002 0.006 -10000 0 -10000 0 0
HIF2A/ARNT 0.23 0.26 0.76 28 -0.53 5 33
EPAS1 0.16 0.18 0.47 61 -0.31 10 71
SP1 0.047 0.029 -10000 0 -10000 0 0
ABCG2 0.24 0.26 0.69 38 -0.59 12 50
EFNA1 0.18 0.22 0.66 21 -0.49 4 25
FXN 0.25 0.24 0.67 46 -0.48 3 49
POU5F1 0.25 0.24 0.71 33 -0.5 3 36
neuron apoptosis -0.23 0.26 0.54 4 -0.75 28 32
EP300 0.033 0.009 -10000 0 -10000 0 0
EGLN3 0.081 0.075 0.28 14 -0.53 1 15
EGLN2 0.06 0.036 0.26 2 -10000 0 2
EGLN1 0.045 0.034 0.25 1 -10000 0 1
VHL/Elongin B/Elongin C 0.054 0.033 -10000 0 -10000 0 0
VHL 0.036 0.018 -10000 0 -10000 0 0
ARNT 0.046 0.039 0.19 3 -10000 0 3
SLC2A1 0.25 0.24 0.67 56 -0.48 4 60
TWIST1 0.21 0.28 0.67 44 -0.54 32 76
ELK1 0.04 0.019 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 0.15 0.18 0.55 23 -0.36 5 28
VEGFA 0.26 0.25 0.72 44 -0.49 4 48
CREBBP 0.032 0.01 -10000 0 -10000 0 0
S1P3 pathway

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.034 0.006 -10000 0 -10000 0 0
mol:S1P 0.001 0.003 0.031 6 -10000 0 6
S1P1/S1P/Gi -0.089 0.16 -10000 0 -0.28 184 184
GNAO1 0.032 0.013 -10000 0 -10000 0 0
S1P/S1P3/G12/G13 0.042 0.017 -10000 0 -10000 0 0
AKT1 -0.01 0.11 -10000 0 -0.5 17 17
AKT3 -0.013 0.12 0.44 1 -0.58 4 5
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.034 0.006 -10000 0 -10000 0 0
GNAI2 0.035 0.011 -10000 0 -10000 0 0
GNAI3 0.035 0.007 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
mol:GDP 0 0 -10000 0 -10000 0 0
S1PR3 0.002 0.004 0.036 6 -10000 0 6
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
mol:Ca2+ -0.069 0.14 0.24 2 -0.34 55 57
MAPK3 -0.06 0.13 0.23 1 -0.34 45 46
MAPK1 -0.067 0.13 0.23 1 -0.33 53 54
JAK2 -0.061 0.14 0.33 1 -0.34 60 61
CXCR4 -0.062 0.14 0.25 2 -0.33 51 53
FLT1 0.035 0.015 -10000 0 -10000 0 0
RhoA/GDP 0.025 0.006 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
SRC -0.065 0.13 0.32 2 -0.33 52 54
S1P/S1P3/Gi -0.07 0.14 0.24 2 -0.34 55 57
RAC1 0.034 0.005 -10000 0 -10000 0 0
RhoA/GTP -0.057 0.14 -10000 0 -0.32 55 55
VEGFA 0.053 0.048 0.18 59 -10000 0 59
S1P/S1P2/Gi -0.073 0.14 -10000 0 -0.34 56 56
VEGFR1 homodimer/VEGFA homodimer 0.063 0.04 0.27 1 -10000 0 1
RHOA 0.033 0.008 -10000 0 -10000 0 0
S1P/S1P3/Gq 0.026 0.038 -10000 0 -0.27 5 5
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.027 0.063 -10000 0 -0.54 6 6
G12/G13 0.046 0.017 -10000 0 -10000 0 0
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
Rac1/GTP -0.058 0.14 -10000 0 -0.32 55 55
Angiopoietin receptor Tie2-mediated signaling

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.007 0.23 -10000 0 -0.9 24 24
NCK1/PAK1/Dok-R -0.034 0.094 -10000 0 -0.42 23 23
NCK1/Dok-R 0.018 0.24 -10000 0 -1 23 23
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
mol:beta2-estradiol -0.001 0.04 0.23 14 -10000 0 14
RELA 0.033 0.007 -10000 0 -10000 0 0
SHC1 0.029 0.014 -10000 0 -10000 0 0
Rac/GDP 0.025 0.004 -10000 0 -10000 0 0
F2 0.018 0.048 0.28 13 -10000 0 13
TNIP2 0.034 0.014 -10000 0 -10000 0 0
NF kappa B/RelA 0.042 0.23 -10000 0 -0.94 23 23
FN1 0.14 0.069 -10000 0 -10000 0 0
PLD2 -0.002 0.23 -10000 0 -1 23 23
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GRB14 0.002 0.19 -10000 0 -0.54 51 51
ELK1 0.006 0.21 -10000 0 -0.93 23 23
GRB7 0.029 0.013 -10000 0 -10000 0 0
PAK1 0.044 0.047 -10000 0 -10000 0 0
Tie2/Ang1/alpha5/beta1 Integrin 0.099 0.25 -10000 0 -0.96 23 23
CDKN1A -0.003 0.19 -10000 0 -0.67 20 20
ITGA5 0.035 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R 0.017 0.24 -10000 0 -1 23 23
CRK 0.031 0.011 -10000 0 -10000 0 0
mol:NO 0.017 0.18 -10000 0 -0.65 24 24
PLG -0.003 0.23 -10000 0 -1 23 23
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis -0.001 0.21 -10000 0 -0.84 24 24
GRB2 0.034 0.019 -10000 0 -10000 0 0
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
ANGPT2 -0.074 0.23 -10000 0 -0.64 38 38
BMX -0.16 0.28 -10000 0 -1.3 23 23
ANGPT1 -0.012 0.21 -10000 0 -1.2 14 14
tube development -0.012 0.2 -10000 0 -0.72 21 21
ANGPT4 0.033 0.008 -10000 0 -10000 0 0
response to hypoxia -0.001 0.015 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 0 0.27 -10000 0 -1.1 23 23
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
STAT5A (dimer) -0.001 0.23 -10000 0 -0.84 21 21
mol:L-citrulline 0.017 0.18 -10000 0 -0.65 24 24
AGTR1 -0.18 0.3 -10000 0 -0.54 208 208
MAPK14 -0.002 0.26 -10000 0 -1.1 25 25
Tie2/SHP2 0.002 0.21 -10000 0 -1 15 15
TEK -0.003 0.22 -10000 0 -1.1 15 15
RPS6KB1 0.02 0.23 -10000 0 -0.86 24 24
Angiotensin II/AT1 -0.13 0.22 -10000 0 -0.39 210 210
Tie2/Ang1/GRB2 0.012 0.24 -10000 0 -1.1 23 23
MAPK3 0.006 0.22 -10000 0 -0.94 22 22
MAPK1 -0.003 0.21 -10000 0 -0.95 23 23
Tie2/Ang1/GRB7 0.005 0.24 -10000 0 -1 23 23
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.003 0.23 -10000 0 -1 23 23
PI3K -0.004 0.26 -10000 0 -1 24 24
FES -0.009 0.26 -10000 0 -1.1 24 24
Crk/Dok-R 0.017 0.23 -10000 0 -1 23 23
Tie2/Ang1/ABIN2 0.013 0.24 -10000 0 -1.1 23 23
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity 0.013 0.21 -10000 0 -0.79 24 24
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 0.033 0.23 -10000 0 -0.83 23 23
Tie2/Ang2 -0.026 0.25 -10000 0 -1 21 21
Tie2/Ang1 0.001 0.25 -10000 0 -1.1 23 23
FOXO1 0.006 0.22 -10000 0 -0.82 24 24
ELF1 0.036 0.027 -10000 0 -10000 0 0
ELF2 0.003 0.23 -10000 0 -1 23 23
mol:Choline -0.001 0.22 -10000 0 -0.98 23 23
cell migration -0.015 0.054 -10000 0 -0.23 24 24
FYN -0.017 0.22 -10000 0 -0.84 21 21
DOK2 0.026 0.039 0.18 1 -0.54 2 3
negative regulation of cell cycle 0.002 0.17 -10000 0 -0.6 20 20
ETS1 0.031 0.056 -10000 0 -0.29 11 11
PXN 0.037 0.2 -10000 0 -0.69 23 23
ITGB1 0.034 0.006 -10000 0 -10000 0 0
NOS3 0.012 0.2 -10000 0 -0.74 24 24
RAC1 0.034 0.005 -10000 0 -10000 0 0
TNF 0.038 0.055 0.27 1 -0.25 14 15
MAPKKK cascade -0.001 0.22 -10000 0 -0.98 23 23
RASA1 0.034 0.012 -10000 0 -10000 0 0
Tie2/Ang1/Shc 0.005 0.24 -10000 0 -1 22 22
NCK1 0.034 0.005 -10000 0 -10000 0 0
vasculogenesis 0.02 0.16 -10000 0 -0.58 24 24
mol:Phosphatidic acid -0.001 0.22 -10000 0 -0.98 23 23
mol:Angiotensin II 0.001 0.001 -10000 0 -10000 0 0
mol:NADP 0.017 0.18 -10000 0 -0.65 24 24
Rac1/GTP 0.014 0.21 -10000 0 -0.8 24 24
MMP2 -0.002 0.23 -10000 0 -1 23 23
Reelin signaling pathway

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.05 0.024 -10000 0 -10000 0 0
VLDLR -0.04 0.19 -10000 0 -0.54 65 65
CRKL 0.032 0.009 -10000 0 -10000 0 0
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
ITGA3 0.03 0.028 -10000 0 -0.54 1 1
RELN/VLDLR/Fyn -0.01 0.16 -10000 0 -0.36 82 82
MAPK8IP1/MKK7/MAP3K11/JNK1 0.077 0.05 -10000 0 -0.3 1 1
AKT1 -0.056 0.14 -10000 0 -0.3 107 107
MAP2K7 0.034 0.005 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
DAB1 0.034 0.007 -10000 0 -10000 0 0
RELN/LRP8/DAB1 0.07 0.084 0.24 1 -0.29 20 21
LRPAP1/LRP8 0.074 0.048 -10000 0 -10000 0 0
RELN/LRP8/DAB1/Fyn 0.075 0.089 -10000 0 -0.27 22 22
DAB1/alpha3/beta1 Integrin 0.018 0.13 -10000 0 -0.3 58 58
long-term memory 0.081 0.11 -10000 0 -0.32 20 20
DAB1/LIS1 0.034 0.15 -10000 0 -0.3 64 64
DAB1/CRLK/C3G 0.017 0.14 -10000 0 -0.3 64 64
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
DAB1/NCK2 0.039 0.15 -10000 0 -0.31 64 64
ARHGEF2 0.031 0.022 -10000 0 -10000 0 0
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.032 0.012 -10000 0 -10000 0 0
CDK5R1 0.033 0.014 -10000 0 -10000 0 0
RELN 0.012 0.11 -10000 0 -0.54 20 20
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
RELN/LRP8/Fyn 0.066 0.095 0.26 1 -0.32 22 23
GRIN2A/RELN/LRP8/DAB1/Fyn 0.083 0.096 -10000 0 -0.3 14 14
MAPK8 0.033 0.026 -10000 0 -0.54 1 1
RELN/VLDLR/DAB1 -0.005 0.15 -10000 0 -0.33 80 80
ITGB1 0.034 0.006 -10000 0 -10000 0 0
MAP1B -0.036 0.16 0.3 10 -0.33 93 103
RELN/LRP8 0.07 0.091 0.26 1 -0.32 20 21
GRIN2B/RELN/LRP8/DAB1/Fyn 0.079 0.11 -10000 0 -0.33 23 23
PI3K 0.006 0.13 -10000 0 -0.4 44 44
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.043 0.027 -10000 0 -0.4 1 1
RAP1A -0.027 0.13 0.36 5 -0.48 5 10
PAFAH1B1 0.032 0.01 -10000 0 -10000 0 0
MAPK8IP1 0.034 0.005 -10000 0 -10000 0 0
CRLK/C3G 0.047 0.015 -10000 0 -10000 0 0
GRIN2B 0.021 0.085 -10000 0 -0.54 11 11
NCK2 0.035 0.008 -10000 0 -10000 0 0
neuron differentiation 0.047 0.071 0.24 3 -0.43 2 5
neuron adhesion -0.01 0.14 0.38 7 -0.46 4 11
LRP8 0.073 0.066 -10000 0 -10000 0 0
GSK3B -0.05 0.14 -10000 0 -0.5 24 24
RELN/VLDLR/DAB1/Fyn 0.005 0.15 -10000 0 -0.31 82 82
MAP3K11 0.033 0.007 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.055 0.16 -10000 0 -0.31 114 114
CDK5 0.038 0.024 -10000 0 -10000 0 0
MAPT 0.016 0.13 0.82 11 -0.49 3 14
neuron migration -0.028 0.15 0.38 4 -0.39 32 36
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.046 0.07 -10000 0 -0.44 2 2
RELN/VLDLR 0.03 0.16 -10000 0 -0.31 80 80
RXR and RAR heterodimerization with other nuclear receptor

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.037 0.11 1 1 -10000 0 1
VDR 0.032 0.037 -10000 0 -0.54 2 2
FAM120B 0.032 0.009 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA 0.063 0.077 0.29 13 -10000 0 13
RXRs/LXRs/DNA/Oxysterols 0.089 0.09 -10000 0 -0.37 2 2
MED1 0.029 0.013 -10000 0 -10000 0 0
mol:9cRA 0.01 0.014 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.032 0.13 -10000 0 -0.5 12 12
RXRs/NUR77 0.071 0.094 -10000 0 -0.3 18 18
RXRs/PPAR -0.15 0.14 -10000 0 -0.4 44 44
NCOR2 0.034 0.005 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.024 0.027 -10000 0 -0.4 2 2
RARs/VDR/DNA/Vit D3 0.016 0.13 -10000 0 -0.3 73 73
RARA 0.031 0.013 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
VDR/VDR/DNA 0.032 0.037 -10000 0 -0.54 2 2
RARs/RARs/DNA/9cRA 0.007 0.12 -10000 0 -0.29 73 73
RARG 0.034 0.004 -10000 0 -10000 0 0
RPS6KB1 0.062 0.17 0.56 51 -10000 0 51
RARs/THRs/DNA/SMRT -0.03 0.13 -10000 0 -0.27 100 100
THRA -0.001 0.13 -10000 0 -0.54 28 28
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.024 0.027 -10000 0 -0.4 2 2
RXRs/PPAR/9cRA/PGJ2/DNA 0.076 0.07 -10000 0 -0.3 4 4
NR1H4 0.035 0.01 -10000 0 -10000 0 0
RXRs/LXRs/DNA 0.11 0.089 -10000 0 -0.28 5 5
NR1H2 0.043 0.016 -10000 0 -10000 0 0
NR1H3 0.044 0.031 -10000 0 -0.54 1 1
RXRs/VDR/DNA/Vit D3 0.078 0.062 -10000 0 -0.29 4 4
NR4A1 0.007 0.12 -10000 0 -0.54 24 24
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 0.056 0.059 -10000 0 -0.28 1 1
RXRG 0.032 0.055 -10000 0 -0.54 4 4
RXR alpha/CCPG 0.053 0.02 -10000 0 -10000 0 0
RXRA 0.043 0.016 -10000 0 -10000 0 0
RXRB 0.044 0.017 -10000 0 -10000 0 0
THRB 0.028 0.057 -10000 0 -0.54 5 5
PPARG -0.38 0.26 -10000 0 -0.54 367 367
PPARD 0.035 0.011 -10000 0 -10000 0 0
TNF 0.083 0.089 -10000 0 -10000 0 0
mol:Oxysterols 0.009 0.013 -10000 0 -10000 0 0
cholesterol transport 0.089 0.089 -10000 0 -0.37 2 2
PPARA 0.031 0.027 -10000 0 -0.54 1 1
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB -0.055 0.21 -10000 0 -0.54 79 79
RXRs/NUR77/BCL2 -0.027 0.12 -10000 0 -0.26 76 76
SREBF1 0.083 0.1 -10000 0 -10000 0 0
RXRs/RXRs/DNA/9cRA 0.076 0.07 -10000 0 -0.3 4 4
ABCA1 0.077 0.11 -10000 0 -1 2 2
RARs/THRs 0.006 0.16 -10000 0 -0.31 98 98
RXRs/FXR 0.085 0.066 -10000 0 -0.31 4 4
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
Syndecan-4-mediated signaling events

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.12 0.12 0.28 7 -0.63 4 11
Syndecan-4/Syndesmos 0.13 0.12 0.41 3 -0.72 4 7
positive regulation of JNK cascade 0.064 0.19 0.41 1 -0.66 6 7
Syndecan-4/ADAM12 0.15 0.13 0.42 4 -0.76 4 8
CCL5 0.029 0.06 -10000 0 -0.54 5 5
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
DNM2 0.034 0.005 -10000 0 -10000 0 0
ITGA5 0.035 0.008 -10000 0 -10000 0 0
SDCBP 0.029 0.028 -10000 0 -0.54 1 1
PLG 0.013 0.04 -10000 0 -0.54 1 1
ADAM12 0.058 0.062 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.032 0.012 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha 0.008 0.023 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 0.13 0.12 0.43 1 -0.76 4 5
Syndecan-4/CXCL12/CXCR4 0.067 0.2 0.43 1 -0.72 6 7
Syndecan-4/Laminin alpha3 0.055 0.16 0.42 2 -0.83 4 6
MDK 0.044 0.038 -10000 0 -10000 0 0
Syndecan-4/FZD7 0.062 0.18 0.41 1 -0.72 5 6
Syndecan-4/Midkine 0.15 0.12 0.41 3 -0.7 4 7
FZD7 -0.13 0.26 -10000 0 -0.54 145 145
Syndecan-4/FGFR1/FGF -0.064 0.16 0.4 1 -0.6 9 10
THBS1 0.038 0.026 -10000 0 -10000 0 0
integrin-mediated signaling pathway 0.14 0.12 0.41 2 -0.72 4 6
positive regulation of MAPKKK cascade 0.064 0.19 0.41 1 -0.66 6 7
Syndecan-4/TACI 0.13 0.12 0.42 2 -0.76 4 6
CXCR4 0.044 0.038 -10000 0 -10000 0 0
cell adhesion 0.093 0.072 0.27 52 -10000 0 52
Syndecan-4/Dynamin 0.14 0.12 0.43 1 -0.76 4 5
Syndecan-4/TSP1 0.14 0.12 0.47 2 -0.76 4 6
Syndecan-4/GIPC 0.14 0.12 0.42 3 -0.76 4 7
Syndecan-4/RANTES 0.13 0.13 0.41 1 -0.76 4 5
ITGB1 0.034 0.006 -10000 0 -10000 0 0
LAMA1 0.033 0.011 -10000 0 -10000 0 0
LAMA3 -0.15 0.27 -10000 0 -0.54 161 161
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.031 0.22 0.7 50 -10000 0 50
Syndecan-4/alpha-Actinin 0.14 0.12 0.43 1 -0.76 4 5
TFPI -0.19 0.28 -10000 0 -0.54 199 199
F2 0.039 0.02 -10000 0 -10000 0 0
alpha5/beta1 Integrin 0.05 0.012 -10000 0 -10000 0 0
positive regulation of cell adhesion 0.045 0.15 0.42 1 -0.8 4 5
ACTN1 0.033 0.007 -10000 0 -10000 0 0
TNC 0.037 0.036 -10000 0 -0.54 1 1
Syndecan-4/CXCL12 0.056 0.19 0.43 1 -0.75 6 7
FGF6 0.03 0.037 -10000 0 -0.54 2 2
RHOA 0.033 0.008 -10000 0 -10000 0 0
CXCL12 -0.14 0.26 -10000 0 -0.54 152 152
TNFRSF13B 0.032 0.014 -10000 0 -10000 0 0
FGF2 -0.39 0.25 -10000 0 -0.54 380 380
FGFR1 0.018 0.076 -10000 0 -0.54 9 9
Syndecan-4/PI-4-5-P2 0.098 0.12 -10000 0 -0.76 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.13 0.076 0.19 158 -10000 0 158
cell migration -0.013 0.009 -10000 0 -10000 0 0
PRKCD 0.017 0.035 -10000 0 -10000 0 0
vasculogenesis 0.14 0.12 0.43 3 -0.72 4 7
SDC4 0.11 0.12 -10000 0 -0.81 4 4
Syndecan-4/Tenascin C 0.14 0.12 0.42 2 -0.76 4 6
Syndecan-4/PI-4-5-P2/PKC alpha -0.005 0.015 -10000 0 -10000 0 0
Syndecan-4/Syntenin 0.12 0.12 0.41 1 -0.76 4 5
MMP9 0.096 0.08 -10000 0 -10000 0 0
Rac1/GTP 0.094 0.072 0.27 51 -10000 0 51
cytoskeleton organization 0.13 0.12 0.41 3 -0.69 4 7
GIPC1 0.035 0.011 -10000 0 -10000 0 0
Syndecan-4/TFPI 0.036 0.19 0.41 2 -0.74 6 8
Regulation of Androgen receptor activity

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.017 0.004 -10000 0 -10000 0 0
SMARCC1 0.016 0.052 -10000 0 -0.68 1 1
REL 0.037 0.024 -10000 0 -10000 0 0
HDAC7 -0.052 0.12 0.32 1 -0.34 32 33
JUN -0.066 0.22 -10000 0 -0.54 89 89
EP300 0.033 0.009 -10000 0 -10000 0 0
KAT2B 0 0 0.003 2 -10000 0 2
KAT5 0 0 -10000 0 -10000 0 0
MAPK14 -0.003 0.063 -10000 0 -0.41 10 10
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
T-DHT/AR -0.026 0.14 0.36 1 -0.36 32 33
MAP2K6 0.009 0.084 -10000 0 -0.55 10 10
BRM/BAF57 0.046 0.018 -10000 0 -10000 0 0
MAP2K4 0.018 0.027 -10000 0 -10000 0 0
SMARCA2 0.033 0.009 -10000 0 -10000 0 0
PDE9A -0.06 0.26 -10000 0 -1 31 31
NCOA2 0.029 0.015 -10000 0 -10000 0 0
CEBPA 0.03 0.044 -10000 0 -0.54 3 3
EHMT2 0.035 0.005 -10000 0 -10000 0 0
cell proliferation 0.036 0.15 0.44 13 -0.46 3 16
NR0B1 -0.094 0.25 0.18 24 -0.54 120 144
EGR1 -0.43 0.23 -10000 0 -0.54 414 414
RXRs/9cRA 0.052 0.043 -10000 0 -0.31 4 4
AR/RACK1/Src 0.002 0.1 0.36 5 -0.34 7 12
AR/GR -0.04 0.14 -10000 0 -0.29 90 90
GNB2L1 0.034 0.006 -10000 0 -10000 0 0
PKN1 0.035 0.011 -10000 0 -10000 0 0
RCHY1 0.029 0.051 -10000 0 -0.54 4 4
epidermal growth factor receptor activity 0 0.001 0.009 4 -10000 0 4
MAPK8 0.003 0.032 -10000 0 -0.43 1 1
T-DHT/AR/TIF2/CARM1 0.006 0.095 0.35 1 -0.36 6 7
SRC -0.01 0.074 0.47 1 -0.33 7 8
NR3C1 -0.011 0.15 -10000 0 -0.54 40 40
KLK3 -0.042 0.099 -10000 0 -10000 0 0
APPBP2 0.018 0.027 -10000 0 -10000 0 0
TRIM24 0.036 0.013 -10000 0 -10000 0 0
T-DHT/AR/TIP60 -0.036 0.072 -10000 0 -0.35 11 11
TMPRSS2 -0.22 0.45 -10000 0 -1 124 124
RXRG 0.025 0.053 -10000 0 -0.54 4 4
mol:9cRA 0 0 0.003 2 -10000 0 2
RXRA 0.034 0.006 -10000 0 -10000 0 0
RXRB 0.034 0.005 -10000 0 -10000 0 0
CARM1 0.036 0.014 -10000 0 -10000 0 0
NR2C2 0.035 0.015 -10000 0 -10000 0 0
KLK2 0.013 0.078 0.38 1 -10000 0 1
AR -0.025 0.11 -10000 0 -0.27 60 60
SENP1 0.035 0.004 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
MDM2 0.032 0.011 -10000 0 -10000 0 0
SRY -0.001 0.002 -10000 0 -0.026 4 4
GATA2 0.042 0.034 -10000 0 -10000 0 0
MYST2 0 0.001 -10000 0 -0.006 4 4
HOXB13 0.08 0.071 0.18 163 -10000 0 163
T-DHT/AR/RACK1/Src 0 0.1 0.37 5 -0.35 7 12
positive regulation of transcription 0.042 0.034 -10000 0 -10000 0 0
DNAJA1 0.019 0.03 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.02 0.032 -10000 0 -0.32 4 4
NCOA1 0.042 0.033 -10000 0 -0.57 1 1
SPDEF -0.018 0.17 -10000 0 -0.54 50 50
T-DHT/AR/TIF2 0.017 0.08 0.41 2 -0.32 4 6
T-DHT/AR/Hsp90 -0.011 0.099 0.39 2 -0.36 11 13
GSK3B 0.033 0.01 -10000 0 -10000 0 0
NR2C1 0.033 0.026 -10000 0 -0.54 1 1
mol:T-DHT -0.019 0.072 0.22 15 -0.35 10 25
SIRT1 0.034 0.005 -10000 0 -10000 0 0
ZMIZ2 0.032 0.008 -10000 0 -10000 0 0
POU2F1 0.003 0.066 -10000 0 -0.18 7 7
T-DHT/AR/DAX-1 -0.073 0.17 0.39 2 -0.34 113 115
CREBBP 0.032 0.01 -10000 0 -10000 0 0
SMARCE1 0.033 0.009 -10000 0 -10000 0 0
Osteopontin-mediated events

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.099 0.077 0.31 6 -0.28 4 10
NF kappa B1 p50/RelA/I kappa B alpha 0.11 0.1 0.37 14 -10000 0 14
alphaV/beta3 Integrin/Osteopontin/Src 0.1 0.073 0.27 2 -0.39 4 6
AP1 -0.14 0.22 0.5 1 -0.46 91 92
ILK 0.076 0.073 0.36 2 -0.3 4 6
bone resorption 0.059 0.071 -10000 0 -10000 0 0
PTK2B 0.028 0.014 -10000 0 -10000 0 0
PYK2/p130Cas 0.1 0.091 0.34 1 -0.28 4 5
ITGAV 0.04 0.029 -10000 0 -0.54 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.048 0.031 -10000 0 -0.4 2 2
alphaV/beta3 Integrin/Osteopontin 0.12 0.079 0.33 3 -0.33 4 7
MAP3K1 0.078 0.078 0.31 8 -0.3 5 13
JUN -0.066 0.22 -10000 0 -0.54 89 89
MAPK3 0.078 0.095 0.35 16 -0.28 3 19
MAPK1 0.077 0.092 0.33 13 -0.28 4 17
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 0.063 0.076 0.3 8 -0.29 6 14
ITGB3 0.042 0.021 -10000 0 -10000 0 0
NFKBIA 0.077 0.099 0.32 32 -10000 0 32
FOS -0.35 0.27 -10000 0 -0.54 344 344
CD44 0.033 0.028 -10000 0 -0.54 1 1
CHUK 0.034 0.005 -10000 0 -10000 0 0
PLAU 0.084 0.15 0.48 13 -0.54 1 14
NF kappa B1 p50/RelA 0.13 0.1 0.42 14 -10000 0 14
BCAR1 0.029 0.013 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.062 0.033 -10000 0 -0.39 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
SYK 0.079 0.074 0.31 8 -0.3 4 12
VAV3 0.062 0.095 0.3 13 -0.29 11 24
MAP3K14 0.086 0.083 0.3 12 -0.3 4 16
ROCK2 0.033 0.026 -10000 0 -0.54 1 1
SPP1 0.097 0.089 -10000 0 -0.54 3 3
RAC1 0.034 0.005 -10000 0 -10000 0 0
Rac1/GTP 0.072 0.087 0.29 7 -0.27 10 17
MMP2 -0.14 0.17 0.48 1 -0.41 73 74
Ceramide signaling pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 -0.021 0.12 -10000 0 -0.4 46 46
MAP4K4 0.005 0.083 -10000 0 -0.3 18 18
BAG4 0.028 0.016 -10000 0 -10000 0 0
PKC zeta/ceramide -0.012 0.067 0.15 3 -0.27 9 12
NFKBIA 0.033 0.007 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BAX 0.008 0.049 -10000 0 -0.35 5 5
RIPK1 0.034 0.006 -10000 0 -10000 0 0
AKT1 0.009 0.076 0.72 5 -10000 0 5
BAD -0.013 0.07 0.18 3 -0.32 6 9
SMPD1 0.019 0.064 0.24 6 -0.25 10 16
RB1 -0.012 0.067 0.16 1 -0.32 6 7
FADD/Caspase 8 0.032 0.12 0.29 11 -0.4 9 20
MAP2K4 -0.013 0.07 0.19 1 -0.35 6 7
NSMAF 0.029 0.028 -10000 0 -0.54 1 1
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.007 0.075 0.27 5 -0.35 4 9
EGF -0.15 0.27 -10000 0 -0.54 163 163
mol:ceramide -0.012 0.074 0.16 35 -0.28 9 44
MADD 0.034 0.005 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.024 0.12 -10000 0 -0.41 47 47
ASAH1 0.027 0.042 -10000 0 -0.54 2 2
negative regulation of cell cycle -0.014 0.068 0.16 1 -0.31 6 7
cell proliferation -0.1 0.14 0.24 1 -0.27 146 147
BID -0.014 0.19 -10000 0 -0.68 34 34
MAP3K1 -0.011 0.073 0.2 1 -0.31 8 9
EIF2A -0.005 0.072 0.28 6 -0.25 5 11
TRADD 0.03 0.012 -10000 0 -10000 0 0
CRADD 0.034 0.005 -10000 0 -10000 0 0
MAPK3 -0.002 0.073 0.26 6 -0.31 5 11
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.008 0.079 0.26 6 -0.35 4 10
Cathepsin D/ceramide 0.012 0.08 0.18 4 -0.25 9 13
FADD 0.029 0.1 0.28 2 -0.31 13 15
KSR1 -0.007 0.073 0.21 7 -0.33 5 12
MAPK8 -0.008 0.07 -10000 0 -0.29 8 8
PRKRA -0.012 0.07 0.2 1 -0.28 8 9
PDGFA -0.018 0.16 -10000 0 -0.54 46 46
TRAF2 0.035 0.013 -10000 0 -10000 0 0
IGF1 -0.25 0.29 -10000 0 -0.54 252 252
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.012 0.074 0.16 35 -0.28 9 44
CTSD 0.047 0.043 -10000 0 -10000 0 0
regulation of nitric oxide biosynthetic process 0.048 0.013 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta -0.11 0.15 -10000 0 -0.29 139 139
PRKCD 0.035 0.018 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.024 0.12 -10000 0 -0.41 47 47
RelA/NF kappa B1 0.048 0.013 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.034 0.03 -10000 0 -0.54 1 1
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD 0.008 0.091 -10000 0 -0.32 20 20
TNFR1A/BAG4/TNF-alpha 0.053 0.035 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate -0.021 0.12 -10000 0 -0.4 46 46
MAP2K1 -0.007 0.074 0.28 5 -0.34 4 9
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
CYCS 0.027 0.082 0.24 19 -0.25 6 25
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
TNFR1A/BAG4 0.038 0.023 -10000 0 -10000 0 0
EIF2AK2 -0.008 0.069 0.21 4 -0.3 5 9
TNF-alpha/TNFR1A/FAN 0.057 0.037 -10000 0 -0.33 1 1
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.019 0.1 -10000 0 -0.4 21 21
MAP2K2 -0.007 0.074 0.28 5 -0.33 4 9
SMPD3 -0.001 0.12 0.26 2 -0.3 56 58
TNF 0.038 0.024 -10000 0 -10000 0 0
PKC zeta/PAR4 0.025 0.022 -10000 0 -0.4 1 1
mol:PHOSPHOCHOLINE 0.083 0.12 0.24 174 -0.22 3 177
NF kappa B1/RelA/I kappa B alpha 0.073 0.034 -10000 0 -0.3 1 1
AIFM1 0.026 0.082 0.23 22 -0.24 7 29
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
IL1-mediated signaling events

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.025 0.004 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
ERC1 0.033 0.013 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.005 0.1 -10000 0 -0.38 19 19
IRAK/TOLLIP 0.04 0.018 -10000 0 -10000 0 0
IKBKB 0.029 0.013 -10000 0 -10000 0 0
IKBKG 0.034 0.004 -10000 0 -10000 0 0
IL1 alpha/IL1R2 0.055 0.044 0.26 1 -0.4 3 4
IL1A 0.036 0.016 -10000 0 -10000 0 0
IL1B -0.017 0.12 -10000 0 -0.42 41 41
IRAK/TRAF6/p62/Atypical PKCs 0.065 0.027 -10000 0 -10000 0 0
IL1R2 0.039 0.055 -10000 0 -0.54 3 3
IL1R1 -0.03 0.18 -10000 0 -0.54 58 58
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.031 0.14 -10000 0 -0.42 33 33
TOLLIP 0.033 0.007 -10000 0 -10000 0 0
TICAM2 0 0 -10000 0 -10000 0 0
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.022 0.006 -10000 0 -10000 0 0
IKK complex/ELKS 0.038 0.068 -10000 0 -0.35 1 1
JUN -0.049 0.1 0.33 1 -0.27 82 83
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.025 0.2 -10000 0 -0.37 112 112
IL1 alpha/IL1R1/IL1RAP/MYD88 0.04 0.13 -10000 0 -0.31 58 58
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.053 0.13 -10000 0 -0.3 57 57
IL1 beta fragment/IL1R1/IL1RAP -0.023 0.16 -10000 0 -0.35 91 91
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 -0.009 0.053 0.34 1 -0.27 11 12
IRAK1 0.019 0.011 -10000 0 -10000 0 0
IL1RN/IL1R1 0.015 0.15 -10000 0 -0.39 58 58
IRAK4 0.034 0.005 -10000 0 -10000 0 0
PRKCI 0.035 0.018 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
PI3K 0.006 0.13 -10000 0 -0.4 44 44
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.022 0.14 -10000 0 -0.44 28 28
CHUK 0.034 0.005 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.023 0.16 -10000 0 -0.35 91 91
IL1 beta/IL1R2 0.007 0.12 -10000 0 -0.36 44 44
IRAK/TRAF6/TAK1/TAB1/TAB2 0.047 0.022 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.033 0.18 -10000 0 -0.48 40 40
IRAK3 0.035 0.033 -10000 0 -0.54 1 1
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.008 0.16 -10000 0 -0.33 88 88
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP 0.001 0.1 -10000 0 -0.38 12 12
IL1 alpha/IL1R1/IL1RAP 0.023 0.13 -10000 0 -0.34 58 58
RELA 0.033 0.007 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
SQSTM1 0.034 0.009 -10000 0 -10000 0 0
MYD88 0.034 0.011 -10000 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.054 0.028 -10000 0 -10000 0 0
IL1RAP 0.034 0.006 -10000 0 -10000 0 0
UBE2N 0.034 0.005 -10000 0 -10000 0 0
IRAK/TRAF6 -0.023 0.12 -10000 0 -0.29 82 82
CASP1 -0.012 0.15 -10000 0 -0.54 38 38
IL1RN/IL1R2 0.068 0.057 0.26 6 -0.4 3 9
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.005 0.16 -10000 0 -0.34 89 89
TMEM189-UBE2V1 0 0 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.005 0.13 -10000 0 -0.35 57 57
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
IL1RN 0.055 0.051 -10000 0 -10000 0 0
TRAF6/TAK1/TAB1/TAB2 0.046 0.016 -10000 0 -10000 0 0
MAP2K6 0.016 0.055 0.36 2 -0.28 10 12
Coregulation of Androgen receptor activity

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.029 0.064 -10000 0 -0.54 6 6
SVIL 0.023 0.084 -10000 0 -0.54 11 11
ZNF318 0.031 0.009 -10000 0 -10000 0 0
JMJD2C 0.007 0.01 0.12 4 -10000 0 4
T-DHT/AR/Ubc9 -0.036 0.14 -10000 0 -0.31 81 81
CARM1 0.035 0.014 -10000 0 -10000 0 0
PRDX1 0.035 0.016 -10000 0 -10000 0 0
PELP1 0.031 0.01 -10000 0 -10000 0 0
CTNNB1 0.03 0.052 -10000 0 -0.54 4 4
AKT1 0.034 0.018 -10000 0 -10000 0 0
PTK2B 0.028 0.015 -10000 0 -10000 0 0
MED1 0.028 0.013 -10000 0 -10000 0 0
MAK 0.037 0.033 -10000 0 -10000 0 0
response to oxidative stress 0 0.001 -10000 0 -10000 0 0
HIP1 0.036 0.008 -10000 0 -10000 0 0
GSN -0.11 0.25 -10000 0 -0.54 132 132
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA6 0.035 0.008 -10000 0 -10000 0 0
DNA-PK 0.054 0.031 -10000 0 -10000 0 0
NCOA4 0.033 0.026 -10000 0 -0.54 1 1
PIAS3 0.029 0.014 -10000 0 -10000 0 0
cell proliferation 0 0.07 -10000 0 -0.47 6 6
XRCC5 0.033 0.006 -10000 0 -10000 0 0
UBE3A 0.035 0.009 -10000 0 -10000 0 0
T-DHT/AR/SNURF -0.051 0.13 -10000 0 -0.31 87 87
FHL2 -0.11 0.32 -10000 0 -0.98 58 58
RANBP9 0.035 0.01 -10000 0 -10000 0 0
JMJD1A -0.027 0.061 -10000 0 -0.14 122 122
CDK6 0.028 0.063 -10000 0 -0.54 6 6
TGFB1I1 0.03 0.045 -10000 0 -0.54 3 3
T-DHT/AR/CyclinD1 -0.036 0.15 -10000 0 -0.38 67 67
XRCC6 0.032 0.009 -10000 0 -10000 0 0
T-DHT/AR -0.057 0.17 -10000 0 -0.36 83 83
CTDSP1 0.035 0.005 -10000 0 -10000 0 0
CTDSP2 0.032 0.008 -10000 0 -10000 0 0
BRCA1 0.037 0.022 -10000 0 -10000 0 0
TCF4 0.024 0.067 -10000 0 -0.54 7 7
CDKN2A 0.053 0.056 -10000 0 -10000 0 0
SRF 0.021 0.059 -10000 0 -10000 0 0
NKX3-1 -0.072 0.11 -10000 0 -0.22 173 173
KLK3 0.015 0.056 -10000 0 -10000 0 0
TMF1 0.034 0.007 -10000 0 -10000 0 0
HNRNPA1 0.033 0.006 -10000 0 -10000 0 0
AOF2 0.001 0.002 -10000 0 -10000 0 0
APPL1 0.016 0.014 -10000 0 -10000 0 0
T-DHT/AR/Caspase 8 -0.04 0.14 -10000 0 -0.32 81 81
AR -0.069 0.2 -10000 0 -0.56 66 66
UBA3 0 0.001 -10000 0 -10000 0 0
PATZ1 0.031 0.01 -10000 0 -10000 0 0
PAWR 0.034 0.03 -10000 0 -0.54 1 1
PRKDC 0.031 0.019 -10000 0 -10000 0 0
PA2G4 0.033 0.007 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.032 0.13 -10000 0 -0.32 63 63
RPS6KA3 0.034 0.037 -10000 0 -0.54 2 2
T-DHT/AR/ARA70 -0.039 0.14 -10000 0 -0.32 82 82
LATS2 0.021 0.076 -10000 0 -0.54 9 9
T-DHT/AR/PRX1 -0.034 0.13 -10000 0 -0.33 66 66
Cyclin D3/CDK11 p58 0.025 0.005 -10000 0 -10000 0 0
VAV3 0.03 0.12 -10000 0 -0.54 19 19
KLK2 -0.018 0.069 -10000 0 -0.42 1 1
CASP8 0.034 0.005 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.019 0.13 -10000 0 -0.32 55 55
TMPRSS2 -0.23 0.42 -10000 0 -0.96 122 122
CCND1 0.024 0.088 -10000 0 -0.54 10 10
PIAS1 0.035 0.007 -10000 0 -10000 0 0
mol:T-DHT -0.017 0.035 0.049 1 -0.071 141 142
CDC2L1 0 0 -10000 0 -10000 0 0
PIAS4 0.038 0.016 -10000 0 -10000 0 0
T-DHT/AR/CDK6 -0.043 0.14 -10000 0 -0.32 87 87
CMTM2 0.03 0.012 -10000 0 -10000 0 0
SNURF 0 0 -10000 0 -10000 0 0
ZMIZ1 0.004 0.053 -10000 0 -10000 0 0
CCND3 0.034 0.006 -10000 0 -10000 0 0
TGIF1 0.031 0.027 -10000 0 -0.54 1 1
FKBP4 0.038 0.027 -10000 0 -10000 0 0
Regulation of p38-alpha and p38-beta

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.041 0.016 -10000 0 -10000 0 0
response to insulin stimulus 0 0 -10000 0 -10000 0 0
RIPK1 0.034 0.006 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.021 0.081 -10000 0 -0.54 10 10
mol:GTP 0 0 -10000 0 -10000 0 0
MAP2K4 0.03 0.012 -10000 0 -10000 0 0
RAC1-CDC42/GTP/PAK family -0.11 0.12 -10000 0 -0.23 240 240
response to UV 0 0 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
interleukin-1 receptor activity 0 0 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
MAP3K12 0.034 0.005 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
p38 alpha/TAB1 -0.042 0.096 -10000 0 -0.31 42 42
PRKG1 0.034 0.006 -10000 0 -10000 0 0
DUSP8 0.033 0.007 -10000 0 -10000 0 0
PGK/cGMP/p38 alpha 0.011 0.12 -10000 0 -0.34 32 32
apoptosis -0.04 0.092 -10000 0 -0.3 42 42
RAL/GTP 0.045 0.01 -10000 0 -10000 0 0
LYN 0.03 0.016 -10000 0 -10000 0 0
DUSP1 -0.2 0.28 -10000 0 -0.54 207 207
PAK1 0.044 0.047 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.072 0.036 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
mol:cGMP 0 0 -10000 0 -10000 0 0
CCM2 0.034 0.005 -10000 0 -10000 0 0
RAC1-CDC42/GTP 0.044 0.012 -10000 0 -10000 0 0
MAPK11 0 0.14 0.38 2 -0.36 34 36
BLK 0.039 0.045 -10000 0 -10000 0 0
HCK 0.037 0.023 -10000 0 -10000 0 0
MAP2K3 0.031 0.011 -10000 0 -10000 0 0
DUSP16 0.033 0.012 -10000 0 -10000 0 0
DUSP10 0.028 0.033 -10000 0 -0.54 1 1
TRAF6/MEKK3 0.038 0.016 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.005 0.13 0.5 1 -0.34 39 40
positive regulation of innate immune response -0.001 0.16 0.59 1 -0.41 38 39
LCK 0.049 0.045 -10000 0 -10000 0 0
p38alpha-beta/MKP7 0.013 0.16 0.58 1 -0.42 32 33
p38alpha-beta/MKP5 0.008 0.15 0.58 1 -0.41 33 34
PGK/cGMP 0.025 0.004 -10000 0 -10000 0 0
PAK2 0.034 0.007 -10000 0 -10000 0 0
p38alpha-beta/MKP1 -0.086 0.2 -10000 0 -0.42 80 80
CDC42 0.033 0.008 -10000 0 -10000 0 0
RALB 0.034 0.005 -10000 0 -10000 0 0
RALA 0.034 0.005 -10000 0 -10000 0 0
PAK3 -0.31 0.28 -10000 0 -0.54 308 308
Regulation of Telomerase

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex 0.003 0.18 -10000 0 -0.74 11 11
RAD9A 0.032 0.01 -10000 0 -10000 0 0
AP1 -0.31 0.26 -10000 0 -0.46 356 356
IFNAR2 0.039 0.012 -10000 0 -10000 0 0
AKT1 -0.005 0.12 -10000 0 -0.38 13 13
ER alpha/Oestrogen -0.041 0.19 -10000 0 -0.39 110 110
NFX1/SIN3/HDAC complex 0.035 0.075 -10000 0 -0.35 12 12
EGF -0.15 0.27 -10000 0 -0.54 163 163
SMG5 0.03 0.018 -10000 0 -10000 0 0
SMG6 0.032 0.01 -10000 0 -10000 0 0
SP3/HDAC2 0.056 0.025 -10000 0 -10000 0 0
TERT/c-Abl 0.012 0.17 -10000 0 -0.69 11 11
SAP18 0.033 0.01 -10000 0 -10000 0 0
MRN complex 0.049 0.033 -10000 0 -10000 0 0
WT1 0.088 0.071 -10000 0 -10000 0 0
WRN 0.028 0.016 -10000 0 -10000 0 0
SP1 0.041 0.016 -10000 0 -10000 0 0
SP3 0.037 0.007 -10000 0 -10000 0 0
TERF2IP 0.029 0.013 -10000 0 -10000 0 0
Telomerase/Nucleolin 0.031 0.16 -10000 0 -0.62 11 11
Mad/Max 0.055 0.018 -10000 0 -10000 0 0
TERT -0.003 0.18 -10000 0 -0.78 11 11
CCND1 0.036 0.26 0.57 10 -1 14 24
MAX 0.036 0.01 -10000 0 -10000 0 0
RBBP7 0.039 0.023 -10000 0 -10000 0 0
RBBP4 0.035 0.006 -10000 0 -10000 0 0
TERF2 0.027 0.028 -10000 0 -0.49 1 1
PTGES3 0.033 0.026 -10000 0 -0.54 1 1
SIN3A 0.035 0.006 -10000 0 -10000 0 0
Telomerase/911 0.04 0.06 -10000 0 -0.45 2 2
CDKN1B 0.044 0.11 0.32 1 -0.61 10 11
RAD1 0.034 0.009 -10000 0 -10000 0 0
XRCC5 0.034 0.005 -10000 0 -10000 0 0
XRCC6 0.033 0.009 -10000 0 -10000 0 0
SAP30 0.035 0.01 -10000 0 -10000 0 0
TRF2/PARP2 0.043 0.029 -10000 0 -0.39 1 1
UBE3A 0.035 0.009 -10000 0 -10000 0 0
JUN -0.065 0.22 -10000 0 -0.54 89 89
E6 0.002 0.004 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.029 0.012 -10000 0 -10000 0 0
FOS -0.35 0.27 -10000 0 -0.54 344 344
IFN-gamma/IRF1 0.083 0.084 0.28 28 -0.32 10 38
PARP2 0.034 0.006 -10000 0 -10000 0 0
BLM 0.075 0.068 -10000 0 -10000 0 0
Telomerase 0.004 0.095 -10000 0 -0.63 5 5
IRF1 0.046 0.048 0.2 4 -0.18 9 13
ESR1 -0.057 0.25 -10000 0 -0.54 106 106
KU/TER 0.048 0.014 -10000 0 -10000 0 0
ATM/TRF2 0.037 0.033 -10000 0 -0.29 1 1
ubiquitin-dependent protein catabolic process 0.043 0.069 -10000 0 -0.35 7 7
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.043 0.07 -10000 0 -0.36 7 7
HDAC1 0.035 0.006 -10000 0 -10000 0 0
HDAC2 0.039 0.021 -10000 0 -10000 0 0
ATM 0.017 0.021 0.21 1 -10000 0 1
SMAD3 0.01 0.017 -10000 0 -10000 0 0
ABL1 0.034 0.005 -10000 0 -10000 0 0
MXD1 0.037 0.009 -10000 0 -10000 0 0
MRE11A 0.031 0.011 -10000 0 -10000 0 0
HUS1 0.035 0.01 -10000 0 -10000 0 0
RPS6KB1 0.03 0.012 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 0.027 0.19 -10000 0 -0.74 11 11
NR2F2 0.008 0.094 -10000 0 -0.55 13 13
MAPK3 0.019 0.022 -10000 0 -0.4 1 1
MAPK1 0.019 0.022 -10000 0 -0.4 1 1
TGFB1/TGF beta receptor Type II 0.033 0.009 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
HNRNPC 0.034 0.006 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.017 0.021 0.21 1 -10000 0 1
NBN 0.028 0.016 -10000 0 -10000 0 0
EGFR -0.27 0.29 -10000 0 -0.54 269 269
mol:Oestrogen 0.001 0.003 -10000 0 -10000 0 0
EGF/EGFR -0.3 0.26 -10000 0 -0.46 355 355
MYC -0.001 0.12 -10000 0 -0.54 25 25
IL2 0.04 0.031 -10000 0 -0.54 1 1
KU 0.048 0.014 -10000 0 -10000 0 0
RAD50 0.034 0.006 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
TGFB1 0.033 0.009 -10000 0 -10000 0 0
TRF2/BLM 0.066 0.057 -10000 0 -0.39 1 1
FRAP1 0 0 -10000 0 -10000 0 0
KU/TERT 0.025 0.18 -10000 0 -0.7 11 11
SP1/HDAC2 0.061 0.032 -10000 0 -10000 0 0
PINX1 0.027 0.014 -10000 0 -10000 0 0
Telomerase/EST1A 0.024 0.16 -10000 0 -0.62 11 11
Smad3/Myc 0.005 0.081 -10000 0 -0.34 25 25
911 complex 0.062 0.026 0.26 1 -10000 0 1
IFNG 0.066 0.074 -10000 0 -0.54 1 1
Telomerase/PinX1 0.013 0.16 -10000 0 -0.62 11 11
Telomerase/AKT1/mTOR/p70S6K 0.022 0.12 0.3 1 -0.49 15 16
SIN3B 0.036 0.014 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
Telomerase/EST1B 0.03 0.16 -10000 0 -0.66 9 9
response to DNA damage stimulus -0.001 0.03 -10000 0 -10000 0 0
MRN complex/TRF2/Rap1 0.062 0.052 -10000 0 -0.31 1 1
TRF2/WRN 0.036 0.03 -10000 0 -0.39 1 1
Telomerase/hnRNP C1/C2 0.031 0.16 -10000 0 -0.64 10 10
E2F1 0.056 0.05 -10000 0 -10000 0 0
ZNFX1 0.034 0.017 -10000 0 -10000 0 0
PIF1 0.039 0.029 -10000 0 -10000 0 0
NCL 0.034 0.006 -10000 0 -10000 0 0
DKC1 0.035 0.012 -10000 0 -10000 0 0
telomeric DNA binding 0 0 -10000 0 -10000 0 0
TCGA08_p53

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A 0.028 0.047 -10000 0 -10000 0 0
TP53 -0.002 0.056 -10000 0 -0.19 37 37
Senescence -0.006 0.061 -10000 0 -0.19 37 37
Apoptosis -0.006 0.061 -10000 0 -0.19 37 37
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 -0.01 0.067 0.3 18 -10000 0 18
MDM4 0.029 0.017 -10000 0 -10000 0 0
Signaling mediated by p38-gamma and p38-delta

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K -0.006 0.029 0.36 1 -0.34 1 2
SNTA1 0.032 0.026 -10000 0 -0.54 1 1
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 0.012 0.058 0.33 6 -0.34 1 7
MAPK12 0.008 0.086 0.21 39 -0.28 24 63
CCND1 0.008 0.085 0.21 2 -0.49 11 13
p38 gamma/SNTA1 0.027 0.086 0.39 1 -0.26 22 23
MAP2K3 0.031 0.011 -10000 0 -10000 0 0
PKN1 0.035 0.011 -10000 0 -10000 0 0
G2/M transition checkpoint 0.008 0.085 0.21 39 -0.27 24 63
MAP2K6 0.014 0.096 0.25 42 -0.3 25 67
MAPT 0.012 0.072 0.27 9 -0.29 10 19
MAPK13 0.018 0.028 -10000 0 -0.4 1 1
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.007 0.062 -10000 0 -0.33 17 17
E-cadherin signaling in the nascent adherens junction

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.037 0.15 -10000 0 -0.43 42 42
KLHL20 0.042 0.12 0.31 41 -0.26 14 55
CYFIP2 0.051 0.048 -10000 0 -10000 0 0
Rac1/GDP 0.003 0.12 0.31 7 -0.3 28 35
ENAH -0.031 0.14 -10000 0 -0.43 37 37
AP1M1 0.034 0.006 -10000 0 -10000 0 0
RAP1B 0.033 0.007 -10000 0 -10000 0 0
RAP1A 0.034 0.005 -10000 0 -10000 0 0
CTNNB1 0.03 0.052 -10000 0 -0.54 4 4
CDC42/GTP 0.009 0.075 -10000 0 -0.28 3 3
ABI1/Sra1/Nap1 -0.015 0.04 -10000 0 -0.17 14 14
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.05 0.095 -10000 0 -0.31 26 26
RAPGEF1 -0.029 0.14 0.31 2 -0.4 40 42
CTNND1 0.034 0.007 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.031 0.16 -10000 0 -0.44 51 51
CRK -0.027 0.14 0.35 1 -0.42 45 46
E-cadherin/gamma catenin/alpha catenin 0.037 0.089 -10000 0 -0.34 21 21
alphaE/beta7 Integrin 0.046 0.016 -10000 0 -10000 0 0
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
NCKAP1 0.034 0.005 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.055 0.042 -10000 0 -0.31 3 3
DLG1 -0.04 0.16 -10000 0 -0.43 50 50
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.021 0.061 -10000 0 -0.2 14 14
MLLT4 0.029 0.046 -10000 0 -0.54 3 3
ARF6/GTP/NME1/Tiam1 0.058 0.025 -10000 0 -10000 0 0
PI3K -0.022 0.081 -10000 0 -0.26 14 14
ARF6 0.034 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.02 0.095 -10000 0 -0.32 33 33
TIAM1 0.035 0.013 -10000 0 -10000 0 0
E-cadherin(dimer)/Ca2+ 0.047 0.089 -10000 0 -0.29 26 26
AKT1 -0.007 0.056 -10000 0 -0.2 1 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
CDH1 0.007 0.12 -10000 0 -0.54 22 22
RhoA/GDP 0.001 0.12 0.31 7 -0.3 27 34
actin cytoskeleton organization 0.037 0.093 0.25 45 -0.19 14 59
CDC42/GDP 0 0.12 0.31 7 -0.3 27 34
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.004 0.067 -10000 0 -0.22 39 39
ITGB7 0.034 0.004 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.051 0.096 -10000 0 -0.31 26 26
E-cadherin/Ca2+/beta catenin/alpha catenin 0.032 0.082 -10000 0 -0.29 26 26
mol:GDP -0.018 0.12 0.31 7 -0.34 35 42
CDC42/GTP/IQGAP1 0.043 0.014 -10000 0 -10000 0 0
JUP 0.033 0.008 -10000 0 -10000 0 0
p120 catenin/RhoA/GDP 0.008 0.12 0.31 6 -0.31 27 33
RAC1/GTP/IQGAP1 0.044 0.011 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.049 0.012 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
CDC42 0.033 0.008 -10000 0 -10000 0 0
CTNNA1 0.034 0.006 -10000 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle 0.016 0.068 0.21 23 -0.22 11 34
NME1 0.031 0.011 -10000 0 -10000 0 0
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 -0.037 0.16 -10000 0 -0.44 47 47
regulation of cell-cell adhesion -0.001 0.061 -10000 0 -0.24 3 3
WASF2 0.02 0.043 0.12 33 -0.11 4 37
Rap1/GTP 0.012 0.087 0.27 2 -0.31 3 5
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.059 0.093 -10000 0 -0.3 21 21
CCND1 0.017 0.08 0.25 20 -0.28 11 31
VAV2 -0.019 0.19 0.39 3 -0.61 21 24
RAP1/GDP 0.011 0.1 0.31 3 -0.33 5 8
adherens junction assembly -0.034 0.15 -10000 0 -0.42 47 47
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.034 0.007 -10000 0 -10000 0 0
PIP5K1C 0.034 0.009 -10000 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.044 0.088 -10000 0 -0.29 24 24
E-cadherin/beta catenin -0.006 0.088 -10000 0 -0.34 33 33
mol:GTP 0 0 -10000 0 -10000 0 0
SRC -0.038 0.16 -10000 0 -0.43 50 50
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
Rac1/GTP 0.014 0.15 0.28 60 -0.42 18 78
E-cadherin/beta catenin/alpha catenin 0.036 0.095 -10000 0 -0.34 26 26
ITGAE 0.031 0.011 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.032 0.17 -10000 0 -0.45 51 51
Noncanonical Wnt signaling pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.03 0.027 -10000 0 -0.54 1 1
GNB1/GNG2 0.025 0.15 -10000 0 -0.44 27 27
mol:DAG 0.005 0.13 -10000 0 -0.41 26 26
PLCG1 0.005 0.13 -10000 0 -0.42 26 26
YES1 -0.003 0.14 0.25 1 -0.48 24 25
FZD3 0.014 0.091 -10000 0 -0.54 13 13
FZD6 0.007 0.11 -10000 0 -0.54 18 18
G protein 0.036 0.15 0.34 5 -0.42 25 30
MAP3K7 -0.005 0.11 0.25 1 -0.38 20 21
mol:Ca2+ 0.006 0.13 -10000 0 -0.4 26 26
mol:IP3 0.005 0.13 -10000 0 -0.41 26 26
NLK 0.003 0.13 -10000 0 -0.8 13 13
GNB1 0.034 0.012 -10000 0 -10000 0 0
CAMK2A -0.001 0.12 0.26 1 -0.4 22 23
MAP3K7IP1 0 0 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.016 0.13 -10000 0 -0.48 25 25
CSNK1A1 0.034 0.006 -10000 0 -10000 0 0
GNAS -0.006 0.13 0.25 1 -0.45 24 25
GO:0007205 -0.001 0.13 0.26 1 -0.41 25 26
WNT6 0.034 0.04 -10000 0 -0.54 2 2
WNT4 0.041 0.034 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.015 0.14 -10000 0 -0.46 20 20
GNG2 0.033 0.026 -10000 0 -0.54 1 1
WNT5A 0.01 0.13 -10000 0 -0.54 25 25
WNT11 0.024 0.079 -10000 0 -0.54 9 9
CDC42 -0.003 0.13 -10000 0 -0.46 22 22
IL2 signaling events mediated by PI3K

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.02 0.093 -10000 0 -10000 0 0
UGCG 0.029 0.12 -10000 0 -0.65 11 11
AKT1/mTOR/p70S6K/Hsp90/TERT 0 0.18 0.33 1 -0.43 36 37
mol:GTP 0 0.001 -10000 0 -10000 0 0
mol:glucosylceramide 0.03 0.11 -10000 0 -0.64 11 11
mol:DAG 0.003 0.11 -10000 0 -0.82 8 8
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.02 0.22 -10000 0 -0.52 39 39
FRAP1 -0.036 0.24 -10000 0 -0.61 40 40
FOXO3 0.005 0.18 0.38 3 -0.6 19 22
AKT1 0.002 0.2 0.39 1 -0.65 20 21
GAB2 0.028 0.014 -10000 0 -10000 0 0
SMPD1 0.008 0.12 -10000 0 -0.66 15 15
SGMS1 0.018 0.083 -10000 0 -0.57 8 8
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.028 0.097 -10000 0 -0.34 44 44
CALM1 0.034 0.006 -10000 0 -10000 0 0
cell proliferation 0.049 0.12 0.42 1 -0.5 8 9
EIF3A 0.034 0.006 -10000 0 -10000 0 0
PI3K 0.005 0.13 -10000 0 -0.4 44 44
RPS6KB1 0.001 0.13 -10000 0 -0.83 8 8
mol:sphingomyelin 0.003 0.11 -10000 0 -0.82 8 8
natural killer cell activation -0.002 0.005 -10000 0 -0.02 3 3
JAK3 0.034 0.009 -10000 0 -10000 0 0
PIK3R1 -0.021 0.17 -10000 0 -0.54 47 47
JAK1 0.033 0.01 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MYC 0.022 0.27 0.54 1 -0.92 31 32
MYB -0.046 0.34 0.46 1 -1.2 42 43
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.027 0.13 0.33 1 -0.4 12 13
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.036 0.13 -10000 0 -0.71 9 9
mol:PI-3-4-5-P3 0.029 0.13 0.33 1 -0.39 12 13
Rac1/GDP -0.011 0.095 -10000 0 -0.31 44 44
T cell proliferation 0.028 0.12 0.31 1 -0.37 11 12
SHC1 0.026 0.016 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity 0.003 0.029 0.096 25 -0.068 41 66
PRKCZ 0.026 0.12 0.31 1 -0.38 12 13
NF kappa B1 p50/RelA -0.01 0.22 -10000 0 -0.54 35 35
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K 0.021 0.098 0.3 1 -0.39 8 9
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
IL2RA 0.039 0.036 -10000 0 -10000 0 0
IL2RB 0.035 0.024 -10000 0 -10000 0 0
TERT 0.032 0.028 -10000 0 -0.54 1 1
E2F1 0.014 0.14 0.32 2 -0.4 46 48
SOS1 0.032 0.01 -10000 0 -10000 0 0
RPS6 0.032 0.026 -10000 0 -0.54 1 1
mol:cAMP -0.002 0.014 0.032 41 -0.051 24 65
PTPN11 0.032 0.011 -10000 0 -10000 0 0
IL2RG 0.043 0.037 -10000 0 -10000 0 0
actin cytoskeleton organization 0.028 0.12 0.31 1 -0.37 11 12
GRB2 0.032 0.02 -10000 0 -10000 0 0
IL2 0.032 0.029 -10000 0 -0.54 1 1
PIK3CA 0.032 0.012 -10000 0 -10000 0 0
Rac1/GTP 0.015 0.1 -10000 0 -0.29 44 44
LCK 0.048 0.046 -10000 0 -10000 0 0
BCL2 -0.12 0.38 0.52 1 -0.84 102 103
Cellular roles of Anthrax toxin

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.035 0.031 -10000 0 -0.54 1 1
ANTXR2 0.023 0.08 -10000 0 -0.54 10 10
negative regulation of myeloid dendritic cell antigen processing and presentation -0.002 0.01 -10000 0 -0.072 11 11
monocyte activation 0.012 0.088 -10000 0 -0.35 27 27
MAP2K2 0.005 0.094 -10000 0 -0.57 13 13
MAP2K1 -0.005 0.01 -10000 0 -10000 0 0
MAP2K7 -0.005 0.01 -10000 0 -10000 0 0
MAP2K6 -0.01 0.042 0.086 1 -0.3 10 11
CYAA -0.01 0.042 -10000 0 -0.29 11 11
MAP2K4 -0.005 0.012 -10000 0 -0.18 1 1
IL1B -0.013 0.05 0.24 1 -0.3 8 9
Channel 0.036 0.053 -10000 0 -0.31 11 11
NLRP1 -0.007 0.028 -10000 0 -0.27 5 5
CALM1 0.034 0.006 -10000 0 -10000 0 0
negative regulation of phagocytosis 0.002 0.075 -10000 0 -0.41 16 16
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.002 0.01 0.072 11 -10000 0 11
MAPK3 -0.005 0.01 -10000 0 -10000 0 0
MAPK1 -0.005 0.01 -10000 0 -10000 0 0
PGR -0.063 0.14 0.086 110 -0.29 143 253
PA/Cellular Receptors 0.038 0.058 -10000 0 -0.34 11 11
apoptosis -0.002 0.01 -10000 0 -0.072 11 11
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.036 0.05 -10000 0 -0.29 11 11
macrophage activation 0.007 0.051 0.18 39 -10000 0 39
TNF 0.038 0.024 -10000 0 -10000 0 0
VCAM1 0.011 0.088 -10000 0 -0.35 27 27
platelet activation 0.002 0.075 -10000 0 -0.41 16 16
MAPKKK cascade -0.003 0.029 0.12 3 -0.14 4 7
IL18 -0.001 0.039 0.14 1 -0.17 9 10
negative regulation of macrophage activation -0.002 0.01 -10000 0 -0.072 11 11
LEF -0.002 0.01 -10000 0 -0.073 11 11
CASP1 -0.006 0.032 -10000 0 -0.11 34 34
mol:cAMP 0.002 0.075 -10000 0 -0.41 16 16
necrosis -0.002 0.01 -10000 0 -0.072 11 11
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.036 0.05 -10000 0 -0.29 11 11
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Hedgehog signaling events mediated by Gli proteins

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC2 0.034 0.017 0.18 5 -10000 0 5
GNB1/GNG2 0.048 0.088 -10000 0 -0.34 23 23
forebrain development -0.041 0.2 -10000 0 -0.57 45 45
GNAO1 0.031 0.012 -10000 0 -10000 0 0
SMO/beta Arrestin2 0.029 0.092 -10000 0 -0.4 22 22
SMO 0.012 0.12 -10000 0 -0.54 22 22
ARRB2 0.032 0.011 -10000 0 -10000 0 0
GLI3/SPOP 0.03 0.11 0.29 1 -0.46 11 12
mol:GTP 0.001 0.001 -10000 0 -10000 0 0
GSK3B 0.034 0.009 -10000 0 -10000 0 0
GNAI2 0.034 0.01 -10000 0 -10000 0 0
SIN3/HDAC complex 0.078 0.032 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
XPO1 0.037 0.006 -10000 0 -10000 0 0
GLI1/Su(fu) -0.031 0.19 -10000 0 -0.67 25 25
SAP30 0.034 0.009 -10000 0 -10000 0 0
mol:GDP 0.012 0.12 -10000 0 -0.54 22 22
MIM/GLI2A 0.033 0.03 0.32 1 -10000 0 1
IFT88 0.031 0.027 -10000 0 -0.54 1 1
GNAI3 0.035 0.006 -10000 0 -10000 0 0
GLI2 0.017 0.084 -10000 0 -0.37 14 14
GLI3 0.017 0.11 0.3 1 -0.44 14 15
CSNK1D 0.033 0.008 -10000 0 -10000 0 0
CSNK1E 0.033 0.009 -10000 0 -10000 0 0
SAP18 0.032 0.009 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.031 0.027 -10000 0 -0.54 1 1
GNG2 0.033 0.026 -10000 0 -0.54 1 1
Gi family/GTP -0.082 0.16 -10000 0 -0.37 71 71
SIN3B 0.035 0.014 -10000 0 -10000 0 0
SIN3A 0.034 0.006 -10000 0 -10000 0 0
GLI3/Su(fu) 0.025 0.11 -10000 0 -0.44 17 17
GLI2/Su(fu) 0.02 0.11 -10000 0 -0.49 10 10
FOXA2 0.017 0.12 -10000 0 -0.73 9 9
neural tube patterning -0.041 0.2 -10000 0 -0.57 45 45
SPOP 0.031 0.011 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.027 0.064 -10000 0 -0.35 1 1
GNB1 0.034 0.012 -10000 0 -10000 0 0
CSNK1G2 0.034 0.007 -10000 0 -10000 0 0
CSNK1G3 0.034 0.007 -10000 0 -10000 0 0
MTSS1 0.033 0.03 0.32 1 -10000 0 1
embryonic limb morphogenesis -0.041 0.2 -10000 0 -0.57 45 45
SUFU 0.019 0.049 -10000 0 -0.38 1 1
LGALS3 -0.029 0.18 -10000 0 -0.54 56 56
catabolic process 0.037 0.14 0.32 1 -0.52 17 18
GLI3A/CBP 0.004 0.11 -10000 0 -0.35 47 47
KIF3A 0.034 0.006 -10000 0 -10000 0 0
GLI1 -0.043 0.2 -10000 0 -0.59 45 45
RAB23 0.035 0.014 -10000 0 -10000 0 0
CSNK1A1 0.034 0.006 -10000 0 -10000 0 0
IFT172 0.033 0.026 -10000 0 -0.54 1 1
RBBP7 0.038 0.023 -10000 0 -10000 0 0
Su(fu)/Galectin3 -0.009 0.13 -10000 0 -0.33 58 58
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
RBBP4 0.034 0.006 -10000 0 -10000 0 0
CSNK1G1 0.033 0.007 -10000 0 -10000 0 0
PIAS1 0.034 0.007 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GLI2/SPOP 0.028 0.089 -10000 0 -0.39 13 13
STK36 0.035 0.026 -10000 0 -0.54 1 1
Gi family/GNB1/GNG2/GDP -0.081 0.16 -10000 0 -0.4 68 68
PTCH1 -0.036 0.18 -10000 0 -0.7 17 17
MIM/GLI1 -0.023 0.18 -10000 0 -0.6 30 30
CREBBP 0.004 0.11 -10000 0 -0.35 47 47
Su(fu)/SIN3/HDAC complex 0.016 0.1 -10000 0 -0.45 17 17
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.028 0.016 -10000 0 -10000 0 0
Caspase 8 (4 units) 0.047 0.14 -10000 0 -0.45 16 16
NEF 0.011 0.022 -10000 0 -10000 0 0
NFKBIA 0.029 0.036 -10000 0 -0.35 1 1
BIRC3 0.009 0.14 0.29 19 -0.44 33 52
CYCS 0.033 0.13 0.28 18 -0.44 14 32
RIPK1 0.034 0.006 -10000 0 -10000 0 0
CD247 0.03 0.11 0.24 17 -0.55 15 32
MAP2K7 0.038 0.19 0.34 4 -0.69 19 23
protein ubiquitination 0.015 0.12 0.37 2 -0.39 15 17
CRADD 0.034 0.005 -10000 0 -10000 0 0
DAXX 0.035 0.008 -10000 0 -10000 0 0
FAS -0.003 0.14 -10000 0 -0.54 33 33
BID 0.03 0.13 0.25 8 -0.45 16 24
NF-kappa-B/RelA/I kappa B alpha 0.059 0.086 -10000 0 -0.3 16 16
TRADD 0.03 0.012 -10000 0 -10000 0 0
MAP3K5 0.004 0.13 -10000 0 -0.54 26 26
CFLAR 0.033 0.026 -10000 0 -0.54 1 1
FADD 0.029 0.015 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.059 0.087 -10000 0 -0.3 16 16
MAPK8 0.037 0.17 0.4 4 -0.64 18 22
APAF1 0.035 0.003 -10000 0 -10000 0 0
TRAF1 0.036 0.015 -10000 0 -10000 0 0
TRAF2 0.035 0.013 -10000 0 -10000 0 0
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG 0.035 0.14 0.27 7 -0.44 19 26
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.014 0.14 -10000 0 -0.49 17 17
CHUK 0.013 0.12 0.38 2 -0.43 15 17
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.038 0.12 -10000 0 -0.33 41 41
TCRz/NEF 0.032 0.093 0.25 17 -0.41 15 32
TNF 0.038 0.024 -10000 0 -10000 0 0
FASLG 0.036 0.11 0.31 42 -0.36 15 57
NFKB1 0.03 0.034 -10000 0 -10000 0 0
TNFR1A/BAG4/TNF-alpha 0.053 0.035 -10000 0 -10000 0 0
CASP6 0.053 0.15 -10000 0 -0.52 18 18
CASP7 0.02 0.19 0.4 17 -0.47 42 59
RELA 0.03 0.033 -10000 0 -0.17 1 1
CASP2 0.034 0.006 -10000 0 -10000 0 0
CASP3 0.016 0.19 0.4 16 -0.47 42 58
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
TNFR1A/BAG4 0.038 0.023 -10000 0 -10000 0 0
CASP8 0.034 0.005 -10000 0 -10000 0 0
CASP9 0.033 0.008 -10000 0 -10000 0 0
MAP3K14 0.016 0.13 0.36 1 -0.45 17 18
APAF-1/Caspase 9 0.019 0.13 0.26 2 -0.38 25 27
BCL2 -0.006 0.18 0.45 6 -0.55 23 29
Signaling events mediated by PRL

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.06 0.057 -10000 0 -10000 0 0
mol:Halofuginone 0.003 0.004 -10000 0 -10000 0 0
ITGA1 0.031 0.037 -10000 0 -0.54 2 2
CDKN1A -0.081 0.1 -10000 0 -0.52 18 18
PRL-3/alpha Tubulin 0.042 0.027 -10000 0 -10000 0 0
mol:Ca2+ -0.005 0.043 -10000 0 -10000 0 0
AGT 0.043 0.05 -10000 0 -10000 0 0
CCNA2 -0.18 0.12 -10000 0 -10000 0 0
TUBA1B 0.035 0.012 -10000 0 -10000 0 0
EGR1 -0.31 0.16 -10000 0 -0.39 413 413
CDK2/Cyclin E1 -0.042 0.11 -10000 0 -0.45 19 19
MAPK3 0.015 0.019 -10000 0 -10000 0 0
PRL-2 /Rab GGTase beta 0.052 0.018 -10000 0 -10000 0 0
MAPK1 0.015 0.018 -10000 0 -10000 0 0
PTP4A1 -0.22 0.13 -10000 0 -10000 0 0
PTP4A3 0.03 0.025 -10000 0 -10000 0 0
PTP4A2 0.037 0.021 -10000 0 -10000 0 0
ITGB1 0.015 0.018 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
RAC1 -0.056 0.075 -10000 0 -0.48 7 7
Rab GGTase beta/Rab GGTase alpha 0.049 0.011 -10000 0 -10000 0 0
PRL-1/ATF-5 -0.21 0.12 -10000 0 -10000 0 0
RABGGTA 0.034 0.006 -10000 0 -10000 0 0
BCAR1 -0.019 0.018 -10000 0 -10000 0 0
RHOC -0.058 0.084 -10000 0 -0.52 9 9
RHOA -0.064 0.1 -10000 0 -0.54 15 15
cell motility -0.084 0.096 0.27 1 -0.39 25 26
PRL-1/alpha Tubulin -0.21 0.12 -10000 0 -10000 0 0
PRL-3/alpha1 Integrin 0.04 0.034 -10000 0 -0.28 2 2
ROCK1 -0.082 0.095 0.27 1 -0.39 23 24
RABGGTB 0.034 0.006 -10000 0 -10000 0 0
CDK2 0.038 0.022 -10000 0 -10000 0 0
mitosis -0.22 0.13 -10000 0 -10000 0 0
ATF5 0.034 0.011 -10000 0 -10000 0 0
E-cadherin signaling events

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.035 0.094 -9999 0 -0.34 25 25
E-cadherin/beta catenin 0.019 0.1 -9999 0 -0.39 26 26
CTNNB1 0.029 0.051 -9999 0 -0.54 4 4
JUP 0.033 0.008 -9999 0 -10000 0 0
CDH1 0.007 0.12 -9999 0 -0.54 22 22
Caspase cascade in apoptosis

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 0.033 0.085 0.29 2 -0.4 9 11
ACTA1 0.006 0.083 0.24 3 -0.44 2 5
NUMA1 0.026 0.084 0.29 2 -0.37 9 11
SPTAN1 0.02 0.069 0.3 6 -0.48 1 7
LIMK1 0.033 0.074 0.28 11 -0.48 1 12
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BIRC2 0.031 0.011 -10000 0 -10000 0 0
BAX 0.035 0.012 -10000 0 -10000 0 0
CASP10 -0.003 0.04 0.25 8 -0.34 1 9
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -0.001 37 37
PTK2 0.029 0.095 0.28 3 -0.45 10 13
DIABLO 0.035 0.003 -10000 0 -10000 0 0
apoptotic nuclear changes 0.02 0.069 0.3 6 -0.48 1 7
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.034 0.005 -10000 0 -10000 0 0
GSN -0.054 0.14 0.35 1 -0.29 89 90
MADD 0.034 0.005 -10000 0 -10000 0 0
TFAP2A 0.039 0.1 -10000 0 -0.65 9 9
BID 0.013 0.025 0.16 9 -0.2 1 10
MAP3K1 0.011 0.095 -10000 0 -0.39 22 22
TRADD 0.03 0.012 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.049 0.012 -10000 0 -10000 0 0
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB 0.024 0.07 0.3 5 -0.48 1 6
CASP9 0.033 0.008 -10000 0 -10000 0 0
DNA repair -0.034 0.059 0.32 3 -0.2 17 20
neuron apoptosis 0.006 0.15 -10000 0 -0.68 21 21
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis 0.023 0.075 0.29 2 -0.46 2 4
APAF1 0.035 0.003 -10000 0 -10000 0 0
CASP6 0.021 0.14 -10000 0 -0.85 12 12
TRAF2 0.035 0.013 -10000 0 -10000 0 0
ICAD/CAD 0.017 0.062 0.28 2 -0.47 1 3
CASP7 0.015 0.083 0.26 26 -0.29 6 32
KRT18 0.036 0.096 -10000 0 -0.73 6 6
apoptosis 0.011 0.11 0.32 1 -0.45 9 10
DFFA 0.02 0.065 0.28 3 -0.48 1 4
DFFB 0.02 0.065 0.28 3 -0.48 1 4
PARP1 0.034 0.06 0.2 17 -0.33 3 20
actin filament polymerization 0.016 0.13 0.38 4 -0.3 8 12
TNF 0.038 0.024 -10000 0 -10000 0 0
CYCS 0.023 0.045 0.22 6 -0.23 3 9
SATB1 -0.012 0.16 -10000 0 -0.78 14 14
SLK 0.019 0.067 0.28 3 -0.38 2 5
p15 BID/BAX 0.026 0.051 -10000 0 -0.31 3 3
CASP2 0.005 0.085 0.28 2 -0.31 15 17
JNK cascade -0.011 0.095 0.39 22 -10000 0 22
CASP3 0.024 0.071 0.31 3 -0.51 1 4
LMNB2 0.018 0.13 0.31 3 -0.51 21 24
RIPK1 0.034 0.006 -10000 0 -10000 0 0
CASP4 0.025 0.057 -10000 0 -0.54 5 5
Mammalian IAPs/DIABLO 0.046 0.078 -10000 0 -0.31 17 17
negative regulation of DNA binding 0.04 0.1 -10000 0 -0.64 9 9
stress fiber formation 0.019 0.067 0.28 3 -0.37 2 5
GZMB 0.022 0.046 0.29 7 -0.4 2 9
CASP1 -0.017 0.12 -10000 0 -0.4 41 41
LMNB1 0.042 0.13 0.35 3 -0.57 13 16
APP 0.006 0.15 -10000 0 -0.69 21 21
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
response to stress 0 0 0.001 16 -0.001 24 40
CASP8 0.009 0.001 -10000 0 -10000 0 0
VIM 0.014 0.11 0.31 2 -0.45 10 12
LMNA 0.023 0.083 0.34 2 -0.38 8 10
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.006 0.088 -10000 0 -0.31 18 18
LRDD 0 0 -10000 0 -10000 0 0
SREBF1 0.027 0.069 0.28 4 -0.41 1 5
APAF-1/Caspase 9 0.017 0.12 -10000 0 -0.6 16 16
nuclear fragmentation during apoptosis 0.026 0.083 0.28 2 -0.36 9 11
CFL2 -0.017 0.13 0.31 8 -0.38 4 12
GAS2 -0.15 0.15 0.3 5 -0.28 238 243
positive regulation of apoptosis 0.036 0.12 0.31 4 -0.48 17 21
PRF1 0.038 0.023 -10000 0 -10000 0 0
ceramide signaling pathway

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.003 0.13 0.28 1 -0.46 21 22
BAG4 0.028 0.016 -10000 0 -10000 0 0
BAD 0.007 0.047 0.2 2 -0.18 7 9
NFKBIA 0.033 0.007 -10000 0 -10000 0 0
BIRC3 0.017 0.11 -10000 0 -0.54 17 17
BAX 0.008 0.052 0.3 2 -0.18 7 9
EnzymeConsortium:3.1.4.12 0.003 0.033 0.09 4 -0.097 21 25
IKBKB 0.013 0.13 0.29 5 -0.44 16 21
MAP2K2 0.012 0.06 0.23 10 -0.22 2 12
MAP2K1 0.012 0.062 0.23 11 -0.22 2 13
SMPD1 0.004 0.04 0.2 1 -0.17 10 11
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 0.031 0.15 0.35 5 -0.45 20 25
MAP2K4 0.007 0.052 0.2 3 -0.25 5 8
protein ubiquitination 0.003 0.13 0.36 3 -0.44 20 23
EnzymeConsortium:2.7.1.37 0.011 0.064 0.24 10 -0.24 2 12
response to UV 0 0.001 0.003 13 -0.002 1 14
RAF1 0.012 0.061 0.21 21 -0.23 2 23
CRADD 0.034 0.005 -10000 0 -10000 0 0
mol:ceramide 0.008 0.05 0.15 4 -0.15 20 24
I-kappa-B-alpha/RELA/p50/ubiquitin 0.043 0.015 -10000 0 -0.14 1 1
MADD 0.034 0.006 -10000 0 -10000 0 0
MAP3K1 0.008 0.054 0.2 2 -0.24 7 9
TRADD 0.03 0.012 -10000 0 -10000 0 0
RELA/p50 0.033 0.007 -10000 0 -10000 0 0
MAPK3 0.015 0.061 0.23 10 -0.24 1 11
MAPK1 0.011 0.07 0.23 11 -0.23 6 17
p50/RELA/I-kappa-B-alpha 0.047 0.017 -10000 0 -0.17 1 1
FADD 0.028 0.14 0.3 8 -0.46 18 26
KSR1 0.012 0.057 0.2 14 -0.18 7 21
MAPK8 0.004 0.057 0.26 4 -0.24 5 9
TRAF2 0.035 0.013 -10000 0 -10000 0 0
response to radiation 0 0 0.002 4 -10000 0 4
CHUK -0.006 0.13 -10000 0 -0.45 19 19
TNF R/SODD 0.038 0.023 -10000 0 -10000 0 0
TNF 0.038 0.024 -10000 0 -10000 0 0
CYCS 0.025 0.07 0.18 22 -0.18 7 29
IKBKG -0.006 0.13 0.45 1 -0.45 19 20
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.002 0.14 -10000 0 -0.48 21 21
RELA 0.033 0.007 -10000 0 -10000 0 0
RIPK1 0.034 0.006 -10000 0 -10000 0 0
AIFM1 0.024 0.069 0.18 18 -0.18 8 26
TNF/TNF R/SODD 0.053 0.035 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
response to heat 0 0 0.002 4 -10000 0 4
CASP8 0.007 0.16 -10000 0 -0.65 25 25
NSMAF 0.016 0.14 0.28 3 -0.45 19 22
response to hydrogen peroxide 0 0.001 0.003 13 -0.002 1 14
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
Signaling events mediated by VEGFR1 and VEGFR2

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.05 0.027 -10000 0 -0.4 1 1
AKT1 0.025 0.13 0.35 1 -0.46 15 16
PTK2B 0.014 0.085 0.36 2 -0.42 1 3
VEGFR2 homodimer/Frs2 0.022 0.086 -10000 0 -0.33 27 27
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
CALM1 0.034 0.006 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.049 0.091 -10000 0 -0.3 23 23
endothelial cell proliferation 0.051 0.13 0.4 10 -0.44 8 18
mol:Ca2+ 0.021 0.091 0.37 1 -0.41 7 8
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.07 0.093 -10000 0 -0.29 22 22
RP11-342D11.1 0.003 0.087 0.27 1 -0.31 27 28
CDH5 0.03 0.012 -10000 0 -10000 0 0
VEGFA homodimer 0.071 0.059 0.27 3 -0.28 3 6
SHC1 0.028 0.014 -10000 0 -10000 0 0
SHC2 0.006 0.12 -10000 0 -0.54 24 24
HRAS/GDP 0.031 0.083 -10000 0 -0.45 4 4
SH2D2A 0.045 0.049 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.057 0.12 -10000 0 -0.48 11 11
VEGFR2 homodimer/VEGFA homodimer/TsAd 0.05 0.096 -10000 0 -0.31 19 19
VEGFR1 homodimer 0.033 0.013 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.057 0.1 -10000 0 -0.48 4 4
GRB10 0.018 0.11 -10000 0 -0.61 7 7
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GRB2 0.034 0.019 -10000 0 -10000 0 0
PAK1 0.044 0.047 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.068 0.1 -10000 0 -0.43 1 1
HRAS 0.034 0.013 -10000 0 -10000 0 0
VEGF/Rho/ROCK1/Integrin Complex 0.028 0.081 -10000 0 -0.37 7 7
HIF1A 0.031 0.054 -10000 0 -0.54 4 4
FRS2 0.033 0.029 -10000 0 -0.54 1 1
oxygen and reactive oxygen species metabolic process 0.067 0.092 -10000 0 -0.29 22 22
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 0.034 0.006 -10000 0 -10000 0 0
Nck/Pak 0.053 0.038 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.045 0.095 -10000 0 -0.31 26 26
mol:GDP 0.043 0.093 -10000 0 -0.47 4 4
mol:NADP 0.032 0.11 0.59 1 -0.42 14 15
eNOS/Hsp90 0.046 0.11 0.58 1 -0.4 14 15
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.021 0.092 0.37 1 -0.5 4 5
HIF1A/ARNT 0.038 0.042 -10000 0 -0.34 4 4
SHB 0.036 0.018 -10000 0 -10000 0 0
VEGFA 0.051 0.049 0.18 59 -10000 0 59
VEGFC 0.021 0.084 -10000 0 -0.54 11 11
FAK1/Vinculin 0.041 0.11 0.37 1 -0.38 6 7
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.069 0.097 -10000 0 -0.29 25 25
PTPN6 0.034 0.016 -10000 0 -10000 0 0
EPAS1 0.011 0.13 -10000 0 -0.54 28 28
mol:L-citrulline 0.032 0.11 0.59 1 -0.42 14 15
ITGAV 0.034 0.027 -10000 0 -0.54 1 1
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.063 0.094 -10000 0 -0.29 22 22
VEGFR2 homodimer/VEGFA homodimer 0.05 0.11 -10000 0 -0.34 27 27
VEGFR2/3 heterodimer 0.023 0.087 -10000 0 -0.33 28 28
VEGFB 0.034 0.007 -10000 0 -10000 0 0
MAPK11 0.003 0.1 -10000 0 -0.44 9 9
VEGFR2 homodimer 0.003 0.095 -10000 0 -0.39 28 28
FLT1 0.033 0.013 -10000 0 -10000 0 0
NEDD4 0.028 0.058 -10000 0 -0.54 5 5
MAPK3 0.017 0.093 0.37 1 -0.45 4 5
MAPK1 0.012 0.093 0.34 2 -0.45 4 6
VEGFA145/NRP2 0.061 0.038 0.26 1 -10000 0 1
VEGFR1/2 heterodimer 0.021 0.087 -10000 0 -0.33 28 28
KDR 0.003 0.096 -10000 0 -0.39 28 28
VEGFA165/NRP1/VEGFR2 homodimer 0.054 0.1 -10000 0 -0.42 7 7
SRC 0.033 0.008 -10000 0 -10000 0 0
platelet activating factor biosynthetic process 0.018 0.097 0.37 2 -0.46 4 6
PI3K 0.019 0.12 -10000 0 -0.48 9 9
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.051 0.092 -10000 0 -0.31 24 24
FES 0.019 0.096 -10000 0 -0.55 4 4
GAB1 0.042 0.1 0.36 1 -0.41 7 8
VEGFR2 homodimer/VEGFA homodimer/Src 0.05 0.089 -10000 0 -0.31 21 21
CTNNB1 0.029 0.051 -10000 0 -0.54 4 4
SOS1 0.034 0.004 -10000 0 -10000 0 0
ARNT 0.028 0.014 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.13 0.16 -10000 0 -0.45 41 41
VEGFR2 homodimer/VEGFA homodimer/Yes 0.049 0.093 -10000 0 -0.31 24 24
PI3K/GAB1 0.029 0.15 0.39 2 -0.45 14 16
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.075 0.096 -10000 0 -0.28 14 14
PRKACA 0.034 0.005 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.032 0.1 -10000 0 -0.32 38 38
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
CDC42 0.02 0.097 0.37 1 -0.55 4 5
actin cytoskeleton reorganization 0.05 0.095 -10000 0 -0.31 19 19
PTK2 0.023 0.09 -10000 0 -0.39 7 7
EDG1 0.003 0.087 0.27 1 -0.31 27 28
mol:DAG 0.021 0.092 0.37 1 -0.5 4 5
CaM/Ca2+ 0.034 0.088 -10000 0 -0.47 4 4
MAP2K3 0.003 0.087 -10000 0 -0.53 4 4
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.047 0.12 -10000 0 -0.63 7 7
PLCG1 0.021 0.092 0.37 1 -0.51 4 5
VEGFR2 homodimer/VEGFA homodimer/Src/Shb 0.069 0.094 0.37 1 -0.29 21 22
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
VEGFR2 homodimer/VEGFA homodimer/SHP2 0.052 0.093 -10000 0 -0.31 24 24
VEGFR2 homodimer/VEGFA homodimer/SHP1 0.05 0.092 -10000 0 -0.31 23 23
cell migration 0.043 0.11 0.35 1 -0.47 2 3
mol:PI-3-4-5-P3 0.019 0.11 0.32 1 -0.45 9 10
FYN 0.03 0.037 -10000 0 -0.54 2 2
VEGFB/NRP1 0.023 0.089 -10000 0 -0.43 6 6
mol:NO 0.032 0.11 0.59 1 -0.42 14 15
PXN 0.034 0.004 -10000 0 -10000 0 0
HRAS/GTP 0.013 0.073 -10000 0 -0.44 4 4
VEGFR2 homodimer/VEGFA homodimer/GRB10 0.039 0.11 -10000 0 -0.62 7 7
VHL 0.036 0.018 -10000 0 -10000 0 0
ITGB3 0.035 0.019 -10000 0 -10000 0 0
NOS3 0.031 0.12 0.6 1 -0.48 14 15
VEGFR2 homodimer/VEGFA homodimer/Sck 0.033 0.12 -10000 0 -0.32 38 38
RAC1 0.034 0.005 -10000 0 -10000 0 0
PRKCA 0.007 0.08 0.37 1 -0.43 4 5
PRKCB 0.006 0.084 0.36 1 -0.47 4 5
VCL 0.034 0.005 -10000 0 -10000 0 0
VEGFA165/NRP1 0.027 0.094 0.29 1 -0.31 27 28
VEGFR1/2 heterodimer/VEGFA homodimer 0.047 0.093 -10000 0 -0.31 24 24
VEGFA165/NRP2 0.061 0.038 0.26 1 -10000 0 1
MAPKKK cascade 0.062 0.12 0.38 6 -0.55 6 12
NRP2 0.035 0.016 -10000 0 -10000 0 0
VEGFC homodimer 0.021 0.084 -10000 0 -0.54 11 11
NCK1 0.034 0.005 -10000 0 -10000 0 0
ROCK1 0.034 0.006 -10000 0 -10000 0 0
FAK1/Paxillin 0.042 0.11 0.44 2 -0.38 6 8
MAP3K13 0.018 0.095 -10000 0 -0.44 7 7
PDPK1 0.005 0.098 0.3 1 -0.41 9 10
Wnt signaling

Figure S88.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S88.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.016 0.13 -9999 0 -0.48 25 25
FZD6 0.007 0.11 -9999 0 -0.54 18 18
WNT6 0.034 0.04 -9999 0 -0.54 2 2
WNT4 0.041 0.034 -9999 0 -10000 0 0
FZD3 0.014 0.091 -9999 0 -0.54 13 13
WNT5A 0.01 0.13 -9999 0 -0.54 25 25
WNT11 0.024 0.079 -9999 0 -0.54 9 9
BCR signaling pathway

Figure S89.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S89.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN 0.015 0.15 0.36 6 -0.38 17 23
IKBKB 0.049 0.091 0.35 7 -0.36 2 9
AKT1 0.061 0.11 0.31 47 -0.25 2 49
IKBKG 0.054 0.077 0.36 5 -0.29 3 8
CALM1 0.031 0.086 0.28 8 -0.39 6 14
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
MAP3K1 0.066 0.14 0.4 6 -0.49 12 18
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0.032 0.091 0.29 8 -0.36 9 17
DOK1 0.036 0.016 -10000 0 -10000 0 0
AP-1 -0.073 0.11 0.33 1 -0.24 63 64
LYN 0.03 0.016 -10000 0 -10000 0 0
BLNK 0.039 0.027 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
BCR complex 0.042 0.07 0.26 3 -0.4 10 13
CD22 0.015 0.089 0.28 6 -0.45 11 17
CAMK2G 0.029 0.084 0.26 10 -0.37 6 16
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.024 0.044 -10000 0 -0.27 6 6
GO:0007205 0.032 0.092 0.29 8 -0.37 9 17
SYK 0.039 0.027 -10000 0 -10000 0 0
ELK1 0.033 0.09 0.28 8 -0.38 7 15
NFATC1 0.062 0.11 0.29 22 -0.38 10 32
B-cell antigen/BCR complex 0.042 0.07 0.26 3 -0.4 10 13
PAG1/CSK 0.043 0.029 0.26 1 -10000 0 1
NFKBIB 0.04 0.057 0.21 8 -0.13 9 17
HRAS 0.043 0.094 0.27 15 -0.35 8 23
NFKBIA 0.04 0.056 0.21 8 -0.14 1 9
NF-kappa-B/RelA/I kappa B beta 0.044 0.051 0.21 8 -10000 0 8
RasGAP/Csk 0.066 0.08 0.35 2 -0.39 6 8
mol:GDP 0.032 0.089 0.28 8 -0.38 7 15
PTEN 0.03 0.045 -10000 0 -0.54 3 3
CD79B 0.021 0.081 -10000 0 -0.54 10 10
NF-kappa-B/RelA/I kappa B alpha 0.044 0.051 0.21 8 -10000 0 8
GRB2 0.034 0.019 -10000 0 -10000 0 0
PI3K/BCAP/CD19 0.048 0.15 0.38 9 -0.47 15 24
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.031 0.09 0.29 7 -0.38 8 15
CSK 0.034 0.011 -10000 0 -10000 0 0
FOS -0.14 0.14 0.28 1 -0.36 60 61
CHUK 0.052 0.084 0.34 6 -0.32 7 13
IBTK 0.033 0.008 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 0.054 0.09 0.31 3 -0.36 6 9
PTPN6 0.031 0.1 0.29 13 -0.43 11 24
RELA 0.034 0.007 -10000 0 -10000 0 0
BCL2A1 0.04 0.045 0.2 9 -10000 0 9
VAV2 0.043 0.11 0.32 5 -0.57 6 11
ubiquitin-dependent protein catabolic process 0.043 0.056 0.21 8 -0.13 9 17
BTK 0.017 0.091 -10000 0 -0.97 4 4
CD19 0.022 0.093 0.31 5 -0.43 11 16
MAP4K1 0.037 0.021 -10000 0 -10000 0 0
CD72 0.063 0.06 -10000 0 -10000 0 0
PAG1 0.031 0.026 -10000 0 -10000 0 0
MAPK14 0.063 0.13 0.4 8 -0.42 12 20
SH3BP5 0.018 0.094 -10000 0 -0.54 14 14
PIK3AP1 0.03 0.096 0.33 6 -0.42 8 14
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 0.048 0.095 0.28 10 -0.44 7 17
RAF1 0.042 0.09 0.26 14 -0.35 6 20
RasGAP/p62DOK/SHIP 0.055 0.071 0.31 1 -0.37 6 7
CD79A 0.042 0.035 -10000 0 -10000 0 0
re-entry into mitotic cell cycle -0.071 0.11 0.33 1 -0.24 57 58
RASA1 0.034 0.012 -10000 0 -10000 0 0
MAPK3 0.049 0.092 0.27 20 -0.34 4 24
MAPK1 0.038 0.083 0.29 6 -0.34 4 10
CD72/SHP1 0.093 0.12 0.34 28 -0.52 6 34
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAPK8 0.063 0.13 0.38 9 -0.42 12 21
actin cytoskeleton organization 0.07 0.11 0.32 18 -0.49 6 24
NF-kappa-B/RelA 0.088 0.095 0.36 8 -0.23 1 9
Calcineurin 0.042 0.091 0.28 1 -0.34 8 9
PI3K -0.003 0.074 -10000 0 -0.4 7 7
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 0.033 0.094 0.31 7 -0.44 8 15
SOS1 0.034 0.004 -10000 0 -10000 0 0
Bam32/HPK1 0.062 0.16 -10000 0 -0.63 18 18
DAPP1 0.027 0.17 -10000 0 -0.7 19 19
cytokine secretion 0.062 0.11 0.28 25 -0.36 10 35
mol:DAG 0.031 0.09 0.29 7 -0.38 8 15
PLCG2 0.021 0.073 -10000 0 -0.54 8 8
MAP2K1 0.04 0.087 0.27 8 -0.37 4 12
B-cell antigen/BCR complex/FcgammaRIIB 0.047 0.074 0.29 3 -0.42 7 10
mol:PI-3-4-5-P3 0.027 0.091 0.26 18 -0.3 5 23
ETS1 0.027 0.08 0.29 4 -0.34 7 11
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.077 0.078 0.44 1 -0.3 8 9
B-cell antigen/BCR complex/LYN 0.016 0.084 -10000 0 -0.47 11 11
MALT1 0.034 0.01 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
RAC1 0.062 0.11 0.32 16 -0.52 6 22
B-cell antigen/BCR complex/LYN/SYK 0.044 0.1 0.34 5 -0.53 6 11
CARD11 0.034 0.093 0.29 12 -0.38 7 19
FCGR2B 0.026 0.039 -10000 0 -0.54 2 2
PPP3CA 0.03 0.051 -10000 0 -0.54 4 4
BCL10 0.033 0.007 -10000 0 -10000 0 0
IKK complex 0.044 0.057 0.18 30 -0.14 1 31
PTPRC 0.035 0.035 -10000 0 -10000 0 0
PDPK1 0.035 0.085 0.25 30 -0.22 4 34
PPP3CB 0.034 0.004 -10000 0 -10000 0 0
PPP3CC 0.024 0.046 -10000 0 -0.54 3 3
POU2F2 0.035 0.04 0.24 5 -10000 0 5
VEGFR1 specific signals

Figure S90.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S90.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.037 0.039 -10000 0 -0.33 4 4
VEGFR1 homodimer/NRP1 0.016 0.034 -10000 0 -0.33 4 4
mol:DAG 0.02 0.042 -10000 0 -0.3 4 4
VEGFR1 homodimer/NRP1/VEGFR 121 0.043 0.045 -10000 0 -0.3 3 3
CaM/Ca2+ 0.038 0.042 -10000 0 -0.29 4 4
HIF1A 0.039 0.055 -10000 0 -0.53 4 4
GAB1 0.033 0.027 -10000 0 -0.54 1 1
AKT1 -0.007 0.1 -10000 0 -0.36 4 4
PLCG1 0.02 0.042 -10000 0 -0.3 4 4
NOS3 0.02 0.087 -10000 0 -0.49 6 6
CBL 0.031 0.011 -10000 0 -10000 0 0
mol:NO 0.02 0.093 -10000 0 -0.48 7 7
FLT1 0.022 0.043 -10000 0 -0.39 4 4
PGF 0.034 0.012 -10000 0 -10000 0 0
VEGFR1 homodimer/NRP2/VEGFR121 0.062 0.051 -10000 0 -0.31 3 3
CALM1 0.034 0.006 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
eNOS/Hsp90 0.036 0.094 -10000 0 -0.46 7 7
endothelial cell proliferation 0.027 0.07 0.36 3 -10000 0 3
mol:Ca2+ 0.02 0.042 -10000 0 -0.3 4 4
MAPK3 -0.005 0.035 0.25 1 -10000 0 1
MAPK1 -0.006 0.037 0.25 1 -10000 0 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
PLGF homodimer 0.034 0.012 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 -0.38 0.26 -10000 0 -0.54 364 364
VEGFA homodimer 0.051 0.048 0.18 59 -10000 0 59
VEGFR1 homodimer/VEGFA homodimer 0.047 0.05 -10000 0 -0.33 3 3
platelet activating factor biosynthetic process 0.021 0.074 0.34 2 -10000 0 2
PI3K 0.038 0.11 -10000 0 -0.3 42 42
PRKCA -0.004 0.041 0.26 1 -10000 0 1
PRKCB -0.002 0.04 -10000 0 -0.28 4 4
VEGFR1 homodimer/PLGF homodimer 0.038 0.039 -10000 0 -0.33 4 4
VEGFA 0.051 0.048 0.18 59 -10000 0 59
VEGFB 0.034 0.007 -10000 0 -10000 0 0
mol:IP3 0.02 0.042 -10000 0 -0.3 4 4
RASA1 0.02 0.043 -10000 0 -0.3 4 4
NRP2 0.035 0.016 -10000 0 -10000 0 0
VEGFR1 homodimer 0.021 0.043 -10000 0 -0.39 4 4
VEGFB homodimer 0.033 0.007 -10000 0 -10000 0 0
NCK1 0.034 0.005 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.16 0.16 -10000 0 -0.47 27 27
PTPN11 0.034 0.004 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.036 0.11 -10000 0 -0.3 44 44
mol:L-citrulline 0.02 0.093 -10000 0 -0.48 7 7
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.076 0.06 -10000 0 -0.29 3 3
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.062 0.05 -10000 0 -0.31 3 3
CD2AP 0.034 0.01 -10000 0 -10000 0 0
PI3K/GAB1 0.048 0.12 -10000 0 -0.54 1 1
PDPK1 -0.001 0.095 -10000 0 -0.36 1 1
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.062 0.05 -10000 0 -0.31 3 3
mol:NADP 0.02 0.093 -10000 0 -0.48 7 7
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.073 0.058 -10000 0 -0.29 3 3
VEGFR1 homodimer/NRP2 0.039 0.04 -10000 0 -0.33 4 4
IFN-gamma pathway

Figure S91.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S91.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.087 0.075 0.32 1 -0.28 5 6
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.032 0.009 -10000 0 -10000 0 0
STAT1 (dimer)/Cbp/p300 0.1 0.11 0.41 35 -10000 0 35
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.063 0.055 -10000 0 -0.34 5 5
antigen processing and presentation of peptide antigen via MHC class I -0.003 0.096 0.17 4 -0.28 35 39
CaM/Ca2+ 0.085 0.072 -10000 0 -0.27 5 5
RAP1A 0.034 0.005 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 0.078 0.09 0.32 26 -0.27 4 30
AKT1 0.02 0.11 0.32 9 -0.4 6 15
MAP2K1 0.027 0.075 0.31 5 -0.27 1 6
MAP3K11 0.044 0.071 0.32 5 -0.27 5 10
IFNGR1 0.031 0.058 -10000 0 -0.54 5 5
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII 0.047 0.088 -10000 0 -0.44 6 6
Rap1/GTP 0.018 0.035 -10000 0 -10000 0 0
CRKL/C3G 0.047 0.015 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.094 0.076 -10000 0 -0.3 5 5
CEBPB 0.057 0.14 0.41 7 -0.59 5 12
STAT3 0.033 0.007 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.092 0.11 -10000 0 -0.76 4 4
STAT1 0.061 0.093 0.3 28 -0.27 4 32
CALM1 0.034 0.006 -10000 0 -10000 0 0
IFN-gamma (dimer) 0.062 0.065 -10000 0 -0.54 1 1
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
STAT1 (dimer)/PIAS1 0.076 0.09 0.31 28 -0.26 4 32
CEBPB/PTGES2/Cbp/p300 0.04 0.086 0.29 3 -0.37 5 8
mol:Ca2+ 0.082 0.072 0.3 1 -0.28 5 6
MAPK3 0.044 0.12 -10000 0 -0.65 8 8
STAT1 (dimer) 0.021 0.15 0.32 3 -0.43 25 28
MAPK1 0.012 0.2 -10000 0 -0.7 33 33
JAK2 0.036 0.017 0.18 1 -10000 0 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
JAK1 0.036 0.014 -10000 0 -10000 0 0
CAMK2D 0.03 0.052 -10000 0 -0.54 4 4
DAPK1 0.058 0.11 0.41 12 -0.37 2 14
SMAD7 0.023 0.071 0.23 8 -0.19 5 13
CBL/CRKL/C3G 0.068 0.07 0.33 4 -10000 0 4
PI3K 0.049 0.12 -10000 0 -0.3 33 33
IFNG 0.062 0.065 -10000 0 -0.55 1 1
apoptosis 0.049 0.12 0.38 11 -0.48 7 18
CAMK2G 0.034 0.004 -10000 0 -10000 0 0
STAT3 (dimer) 0.033 0.007 -10000 0 -10000 0 0
CAMK2A 0.034 0.006 -10000 0 -10000 0 0
CAMK2B 0.039 0.069 -10000 0 -0.54 5 5
FRAP1 0.003 0.1 0.3 11 -0.37 6 17
PRKCD 0.02 0.11 0.33 10 -0.35 8 18
RAP1B 0.033 0.007 -10000 0 -10000 0 0
negative regulation of cell growth -0.003 0.096 0.17 4 -0.28 35 39
PTPN2 0.033 0.007 -10000 0 -10000 0 0
EP300 0.034 0.009 -10000 0 -10000 0 0
IRF1 0.067 0.11 0.4 35 -10000 0 35
STAT1 (dimer)/PIASy 0.075 0.091 0.31 27 -0.27 3 30
SOCS1 0.019 0.1 -10000 0 -1 5 5
mol:GDP 0.063 0.066 0.32 3 -10000 0 3
CASP1 0.006 0.11 0.24 11 -0.27 57 68
PTGES2 0.034 0.005 -10000 0 -10000 0 0
IRF9 0.052 0.068 0.27 17 -10000 0 17
mol:PI-3-4-5-P3 0.031 0.1 -10000 0 -0.3 33 33
RAP1/GDP 0.051 0.052 -10000 0 -10000 0 0
CBL 0.042 0.07 0.31 5 -0.27 5 10
MAP3K1 0.047 0.073 0.32 4 -0.27 5 9
PIAS1 0.034 0.007 -10000 0 -10000 0 0
PIAS4 0.035 0.016 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II -0.003 0.096 0.17 4 -0.28 35 39
PTPN11 0.045 0.072 0.3 6 -0.28 5 11
CREBBP 0.033 0.011 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
FoxO family signaling

Figure S92.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S92.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.003 0.096 -10000 0 -10000 0 0
PLK1 0.13 0.22 0.62 18 -0.86 4 22
CDKN1B 0.1 0.18 0.49 6 -0.45 14 20
FOXO3 0.11 0.23 0.54 24 -0.63 16 40
KAT2B 0.02 0.031 0.085 38 -0.058 10 48
FOXO1/SIRT1 0.006 0.1 -10000 0 -0.32 8 8
CAT 0.055 0.36 0.67 7 -1 41 48
CTNNB1 0.029 0.051 -10000 0 -0.54 4 4
AKT1 0.053 0.046 -10000 0 -10000 0 0
FOXO1 0.002 0.11 -10000 0 -0.33 10 10
MAPK10 0.024 0.058 0.24 2 -0.28 10 12
mol:GTP 0 0.004 -10000 0 -10000 0 0
FOXO4 0.043 0.12 0.4 3 -0.42 5 8
response to oxidative stress 0.023 0.033 0.091 38 -0.063 8 46
FOXO3A/SIRT1 0.086 0.2 0.47 15 -0.59 16 31
XPO1 0.034 0.005 -10000 0 -10000 0 0
EP300 0.035 0.01 -10000 0 -10000 0 0
BCL2L11 0.058 0.082 -10000 0 -0.82 3 3
FOXO1/SKP2 0.017 0.1 -10000 0 -0.31 9 9
mol:GDP 0.023 0.033 0.091 38 -0.063 8 46
RAN 0.035 0.005 -10000 0 -10000 0 0
GADD45A 0.082 0.21 -10000 0 -0.76 17 17
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
FOXO1/14-3-3 family 0.036 0.15 -10000 0 -0.53 21 21
MST1 0.048 0.042 -10000 0 -10000 0 0
CSNK1D 0.033 0.008 -10000 0 -10000 0 0
CSNK1E 0.033 0.009 -10000 0 -10000 0 0
FOXO4/14-3-3 family 0.024 0.14 -10000 0 -0.46 28 28
YWHAB 0.033 0.008 -10000 0 -10000 0 0
MAPK8 0.029 0.04 0.24 2 -0.27 1 3
MAPK9 0.029 0.039 0.24 2 -10000 0 2
YWHAG 0.035 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
SIRT1 0.022 0.023 -10000 0 -10000 0 0
SOD2 0.096 0.2 0.57 9 -0.56 11 20
RBL2 0.035 0.32 0.55 2 -0.79 47 49
RAL/GDP 0.058 0.036 -10000 0 -10000 0 0
CHUK 0.048 0.043 -10000 0 -10000 0 0
Ran/GTP 0.024 0.014 -10000 0 -10000 0 0
CSNK1G2 0.034 0.007 -10000 0 -10000 0 0
RAL/GTP 0.058 0.042 -10000 0 -10000 0 0
CSNK1G1 0.033 0.007 -10000 0 -10000 0 0
FASLG 0.075 0.12 -10000 0 -1.4 1 1
SKP2 0.036 0.019 -10000 0 -10000 0 0
USP7 0.032 0.01 -10000 0 -10000 0 0
IKBKB 0.041 0.041 -10000 0 -10000 0 0
CCNB1 0.15 0.24 0.66 7 -0.93 3 10
FOXO1-3a-4/beta catenin 0.096 0.22 0.52 11 -0.4 45 56
proteasomal ubiquitin-dependent protein catabolic process 0.017 0.1 -10000 0 -0.3 9 9
CSNK1A1 0.034 0.006 -10000 0 -10000 0 0
SGK1 0.02 0.031 0.085 38 -0.058 10 48
CSNK1G3 0.034 0.007 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.045 0.02 -10000 0 -10000 0 0
ZFAND5 0.043 0.11 0.44 2 -10000 0 2
SFN 0.033 0.04 -10000 0 -0.54 2 2
CDK2 0.04 0.022 -10000 0 -10000 0 0
FOXO3A/14-3-3 0.053 0.13 -10000 0 -0.48 15 15
CREBBP 0.034 0.011 -10000 0 -10000 0 0
FBXO32 0.12 0.35 0.65 27 -1.1 26 53
BCL6 0.017 0.4 0.55 1 -1.1 55 56
RALB 0.035 0.005 -10000 0 -10000 0 0
RALA 0.034 0.006 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
Sphingosine 1-phosphate (S1P) pathway

Figure S93.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S93.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.034 0.005 -10000 0 -10000 0 0
SPHK1 0.034 0.06 -10000 0 -0.54 4 4
GNAI2 0.034 0.01 -10000 0 -10000 0 0
mol:S1P 0.02 0.034 0.2 2 -0.26 4 6
GNAO1 0.03 0.012 -10000 0 -10000 0 0
mol:Sphinganine-1-P 0.018 0.045 -10000 0 -0.4 4 4
growth factor activity 0 0 -10000 0 -10000 0 0
S1P/S1P2/G12/G13 0.054 0.041 -10000 0 -0.21 2 2
GNAI3 0.034 0.006 -10000 0 -10000 0 0
G12/G13 0.046 0.017 -10000 0 -10000 0 0
S1PR3 0 0 -10000 0 -10000 0 0
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
S1P1/S1P 0.011 0.031 -10000 0 -0.24 4 4
S1PR5 0 0 -10000 0 -10000 0 0
S1PR4 0 0 -10000 0 -10000 0 0
GNAI1 -0.17 0.28 -10000 0 -0.54 183 183
S1P/S1P5/G12 0.042 0.04 -10000 0 -0.22 4 4
S1P/S1P3/Gq 0.037 0.054 -10000 0 -0.29 6 6
S1P/S1P4/Gi -0.066 0.15 0.27 1 -0.34 57 58
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.026 0.062 -10000 0 -0.54 6 6
GNA14 0.044 0.068 -10000 0 -0.54 4 4
GNA15 0.036 0.019 -10000 0 -10000 0 0
GNA12 0.034 0.005 -10000 0 -10000 0 0
GNA13 0.031 0.01 -10000 0 -10000 0 0
GNA11 0.034 0.006 -10000 0 -10000 0 0
ABCC1 0.035 0.024 -10000 0 -10000 0 0
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S94.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S94.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.034 0.006 -10000 0 -10000 0 0
VLDLR -0.04 0.19 -10000 0 -0.54 65 65
LRPAP1 0.033 0.008 -10000 0 -10000 0 0
NUDC 0.033 0.008 -10000 0 -10000 0 0
RELN/LRP8 0.07 0.091 0.26 1 -0.32 20 21
CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
KATNA1 0.033 0.009 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 0.029 0.079 0.28 3 -0.29 20 23
IQGAP1/CaM 0.048 0.014 -10000 0 -10000 0 0
DAB1 0.034 0.007 -10000 0 -10000 0 0
IQGAP1 0.033 0.008 -10000 0 -10000 0 0
PLA2G7 0.044 0.098 -10000 0 -0.54 10 10
CALM1 0.034 0.006 -10000 0 -10000 0 0
DYNLT1 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.074 0.048 -10000 0 -10000 0 0
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.035 0.007 -10000 0 -10000 0 0
CDK5R1 0.033 0.014 -10000 0 -10000 0 0
LIS1/Poliovirus Protein 3A 0.011 0.004 -10000 0 -10000 0 0
CDK5R2 0.034 0.005 -10000 0 -10000 0 0
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.008 0.16 -10000 0 -0.36 80 80
YWHAE 0.031 0.011 -10000 0 -10000 0 0
NDEL1/14-3-3 E 0.042 0.079 0.36 3 -0.32 2 5
MAP1B -0.021 0.089 -10000 0 -0.29 49 49
RAC1 0.016 0.007 -10000 0 -10000 0 0
p35/CDK5 0.035 0.073 0.27 3 -0.28 13 16
RELN 0.012 0.11 -10000 0 -0.54 20 20
PAFAH/LIS1 0.04 0.068 -10000 0 -0.34 10 10
LIS1/CLIP170 0.034 0.014 -10000 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain 0.033 0.069 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.008 0.13 -10000 0 -0.3 54 54
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 0.025 0.073 0.31 5 -0.33 2 7
LIS1/IQGAP1 0.033 0.014 -10000 0 -10000 0 0
RHOA 0.016 0.007 -10000 0 -10000 0 0
PAFAH1B1 0.015 0.006 -10000 0 -10000 0 0
PAFAH1B3 0.084 0.07 -10000 0 -10000 0 0
PAFAH1B2 0.03 0.012 -10000 0 -10000 0 0
MAP1B/LIS1/Dynein heavy chain 0.006 0.075 -10000 0 -0.36 2 2
NDEL1/Katanin 60/Dynein heavy chain 0.048 0.087 0.36 3 -0.31 2 5
LRP8 0.073 0.066 -10000 0 -10000 0 0
NDEL1/Katanin 60 0.035 0.083 0.36 3 -0.32 2 5
P39/CDK5 0.036 0.072 0.27 2 -0.28 13 15
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.033 0.014 -10000 0 -10000 0 0
CDK5 0.006 0.076 0.28 2 -0.3 13 15
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.029 0.012 -10000 0 -10000 0 0
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 0.002 0.14 -10000 0 -0.32 80 80
RELN/VLDLR 0.03 0.16 -10000 0 -0.31 80 80
CDC42 0.016 0.007 -10000 0 -10000 0 0
EPO signaling pathway

Figure S95.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S95.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.024 0.14 -10000 0 -10000 0 0
CRKL 0.016 0.068 0.32 4 -10000 0 4
mol:DAG 0.035 0.08 -10000 0 -10000 0 0
HRAS 0.049 0.088 0.33 12 -10000 0 12
MAPK8 0.048 0.075 0.27 13 -0.32 1 14
RAP1A 0.016 0.069 0.32 4 -10000 0 4
GAB1 0.018 0.067 0.32 3 -10000 0 3
MAPK14 0.048 0.074 0.27 13 -10000 0 13
EPO 0.047 0.053 0.19 1 -10000 0 1
PLCG1 0.026 0.076 -10000 0 -10000 0 0
EPOR/TRPC2/IP3 Receptors 0.029 0.024 -10000 0 -10000 0 0
RAPGEF1 0.034 0.006 -10000 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.055 0.079 -10000 0 -0.35 11 11
GAB1/SHC/GRB2/SOS1 0.045 0.066 0.33 1 -10000 0 1
EPO/EPOR (dimer) 0.054 0.048 -10000 0 -10000 0 0
IRS2 -0.051 0.14 0.3 2 -0.32 90 92
STAT1 0.044 0.12 -10000 0 -0.36 1 1
STAT5B 0.03 0.1 -10000 0 -10000 0 0
cell proliferation 0.026 0.081 0.26 16 -0.3 1 17
GAB1/SHIP/PIK3R1/SHP2/SHC 0.003 0.088 -10000 0 -0.26 24 24
TEC 0.016 0.066 0.3 2 -10000 0 2
SOCS3 0.019 0.087 -10000 0 -0.54 12 12
STAT1 (dimer) 0.043 0.12 -10000 0 -0.35 1 1
JAK2 0.032 0.018 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
EPO/EPOR (dimer)/JAK2 0.069 0.092 0.32 1 -0.22 1 2
EPO/EPOR 0.054 0.048 -10000 0 -10000 0 0
LYN 0.022 0.026 -10000 0 -10000 0 0
TEC/VAV2 0.033 0.072 0.29 3 -10000 0 3
elevation of cytosolic calcium ion concentration 0.029 0.024 -10000 0 -10000 0 0
SHC1 0.028 0.014 -10000 0 -10000 0 0
EPO/EPOR (dimer)/LYN 0.055 0.059 -10000 0 -10000 0 0
mol:IP3 0.035 0.08 -10000 0 -10000 0 0
PI3K regualtory subunit polypeptide 1/IRS2/SHIP -0.068 0.15 -10000 0 -0.31 123 123
SH2B3 0.034 0.016 -10000 0 -10000 0 0
NFKB1 0.048 0.073 0.27 13 -10000 0 13
EPO/EPOR (dimer)/JAK2/SOCS3 0.024 0.055 -10000 0 -0.27 10 10
PTPN6 0.01 0.061 -10000 0 -0.22 1 1
TEC/VAV2/GRB2 0.046 0.076 -10000 0 -10000 0 0
EPOR 0.029 0.024 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.042 0.067 0.33 1 -10000 0 1
SOS1 0.034 0.004 -10000 0 -10000 0 0
PLCG2 0.022 0.073 -10000 0 -0.54 8 8
CRKL/CBL/C3G 0.038 0.077 0.3 3 -10000 0 3
VAV2 0.019 0.07 0.3 6 -10000 0 6
CBL 0.015 0.068 0.3 5 -10000 0 5
SHC/Grb2/SOS1 0.031 0.059 -10000 0 -10000 0 0
STAT5A 0.029 0.1 -10000 0 -0.32 1 1
GRB2 0.034 0.019 -10000 0 -10000 0 0
STAT5 (dimer) 0.026 0.15 -10000 0 -0.37 15 15
LYN/PLCgamma2 0.029 0.061 0.25 1 -0.35 10 11
PTPN11 0.034 0.004 -10000 0 -10000 0 0
BTK 0.021 0.072 0.3 5 -10000 0 5
BCL2 -0.089 0.36 -10000 0 -0.82 98 98
JNK signaling in the CD4+ TCR pathway

Figure S96.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S96.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.081 0.056 0.4 6 -10000 0 6
MAP4K1 0.037 0.021 -10000 0 -10000 0 0
MAP3K8 -0.039 0.19 -10000 0 -0.54 65 65
PRKCB 0 0 -10000 0 -10000 0 0
DBNL 0.035 0.012 -10000 0 -10000 0 0
CRKL 0.032 0.009 -10000 0 -10000 0 0
MAP3K1 0.031 0.058 0.3 3 -0.33 2 5
JUN -0.04 0.13 -10000 0 -0.37 33 33
MAP3K7 0.029 0.051 0.27 3 -10000 0 3
GRAP2 0.035 0.019 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
MAP2K4 0 0.1 0.28 3 -0.36 18 21
LAT 0.036 0.025 -10000 0 -10000 0 0
LCP2 0.037 0.024 -10000 0 -10000 0 0
MAPK8 0.011 0.081 -10000 0 -0.58 8 8
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0.037 0.06 0.3 3 -0.29 4 7
LAT/GRAP2/SLP76/HPK1/HIP-55 0.091 0.06 0.4 6 -10000 0 6
Arf6 downstream pathway

Figure S97.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S97.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR 0.1 0.13 0.38 22 -10000 0 22
regulation of axonogenesis -0.022 0.05 0.24 1 -10000 0 1
myoblast fusion -0.066 0.074 -10000 0 -0.24 11 11
mol:GTP 0.048 0.045 -10000 0 -0.16 1 1
regulation of calcium-dependent cell-cell adhesion -0.092 0.067 -10000 0 -10000 0 0
ARF1/GTP 0.053 0.044 -10000 0 -10000 0 0
mol:GM1 0.033 0.04 -10000 0 -10000 0 0
mol:Choline 0.017 0.076 -10000 0 -0.31 20 20
lamellipodium assembly 0.057 0.079 0.25 7 -0.33 1 8
MAPK3 0.072 0.078 0.22 113 -10000 0 113
ARF6/GTP/NME1/Tiam1 0.093 0.068 -10000 0 -10000 0 0
ARF1 0.028 0.014 -10000 0 -10000 0 0
ARF6/GDP 0.066 0.074 0.24 11 -10000 0 11
ARF1/GDP 0.058 0.07 0.23 8 -10000 0 8
ARF6 0.055 0.026 -10000 0 -10000 0 0
RAB11A 0.034 0.007 -10000 0 -10000 0 0
TIAM1 0.04 0.015 0.19 1 -10000 0 1
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.073 0.08 0.22 22 -10000 0 22
actin filament bundle formation -0.076 0.064 -10000 0 -10000 0 0
KALRN 0.043 0.056 -10000 0 -10000 0 0
RAB11FIP3/RAB11A 0.045 0.017 -10000 0 -10000 0 0
RhoA/GDP 0.077 0.064 -10000 0 -10000 0 0
NME1 0.036 0.015 -10000 0 -10000 0 0
Rac1/GDP 0.079 0.063 0.24 7 -10000 0 7
substrate adhesion-dependent cell spreading 0.048 0.045 -10000 0 -0.16 1 1
cortical actin cytoskeleton organization 0.057 0.079 0.25 7 -0.33 1 8
RAC1 0.034 0.005 -10000 0 -10000 0 0
liver development 0.048 0.045 -10000 0 -0.16 1 1
ARF6/GTP 0.048 0.045 -10000 0 -0.16 1 1
RhoA/GTP 0.063 0.041 -10000 0 -10000 0 0
mol:GDP 0.052 0.077 0.21 100 -0.2 1 101
ARF6/GTP/RAB11FIP3/RAB11A 0.076 0.044 -10000 0 -10000 0 0
RHOA 0.033 0.008 -10000 0 -10000 0 0
PLD1 0.029 0.087 -10000 0 -0.35 20 20
RAB11FIP3 0.032 0.01 -10000 0 -10000 0 0
tube morphogenesis 0.057 0.079 0.25 7 -0.33 1 8
ruffle organization 0.022 0.05 -10000 0 -0.24 1 1
regulation of epithelial cell migration 0.048 0.045 -10000 0 -0.16 1 1
PLD2 0.043 0.046 -10000 0 -0.36 1 1
PIP5K1A 0.022 0.051 -10000 0 -0.24 1 1
mol:Phosphatidic acid 0.017 0.076 -10000 0 -0.31 20 20
Rac1/GTP 0.057 0.079 0.25 7 -0.33 1 8
Class I PI3K signaling events mediated by Akt

Figure S98.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S98.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.016 0.004 -10000 0 -10000 0 0
BAD/BCL-XL/YWHAZ 0.042 0.028 -10000 0 -10000 0 0
CDKN1B 0.018 0.071 0.3 4 -0.63 1 5
CDKN1A 0.02 0.067 -10000 0 -0.63 1 1
FRAP1 0 0 -10000 0 -10000 0 0
PRKDC 0.031 0.019 -10000 0 -10000 0 0
FOXO3 0.023 0.061 -10000 0 -0.63 1 1
AKT1 0.022 0.064 -10000 0 -0.41 4 4
BAD 0.033 0.007 -10000 0 -10000 0 0
AKT3 0.015 0.012 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
FOXO4 0.019 0.062 -10000 0 -0.63 1 1
AKT1/ASK1 0.033 0.095 -10000 0 -0.39 6 6
BAD/YWHAZ 0.051 0.033 -10000 0 -10000 0 0
RICTOR 0.034 0.006 -10000 0 -10000 0 0
RAF1 0.034 0.006 -10000 0 -10000 0 0
JNK cascade -0.032 0.092 0.37 6 -10000 0 6
TSC1 0.021 0.056 -10000 0 -0.63 1 1
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
AKT1/RAF1 0.055 0.077 0.32 1 -0.63 1 2
EP300 0.033 0.009 -10000 0 -10000 0 0
mol:GDP 0.022 0.063 -10000 0 -0.41 4 4
mol:PI-3-4-5-P3 0 0 -10000 0 -10000 0 0
TSC2 0.026 0.079 0.28 20 -0.63 1 21
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
TBC1D4 0.003 0.048 0.25 2 -0.32 10 12
MAP3K5 0.004 0.13 -10000 0 -0.54 26 26
MAPKAP1 0.034 0.006 -10000 0 -10000 0 0
negative regulation of cell cycle -0.041 0.079 0.28 9 -0.28 2 11
YWHAH 0.033 0.014 -10000 0 -10000 0 0
AKT1S1 0.023 0.068 -10000 0 -0.63 1 1
CASP9 0.022 0.046 -10000 0 -10000 0 0
YWHAB 0.033 0.008 -10000 0 -10000 0 0
p27Kip1/KPNA1 0.049 0.084 0.35 2 -0.6 1 3
GBL 0 0 -10000 0 -10000 0 0
PDK1/Src/Hsp90 0.059 0.026 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
SRC 0.033 0.008 -10000 0 -10000 0 0
AKT2/p21CIP1 0.023 0.062 -10000 0 -0.42 3 3
KIAA1303 0 0 -10000 0 -10000 0 0
mTOR/RHEB/GTP/Raptor/GBL 0.017 0.054 -10000 0 -0.33 9 9
CHUK 0.02 0.061 -10000 0 -0.63 1 1
BAD/BCL-XL 0.057 0.073 -10000 0 -0.6 1 1
mTORC2 0.042 0.01 -10000 0 -10000 0 0
AKT2 0.017 0.006 -10000 0 -10000 0 0
FOXO1-3a-4/14-3-3 family 0.043 0.11 0.37 4 -0.42 10 14
PDPK1 0.032 0.01 -10000 0 -10000 0 0
MDM2 0.024 0.071 0.28 3 -0.63 1 4
MAPKKK cascade -0.055 0.076 0.62 1 -0.31 1 2
MDM2/Cbp/p300 0.062 0.081 0.4 1 -0.58 1 2
TSC1/TSC2 0.025 0.079 0.35 3 -0.62 1 4
proteasomal ubiquitin-dependent protein catabolic process 0.059 0.078 0.39 1 -0.55 1 2
glucose import -0.15 0.15 0.21 1 -0.31 238 239
mTOR/RHEB/GDP/Raptor/GBL/PRAS40 0.022 0.055 -10000 0 -0.64 1 1
response to stress 0 0 -10000 0 -10000 0 0
SLC2A4 -0.15 0.16 0.21 1 -0.31 238 239
GSK3A 0.021 0.065 -10000 0 -0.63 1 1
FOXO1 -0.004 0.095 -10000 0 -0.47 7 7
GSK3B 0.021 0.063 -10000 0 -0.63 1 1
SFN 0.033 0.04 -10000 0 -0.54 2 2
G1/S transition of mitotic cell cycle 0.032 0.076 0.4 1 -0.62 1 2
p27Kip1/14-3-3 family 0.031 0.044 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
KPNA1 0.034 0.005 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
RHEB 0.034 0.009 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
Signaling events mediated by HDAC Class III

Figure S99.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S99.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.033 0.009 -10000 0 -10000 0 0
HDAC4 0.034 0.007 -10000 0 -10000 0 0
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle 0.005 0.008 -10000 0 -10000 0 0
CDKN1A -0.01 0.043 -10000 0 -0.66 2 2
KAT2B 0 0 -10000 0 -10000 0 0
BAX 0.035 0.012 -10000 0 -10000 0 0
FOXO3 -0.006 0.004 -10000 0 -10000 0 0
FOXO1 -0.023 0.17 -10000 0 -0.54 48 48
FOXO4 0.018 0.007 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0.033 0.009 -10000 0 -10000 0 0
TAT 0.029 0.05 0.18 10 -0.54 3 13
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 0.009 0.03 -10000 0 -0.4 2 2
PPARGC1A -0.022 0.17 -10000 0 -0.54 51 51
FHL2 -0.026 0.18 -10000 0 -0.54 55 55
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0.045 0.016 -10000 0 -10000 0 0
HIST2H4A -0.005 0.008 -10000 0 -10000 0 0
SIRT1/FOXO3a 0.022 0.031 -10000 0 -0.2 1 1
SIRT1 0.031 0.012 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0.054 0.029 -10000 0 -10000 0 0
SIRT1/Histone H1b 0.052 0.052 -10000 0 -0.23 2 2
apoptosis -0.062 0.022 -10000 0 -10000 0 0
SIRT1/PGC1A 0.004 0.12 -10000 0 -0.34 50 50
p53/SIRT1 0.037 0.025 0.42 1 -10000 0 1
SIRT1/FOXO4 0.033 0.044 -10000 0 -0.23 2 2
FOXO1/FHL2/SIRT1 -0.019 0.16 -10000 0 -0.34 91 91
HIST1H1E 0.04 0.041 -10000 0 -10000 0 0
SIRT1/p300 0.045 0.016 -10000 0 -10000 0 0
muscle cell differentiation -0.019 0.026 0.34 2 -10000 0 2
TP53 0.028 0.017 0.22 1 -10000 0 1
KU70/SIRT1/BAX 0.063 0.023 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
MEF2D 0.029 0.013 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 0.04 0.042 -10000 0 -0.4 3 3
ACSS2 0.014 0.007 -10000 0 -10000 0 0
SIRT1/PCAF/MYOD 0.019 0.026 -10000 0 -0.34 2 2
TRAIL signaling pathway

Figure S100.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S100.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 0.012 0.11 -10000 0 -0.54 19 19
positive regulation of NF-kappaB transcription factor activity 0.023 0.085 -10000 0 -0.39 19 19
MAP2K4 0.015 0.085 -10000 0 -0.4 12 12
IKBKB 0.029 0.013 -10000 0 -10000 0 0
TNFRSF10B 0.028 0.016 -10000 0 -10000 0 0
TNFRSF10A 0.028 0.019 -10000 0 -10000 0 0
SMPD1 0.004 0.057 -10000 0 -0.27 18 18
IKBKG 0.034 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
TNFRSF10D 0.027 0.014 -10000 0 -10000 0 0
TRAIL/TRAILR2 0.023 0.086 -10000 0 -0.4 19 19
TRAIL/TRAILR3 0.024 0.086 -10000 0 -0.38 20 20
TRAIL/TRAILR1 0.023 0.085 -10000 0 -0.37 21 21
TRAIL/TRAILR4 0.023 0.085 -10000 0 -0.4 19 19
TRAIL/TRAILR1/DAP3/GTP 0.031 0.067 -10000 0 -0.3 14 14
IKK complex 0.024 0.074 -10000 0 -0.4 6 6
RIPK1 0.034 0.006 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
DAP3/GTP 0.021 0.01 -10000 0 -10000 0 0
MAPK3 0.001 0.076 -10000 0 -0.4 18 18
MAP3K1 0.016 0.1 -10000 0 -0.46 14 14
TRAILR4 (trimer) 0.027 0.014 -10000 0 -10000 0 0
TRADD 0.03 0.012 -10000 0 -10000 0 0
TRAILR1 (trimer) 0.028 0.019 -10000 0 -10000 0 0
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 -0.001 0.081 -10000 0 -0.37 15 15
CFLAR 0.033 0.026 -10000 0 -0.54 1 1
MAPK1 0.001 0.076 -10000 0 -0.4 18 18
TRAIL/TRAILR1/FADD/TRADD/RIP 0.047 0.079 -10000 0 -0.29 14 14
mol:ceramide 0.004 0.057 -10000 0 -0.26 18 18
FADD 0.029 0.015 -10000 0 -10000 0 0
MAPK8 0 0.1 -10000 0 -0.4 17 17
TRAF2 0.035 0.013 -10000 0 -10000 0 0
TRAILR3 (trimer) 0.028 0.017 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
TRAIL/TRAILR1/FADD 0.034 0.073 -10000 0 -0.33 14 14
DAP3 0.029 0.013 -10000 0 -10000 0 0
CASP10 0.024 0.077 0.34 3 -0.34 5 8
JNK cascade 0.023 0.085 -10000 0 -0.39 19 19
TRAIL (trimer) 0.012 0.11 -10000 0 -0.54 19 19
TNFRSF10C 0.028 0.017 -10000 0 -10000 0 0
TRAIL/TRAILR1/DAP3/GTP/FADD 0.036 0.065 -10000 0 -0.28 10 10
TRAIL/TRAILR2/FADD 0.033 0.074 -10000 0 -0.34 14 14
cell death 0.004 0.056 -10000 0 -0.26 18 18
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 -0.002 0.081 -10000 0 -0.36 16 16
TRAILR2 (trimer) 0.028 0.016 -10000 0 -10000 0 0
CASP8 0.019 0.057 -10000 0 -0.58 3 3
negative regulation of caspase activity 0 0 -10000 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.046 0.08 -10000 0 -0.29 14 14
Signaling events mediated by HDAC Class II

Figure S101.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S101.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G beta1gamma2/HDAC5 0.074 0.039 -10000 0 -0.31 1 1
HDAC3 0.034 0.006 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 -0.01 0.002 -10000 0 -10000 0 0
GATA1/HDAC4 0.049 0.011 -10000 0 -10000 0 0
GATA1/HDAC5 0.049 0.012 -10000 0 -10000 0 0
GATA2/HDAC5 0.054 0.027 -10000 0 -10000 0 0
HDAC5/BCL6/BCoR 0.024 0.12 -10000 0 -0.34 50 50
HDAC9 0.035 0.016 -10000 0 -10000 0 0
Glucocorticoid receptor/Hsp90/HDAC6 0.034 0.11 -10000 0 -0.34 40 40
HDAC4/ANKRA2 0.046 0.032 -10000 0 -0.32 3 3
HDAC5/YWHAB 0.047 0.016 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.018 0.02 -10000 0 -0.17 3 3
GATA2 0.042 0.034 -10000 0 -10000 0 0
HDAC4/RFXANK 0.049 0.012 -10000 0 -10000 0 0
BCOR 0.035 0.003 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
HDAC10 0.031 0.028 0.18 1 -0.54 1 2
HDAC5 0.033 0.007 -10000 0 -10000 0 0
GNB1/GNG2 0.048 0.024 -10000 0 -0.4 1 1
Histones 0.024 0.051 -10000 0 -0.28 4 4
ADRBK1 0.032 0.01 -10000 0 -10000 0 0
HDAC4 0.034 0.007 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
HDAC5/ANKRA2 0.046 0.033 -10000 0 -0.32 3 3
HDAC4/Ubc9 0.045 0.017 -10000 0 -10000 0 0
HDAC7 0 0 -10000 0 -10000 0 0
HDAC5/14-3-3 E 0.046 0.019 -10000 0 -0.17 1 1
TUBA1B 0.035 0.012 -10000 0 -10000 0 0
HDAC6 0.035 0.003 -10000 0 -10000 0 0
HDAC5/RFXANK 0.048 0.013 -10000 0 -10000 0 0
CAMK4 0.035 0.017 -10000 0 -10000 0 0
Tubulin/HDAC6 0.06 0.057 -10000 0 -0.34 9 9
SUMO1 0.034 0.005 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
YWHAB 0.033 0.008 -10000 0 -10000 0 0
GATA1 0.035 0.003 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
NR3C1 -0.011 0.15 -10000 0 -0.54 40 40
SUMO1/HDAC4 0.051 0.051 -10000 0 -0.25 3 3
SRF 0.034 0.006 -10000 0 -10000 0 0
HDAC4/YWHAB 0.047 0.015 -10000 0 -10000 0 0
Tubulin 0.042 0.06 -10000 0 -0.4 9 9
HDAC4/14-3-3 E 0.045 0.019 -10000 0 -0.17 1 1
GNB1 0.034 0.012 -10000 0 -10000 0 0
RANGAP1 0.038 0.03 -10000 0 -10000 0 0
BCL6/BCoR 0.005 0.13 -10000 0 -0.39 51 51
HDAC4/HDAC3/SMRT (N-CoR2) 0.066 0.018 -10000 0 -10000 0 0
HDAC4/SRF 0.066 0.022 -10000 0 -10000 0 0
HDAC4/ER alpha -0.028 0.2 -10000 0 -0.39 110 110
EntrezGene:23225 0 0 -10000 0 -10000 0 0
positive regulation of chromatin silencing 0.024 0.051 -10000 0 -0.28 4 4
cell motility 0.06 0.056 -10000 0 -0.34 9 9
EntrezGene:23636 0 0 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
HDAC7/HDAC3 0.025 0.004 -10000 0 -10000 0 0
BCL6 -0.024 0.17 -10000 0 -0.54 51 51
HDAC4/CaMK II delta B 0.034 0.007 -10000 0 -10000 0 0
Hsp90/HDAC6 0.049 0.011 -10000 0 -10000 0 0
ESR1 -0.058 0.25 -10000 0 -0.54 106 106
HDAC6/HDAC11 0.053 0.02 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.052 0.05 -10000 0 -0.26 3 3
NPC 0.02 0.002 -10000 0 -10000 0 0
MEF2C 0.006 0.12 -10000 0 -0.54 25 25
RAN 0.034 0.005 -10000 0 -10000 0 0
HDAC4/MEF2C 0.067 0.092 -10000 0 -0.3 24 24
GNG2 0.033 0.026 -10000 0 -0.54 1 1
NCOR2 0.034 0.005 -10000 0 -10000 0 0
TUBB2A 0.024 0.076 -10000 0 -0.54 9 9
HDAC11 0.038 0.026 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
RANBP2 0.034 0.004 -10000 0 -10000 0 0
ANKRA2 0.031 0.037 -10000 0 -0.54 2 2
RFXANK 0.034 0.005 -10000 0 -10000 0 0
nuclear import -0.038 0.021 -10000 0 -10000 0 0
Circadian rhythm pathway

Figure S102.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S102.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification 0.1 0.087 -10000 0 -10000 0 0
CLOCK 0.039 0.01 -10000 0 -10000 0 0
TIMELESS/CRY2 0.069 0.07 -10000 0 -10000 0 0
DEC1/BMAL1 0.052 0.025 -10000 0 -0.4 1 1
ATR 0.034 0.006 -10000 0 -10000 0 0
NR1D1 0.04 0.053 -10000 0 -10000 0 0
ARNTL 0.038 0.028 -10000 0 -0.54 1 1
TIMELESS 0.059 0.091 -10000 0 -10000 0 0
NPAS2 0.042 0.02 -10000 0 -10000 0 0
CRY2 0.034 0.005 -10000 0 -10000 0 0
mol:CO -0.021 0.03 -10000 0 -0.11 54 54
CHEK1 0.088 0.076 -10000 0 -10000 0 0
mol:HEME 0.021 0.03 0.11 54 -10000 0 54
PER1 0.024 0.063 -10000 0 -0.54 6 6
BMAL/CLOCK/NPAS2 0.089 0.045 -10000 0 -0.34 1 1
BMAL1/CLOCK 0.057 0.074 -10000 0 -10000 0 0
S phase of mitotic cell cycle 0.1 0.087 -10000 0 -10000 0 0
TIMELESS/CHEK1/ATR 0.11 0.088 -10000 0 -10000 0 0
mol:NADPH 0.021 0.03 0.11 54 -10000 0 54
PER1/TIMELESS 0.059 0.074 -10000 0 -10000 0 0
PER1-2 / CRY1-2 0 0 -10000 0 -10000 0 0
DEC1 0.035 0.01 -10000 0 -10000 0 0
Paxillin-independent events mediated by a4b1 and a4b7

Figure S103.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S103.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.027 0.027 -10000 0 -10000 0 0
CRKL 0.032 0.009 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.004 -10000 0 -10000 0 0
DOCK1 0.03 0.044 -10000 0 -0.54 3 3
ITGA4 0.04 0.03 -10000 0 -10000 0 0
alpha4/beta7 Integrin/MAdCAM1 0.085 0.033 -10000 0 -10000 0 0
EPO 0.054 0.051 0.18 70 -10000 0 70
alpha4/beta7 Integrin 0.054 0.023 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.031 0.011 -10000 0 -10000 0 0
alpha4/beta1 Integrin 0.053 0.023 -10000 0 -10000 0 0
EPO/EPOR (dimer) 0.064 0.038 -10000 0 -10000 0 0
lamellipodium assembly -0.004 0.11 -10000 0 -0.36 21 21
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
PI3K 0.006 0.13 -10000 0 -0.4 44 44
ARF6 0.034 0.005 -10000 0 -10000 0 0
JAK2 0.043 0.035 -10000 0 -10000 0 0
PXN 0.034 0.004 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
MADCAM1 0.034 0.013 -10000 0 -10000 0 0
cell adhesion 0.083 0.032 -10000 0 -10000 0 0
CRKL/CBL 0.044 0.019 -10000 0 -10000 0 0
ITGB1 0.034 0.006 -10000 0 -10000 0 0
SRC 0.021 0.064 0.38 2 -0.31 11 13
ITGB7 0.034 0.004 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 0.062 0.067 0.26 4 -0.34 11 15
p130Cas/Crk/Dock1 0.04 0.071 0.37 1 -0.28 14 15
VCAM1 0.024 0.086 -10000 0 -0.54 11 11
RHOA 0.033 0.008 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.083 0.035 -10000 0 -10000 0 0
BCAR1 -0.007 0.061 0.39 2 -0.29 11 13
EPOR 0.034 0.005 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
CBL 0.031 0.011 -10000 0 -10000 0 0
GIT1 0.033 0.011 -10000 0 -10000 0 0
Rac1/GTP -0.005 0.12 -10000 0 -0.38 21 21
PDGFR-beta signaling pathway

Figure S104.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S104.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.04 0.086 0.34 1 -0.32 9 10
PDGFB-D/PDGFRB/SLAP 0.041 0.028 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/APS/CBL 0.041 0.017 -10000 0 -10000 0 0
AKT1 0.026 0.12 0.39 15 -10000 0 15
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.047 0.095 0.35 3 -0.35 10 13
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
FGR 0.01 0.1 -10000 0 -0.45 17 17
mol:Ca2+ 0.036 0.093 0.34 3 -0.38 11 14
MYC 0.047 0.23 0.42 10 -0.78 29 39
SHC1 0.028 0.014 -10000 0 -10000 0 0
HRAS/GDP 0.049 0.046 0.27 1 -10000 0 1
LRP1/PDGFRB/PDGFB 0.065 0.023 -10000 0 -10000 0 0
GRB10 0.03 0.051 -10000 0 -0.54 4 4
PTPN11 0.034 0.004 -10000 0 -10000 0 0
GO:0007205 0.036 0.094 0.34 3 -0.38 11 14
PTEN 0.029 0.045 -10000 0 -0.54 3 3
GRB2 0.034 0.019 -10000 0 -10000 0 0
GRB7 0.029 0.013 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SHP2 0.05 0.011 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB10 0.047 0.041 -10000 0 -0.4 4 4
cell cycle arrest 0.041 0.028 -10000 0 -10000 0 0
HRAS 0.034 0.013 -10000 0 -10000 0 0
HIF1A 0.021 0.12 0.37 15 -0.33 1 16
GAB1 0.038 0.1 0.33 4 -0.39 9 13
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 0.037 0.096 0.38 4 -0.34 7 11
PDGFB-D/PDGFRB 0.061 0.037 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.049 0.018 -10000 0 -0.17 2 2
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB 0.03 0.079 -10000 0 -0.37 4 4
positive regulation of MAPKKK cascade 0.05 0.011 -10000 0 -10000 0 0
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
mol:IP3 0.036 0.095 0.34 3 -0.39 11 14
E5 0 0.001 -10000 0 -10000 0 0
CSK 0.033 0.012 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7 0.043 0.021 -10000 0 -10000 0 0
SHB 0.036 0.018 -10000 0 -10000 0 0
BLK -0.035 0.17 -10000 0 -0.4 77 77
PTPN2 0.034 0.009 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.049 0.014 -10000 0 -10000 0 0
BCAR1 0.029 0.013 -10000 0 -10000 0 0
VAV2 0.037 0.12 0.37 3 -0.42 11 14
CBL 0.031 0.011 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.05 0.015 -10000 0 -10000 0 0
LCK 0.025 0.097 -10000 0 -0.49 11 11
PDGFRB 0.035 0.009 -10000 0 -10000 0 0
ACP1 0.034 0.006 -10000 0 -10000 0 0
HCK 0.025 0.076 -10000 0 -0.62 4 4
ABL1 0.032 0.098 0.33 4 -0.39 9 13
PDGFB-D/PDGFRB/CBL 0.033 0.11 0.35 1 -0.43 13 14
PTPN1 0.037 0.03 -10000 0 -10000 0 0
SNX15 0.033 0.007 -10000 0 -10000 0 0
STAT3 0.033 0.007 -10000 0 -10000 0 0
STAT1 0.059 0.056 -10000 0 -10000 0 0
cell proliferation 0.051 0.21 0.4 14 -0.68 29 43
SLA 0.029 0.025 -10000 0 -10000 0 0
actin cytoskeleton reorganization 0.051 0.059 0.45 2 -10000 0 2
SRC 0.021 0.06 -10000 0 -0.62 2 2
PI3K -0.011 0.066 -10000 0 -0.27 20 20
PDGFB-D/PDGFRB/GRB7/SHC 0.047 0.034 -10000 0 -10000 0 0
SH2B2 0 0 -10000 0 -10000 0 0
PLCgamma1/SPHK1 0.047 0.097 0.35 3 -0.36 10 13
LYN 0.022 0.056 -10000 0 -0.41 3 3
LRP1 0.034 0.005 -10000 0 -10000 0 0
SOS1 0.034 0.004 -10000 0 -10000 0 0
STAT5B 0.033 0.01 0.18 1 -10000 0 1
STAT5A 0.032 0.026 -10000 0 -0.54 1 1
NCK1-2/p130 Cas 0.075 0.054 -10000 0 -10000 0 0
SPHK1 0.035 0.06 -10000 0 -0.55 4 4
EDG1 0.001 0.003 -10000 0 -10000 0 0
mol:DAG 0.036 0.095 0.34 3 -0.39 11 14
PLCG1 0.036 0.096 0.34 3 -0.4 11 14
NHERF/PDGFRB 0.075 0.051 -10000 0 -10000 0 0
YES1 0.009 0.11 -10000 0 -0.52 18 18
cell migration 0.074 0.05 -10000 0 -10000 0 0
SHC/Grb2/SOS1 0.067 0.057 -10000 0 -10000 0 0
SLC9A3R2 0.033 0.015 -10000 0 -10000 0 0
SLC9A3R1 0.06 0.06 0.18 97 -10000 0 97
NHERF1-2/PDGFRB/PTEN 0.081 0.069 -10000 0 -0.31 3 3
FYN 0.005 0.11 -10000 0 -0.43 20 20
DOK1 0.037 0.05 -10000 0 -10000 0 0
HRAS/GTP 0.025 0.009 -10000 0 -10000 0 0
PDGFB 0.034 0.016 -10000 0 -10000 0 0
RAC1 0.023 0.16 0.38 2 -0.5 29 31
PRKCD 0.038 0.056 0.34 3 -10000 0 3
FER 0.036 0.055 0.38 2 -10000 0 2
MAPKKK cascade 0.048 0.099 0.34 21 -10000 0 21
RASA1 0.036 0.054 0.38 2 -10000 0 2
NCK1 0.034 0.005 -10000 0 -10000 0 0
NCK2 0.035 0.008 -10000 0 -10000 0 0
p62DOK/Csk 0.054 0.045 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SHB 0.05 0.02 -10000 0 -10000 0 0
chemotaxis 0.032 0.096 0.33 4 -0.38 9 13
STAT1-3-5/STAT1-3-5 0.08 0.049 -10000 0 -0.29 1 1
Bovine Papilomavirus E5/PDGFRB 0.026 0.007 -10000 0 -10000 0 0
PTPRJ 0.036 0.017 -10000 0 -10000 0 0
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S105.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S105.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.034 0.006 -10000 0 -10000 0 0
NFATC1 0.042 0.087 0.38 2 -0.39 6 8
NFATC2 0.003 0.074 0.23 2 -0.25 16 18
NFATC3 0.013 0.008 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/CABIN1 0.031 0.062 0.26 1 -0.27 6 7
Exportin 1/Ran/NUP214 0.066 0.017 -10000 0 -10000 0 0
mol:DAG 0 0.002 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV 0.055 0.065 -10000 0 -10000 0 0
BCL2/BAX -0.033 0.17 -10000 0 -0.4 91 91
CaM/Ca2+/Calcineurin A alpha-beta B1 0.024 0.012 -10000 0 -10000 0 0
CaM/Ca2+ 0.024 0.012 -10000 0 -10000 0 0
BAX 0.035 0.012 -10000 0 -10000 0 0
MAPK14 0.034 0.005 -10000 0 -10000 0 0
BAD 0.033 0.007 -10000 0 -10000 0 0
CABIN1/MEF2D 0.038 0.06 -10000 0 -0.26 6 6
Calcineurin A alpha-beta B1/BCL2 -0.069 0.22 -10000 0 -0.54 91 91
FKBP8 0.034 0.009 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.038 0.06 0.26 6 -10000 0 6
KPNB1 0.033 0.009 -10000 0 -10000 0 0
KPNA2 0.06 0.061 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
MAP3K8 -0.039 0.19 -10000 0 -0.54 65 65
NFAT4/CK1 alpha 0.029 0.038 -10000 0 -0.32 1 1
MEF2D/NFAT1/Cbp/p300 0.034 0.1 -10000 0 -0.31 19 19
CABIN1 0.031 0.061 0.26 1 -0.28 6 7
CALM1 0.033 0.008 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
CAMK4 0.035 0.017 -10000 0 -10000 0 0
mol:Ca2+ 0 0.004 -10000 0 -10000 0 0
MAPK3 0.032 0.01 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/AKAP79/PKA 0.054 0.04 -10000 0 -0.4 2 2
YWHAB 0.033 0.008 -10000 0 -10000 0 0
MAPK8 0.033 0.026 -10000 0 -0.54 1 1
MAPK9 0.034 0.009 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
FKBP1A 0.034 0.012 -10000 0 -10000 0 0
NFAT1-c-4/YWHAQ 0.044 0.1 0.32 1 -0.38 10 11
PRKCH 0.029 0.051 -10000 0 -0.54 4 4
CABIN1/Cbp/p300 0.042 0.024 -10000 0 -10000 0 0
CASP3 0.033 0.008 -10000 0 -10000 0 0
PIM1 0.036 0.015 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.022 0.009 -10000 0 -10000 0 0
apoptosis -0.003 0.058 -10000 0 -10000 0 0
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 0.039 0.047 -10000 0 -10000 0 0
PRKCB 0 0 -10000 0 -10000 0 0
PRKCE 0.034 0.004 -10000 0 -10000 0 0
JNK2/NFAT4 0.01 0.064 -10000 0 -10000 0 0
BAD/BCL-XL 0.048 0.014 -10000 0 -10000 0 0
PRKCD 0.035 0.018 -10000 0 -10000 0 0
NUP214 0.034 0.005 -10000 0 -10000 0 0
PRKCZ 0 0.002 -10000 0 -10000 0 0
PRKCA 0.031 0.013 -10000 0 -10000 0 0
PRKCG 0.034 0.006 -10000 0 -10000 0 0
PRKCQ 0.039 0.031 -10000 0 -10000 0 0
FKBP38/BCL2 -0.033 0.17 -10000 0 -0.4 88 88
EP300 0.03 0.015 -10000 0 -10000 0 0
PRKCB1 0 0 -10000 0 -10000 0 0
CSNK2A1 0.033 0.008 -10000 0 -10000 0 0
NFATc/JNK1 0.057 0.087 0.34 1 -0.37 6 7
CaM/Ca2+/FKBP38 0.044 0.016 -10000 0 -10000 0 0
FKBP12/FK506 0.025 0.008 -10000 0 -10000 0 0
CSNK1A1 0.016 0.012 -10000 0 -10000 0 0
CaM/Ca2+/CAMK IV 0.044 0.018 -10000 0 -10000 0 0
NFATc/ERK1 0.054 0.086 0.34 1 -0.38 5 6
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV 0.066 0.063 -10000 0 -10000 0 0
NR4A1 0.024 0.14 -10000 0 -0.48 25 25
GSK3B 0.034 0.01 -10000 0 -10000 0 0
positive T cell selection 0.013 0.008 -10000 0 -10000 0 0
NFAT1/CK1 alpha 0.007 0.061 -10000 0 -0.26 8 8
RCH1/ KPNB1 0.063 0.047 -10000 0 -10000 0 0
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
AKAP5 0.04 0.052 -10000 0 -0.54 2 2
MEF2D 0.028 0.016 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
NFATc/p38 alpha 0.058 0.086 0.34 1 -0.37 6 7
CREBBP 0.03 0.015 -10000 0 -10000 0 0
BCL2 -0.069 0.22 -10000 0 -0.54 91 91
Retinoic acid receptors-mediated signaling

Figure S106.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S106.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC3 0.034 0.006 -10000 0 -10000 0 0
VDR 0.032 0.037 -10000 0 -0.54 2 2
Cbp/p300/PCAF 0.04 0.017 -10000 0 -10000 0 0
EP300 0.033 0.009 -10000 0 -10000 0 0
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.001 0.088 0.19 1 -0.3 17 18
KAT2B 0 0 -10000 0 -10000 0 0
MAPK14 0.034 0.005 -10000 0 -10000 0 0
AKT1 -0.007 0.11 0.26 3 -0.26 53 56
RAR alpha/9cRA/Cyclin H 0.078 0.065 -10000 0 -10000 0 0
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.001 0.1 -10000 0 -0.34 16 16
CDC2 0 0.003 -10000 0 -10000 0 0
response to UV 0.001 0.004 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.046 0.046 -10000 0 -0.44 1 1
NCOR2 0.034 0.005 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.024 0.027 -10000 0 -0.4 2 2
RXRs/RARs/NRIP1/9cRA 0.024 0.12 0.39 1 -0.51 10 11
NCOA2 0.029 0.015 -10000 0 -10000 0 0
NCOA3 0.032 0.009 -10000 0 -10000 0 0
NCOA1 0.033 0.026 -10000 0 -0.54 1 1
VDR/VDR/DNA 0.032 0.037 -10000 0 -0.54 2 2
RARG 0.035 0.008 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.046 0.009 -10000 0 -10000 0 0
MAPK3 0.032 0.013 -10000 0 -10000 0 0
MAPK1 0.033 0.009 -10000 0 -10000 0 0
MAPK8 0.033 0.028 -10000 0 -0.54 1 1
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0.069 0.067 -10000 0 -0.36 1 1
RARA 0.021 0.025 0.2 1 -0.23 1 2
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0.001 0.091 -10000 0 -0.23 45 45
PRKCA 0.033 0.019 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC1 0.028 0.13 0.41 4 -0.52 10 14
RXRG 0.022 0.034 0.22 1 -0.32 3 4
RXRA 0.04 0.054 -10000 0 -0.28 3 3
RXRB 0.027 0.019 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.024 0.027 -10000 0 -0.4 2 2
RBP1 0.007 0.13 -10000 0 -0.54 26 26
CRBP1/9-cic-RA 0.006 0.094 -10000 0 -0.4 26 26
RARB -0.054 0.21 -10000 0 -0.54 79 79
PRKCG 0.035 0.015 -10000 0 -10000 0 0
MNAT1 0.034 0.006 -10000 0 -10000 0 0
RAR alpha/RXRs 0.01 0.11 -10000 0 -0.49 3 3
RXRs/RARs/SMRT(N-CoR2)/9cRA 0.028 0.11 -10000 0 -0.43 4 4
proteasomal ubiquitin-dependent protein catabolic process 0.017 0.095 0.25 6 -0.31 10 16
RXRs/RARs/NRIP1/9cRA/HDAC3 0.027 0.13 0.41 4 -0.54 10 14
positive regulation of DNA binding 0.06 0.056 -10000 0 -0.27 1 1
NRIP1 0.02 0.19 0.57 2 -1.1 9 11
RXRs/RARs 0.03 0.12 0.35 5 -0.45 9 14
RXRs/RXRs/DNA/9cRA 0.026 0.056 -10000 0 -0.37 1 1
PRKACA 0.034 0.005 -10000 0 -10000 0 0
CDK7 0.033 0.008 -10000 0 -10000 0 0
TFIIH 0.066 0.018 -10000 0 -10000 0 0
RAR alpha/9cRA 0.081 0.05 -10000 0 -10000 0 0
CCNH 0.033 0.007 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
RAR gamma2/9cRA 0.063 0.024 -10000 0 -10000 0 0
Paxillin-dependent events mediated by a4b1

Figure S107.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S107.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.032 0.009 -9999 0 -10000 0 0
Rac1/GDP 0.031 0.013 -9999 0 -10000 0 0
DOCK1 0.03 0.044 -9999 0 -0.54 3 3
ITGA4 0.04 0.03 -9999 0 -10000 0 0
RAC1 0.034 0.005 -9999 0 -10000 0 0
alpha4/beta7 Integrin 0.054 0.023 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.031 0.011 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.07 0.026 -9999 0 -10000 0 0
alpha4/beta7 Integrin/Paxillin 0.059 0.024 -9999 0 -10000 0 0
lamellipodium assembly -0.032 0.16 -9999 0 -0.44 58 58
PIK3CA 0.033 0.008 -9999 0 -10000 0 0
PI3K 0.006 0.13 -9999 0 -0.4 44 44
ARF6 0.034 0.005 -9999 0 -10000 0 0
TLN1 0.034 0.006 -9999 0 -10000 0 0
PXN 0.017 0.003 -9999 0 -10000 0 0
PIK3R1 -0.02 0.17 -9999 0 -0.54 47 47
ARF6/GTP 0.069 0.033 -9999 0 -10000 0 0
cell adhesion 0.074 0.029 -9999 0 -10000 0 0
CRKL/CBL 0.044 0.019 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin 0.059 0.024 -9999 0 -10000 0 0
ITGB1 0.034 0.006 -9999 0 -10000 0 0
ITGB7 0.034 0.004 -9999 0 -10000 0 0
ARF6/GDP 0.03 0.013 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/VCAM1 0.07 0.064 -9999 0 -0.3 11 11
p130Cas/Crk/Dock1 0.053 0.044 -9999 0 -0.34 3 3
VCAM1 0.024 0.086 -9999 0 -0.54 11 11
alpha4/beta1 Integrin/Paxillin/Talin 0.076 0.03 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.074 0.034 -9999 0 -10000 0 0
BCAR1 0.029 0.013 -9999 0 -10000 0 0
mol:GDP -0.071 0.033 -9999 0 -10000 0 0
CBL 0.031 0.011 -9999 0 -10000 0 0
PRKACA 0.034 0.005 -9999 0 -10000 0 0
GIT1 0.033 0.011 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.076 0.03 -9999 0 -10000 0 0
Rac1/GTP -0.038 0.18 -9999 0 -0.49 58 58
Arf6 trafficking events

Figure S108.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S108.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 -0.25 0.28 -10000 0 -0.54 252 252
CLTC 0.034 0.057 -10000 0 -0.42 3 3
calcium ion-dependent exocytosis 0.015 0.043 -10000 0 -0.37 2 2
Dynamin 2/GTP 0.03 0.013 -10000 0 -10000 0 0
EXOC4 0.034 0.006 -10000 0 -10000 0 0
CD59 0.02 0.044 -10000 0 -0.34 2 2
CPE -0.04 0.13 -10000 0 -0.34 83 83
CTNNB1 0.029 0.051 -10000 0 -0.54 4 4
membrane fusion 0.012 0.035 -10000 0 -0.35 1 1
CTNND1 0.031 0.054 0.37 1 -10000 0 1
DNM2 0.034 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.022 0.046 0.23 2 -0.41 1 3
TSHR 0.015 0.028 -10000 0 -0.34 3 3
INS 0.008 0.099 -10000 0 -0.5 18 18
BIN1 0.034 0.005 -10000 0 -10000 0 0
mol:Choline 0.012 0.035 -10000 0 -0.35 1 1
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.016 0.006 -10000 0 -10000 0 0
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0.034 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0.03 0.013 -10000 0 -10000 0 0
JUP 0.022 0.036 -10000 0 -0.29 2 2
ASAP2/amphiphysin II 0.043 0.009 -10000 0 -10000 0 0
ARF6/GTP 0.025 0.004 -10000 0 -10000 0 0
CDH1 0.008 0.066 -10000 0 -0.38 4 4
clathrin-independent pinocytosis 0.025 0.004 -10000 0 -10000 0 0
MAPK8IP3 0.03 0.038 -10000 0 -0.54 2 2
positive regulation of endocytosis 0.025 0.004 -10000 0 -10000 0 0
EXOC2 0.041 0.033 -10000 0 -10000 0 0
substrate adhesion-dependent cell spreading 0.036 0.053 -10000 0 -0.33 4 4
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0.031 0.011 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.045 0.082 0.36 4 -10000 0 4
positive regulation of phagocytosis 0.017 0.005 -10000 0 -10000 0 0
ARF6/GTP/JIP3 0.041 0.029 -10000 0 -0.34 2 2
ACAP1 0.011 0.035 -10000 0 -0.23 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 0.027 0.04 -10000 0 -0.29 2 2
clathrin heavy chain/ACAP1 0.03 0.069 0.3 3 -0.42 2 5
JIP4/KLC1 0.056 0.025 -10000 0 -10000 0 0
EXOC1 0.034 0.005 -10000 0 -10000 0 0
exocyst 0.036 0.053 -10000 0 -0.33 4 4
RALA/GTP 0.025 0.004 -10000 0 -10000 0 0
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0.041 0.016 -10000 0 -10000 0 0
receptor recycling 0.025 0.004 -10000 0 -10000 0 0
CTNNA1 0.031 0.055 0.37 1 -10000 0 1
NME1 0.016 0.006 -10000 0 -10000 0 0
clathrin coat assembly 0.037 0.065 0.32 1 -0.42 3 4
IL2RA 0.027 0.047 -10000 0 -0.36 3 3
VAMP3 0.017 0.005 -10000 0 -10000 0 0
GLUT4/clathrin heavy chain/ACAP1 -0.1 0.13 -10000 0 -0.34 17 17
EXOC6 0.034 0.027 -10000 0 -0.54 1 1
PLD1 0.005 0.062 -10000 0 -0.28 21 21
PLD2 0.016 0.016 -10000 0 -0.27 1 1
EXOC5 0.034 0.006 -10000 0 -10000 0 0
PIP5K1C 0.019 0.038 0.22 1 -0.42 1 2
SDC1 0.037 0.051 -10000 0 -0.36 3 3
ARF6/GDP 0.029 0.011 -10000 0 -10000 0 0
EXOC7 0.032 0.009 -10000 0 -10000 0 0
E-cadherin/beta catenin 0.047 0.085 -10000 0 -0.37 4 4
mol:Phosphatidic acid 0.012 0.035 -10000 0 -0.35 1 1
endocytosis -0.041 0.009 -10000 0 -10000 0 0
SCAMP2 0.034 0.006 -10000 0 -10000 0 0
ADRB2 -0.11 0.15 -10000 0 -0.42 13 13
EXOC3 0.033 0.008 -10000 0 -10000 0 0
ASAP2 0 0 -10000 0 -10000 0 0
Dynamin 2/GDP 0.037 0.022 -10000 0 -10000 0 0
KLC1 0.034 0.006 -10000 0 -10000 0 0
AVPR2 0.032 0.068 0.29 2 -0.38 4 6
RALA 0.034 0.005 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.04 0.084 0.34 2 -0.38 3 5
p38 MAPK signaling pathway

Figure S109.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S109.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TRAF6/ASK1 0.008 0.069 -10000 0 -0.28 26 26
TRAF2/ASK1 0.022 0.087 -10000 0 -0.29 34 34
ATM 0.03 0.012 -10000 0 -10000 0 0
MAP2K3 -0.016 0.14 0.29 1 -0.42 30 31
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 -0.014 0.13 0.28 1 -0.41 27 28
hyperosmotic response 0 0 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
GADD45G 0.036 0.018 0.18 7 -10000 0 7
TXN 0.01 0.006 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
GADD45A 0.025 0.072 -10000 0 -0.54 8 8
GADD45B 0.032 0.037 -10000 0 -0.54 2 2
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
MAP3K6 0.033 0.008 -10000 0 -10000 0 0
MAP3K7 0.032 0.009 -10000 0 -10000 0 0
MAP3K4 0.032 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
ASK1/ASK2 0.022 0.1 -10000 0 -0.4 26 26
TAK1/TAB family -0.002 0.021 -10000 0 -0.21 1 1
RAC1/OSM/MEKK3 0.058 0.024 -10000 0 -10000 0 0
TRAF2 0.035 0.013 -10000 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.008 0.12 -10000 0 -0.35 22 22
TRAF6 0.009 0.002 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
CAMK2B 0.039 0.069 -10000 0 -0.54 5 5
CCM2 0.034 0.005 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB 0.047 0.047 -10000 0 -0.34 5 5
MAPK11 0.032 0.009 -10000 0 -10000 0 0
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB/ASK1 0.042 0.094 -10000 0 -0.3 31 31
OSM/MEKK3 0.045 0.018 -10000 0 -10000 0 0
TAOK1 0.017 0.013 -10000 0 -10000 0 0
TAOK2 0.015 0.008 -10000 0 -10000 0 0
TAOK3 0.016 0.007 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.034 0.005 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
MAP3K5 0.004 0.13 -10000 0 -0.54 26 26
MAP3K10 0.033 0.039 -10000 0 -0.54 2 2
MAP3K3 0.031 0.011 -10000 0 -10000 0 0
TRX/ASK1 0.01 0.082 -10000 0 -0.32 28 28
GADD45/MTK1/MTK1 0.067 0.059 -10000 0 -0.29 10 10
Visual signal transduction: Cones

Figure S110.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S110.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.048 0.037 -10000 0 -0.29 3 3
RGS9BP 0.055 0.066 -10000 0 -0.54 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
mol:Na + 0.044 0.042 0.23 1 -0.34 2 3
mol:ADP 0.008 0.019 0.14 1 -0.4 1 2
GNAT2 0.031 0.045 -10000 0 -0.54 3 3
RGS9-1/Gbeta5/R9AP 0.05 0.1 -10000 0 -0.32 28 28
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.041 0.038 -10000 0 -0.34 4 4
GRK7 0.033 0.027 -10000 0 -0.54 1 1
CNGB3 0.033 0.031 -10000 0 -10000 0 0
Cone Metarhodopsin II/X-Arrestin 0.026 0.001 -10000 0 -10000 0 0
mol:Ca2+ 0.056 0.075 0.28 8 -0.31 2 10
Cone PDE6 0.071 0.1 -10000 0 -0.3 21 21
Cone Metarhodopsin II 0.021 0.015 -10000 0 -0.31 1 1
Na + (4 Units) 0.056 0.046 0.24 1 -0.31 2 3
GNAT2/GDP 0.057 0.096 -10000 0 -0.28 30 30
GNB5 0.032 0.026 -10000 0 -0.54 1 1
mol:GMP (4 units) 0.021 0.044 -10000 0 -0.31 5 5
Cone Transducin 0.052 0.04 -10000 0 -0.31 3 3
SLC24A2 0.033 0.01 -10000 0 -10000 0 0
GNB3/GNGT2 0.043 0.02 -10000 0 -10000 0 0
GNB3 0.033 0.011 -10000 0 -10000 0 0
GNAT2/GTP 0.023 0.034 -10000 0 -0.34 4 4
CNGA3 0.043 0.053 -10000 0 -0.54 2 2
ARR3 0.035 0.002 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.044 0.043 0.23 1 -0.34 2 3
mol:Pi 0.049 0.1 -10000 0 -0.32 28 28
Cone CNG Channel 0.064 0.063 -10000 0 -0.29 6 6
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.033 0.01 -10000 0 -10000 0 0
RGS9 0.002 0.13 -10000 0 -0.54 27 27
PDE6C 0.034 0.028 -10000 0 -0.54 1 1
GNGT2 0.031 0.011 -10000 0 -10000 0 0
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H 0.033 0.03 -10000 0 -0.54 1 1
Insulin-mediated glucose transport

Figure S111.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S111.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Insulin responsive Vesicles -0.075 0.14 0.38 1 -0.29 38 39
CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
AKT1 0.035 0.017 -10000 0 -10000 0 0
AKT2 0.034 0.005 -10000 0 -10000 0 0
STXBP4 0.031 0.015 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucose -0.091 0.13 0.41 1 -0.28 55 56
YWHAZ 0.027 0.018 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
YWHAQ 0.034 0.005 -10000 0 -10000 0 0
TBC1D4 0.006 0.069 -10000 0 -0.4 14 14
mol:Ca2+ 0 0 -10000 0 -10000 0 0
YWHAH 0.033 0.014 -10000 0 -10000 0 0
YWHAB 0.033 0.008 -10000 0 -10000 0 0
SNARE/Synip 0.053 0.032 -10000 0 -10000 0 0
YWHAG 0.035 0.008 -10000 0 -10000 0 0
ASIP 0 0 -10000 0 -10000 0 0
PRKCI 0.035 0.018 -10000 0 -10000 0 0
AS160/CaM/Ca2+ 0.025 0.005 -10000 0 -10000 0 0
RHOQ 0.033 0.026 -10000 0 -0.54 1 1
GYS1 0.017 0.021 0.26 3 -10000 0 3
PRKCZ 0 0 -10000 0 -10000 0 0
TRIP10 0.033 0.026 -10000 0 -0.54 1 1
TC10/GTP/CIP4/Exocyst 0.044 0.026 -10000 0 -0.34 2 2
AS160/14-3-3 0.025 0.078 -10000 0 -0.37 8 8
VAMP2 0.031 0.011 -10000 0 -10000 0 0
SLC2A4 -0.1 0.14 0.42 1 -0.31 55 56
STX4 0.032 0.01 -10000 0 -10000 0 0
GSK3B 0.028 0.014 -10000 0 -10000 0 0
SFN 0.033 0.04 -10000 0 -0.54 2 2
LNPEP 0.035 0.016 -10000 0 -10000 0 0
YWHAE 0.031 0.011 -10000 0 -10000 0 0
Class I PI3K signaling events

Figure S112.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S112.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.007 0.049 0.24 7 -10000 0 7
DAPP1 0.033 0.11 0.28 7 -0.32 21 28
Src family/SYK family/BLNK-LAT/BTK-ITK 0.043 0.14 0.37 11 -0.46 17 28
mol:DAG 0.042 0.094 0.27 35 -0.19 2 37
HRAS 0.036 0.014 -10000 0 -10000 0 0
RAP1A 0.036 0.007 -10000 0 -10000 0 0
ARF5/GDP 0.047 0.08 -10000 0 -0.35 8 8
PLCG2 0.022 0.073 -10000 0 -0.54 8 8
PLCG1 0.033 0.008 -10000 0 -10000 0 0
ARF5 0.034 0.005 -10000 0 -10000 0 0
mol:GTP -0.008 0.05 0.32 5 -10000 0 5
ARF1/GTP 0.002 0.044 0.29 6 -10000 0 6
RHOA 0.033 0.008 -10000 0 -10000 0 0
YES1 0.032 0.027 -10000 0 -0.54 1 1
RAP1A/GTP -0.004 0.052 0.24 8 -10000 0 8
ADAP1 -0.009 0.039 0.22 6 -10000 0 6
ARAP3 -0.008 0.049 0.32 5 -10000 0 5
INPPL1 0.032 0.01 -10000 0 -10000 0 0
PREX1 0.056 0.08 -10000 0 -0.54 4 4
ARHGEF6 0.014 0.11 -10000 0 -0.54 18 18
ARHGEF7 0.032 0.013 -10000 0 -10000 0 0
ARF1 0.028 0.014 -10000 0 -10000 0 0
NRAS 0.037 0.017 -10000 0 -10000 0 0
FYN 0.03 0.037 -10000 0 -0.54 2 2
ARF6 0.034 0.005 -10000 0 -10000 0 0
FGR 0.033 0.008 -10000 0 -10000 0 0
mol:Ca2+ 0.026 0.064 0.22 23 -10000 0 23
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.035 0.013 -10000 0 -10000 0 0
ZAP70 0.038 0.024 -10000 0 -10000 0 0
mol:IP3 0.029 0.078 0.23 36 -0.17 1 37
LYN 0.03 0.016 -10000 0 -10000 0 0
ARF1/GDP 0.038 0.078 0.42 1 -0.35 8 9
RhoA/GDP 0.05 0.058 0.3 3 -10000 0 3
PDK1/Src/Hsp90 0.059 0.026 -10000 0 -10000 0 0
BLNK 0.039 0.027 -10000 0 -10000 0 0
actin cytoskeleton reorganization 0.036 0.084 0.38 5 -0.33 4 9
SRC 0.033 0.008 -10000 0 -10000 0 0
PLEKHA2 -0.005 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
PTEN 0.028 0.044 -10000 0 -0.52 3 3
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
ARF6/GTP -0.007 0.049 0.24 7 -10000 0 7
RhoA/GTP -0.006 0.054 0.32 5 -10000 0 5
Src family/SYK family/BLNK-LAT 0.043 0.092 0.31 11 -0.36 7 18
BLK 0.039 0.045 -10000 0 -10000 0 0
PDPK1 0.032 0.01 -10000 0 -10000 0 0
CYTH1 -0.009 0.039 0.22 6 -10000 0 6
HCK 0.037 0.023 -10000 0 -10000 0 0
CYTH3 -0.009 0.039 0.22 6 -10000 0 6
CYTH2 -0.009 0.039 0.22 6 -10000 0 6
KRAS 0.036 0.019 -10000 0 -10000 0 0
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.013 0.031 0.26 1 -10000 0 1
SGK1 0.016 0.034 0.27 1 -10000 0 1
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.031 0.081 0.32 2 -0.35 9 11
SOS1 0.034 0.004 -10000 0 -10000 0 0
SYK 0.039 0.027 -10000 0 -10000 0 0
ARF6/GDP 0.031 0.062 0.34 6 -10000 0 6
mol:PI-3-4-5-P3 -0.009 0.043 0.25 6 -10000 0 6
ARAP3/RAP1A/GTP -0.004 0.052 0.24 8 -10000 0 8
VAV1 0.038 0.025 -10000 0 -10000 0 0
mol:PI-3-4-P2 0.008 0.003 -10000 0 -10000 0 0
RAS family/GTP/PI3K Class I 0.056 0.044 0.29 2 -10000 0 2
PLEKHA1 -0.008 0.021 -10000 0 -0.34 2 2
Rac1/GDP 0.048 0.08 -10000 0 -0.35 8 8
LAT 0.036 0.025 -10000 0 -10000 0 0
Rac1/GTP 0.027 0.085 -10000 0 -0.32 20 20
ITK -0.004 0.057 0.31 5 -0.29 2 7
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma 0.043 0.11 0.31 30 -0.25 4 34
LCK 0.049 0.045 -10000 0 -10000 0 0
BTK -0.003 0.055 0.31 5 -10000 0 5
Nephrin/Neph1 signaling in the kidney podocyte

Figure S113.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S113.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity -0.048 0.032 -10000 0 -10000 0 0
KIRREL 0.032 0.018 -10000 0 -10000 0 0
Nephrin/NEPH1Par3/Par6/Atypical PKCs 0.048 0.032 -10000 0 -10000 0 0
PLCG1 0.033 0.008 -10000 0 -10000 0 0
ARRB2 0.031 0.011 -10000 0 -10000 0 0
WASL 0.033 0.026 -10000 0 -0.54 1 1
Nephrin/NEPH1/podocin/CD2AP 0.072 0.047 -10000 0 -10000 0 0
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP 0.031 0.028 -10000 0 -0.24 1 1
FYN 0.064 0.095 0.28 68 -0.24 2 70
mol:Ca2+ 0.066 0.047 -10000 0 -10000 0 0
mol:DAG 0.068 0.048 -10000 0 -10000 0 0
NPHS2 0.033 0.017 -10000 0 -10000 0 0
mol:IP3 0.068 0.048 -10000 0 -10000 0 0
regulation of endocytosis 0.054 0.044 -10000 0 -0.22 2 2
Nephrin/NEPH1/podocin/Cholesterol 0.056 0.038 -10000 0 -10000 0 0
establishment of cell polarity 0.048 0.032 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2 0.084 0.053 -10000 0 -10000 0 0
Nephrin/NEPH1/beta Arrestin2 0.056 0.046 -10000 0 -0.22 2 2
NPHS1 0.049 0.032 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin 0.057 0.043 -10000 0 -0.24 2 2
TJP1 0.032 0.027 -10000 0 -0.54 1 1
NCK1 0.034 0.005 -10000 0 -10000 0 0
NCK2 0.035 0.008 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 0.069 0.049 -10000 0 -10000 0 0
CD2AP 0.034 0.01 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/GRB2 0.069 0.05 -10000 0 -10000 0 0
GRB2 0.034 0.019 -10000 0 -10000 0 0
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 0.056 0.11 0.3 64 -0.3 12 76
cytoskeleton organization 0.034 0.056 0.3 5 -10000 0 5
Nephrin/NEPH1 0.04 0.027 -10000 0 -10000 0 0
Nephrin/NEPH1/ZO-1 0.058 0.042 -10000 0 -0.36 1 1
Canonical NF-kappaB pathway

Figure S114.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S114.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.035 0.009 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.061 0.12 0.34 5 -0.33 10 15
ERC1 0.033 0.013 -10000 0 -10000 0 0
RIP2/NOD2 0.054 0.052 0.26 3 -10000 0 3
NFKBIA 0.015 0.027 -10000 0 -0.32 1 1
BIRC2 0.031 0.011 -10000 0 -10000 0 0
IKBKB 0.029 0.013 -10000 0 -10000 0 0
RIPK2 0.029 0.022 -10000 0 -10000 0 0
IKBKG 0.019 0.14 -10000 0 -0.39 42 42
IKK complex/A20 0.04 0.15 -10000 0 -0.42 22 22
NEMO/A20/RIP2 0.029 0.022 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
NEMO/ATM 0.03 0.15 -10000 0 -0.41 32 32
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
Exportin 1/RanGTP 0.045 0.009 -10000 0 -10000 0 0
IKK complex/ELKS 0.025 0.13 -10000 0 -0.41 21 21
BCL10/MALT1/TRAF6 0.064 0.021 -10000 0 -10000 0 0
NOD2 0.06 0.063 -10000 0 -10000 0 0
NFKB1 0.036 0.008 -10000 0 -10000 0 0
RELA 0.035 0.009 -10000 0 -10000 0 0
MALT1 0.034 0.01 -10000 0 -10000 0 0
cIAP1/UbcH5C 0.045 0.018 -10000 0 -10000 0 0
ATM 0.03 0.012 -10000 0 -10000 0 0
TNF/TNFR1A 0.05 0.021 -10000 0 -10000 0 0
TRAF6 0.034 0.006 -10000 0 -10000 0 0
PRKCA 0.031 0.013 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
UBE2D3 0.034 0.005 -10000 0 -10000 0 0
TNF 0.038 0.024 -10000 0 -10000 0 0
NF kappa B1 p50/RelA 0.072 0.026 -10000 0 -10000 0 0
BCL10 0.034 0.007 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.015 0.027 -10000 0 -0.32 1 1
beta TrCP1/SCF ubiquitin ligase complex 0.035 0.009 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
IKK complex 0.032 0.15 -10000 0 -0.43 23 23
CYLD 0.03 0.012 -10000 0 -10000 0 0
IKK complex/PKC alpha 0.035 0.14 -10000 0 -0.42 20 20
Signaling events mediated by HDAC Class I

Figure S115.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S115.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA 0.077 0.055 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC1 -0.01 0.002 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.049 0.065 -10000 0 -0.31 1 1
SUMO1 0.034 0.005 -10000 0 -10000 0 0
ZFPM1 0.029 0.015 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.018 0.02 -10000 0 -0.17 3 3
FKBP3 0.034 0.005 -10000 0 -10000 0 0
Histones 0.077 0.048 -10000 0 -10000 0 0
YY1/LSF 0.031 0.056 -10000 0 -0.26 8 8
SMG5 0.03 0.018 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
I kappa B alpha/HDAC3 0.031 0.026 -10000 0 -10000 0 0
I kappa B alpha/HDAC1 0.042 0.043 -10000 0 -0.25 1 1
SAP18 0.032 0.009 -10000 0 -10000 0 0
RELA 0.023 0.051 -10000 0 -0.23 8 8
HDAC1/Smad7 0.065 0.019 -10000 0 -10000 0 0
RANGAP1 0.038 0.03 -10000 0 -10000 0 0
HDAC3/TR2 0.045 0.04 -10000 0 -0.29 1 1
NuRD/MBD3 Complex 0.039 0.06 -10000 0 -0.31 6 6
NF kappa B1 p50/RelA 0.04 0.07 0.4 1 -0.33 2 3
EntrezGene:23225 0 0 -10000 0 -10000 0 0
GATA2 0.042 0.034 -10000 0 -10000 0 0
GATA1 0.035 0.003 -10000 0 -10000 0 0
Mad/Max 0.049 0.013 -10000 0 -10000 0 0
NuRD/MBD3 Complex/GATA1/Fog1 0.028 0.094 -10000 0 -0.36 15 15
RBBP7 0.038 0.023 -10000 0 -10000 0 0
NPC 0.02 0.002 -10000 0 -10000 0 0
RBBP4 0.034 0.006 -10000 0 -10000 0 0
MAX 0.033 0.007 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
FBXW11 0.034 0.007 -10000 0 -10000 0 0
NFKBIA 0.028 0.019 -10000 0 -0.27 1 1
KAT2B 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SIN3/HDAC complex 0.028 0.052 -10000 0 -0.3 4 4
SIN3 complex 0.078 0.032 -10000 0 -10000 0 0
SMURF1 0.034 0.005 -10000 0 -10000 0 0
CHD3 0.032 0.016 -10000 0 -10000 0 0
SAP30 0.034 0.009 -10000 0 -10000 0 0
EntrezGene:23636 0 0 -10000 0 -10000 0 0
NCOR1 0.031 0.011 -10000 0 -10000 0 0
YY1/HDAC3 0.032 0.05 -10000 0 -0.36 2 2
YY1/HDAC2 0.034 0.046 -10000 0 -0.23 5 5
YY1/HDAC1 0.034 0.049 -10000 0 -0.24 6 6
NuRD/MBD2 Complex (MeCP1) 0.038 0.057 -10000 0 -0.25 5 5
PPARG -0.21 0.16 -10000 0 -0.31 336 336
HDAC8/hEST1B 0.058 0.029 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.007 -10000 0 -10000 0 0
TNFRSF1A 0.033 0.009 -10000 0 -10000 0 0
HDAC3/SMRT (N-CoR2) 0.045 0.038 -10000 0 -10000 0 0
MBD3L2 0.033 0.026 -10000 0 -0.54 1 1
ubiquitin-dependent protein catabolic process 0.064 0.019 -10000 0 -10000 0 0
CREBBP 0.032 0.01 -10000 0 -10000 0 0
NuRD/MBD3/MBD3L2 Complex 0.04 0.083 -10000 0 -0.34 10 10
HDAC1 0.034 0.006 -10000 0 -10000 0 0
HDAC3 0.03 0.013 -10000 0 -10000 0 0
HDAC2 0.034 0.017 0.18 5 -10000 0 5
YY1 0.017 0.008 -10000 0 -10000 0 0
HDAC8 0.035 0.002 -10000 0 -10000 0 0
SMAD7 0.033 0.008 -10000 0 -10000 0 0
NCOR2 0.034 0.005 -10000 0 -10000 0 0
MXD1 0.035 0.008 -10000 0 -10000 0 0
STAT3 0.024 0.011 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.034 0.004 -10000 0 -10000 0 0
YY1/LSF/HDAC1 0.049 0.057 -10000 0 -0.25 6 6
YY1/SAP30/HDAC1 0.05 0.053 -10000 0 -0.3 1 1
EP300 0.033 0.009 -10000 0 -10000 0 0
STAT3 (dimer non-phopshorylated) 0.024 0.011 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.028 0.019 -10000 0 -0.27 1 1
histone deacetylation 0.038 0.06 -10000 0 -0.27 6 6
STAT3 (dimer non-phopshorylated)/HDAC3 0.033 0.041 -10000 0 -0.26 1 1
nuclear export -0.057 0.029 -10000 0 -10000 0 0
PRKACA 0.034 0.005 -10000 0 -10000 0 0
GATAD2B 0.028 0.014 -10000 0 -10000 0 0
GATAD2A 0.037 0.022 -10000 0 -10000 0 0
GATA2/HDAC3 0.05 0.044 -10000 0 -10000 0 0
GATA1/HDAC1 0.05 0.01 -10000 0 -10000 0 0
GATA1/HDAC3 0.046 0.037 -10000 0 -10000 0 0
CHD4 0.033 0.009 -10000 0 -10000 0 0
TNF-alpha/TNFR1A 0.05 0.021 -10000 0 -10000 0 0
SIN3/HDAC complex/Mad/Max 0.028 0.063 -10000 0 -0.31 10 10
NuRD Complex 0.04 0.077 -10000 0 -0.33 6 6
positive regulation of chromatin silencing 0.074 0.046 -10000 0 -10000 0 0
SIN3B 0.035 0.014 -10000 0 -10000 0 0
MTA2 0.034 0.006 -10000 0 -10000 0 0
SIN3A 0.034 0.006 -10000 0 -10000 0 0
XPO1 0.034 0.005 -10000 0 -10000 0 0
SUMO1/HDAC1 0.053 0.05 -10000 0 -0.25 3 3
HDAC complex 0.082 0.031 -10000 0 -10000 0 0
GATA1/Fog1 0.043 0.021 -10000 0 -10000 0 0
FKBP25/HDAC1/HDAC2 0.064 0.023 -10000 0 -10000 0 0
TNF 0.038 0.024 -10000 0 -10000 0 0
negative regulation of cell growth 0.025 0.072 -10000 0 -0.33 14 14
NuRD/MBD2/PRMT5 Complex 0.038 0.057 -10000 0 -0.25 5 5
Ran/GTP/Exportin 1 0.052 0.05 -10000 0 -0.26 3 3
NF kappa B/RelA/I kappa B alpha 0.031 0.049 -10000 0 -0.32 1 1
SIN3/HDAC complex/NCoR1 0.02 0.066 -10000 0 -0.31 11 11
TFCP2 0.032 0.036 -10000 0 -0.54 2 2
NR2C1 0.033 0.026 -10000 0 -0.54 1 1
MBD3 0.033 0.007 -10000 0 -10000 0 0
MBD2 0.034 0.012 -10000 0 -10000 0 0
Atypical NF-kappaB pathway

Figure S116.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S116.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.049 0.016 -10000 0 -10000 0 0
FBXW11 0.034 0.007 -10000 0 -10000 0 0
NF kappa B1 p50/c-Rel 0.033 0.022 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.043 0.052 -10000 0 -0.26 2 2
NFKBIA 0.033 0.038 -10000 0 -0.28 1 1
MAPK14 0.034 0.005 -10000 0 -10000 0 0
NF kappa B1 p105/p50 0.031 0.016 -10000 0 -10000 0 0
ARRB2 0.017 0.006 -10000 0 -10000 0 0
REL 0.038 0.024 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
BCL3/NF kappa B1 p50 0.032 0.018 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
NF kappa B1 p105/RelA 0.03 0.016 -10000 0 -10000 0 0
PIK3CA 0.033 0.008 -10000 0 -10000 0 0
NF kappa B1 p50 dimer 0.022 0.015 0.26 1 -10000 0 1
PIK3R1 -0.02 0.17 -10000 0 -0.54 47 47
NFKB1 0.014 0.007 -10000 0 -10000 0 0
RELA 0.033 0.007 -10000 0 -10000 0 0
positive regulation of anti-apoptosis 0.039 0.05 -10000 0 -0.22 3 3
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.041 0.058 -10000 0 -0.29 2 2
SRC 0.033 0.008 -10000 0 -10000 0 0
PI3K 0.006 0.13 -10000 0 -0.4 44 44
NF kappa B1 p50/RelA 0.039 0.05 -10000 0 -0.22 3 3
IKBKB 0.029 0.013 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.007 -10000 0 -10000 0 0
SYK 0.039 0.027 -10000 0 -10000 0 0
I kappa B alpha/PIK3R1 0.017 0.1 -10000 0 -0.27 42 42
cell death 0.04 0.056 -10000 0 -0.28 2 2
NF kappa B1 p105/c-Rel 0.033 0.022 -10000 0 -10000 0 0
LCK 0.049 0.045 -10000 0 -10000 0 0
BCL3 0.035 0.014 -10000 0 -10000 0 0
IL2 signaling events mediated by STAT5

Figure S117.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S117.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.03 0.013 -10000 0 -10000 0 0
ELF1 0.045 0.03 -10000 0 -10000 0 0
CCNA2 0.082 0.07 -10000 0 -10000 0 0
PIK3CA 0.033 0.009 -10000 0 -10000 0 0
JAK3 0.035 0.006 -10000 0 -10000 0 0
PIK3R1 -0.019 0.17 -10000 0 -0.54 47 47
JAK1 0.034 0.007 -10000 0 -10000 0 0
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.064 0.11 0.34 3 -0.42 4 7
SHC1 0.028 0.014 -10000 0 -10000 0 0
SP1 0.036 0.048 -10000 0 -0.35 8 8
IL2RA 0.036 0.058 -10000 0 -10000 0 0
IL2RB 0.036 0.022 -10000 0 -10000 0 0
SOS1 0.035 0.004 -10000 0 -10000 0 0
IL2RG 0.045 0.036 -10000 0 -10000 0 0
G1/S transition of mitotic cell cycle 0.048 0.15 0.4 2 -0.84 9 11
PTPN11 0.035 0.004 -10000 0 -10000 0 0
CCND2 0.01 0.1 -10000 0 -0.74 9 9
LCK 0.05 0.045 -10000 0 -10000 0 0
GRB2 0.035 0.019 -10000 0 -10000 0 0
IL2 0.034 0.027 -10000 0 -0.54 1 1
CDK6 0.028 0.063 -10000 0 -0.54 6 6
CCND3 0.066 0.11 0.5 2 -10000 0 2
Aurora C signaling

Figure S118.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S118.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.046 0.041 -10000 0 -10000 0 0
Aurora C/Aurora B/INCENP 0.079 0.056 0.24 19 -10000 0 19
metaphase 0 0 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
H3F3B 0.017 0.032 -10000 0 -0.31 4 4
AURKB 0.057 0.059 -10000 0 -10000 0 0
AURKC 0.036 0.019 -10000 0 -10000 0 0
Effects of Botulinum toxin

Figure S119.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S119.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.012 0.019 0.14 12 -10000 0 12
UniProt:P19321 0 0 -10000 0 -10000 0 0
RIMS1/UNC13B 0.054 0.029 -10000 0 -10000 0 0
STXBP1 0.034 0.005 -10000 0 -10000 0 0
ACh/CHRNA1 0.023 0.031 0.14 2 -0.12 3 5
RAB3GAP2/RIMS1/UNC13B 0.058 0.038 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
UniProt:P30996 0 0 -10000 0 -10000 0 0
UniProt:Q60393 0 0 -10000 0 -10000 0 0
CST086 0 0 -10000 0 -10000 0 0
RIMS1 0.042 0.036 -10000 0 -10000 0 0
mol:ACh 0 0.032 0.091 14 -0.12 11 25
RAB3GAP2 0.028 0.014 -10000 0 -10000 0 0
STX1A/SNAP25/VAMP2 0.041 0.056 -10000 0 -10000 0 0
UniProt:P10844 0 0 -10000 0 -10000 0 0
muscle contraction 0.023 0.031 0.14 2 -0.12 3 5
UNC13B 0.035 0.015 -10000 0 -10000 0 0
CHRNA1 0.035 0.01 0.18 2 -10000 0 2
UniProt:P10845 0 0 -10000 0 -10000 0 0
ACh/Synaptotagmin 1 0.053 0.078 0.18 12 -0.33 9 21
SNAP25 0.007 0.035 -10000 0 -0.3 5 5
VAMP2 0.006 0.002 -10000 0 -10000 0 0
SYT1 0.071 0.1 -10000 0 -0.54 8 8
UniProt:Q00496 0 0 -10000 0 -10000 0 0
STXIA/STXBP1 0.033 0.015 -10000 0 -10000 0 0
STX1A/SNAP25 fragment 1/VAMP2 0.041 0.056 -10000 0 -10000 0 0
LPA4-mediated signaling events

Figure S120.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S120.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 -0.01 0.033 -10000 0 -0.34 5 5
ADCY5 -0.006 0.021 -10000 0 -0.34 1 1
ADCY6 -0.007 0.001 -10000 0 -10000 0 0
ADCY7 -0.003 0.019 -10000 0 -10000 0 0
ADCY1 -0.006 0.009 -10000 0 -10000 0 0
ADCY2 -0.009 0.042 -10000 0 -0.34 7 7
ADCY3 -0.007 0.007 -10000 0 -10000 0 0
ADCY8 -0.004 0.015 -10000 0 -10000 0 0
PRKCE 0.009 0.001 -10000 0 -10000 0 0
ADCY9 -0.004 0.016 -10000 0 -10000 0 0
mol:DAG 0 0 -10000 0 -10000 0 0
cAMP biosynthetic process 0.035 0.07 0.24 15 -10000 0 15
Aurora A signaling

Figure S121.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S121.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.047 0.055 -10000 0 -0.29 8 8
BIRC5 0.12 0.076 -10000 0 -10000 0 0
NFKBIA 0.023 0.041 0.27 5 -10000 0 5
CPEB1 0.02 0.092 -10000 0 -0.54 13 13
AKT1 0.023 0.041 0.31 3 -10000 0 3
NDEL1 0.031 0.011 -10000 0 -10000 0 0
Aurora A/BRCA1 0.04 0.035 -10000 0 -10000 0 0
NDEL1/TACC3 0.096 0.067 0.26 2 -10000 0 2
GADD45A 0.025 0.072 -10000 0 -0.54 8 8
GSK3B 0.003 0.027 -10000 0 -10000 0 0
PAK1/Aurora A 0.057 0.05 -10000 0 -10000 0 0
MDM2 0.033 0.01 -10000 0 -10000 0 0
JUB 0 0 -10000 0 -10000 0 0
TPX2 0.11 0.06 -10000 0 -10000 0 0
TP53 0.022 0.059 -10000 0 -0.21 15 15
DLG7 0.023 0.033 -10000 0 -10000 0 0
AURKAIP1 0.034 0.013 -10000 0 -10000 0 0
ARHGEF7 0.032 0.013 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.1 0.071 0.27 2 -10000 0 2
G2/M transition of mitotic cell cycle 0.04 0.035 -10000 0 -10000 0 0
AURKA 0.032 0.042 -10000 0 -10000 0 0
AURKB 0.044 0.055 -10000 0 -10000 0 0
CDC25B 0.035 0.047 -10000 0 -10000 0 0
G2/M transition checkpoint 0.016 0.028 -10000 0 -10000 0 0
mRNA polyadenylation 0.031 0.059 -10000 0 -0.28 13 13
Aurora A/CPEB 0.031 0.06 -10000 0 -0.28 13 13
Aurora A/TACC1/TRAP/chTOG 0.054 0.088 -10000 0 -0.28 21 21
BRCA1 0.036 0.022 -10000 0 -10000 0 0
centrosome duplication 0.056 0.049 -10000 0 -10000 0 0
regulation of centrosome cycle 0.093 0.066 0.25 1 -10000 0 1
spindle assembly 0.052 0.086 -10000 0 -0.28 21 21
TDRD7 0.034 0.005 -10000 0 -10000 0 0
Aurora A/RasGAP/Survivin 0.12 0.073 0.28 8 -10000 0 8
CENPA 0.062 0.057 -10000 0 -0.23 1 1
Aurora A/PP2A 0.053 0.036 -10000 0 -10000 0 0
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process 0.029 0.037 0.27 1 -10000 0 1
negative regulation of DNA binding 0.022 0.06 0.2 1 -0.21 15 16
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.044 0.02 -10000 0 -10000 0 0
RASA1 0.034 0.012 -10000 0 -10000 0 0
Ajuba/Aurora A 0.016 0.028 -10000 0 -10000 0 0
mitotic prometaphase 0.006 0.024 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.032 0.042 -10000 0 -10000 0 0
TACC1 0.003 0.12 -10000 0 -0.54 23 23
TACC3 0.097 0.075 -10000 0 -10000 0 0
Aurora A/Antizyme1 0.069 0.037 -10000 0 -10000 0 0
Aurora A/RasGAP 0.051 0.036 -10000 0 -10000 0 0
OAZ1 0.034 0.007 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.003 0.027 -10000 0 -10000 0 0
GIT1 0.033 0.011 -10000 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.059 0.044 -10000 0 -10000 0 0
Importin alpha/Importin beta/TPX2 0.11 0.059 -10000 0 -10000 0 0
PPP2R5D 0.034 0.006 -10000 0 -10000 0 0
Aurora A/TPX2 0.11 0.063 0.25 5 -10000 0 5
PAK1 0.044 0.047 -10000 0 -10000 0 0
CKAP5 0.036 0.015 -10000 0 -10000 0 0
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S122.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S122.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 0.033 0.008 -10000 0 -10000 0 0
SMAD2 -0.007 0.05 -10000 0 -0.25 8 8
SMAD3 0.028 0.045 0.29 2 -10000 0 2
SMAD3/SMAD4 0.059 0.065 -10000 0 -0.42 4 4
SMAD4/Ubc9/PIASy 0.059 0.031 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4 0.066 0.073 -10000 0 -0.32 1 1
PPM1A 0.034 0.006 -10000 0 -10000 0 0
CALM1 0.034 0.006 -10000 0 -10000 0 0
SMAD2/SMAD4 0.01 0.056 -10000 0 -0.27 5 5
MAP3K1 0.036 0.046 -10000 0 -0.54 2 2
TRAP-1/SMAD4 0.048 0.019 -10000 0 -0.17 2 2
MAPK3 0.032 0.01 -10000 0 -10000 0 0
MAPK1 0.033 0.009 -10000 0 -10000 0 0
NUP214 0.034 0.005 -10000 0 -10000 0 0
CTDSP1 0.034 0.005 -10000 0 -10000 0 0
CTDSP2 0.034 0.006 -10000 0 -10000 0 0
CTDSPL 0.031 0.036 -10000 0 -0.54 2 2
KPNB1 0.033 0.009 -10000 0 -10000 0 0
TGFBRAP1 0.034 0.004 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
NUP153 0.034 0.006 -10000 0 -10000 0 0
KPNA2 0.06 0.061 -10000 0 -10000 0 0
PIAS4 0.035 0.016 -10000 0 -10000 0 0
BARD1 signaling events

Figure S123.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S123.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 0.048 0.023 -10000 0 -10000 0 0
ATM 0.03 0.012 -10000 0 -10000 0 0
UBE2D3 0.034 0.005 -10000 0 -10000 0 0
PRKDC 0.031 0.019 -10000 0 -10000 0 0
ATR 0.034 0.006 -10000 0 -10000 0 0
UBE2L3 0.032 0.009 -10000 0 -10000 0 0
FANCD2 0.025 0.015 -10000 0 -10000 0 0
protein ubiquitination 0.089 0.059 -10000 0 -10000 0 0
XRCC5 0.034 0.005 -10000 0 -10000 0 0
XRCC6 0.033 0.009 -10000 0 -10000 0 0
M/R/N Complex 0.049 0.033 -10000 0 -10000 0 0
MRE11A 0.031 0.011 -10000 0 -10000 0 0
DNA-PK 0.057 0.031 -10000 0 -10000 0 0
FA complex/FANCD2/Ubiquitin 0.026 0.11 -10000 0 -0.43 15 15
FANCF 0.034 0.006 -10000 0 -10000 0 0
BRCA1 0.036 0.022 -10000 0 -10000 0 0
CCNE1 0.06 0.057 -10000 0 -10000 0 0
CDK2/Cyclin E1 0.069 0.047 0.26 8 -10000 0 8
FANCG 0.034 0.009 -10000 0 -10000 0 0
BRCA1/BACH1/BARD1 0.053 0.025 -10000 0 -10000 0 0
FANCE 0.033 0.027 -10000 0 -0.54 1 1
FANCC 0.036 0.017 0.18 6 -10000 0 6
NBN 0.028 0.016 -10000 0 -10000 0 0
FANCA 0.062 0.066 -10000 0 -10000 0 0
DNA repair 0.075 0.1 0.32 11 -0.38 3 14
BRCA1/BARD1/ubiquitin 0.053 0.025 -10000 0 -10000 0 0
BARD1/DNA-PK 0.073 0.04 -10000 0 -10000 0 0
FANCL 0.034 0.004 -10000 0 -10000 0 0
mRNA polyadenylation -0.048 0.023 -10000 0 -10000 0 0
BRCA1/BARD1/CTIP/M/R/N Complex 0.024 0.074 -10000 0 -0.31 3 3
BRCA1/BACH1/BARD1/TopBP1 0.069 0.029 0.26 1 -10000 0 1
BRCA1/BARD1/P53 0.078 0.039 -10000 0 -10000 0 0
BARD1/CSTF1/BRCA1 0.064 0.033 -10000 0 -10000 0 0
BRCA1/BACH1 0.036 0.022 -10000 0 -10000 0 0
BARD1 0.038 0.023 -10000 0 -10000 0 0
PCNA 0.038 0.027 -10000 0 -10000 0 0
BRCA1/BARD1/UbcH5C 0.069 0.028 -10000 0 -10000 0 0
BRCA1/BARD1/UbcH7 0.066 0.03 -10000 0 -10000 0 0
BRCA1/BARD1/RAD51/PCNA 0.13 0.073 0.36 2 -10000 0 2
BARD1/DNA-PK/P53 0.077 0.051 -10000 0 -10000 0 0
BRCA1/BARD1/Ubiquitin 0.053 0.025 -10000 0 -10000 0 0
BRCA1/BARD1/CTIP 0.048 0.04 -10000 0 -0.31 2 2
FA complex 0.043 0.054 -10000 0 -0.3 2 2
BARD1/EWS 0.05 0.02 -10000 0 -10000 0 0
RBBP8 0.013 0.028 -10000 0 -0.4 2 2
TP53 0.031 0.015 -10000 0 -10000 0 0
TOPBP1 0.035 0.013 0.18 3 -10000 0 3
G1/S transition of mitotic cell cycle -0.075 0.038 -10000 0 -10000 0 0
BRCA1/BARD1 0.097 0.064 -10000 0 -10000 0 0
CSTF1 0.032 0.01 -10000 0 -10000 0 0
BARD1/EWS-Fli1 0.028 0.016 -10000 0 -10000 0 0
CDK2 0.038 0.022 -10000 0 -10000 0 0
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.12 0.075 -10000 0 -10000 0 0
RAD50 0.034 0.006 -10000 0 -10000 0 0
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme 0.053 0.025 -10000 0 -10000 0 0
EWSR1 0.033 0.009 -10000 0 -10000 0 0
Ephrin A reverse signaling

Figure S124.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S124.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade 0.043 0.022 -9999 0 -0.34 1 1
EFNA5 0.033 0.029 -9999 0 -0.54 1 1
FYN 0.017 0.031 -9999 0 -0.31 3 3
neuron projection morphogenesis 0.043 0.022 -9999 0 -0.34 1 1
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 0.044 0.022 -9999 0 -0.34 1 1
EPHA5 0.034 0.005 -9999 0 -10000 0 0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S125.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S125.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A 0.034 0.004 -10000 0 -10000 0 0
oxygen homeostasis 0 0 -10000 0 -10000 0 0
TCEB2 0.032 0.01 -10000 0 -10000 0 0
TCEB1 0.028 0.014 -10000 0 -10000 0 0
HIF1A/p53 0.045 0.06 -10000 0 -0.28 7 7
HIF1A 0.03 0.05 -10000 0 -0.27 6 6
COPS5 0.029 0.013 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 0.072 0.051 -10000 0 -10000 0 0
FIH (dimer) 0.034 0.005 -10000 0 -10000 0 0
CDKN2A 0.054 0.055 -10000 0 -10000 0 0
ARNT/IPAS 0.04 0.021 -10000 0 -10000 0 0
HIF1AN 0.034 0.005 -10000 0 -10000 0 0
GNB2L1 0.034 0.006 -10000 0 -10000 0 0
HIF1A/ARNT 0.033 0.056 -10000 0 -0.27 8 8
CUL2 0.034 0.009 -10000 0 -10000 0 0
OS9 0.034 0.006 -10000 0 -10000 0 0
RACK1/Elongin B/Elongin C 0.053 0.031 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF1A/Hsp90 0.049 0.059 -10000 0 -0.28 7 7
PHD1-3/OS9 0.077 0.06 -10000 0 -0.31 1 1
HIF1A/RACK1/Elongin B/Elongin C 0.058 0.065 -10000 0 -0.27 5 5
VHL 0.036 0.018 -10000 0 -10000 0 0
HSP90AA1 0.034 0.007 -10000 0 -10000 0 0
HIF1A/JAB1 0.039 0.059 -10000 0 -0.28 6 6
EGLN3 0.06 0.065 -10000 0 -0.54 1 1
EGLN2 0.036 0.017 -10000 0 -10000 0 0
EGLN1 0.028 0.014 -10000 0 -10000 0 0
TP53 0.031 0.015 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.044 0.066 -10000 0 -0.46 7 7
ARNT 0.028 0.014 -10000 0 -10000 0 0
ARD1A 0 0 -10000 0 -10000 0 0
RBX1 0.033 0.009 -10000 0 -10000 0 0
HIF1A/p19ARF 0.06 0.069 0.27 3 -0.27 6 9
Rapid glucocorticoid signaling

Figure S126.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S126.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma 0.054 0.036 -10000 0 -0.29 4 4
MAPK9 0.009 0.005 -10000 0 -10000 0 0
adrenocorticotropin secretion 0.01 0.017 0.14 9 -10000 0 9
GNB1/GNG2 0.044 0.021 -10000 0 -0.34 1 1
GNB1 0.034 0.012 -10000 0 -10000 0 0
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.009 0.001 -10000 0 -10000 0 0
Gs family/GTP 0.019 0.025 -10000 0 -0.31 3 3
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0.001 0.006 0.08 3 -10000 0 3
GNAL 0.03 0.044 -10000 0 -0.54 3 3
GNG2 0.033 0.026 -10000 0 -0.54 1 1
CRH 0.031 0.024 -10000 0 -10000 0 0
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.009 0.016 -10000 0 -0.34 1 1
MAPK11 0.009 0.003 -10000 0 -10000 0 0
Arf1 pathway

Figure S127.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S127.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
coatomer protein complex 0.016 0.037 -10000 0 -10000 0 0
EntrezGene:79658 0 0 -10000 0 -10000 0 0
ARF1/GDP/Membrin/GBF1/p115/Brefeldin A 0.034 0.052 -10000 0 -0.17 4 4
AP2 0.049 0.018 0.26 1 -10000 0 1
mol:DAG 0 0 -10000 0 -10000 0 0
Arfaptin 2/Rac/GTP 0.044 0.015 -10000 0 -10000 0 0
CLTB 0.034 0.007 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ER cargo protein 0.018 0.019 -10000 0 -10000 0 0
CD4 0.033 0.009 -10000 0 -10000 0 0
CLTA 0.034 0.006 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 -10000 0 -10000 0 0
ARFGAP1 0.009 0.008 0.14 2 -10000 0 2
mol:PI-4-5-P2 0.009 0.02 -10000 0 -0.19 1 1
ARF1/GTP 0.015 0.014 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1/ER cargo protein 0.012 0.022 0.18 5 -10000 0 5
mol:Choline 0.008 0.02 -10000 0 -0.2 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
ARF1 0.029 0.015 -10000 0 -10000 0 0
DDEF1 0.007 0.02 -10000 0 -0.2 1 1
ARF1/GDP 0.001 0.022 -10000 0 -10000 0 0
AP2M1 0.034 0.009 -10000 0 -10000 0 0
EntrezGene:1313 0 0 -10000 0 -10000 0 0
actin filament polymerization 0.013 0.008 -10000 0 -10000 0 0
Rac/GTP 0.029 0.007 -10000 0 -10000 0 0
ARF1/GTP/GGA3/ARF-GAP1 0.034 0.024 -10000 0 -10000 0 0
ARFIP2 0.021 0.026 -10000 0 -10000 0 0
COPA 0.028 0.014 -10000 0 -10000 0 0
RAC1 0.034 0.005 -10000 0 -10000 0 0
ARF1/GTP/coatomer protein complex 0.017 0.032 -10000 0 -0.2 3 3
ARF1/GTP/ARHGAP10 0.019 0.01 -10000 0 -10000 0 0
GGA3 0.032 0.009 -10000 0 -10000 0 0
ARF1/GTP/Membrin 0.016 0.041 -10000 0 -0.23 9 9
AP2A1 0.035 0.013 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1 0.011 0.032 -10000 0 -0.23 5 5
ARF1/GDP/Membrin 0.019 0.05 -10000 0 -0.24 14 14
Arfaptin 2/Rac/GDP 0.041 0.016 -10000 0 -10000 0 0
CYTH2 -0.001 0.002 -10000 0 -10000 0 0
ARF1/GTP/GGA3 0.034 0.021 -10000 0 -10000 0 0
mol:ATP 0 0 -10000 0 -10000 0 0
Rac/GDP 0.025 0.004 -10000 0 -10000 0 0
mol:Brefeldin A 0 0 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex/Coatomer protein complex/ARF1/GTP 0.025 0.033 -10000 0 -10000 0 0
PLD2 0.008 0.02 -10000 0 -0.2 1 1
ARF-GAP1/v-SNARE 0.009 0.008 0.14 2 -10000 0 2
PIP5K1A 0.009 0.02 -10000 0 -0.19 1 1
ARF1/GTP/Membrin/GBF1/p115 0.015 0.024 -10000 0 -10000 0 0
mol:Phosphatic acid 0 0 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.008 0.02 -10000 0 -0.2 1 1
KDEL Receptor/Ligand/ARF-GAP1 0.009 0.008 0.14 2 -10000 0 2
GOSR2 0.013 0.018 -10000 0 -0.26 1 1
USO1 0.012 0.028 -10000 0 -0.31 3 3
GBF1 0.013 0.02 -10000 0 -0.31 1 1
ARF1/GTP/Arfaptin 2 0.036 0.022 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex 0.062 0.026 0.26 1 -10000 0 1
a4b1 and a4b7 Integrin signaling

Figure S128.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S128.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.034 0.006 -9999 0 -9999 0 0
ITGB7 0.034 0.004 -9999 0 -9999 0 0
ITGA4 0.04 0.03 -9999 0 -9999 0 0
alpha4/beta7 Integrin 0.054 0.023 -9999 0 -9999 0 0
alpha4/beta1 Integrin 0.053 0.023 -9999 0 -9999 0 0
Glypican 2 network

Figure S129.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S129.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK 0.044 0.038 -9999 0 -9999 0 0
GPC2 0 0 -9999 0 -9999 0 0
GPC2/Midkine 0.032 0.027 -9999 0 -9999 0 0
neuron projection morphogenesis 0.032 0.027 -9999 0 -9999 0 0
Sumoylation by RanBP2 regulates transcriptional repression

Figure S130.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S130.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.034 0.006 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.006 0.014 -10000 0 -10000 0 0
MDM2/SUMO1 0.049 0.052 -10000 0 -0.25 3 3
HDAC4 0.034 0.007 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC1 0.006 0.014 -10000 0 -10000 0 0
SUMO1 0.034 0.005 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1 0.016 0.026 -10000 0 -0.29 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
XPO1 0.007 0.034 -10000 0 -0.27 3 3
EntrezGene:23636 0 0 -10000 0 -10000 0 0
RAN 0.034 0.005 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.034 0.004 -10000 0 -10000 0 0
SUMO1/HDAC4 0.051 0.051 -10000 0 -0.25 3 3
SUMO1/HDAC1 0.053 0.05 -10000 0 -0.25 3 3
RANGAP1 0.038 0.03 -10000 0 -10000 0 0
MDM2/SUMO1/SUMO1 0.078 0.031 -10000 0 -10000 0 0
NPC/RanGAP1/SUMO1/RanBP2/Ubc9 0.018 0.02 -10000 0 -0.17 3 3
Ran/GTP 0.036 0.046 -10000 0 -0.26 3 3
EntrezGene:23225 0 0 -10000 0 -10000 0 0
MDM2 0.033 0.01 -10000 0 -10000 0 0
UBE2I 0.032 0.01 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.035 0.05 0.26 2 -0.26 3 5
NPC 0.02 0.002 -10000 0 -10000 0 0
PIAS2 0.033 0.007 -10000 0 -10000 0 0
PIAS1 0.034 0.007 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
Alternative NF-kappaB pathway

Figure S131.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S131.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.048 0.015 -10000 0 -0.16 1 1
FBXW11 0.034 0.007 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0 0 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.034 0.007 -10000 0 -10000 0 0
CHUK 0.034 0.005 -10000 0 -10000 0 0
NF kappa B2 p100/RelB 0.096 0.036 -10000 0 -10000 0 0
NFKB1 0.034 0.005 -10000 0 -10000 0 0
MAP3K14 0.033 0.007 -10000 0 -10000 0 0
NF kappa B1 p50/RelB 0.052 0.017 -10000 0 -10000 0 0
RELB 0.037 0.02 -10000 0 -10000 0 0
NFKB2 0.035 0.012 -10000 0 -10000 0 0
NF kappa B2 p52/RelB 0.048 0.018 0.23 1 -10000 0 1
regulation of B cell activation 0.047 0.018 0.23 1 -10000 0 1
Inferred Pathway Levels Matrix

Table 3.  Get Full Table First 10 out of 7202 rows and 4 out of 513 columns in the PARADIGM inferred pathway levels matrix.

pid_entity TCGA.E2.A1BD TCGA.E2.A1BC TCGA.E2.A1B6 TCGA.E2.A1B5
109_MAP3K5 0.04 0.04 0.095 0.095
47_PPARGC1A 0.035 0.035 0.035 0.18
105_BMP4 0.035 0.035 0.035 0.035
105_BMP6 0.035 0.035 0.035 0.035
105_BMP7 0.035 0.035 0.035 0.035
105_BMP2 0.035 0.035 0.035 0.035
131_RELN/VLDLR 0.09 0.09 -0.31 0.18
30_TGFB1/TGF beta receptor Type II 0.034 0.034 0.034 0.034
84_STAT5B -0.21 -0.0025 -0.029 -0.21
84_STAT5A -0.21 -0.0025 -0.029 -0.21
Methods & Data
Input

  • Expression Data Normalization = Normal controls were used to median center the expression data used in this analysis.

  • mRNA Expression File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_MergeDataFilesPipeline/BRCA-TP/9824371/GDAC_MergeDataFiles_3799172/BRCA-TP.transcriptome__agilentg4502a_07_3__unc_edu__Level_3__unc_lowess_normalization_gene_level__data.data.txt

  • Copy Number File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Gistic2/BRCA-TP/10005885/Gistic2_Analysis_10006113/all_data_by_genes.txt

Data Sets and Pathway Interactions

Both copy number and expression data are incorporated into PARADIGM's inference. Whenever normal tissue controls are available for analysis in the expression data, each patient's gene-value is normalized by subtracting the gene's median level observed in the normal control. Copy number data is also normalized to reflect the difference in copy number between a gene's levels detected in tumor versus control (e.g. blood normal). The collection of pathways used by PARADIGM includes those from NCI-PID on September 15, 2009 containing 131 pathways, 11,563 interactions, and 7,204 entities. All gene identifiers were translated into HUGO standard identifiers wherever possible. We refer to molecular entities as "concepts," which include gene products such as proteins and miRNAs, small molecules, protein complexes, and abstract concepts. Each concept is represented as "node" in PARADIGM's graphical model. The abstract concepts correspond to general cellular processes (such as "apoptosis" or "DNA damage response") and families of genes that share functional activity such as the RAS family of signal transducers. Various types of concept-concept interactions are included in the pathways including protein-protein interactions, transcriptional regulatory interactions, and protein modifications such as phosphorylation and ubiquitinylation interactions.

Pathway Inference Method

The PARADIGM algorithm (described in PMID: 20529912) assigns an integrated pathway level (IPL) reflecting the activity of a concept determined through a belief propagation strategy. The belief propagation is given the copy number and gene expression measurements of all of the genes and iteratively updates hidden states reflecting the activities of all of the genes in a pathway so as to maximize the likelihood of the observed data given the interactions in the pathway. In the end, the inferred level of a concept reflects both the data observed for the concept and the neighborhood of activity surrounding the concept.

Determining significantly altered levels

The significance of the IPL obtained for each concept in each patient sample is assessed using a permutation analysis. Importantly, the permutation analysis preserves data tuples so as to preserve any implicit correlations between the different data modalities. For example, genes that are deleted have concomitantly lower expression levels. Preserving the copy number and expression pairs therefore retains this data property. The simulation therefore makes "null samples" by permuting data tuples across all of the genes in the genome so that each gene in a null sample is associated with a random tuple of another gene with equal probability. This approach has the added benefit of preserving the pathway structure so that every observed IPL can be compared to a distribution of random IPLs derived from exactly the same interaction context. PARADIGM inferences are then obtained for 1000 "null" patients and serve as a background distribution to contrast the observed IPLs against. Pathway concepts are excluded from further analysis if they did not obtain a minimum IPL of 0.5 in any patient sample both observed or simulated.

An IPL I(i,j) for concept i in sample j, is considered to be deviated if its absolute level is two standard deviations from the average level observed for concept i in the 1000 null samples. The degree to which a concept has significantly altered levels across a patient cohort is summarized in the proportion of deviated samples (PDS) score. For example, a protein with a PDS of 0.10 reflects that the protein's level of activity was inferred to be significantly higher or lower in tumors compared to normal in 10% of the patient samples. An average PDS for a pathway is also reported by computing the mean PDS over all concepts in the pathway.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[2] Charles J. Vaske, Stephen C. Benz, J. Zachary Sanborn, Dent Earl, Christopher Szeto, Jingchun Zhu, David Haussler, and Joshua M. Stuart, Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, Bioinformatics 12(26):237-245 (2010)
Copyright © 2014 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle